report_id,medication,side_effect,report_date,age_group,gender,region,outcome
FAERS-10000,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-11-24,18-44,Male,USA,Not specified
FAERS-10001,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-01-18,45-64,Male,USA,Disability
FAERS-10002,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-01-25,45-64,Male,USA,Not specified
FAERS-10003,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2021-02-13,45-64,Male,Other,Hospitalization
FAERS-10004,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-07-03,45-64,Female,Europe,Other
FAERS-10005,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2023-01-22,45-64,Female,USA,Disability
FAERS-10006,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-11-27,18-44,Male,USA,Other
FAERS-10007,LIRAGLUTIDE (SAXENDA),GALLBLADDER DISEASE,2019-11-06,45-64,Female,Europe,Other
FAERS-10008,LIRAGLUTIDE (VICTOZA),DIARRHEA,2022-11-11,45-64,Unknown,USA,Not specified
FAERS-10009,TIRZEPATIDE (ZEPBOUND),CONSTIPATION,2020-10-23,18-44,Male,USA,Other
FAERS-10010,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-04-24,45-64,Female,USA,Other
FAERS-10011,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2020-03-17,45-64,Female,USA,Other
FAERS-10012,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-10-03,65-74,Male,USA,Other
FAERS-10013,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-11-24,45-64,Male,USA,Hospitalization
FAERS-10014,SEMAGLUTIDE (WEGOVY),ASPIRATION,2021-03-15,65-74,Female,USA,Hospitalization
FAERS-10015,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2022-02-28,65-74,Unknown,Europe,Other
FAERS-10016,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2020-09-01,45-64,Male,USA,Other
FAERS-10017,DULAGLUTIDE (TRULICITY),NAUSEA,2021-01-08,75-84,Female,Europe,Not specified
FAERS-10018,TIRZEPATIDE (ZEPBOUND),VOMITING,2023-03-22,45-64,Male,Europe,Other
FAERS-10019,EXENATIDE (BYETTA),DIARRHEA,2023-12-23,45-64,Female,Other,Disability
FAERS-10020,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-02-08,Unknown,Female,USA,Disability
FAERS-10021,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2019-11-02,45-64,Male,USA,Disability
FAERS-10022,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2022-04-18,65-74,Male,USA,Hospitalization
FAERS-10023,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-04-04,45-64,Female,Europe,Hospitalization
FAERS-10024,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-11-04,45-64,Female,Europe,Hospitalization
FAERS-10025,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2022-03-14,65-74,Male,USA,Death
FAERS-10026,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-02-02,65-74,Male,Europe,Other
FAERS-10027,EXENATIDE (BYETTA),SUICIDAL IDEATION,2020-08-16,85+,Female,Europe,Disability
FAERS-10028,DULAGLUTIDE (TRULICITY),ASPIRATION,2023-08-10,18-44,Male,USA,Other
FAERS-10029,EXENATIDE (BYDUREON),THYROID NEOPLASM,2021-01-19,45-64,Female,USA,Other
FAERS-10030,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-09-06,45-64,Male,USA,Hospitalization
FAERS-10031,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-07-04,65-74,Male,USA,Not specified
FAERS-10032,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-10-17,45-64,Male,USA,Other
FAERS-10033,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2020-11-10,45-64,Male,USA,Other
FAERS-10034,SEMAGLUTIDE (WEGOVY),ASPIRATION,2022-02-03,75-84,Male,USA,Other
FAERS-10035,TIRZEPATIDE (MOUNJARO),FATIGUE,2020-05-06,18-44,Male,USA,Other
FAERS-10036,TIRZEPATIDE (MOUNJARO),HEADACHE,2022-11-27,45-64,Unknown,Europe,Other
FAERS-10037,EXENATIDE (BYDUREON),VOMITING,2023-03-09,65-74,Male,Canada,Other
FAERS-10038,LIRAGLUTIDE (VICTOZA),INJECTION SITE REACTION,2022-01-03,18-44,Female,USA,Other
FAERS-10039,LIRAGLUTIDE (SAXENDA),NAUSEA,2020-08-18,45-64,Male,Other,Other
FAERS-10040,SEMAGLUTIDE (OZEMPIC),HEADACHE,2020-01-27,18-44,Female,Europe,Other
FAERS-10041,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-01-12,45-64,Male,USA,Disability
FAERS-10042,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-10-24,18-44,Female,Canada,Life-threatening
FAERS-10043,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-01-06,65-74,Unknown,Europe,Other
FAERS-10044,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-05-06,75-84,Female,Canada,Other
FAERS-10045,TIRZEPATIDE (MOUNJARO),VOMITING,2023-08-12,65-74,Female,USA,Other
FAERS-10046,TIRZEPATIDE (MOUNJARO),ALOPECIA,2021-02-25,18-44,Male,USA,Other
FAERS-10047,EXENATIDE (BYDUREON),FATIGUE,2018-05-06,45-64,Female,USA,Other
FAERS-10048,LIRAGLUTIDE (SAXENDA),NAUSEA,2021-09-04,45-64,Male,Europe,Other
FAERS-10049,EXENATIDE (BYETTA),CONSTIPATION,2023-11-24,18-44,Female,USA,Not specified
FAERS-10050,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-10-11,18-44,Female,Australia,Other
FAERS-10051,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2021-12-10,65-74,Female,Europe,Other
FAERS-10052,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2020-10-10,45-64,Female,Europe,Other
FAERS-10053,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-06-15,45-64,Male,Europe,Other
FAERS-10054,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-11-03,45-64,Female,Other,Other
FAERS-10055,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2020-05-08,45-64,Male,Other,Not specified
FAERS-10056,TIRZEPATIDE (MOUNJARO),DIARRHEA,2023-08-14,18-44,Unknown,USA,Not specified
FAERS-10057,EXENATIDE (BYETTA),CONSTIPATION,2022-01-25,45-64,Female,USA,Not specified
FAERS-10058,TIRZEPATIDE (ZEPBOUND),ALOPECIA,2022-09-08,18-44,Female,Europe,Not specified
FAERS-10059,TIRZEPATIDE (ZEPBOUND),HYPOGLYCEMIA,2022-08-20,65-74,Female,Other,Not specified
FAERS-10060,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2020-08-15,45-64,Female,USA,Other
FAERS-10061,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-05-15,45-64,Female,USA,Hospitalization
FAERS-10062,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2020-04-13,45-64,Male,USA,Other
FAERS-10063,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2021-04-27,18-44,Female,USA,Other
FAERS-10064,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-07-16,45-64,Female,Canada,Hospitalization
FAERS-10065,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2021-12-24,65-74,Female,Other,Other
FAERS-10066,TIRZEPATIDE (MOUNJARO),DIZZINESS,2018-06-22,18-44,Male,USA,Other
FAERS-10067,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2022-07-19,65-74,Female,Other,Other
FAERS-10068,TIRZEPATIDE (ZEPBOUND),VOMITING,2021-06-07,45-64,Female,USA,Other
FAERS-10069,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2021-02-16,45-64,Female,Europe,Hospitalization
FAERS-10070,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-11-02,Unknown,Male,Europe,Other
FAERS-10071,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2019-11-04,18-44,Male,USA,Other
FAERS-10072,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-12-23,45-64,Female,USA,Hospitalization
FAERS-10073,SEMAGLUTIDE (WEGOVY),ALOPECIA,2021-11-13,85+,Male,USA,Other
FAERS-10074,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2019-05-28,18-44,Female,USA,Other
FAERS-10075,TIRZEPATIDE (MOUNJARO),ALOPECIA,2022-11-12,65-74,Female,USA,Hospitalization
FAERS-10076,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2021-06-21,18-44,Female,USA,Not specified
FAERS-10077,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2021-09-25,45-64,Female,Other,Other
FAERS-10078,DULAGLUTIDE (TRULICITY),SUICIDAL IDEATION,2023-05-15,45-64,Male,USA,Other
FAERS-10079,DULAGLUTIDE (TRULICITY),HEADACHE,2021-08-07,45-64,Male,USA,Other
FAERS-10080,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-09-07,45-64,Female,Canada,Hospitalization
FAERS-10081,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-08-15,45-64,Female,Europe,Other
FAERS-10082,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-08-18,18-44,Female,USA,Other
FAERS-10083,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2021-05-08,65-74,Male,Europe,Hospitalization
FAERS-10084,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2020-04-24,18-44,Female,Europe,Other
FAERS-10085,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2019-04-10,Unknown,Female,USA,Disability
FAERS-10086,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2023-09-10,18-44,Female,USA,Other
FAERS-10087,LIRAGLUTIDE (VICTOZA),DIZZINESS,2021-08-15,65-74,Male,USA,Other
FAERS-10088,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2022-10-21,65-74,Male,USA,Other
FAERS-10089,LIRAGLUTIDE (VICTOZA),DIARRHEA,2019-07-20,45-64,Male,Other,Other
FAERS-10090,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-10-14,65-74,Female,Japan,Other
FAERS-10091,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2020-04-09,45-64,Female,Australia,Other
FAERS-10092,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-10-16,18-44,Male,USA,Other
FAERS-10093,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2022-05-26,45-64,Female,USA,Other
FAERS-10094,SEMAGLUTIDE (WEGOVY),DIZZINESS,2020-03-09,65-74,Male,USA,Not specified
FAERS-10095,TIRZEPATIDE (MOUNJARO),VOMITING,2022-05-15,18-44,Male,Europe,Hospitalization
FAERS-10096,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2022-02-20,45-64,Female,USA,Hospitalization
FAERS-10097,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2022-10-19,45-64,Male,USA,Not specified
FAERS-10098,EXENATIDE (BYDUREON),ALOPECIA,2022-08-09,45-64,Female,USA,Death
FAERS-10099,EXENATIDE (BYETTA),HYPOGLYCEMIA,2021-06-22,65-74,Female,USA,Hospitalization
FAERS-10100,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2021-09-02,45-64,Female,Europe,Other
FAERS-10101,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-01-22,45-64,Unknown,USA,Not specified
FAERS-10102,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-08-25,18-44,Female,USA,Hospitalization
FAERS-10103,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2022-01-21,18-44,Male,Canada,Other
FAERS-10104,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2019-02-15,18-44,Female,USA,Not specified
FAERS-10105,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-07-27,18-44,Female,USA,Other
FAERS-10106,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-12-05,45-64,Male,USA,Not specified
FAERS-10107,LIRAGLUTIDE (SAXENDA),ALOPECIA,2021-01-10,65-74,Male,Europe,Other
FAERS-10108,EXENATIDE (BYETTA),HEADACHE,2022-06-18,45-64,Female,USA,Other
FAERS-10109,DULAGLUTIDE (TRULICITY),HYPOGLYCEMIA,2022-04-28,45-64,Male,Europe,Other
FAERS-10110,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-11-26,65-74,Female,Europe,Not specified
FAERS-10111,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-02-28,45-64,Male,USA,Not specified
FAERS-10112,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-03-03,75-84,Male,USA,Other
FAERS-10113,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-11-28,45-64,Female,USA,Other
FAERS-10114,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2022-10-03,45-64,Female,USA,Disability
FAERS-10115,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-11-23,45-64,Male,USA,Not specified
FAERS-10116,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-05-12,45-64,Female,USA,Other
FAERS-10117,LIRAGLUTIDE (VICTOZA),ABDOMINAL PAIN,2020-10-28,45-64,Female,USA,Other
FAERS-10118,EXENATIDE (BYDUREON),ABDOMINAL PAIN,2021-05-22,75-84,Male,USA,Hospitalization
FAERS-10119,DULAGLUTIDE (TRULICITY),ASPIRATION,2021-10-10,45-64,Male,USA,Other
FAERS-10120,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-08-04,18-44,Female,USA,Disability
FAERS-10121,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-11-13,45-64,Unknown,USA,Other
FAERS-10122,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-08-27,45-64,Female,USA,Not specified
FAERS-10123,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2022-10-09,65-74,Female,USA,Other
FAERS-10124,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2023-11-02,45-64,Female,USA,Other
FAERS-10125,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2021-12-14,45-64,Female,USA,Life-threatening
FAERS-10126,TIRZEPATIDE (MOUNJARO),DIARRHEA,2023-03-09,45-64,Unknown,USA,Not specified
FAERS-10127,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2022-02-05,45-64,Female,Europe,Other
FAERS-10128,LIRAGLUTIDE (VICTOZA),SUICIDAL IDEATION,2023-06-03,65-74,Unknown,Other,Other
FAERS-10129,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2021-07-27,18-44,Female,Europe,Other
FAERS-10130,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-06-20,45-64,Female,USA,Disability
FAERS-10131,SEMAGLUTIDE (OZEMPIC),VOMITING,2021-03-02,65-74,Female,USA,Not specified
FAERS-10132,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2020-08-12,45-64,Male,Canada,Other
FAERS-10133,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2020-07-21,75-84,Female,Europe,Hospitalization
FAERS-10134,SEMAGLUTIDE (WEGOVY),FATIGUE,2021-08-15,45-64,Female,USA,Not specified
FAERS-10135,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2023-06-02,18-44,Female,USA,Other
FAERS-10136,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2022-11-21,18-44,Female,USA,Other
FAERS-10137,TIRZEPATIDE (ZEPBOUND),NAUSEA,2020-09-07,45-64,Unknown,Europe,Other
FAERS-10138,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2023-03-05,18-44,Female,USA,Other
FAERS-10139,LIRAGLUTIDE (VICTOZA),VOMITING,2023-10-11,65-74,Male,USA,Hospitalization
FAERS-10140,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2019-08-25,18-44,Female,USA,Other
FAERS-10141,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-11-17,45-64,Male,USA,Other
FAERS-10142,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-02-16,18-44,Unknown,Europe,Other
FAERS-10143,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2019-10-21,65-74,Male,USA,Other
FAERS-10144,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2022-07-04,45-64,Female,USA,Other
FAERS-10145,TIRZEPATIDE (MOUNJARO),VOMITING,2023-07-15,45-64,Female,USA,Not specified
FAERS-10146,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2021-06-22,65-74,Female,Europe,Other
FAERS-10147,LIRAGLUTIDE (VICTOZA),DECREASED APPETITE,2021-12-24,45-64,Male,USA,Other
FAERS-10148,LIRAGLUTIDE (VICTOZA),HEADACHE,2019-06-28,45-64,Female,USA,Other
FAERS-10149,DULAGLUTIDE (TRULICITY),SUICIDAL IDEATION,2021-10-17,65-74,Female,USA,Disability
FAERS-10150,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-05-19,18-44,Male,Europe,Disability
FAERS-10151,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-09-01,45-64,Female,USA,Other
FAERS-10152,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-06-12,45-64,Male,USA,Hospitalization
FAERS-10153,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-01-03,45-64,Female,USA,Other
FAERS-10154,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-10-20,45-64,Male,USA,Hospitalization
FAERS-10155,TIRZEPATIDE (MOUNJARO),NAUSEA,2021-11-14,18-44,Female,Europe,Other
FAERS-10156,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2021-05-22,45-64,Female,USA,Other
FAERS-10157,DULAGLUTIDE (TRULICITY),FATIGUE,2019-04-10,45-64,Male,Other,Not specified
FAERS-10158,LIRAGLUTIDE (VICTOZA),INJECTION SITE REACTION,2021-03-13,45-64,Male,USA,Other
FAERS-10159,LIRAGLUTIDE (VICTOZA),FATIGUE,2023-01-14,65-74,Female,USA,Hospitalization
FAERS-10160,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-07-10,65-74,Female,USA,Hospitalization
FAERS-10161,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-06-03,45-64,Female,USA,Other
FAERS-10162,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-12-11,45-64,Female,USA,Disability
FAERS-10163,SEMAGLUTIDE (WEGOVY),ALOPECIA,2020-06-12,18-44,Female,USA,Other
FAERS-10164,SEMAGLUTIDE (WEGOVY),ALOPECIA,2020-10-05,65-74,Male,USA,Other
FAERS-10165,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-10-15,18-44,Female,USA,Other
FAERS-10166,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2023-06-05,45-64,Unknown,USA,Other
FAERS-10167,DULAGLUTIDE (TRULICITY),HYPOGLYCEMIA,2022-05-15,45-64,Male,USA,Other
FAERS-10168,TIRZEPATIDE (ZEPBOUND),GALLBLADDER DISEASE,2019-10-17,45-64,Female,Other,Other
FAERS-10169,EXENATIDE (BYETTA),HEADACHE,2023-11-07,65-74,Female,USA,Other
FAERS-10170,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-06-23,18-44,Male,USA,Hospitalization
FAERS-10171,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-10-06,18-44,Female,Other,Other
FAERS-10172,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2019-11-21,45-64,Female,Europe,Other
FAERS-10173,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-10-28,45-64,Female,USA,Life-threatening
FAERS-10174,SEMAGLUTIDE (WEGOVY),VOMITING,2022-11-13,45-64,Female,USA,Hospitalization
FAERS-10175,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2021-03-22,18-44,Female,USA,Other
FAERS-10176,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-09-12,Unknown,Female,USA,Hospitalization
FAERS-10177,LIRAGLUTIDE (SAXENDA),CONSTIPATION,2020-03-05,18-44,Female,USA,Hospitalization
FAERS-10178,TIRZEPATIDE (ZEPBOUND),FATIGUE,2022-10-05,45-64,Female,USA,Other
FAERS-10179,LIRAGLUTIDE (VICTOZA),DIARRHEA,2020-08-02,65-74,Female,Europe,Other
FAERS-10180,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-08-08,18-44,Female,USA,Other
FAERS-10181,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2021-10-15,65-74,Female,Europe,Other
FAERS-10182,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-10-05,45-64,Female,Other,Not specified
FAERS-10183,SEMAGLUTIDE (WEGOVY),NAUSEA,2023-09-28,45-64,Female,Australia,Hospitalization
FAERS-10184,SEMAGLUTIDE (WEGOVY),VOMITING,2023-02-08,18-44,Female,USA,Not specified
FAERS-10185,TIRZEPATIDE (MOUNJARO),ASPIRATION,2021-07-03,75-84,Female,USA,Other
FAERS-10186,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-03-02,75-84,Female,USA,Other
FAERS-10187,DULAGLUTIDE (TRULICITY),DECREASED APPETITE,2018-02-01,18-44,Female,USA,Other
FAERS-10188,LIRAGLUTIDE (VICTOZA),HEADACHE,2021-05-04,65-74,Female,USA,Hospitalization
FAERS-10189,DULAGLUTIDE (TRULICITY),DIZZINESS,2022-09-01,45-64,Male,Europe,Other
FAERS-10190,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-10-14,65-74,Male,USA,Death
FAERS-10191,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-09-18,45-64,Female,Other,Hospitalization
FAERS-10192,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-06-26,18-44,Female,USA,Hospitalization
FAERS-10193,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2023-03-02,45-64,Male,USA,Other
FAERS-10194,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-08-21,45-64,Female,Europe,Death
FAERS-10195,TIRZEPATIDE (MOUNJARO),DIARRHEA,2020-04-02,65-74,Female,USA,Other
FAERS-10196,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2018-11-07,45-64,Female,USA,Other
FAERS-10197,TIRZEPATIDE (ZEPBOUND),SUICIDAL IDEATION,2023-12-15,45-64,Male,USA,Not specified
FAERS-10198,DULAGLUTIDE (TRULICITY),PANCREATITIS,2023-05-26,18-44,Female,USA,Hospitalization
FAERS-10199,DULAGLUTIDE (TRULICITY),VOMITING,2021-02-11,45-64,Female,USA,Other
FAERS-10200,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2021-01-24,45-64,Female,Europe,Not specified
FAERS-10201,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-02-22,Unknown,Male,Other,Other
FAERS-10202,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2020-10-22,65-74,Female,Other,Other
FAERS-10203,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-10-02,18-44,Female,USA,Other
FAERS-10204,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2022-09-12,75-84,Female,Europe,Other
FAERS-10205,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2022-07-18,18-44,Male,Europe,Hospitalization
FAERS-10206,TIRZEPATIDE (MOUNJARO),ALOPECIA,2022-08-07,45-64,Male,USA,Hospitalization
FAERS-10207,TIRZEPATIDE (ZEPBOUND),HYPOGLYCEMIA,2022-06-22,65-74,Female,USA,Other
FAERS-10208,TIRZEPATIDE (ZEPBOUND),HEADACHE,2023-12-21,45-64,Male,USA,Life-threatening
FAERS-10209,LIRAGLUTIDE (SAXENDA),FATIGUE,2023-01-12,18-44,Male,USA,Other
FAERS-10210,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2019-05-13,65-74,Female,USA,Not specified
FAERS-10211,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2019-06-21,45-64,Female,Europe,Hospitalization
FAERS-10212,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-10-06,45-64,Male,Europe,Other
FAERS-10213,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-05-06,45-64,Female,Europe,Life-threatening
FAERS-10214,SEMAGLUTIDE (WEGOVY),ASPIRATION,2021-02-09,18-44,Female,USA,Disability
FAERS-10215,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2019-11-06,45-64,Female,USA,Other
FAERS-10216,TIRZEPATIDE (MOUNJARO),HEADACHE,2021-10-02,18-44,Female,Japan,Not specified
FAERS-10217,TIRZEPATIDE (ZEPBOUND),VOMITING,2020-10-14,75-84,Female,USA,Other
FAERS-10218,TIRZEPATIDE (ZEPBOUND),FATIGUE,2022-11-13,45-64,Male,Other,Other
FAERS-10219,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2021-03-11,18-44,Female,USA,Not specified
FAERS-10220,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-09-18,Unknown,Male,USA,Hospitalization
FAERS-10221,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2019-07-28,18-44,Female,USA,Other
FAERS-10222,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-06-07,65-74,Male,USA,Other
FAERS-10223,SEMAGLUTIDE (WEGOVY),FATIGUE,2018-07-17,45-64,Female,USA,Other
FAERS-10224,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2022-11-22,45-64,Male,USA,Other
FAERS-10225,TIRZEPATIDE (MOUNJARO),HEADACHE,2023-07-12,65-74,Female,Canada,Hospitalization
FAERS-10226,TIRZEPATIDE (MOUNJARO),NAUSEA,2021-08-25,45-64,Female,USA,Other
FAERS-10227,EXENATIDE (BYETTA),DECREASED APPETITE,2023-06-18,18-44,Unknown,USA,Not specified
FAERS-10228,LIRAGLUTIDE (VICTOZA),CONSTIPATION,2020-06-26,45-64,Female,USA,Other
FAERS-10229,DULAGLUTIDE (TRULICITY),DIARRHEA,2021-07-20,65-74,Male,Australia,Other
FAERS-10230,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-05-16,45-64,Female,USA,Not specified
FAERS-10231,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-12-28,45-64,Unknown,USA,Other
FAERS-10232,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-10-08,45-64,Female,Europe,Other
FAERS-10233,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-03-27,18-44,Female,USA,Other
FAERS-10234,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-03-14,75-84,Male,USA,Other
FAERS-10235,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-01-23,65-74,Female,Canada,Hospitalization
FAERS-10236,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2021-03-15,45-64,Female,USA,Not specified
FAERS-10237,LIRAGLUTIDE (SAXENDA),HEADACHE,2023-05-20,45-64,Female,Europe,Other
FAERS-10238,LIRAGLUTIDE (VICTOZA),ABDOMINAL PAIN,2023-12-07,45-64,Female,Other,Other
FAERS-10239,DULAGLUTIDE (TRULICITY),PANCREATITIS,2021-02-19,45-64,Female,Europe,Other
FAERS-10240,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-05-02,Unknown,Female,Other,Other
FAERS-10241,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-04-27,45-64,Female,USA,Other
FAERS-10242,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2022-04-02,45-64,Male,USA,Other
FAERS-10243,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-02-22,45-64,Male,USA,Other
FAERS-10244,SEMAGLUTIDE (WEGOVY),NAUSEA,2023-08-16,45-64,Female,USA,Other
FAERS-10245,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-11-19,45-64,Male,USA,Disability
FAERS-10246,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2021-03-02,65-74,Male,Japan,Not specified
FAERS-10247,DULAGLUTIDE (TRULICITY),ALOPECIA,2021-01-01,18-44,Female,Canada,Other
FAERS-10248,EXENATIDE (BYETTA),VOMITING,2022-08-05,Unknown,Male,Other,Not specified
FAERS-10249,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2022-12-06,65-74,Male,Europe,Hospitalization
FAERS-10250,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-11-13,45-64,Female,USA,Not specified
FAERS-10251,SEMAGLUTIDE (OZEMPIC),FATIGUE,2020-06-08,18-44,Female,USA,Hospitalization
FAERS-10252,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-10-01,45-64,Male,USA,Other
FAERS-10253,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2020-11-17,18-44,Female,USA,Not specified
FAERS-10254,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-06-20,65-74,Female,USA,Disability
FAERS-10255,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2021-12-18,45-64,Female,Other,Not specified
FAERS-10256,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2022-10-28,65-74,Female,Europe,Other
FAERS-10257,EXENATIDE (BYETTA),HYPOGLYCEMIA,2019-09-17,45-64,Male,USA,Disability
FAERS-10258,EXENATIDE (BYETTA),DIARRHEA,2020-10-16,45-64,Female,USA,Hospitalization
FAERS-10259,EXENATIDE (BYETTA),HYPOGLYCEMIA,2022-09-15,18-44,Male,USA,Other
FAERS-10260,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2020-02-02,18-44,Male,USA,Other
FAERS-10261,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-08-02,45-64,Male,Canada,Other
FAERS-10262,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-06-13,18-44,Female,Europe,Other
FAERS-10263,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-03-21,45-64,Male,Other,Not specified
FAERS-10264,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-01-25,Unknown,Female,USA,Hospitalization
FAERS-10265,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-04-15,45-64,Female,USA,Other
FAERS-10266,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2023-07-20,75-84,Female,USA,Other
FAERS-10267,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2022-01-08,18-44,Female,USA,Other
FAERS-10268,DULAGLUTIDE (TRULICITY),HYPOGLYCEMIA,2020-05-08,45-64,Female,Europe,Not specified
FAERS-10269,EXENATIDE (BYDUREON),HEADACHE,2020-03-22,45-64,Female,Europe,Other
FAERS-10270,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-03-21,45-64,Female,USA,Other
FAERS-10271,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-09-11,18-44,Male,USA,Other
FAERS-10272,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2020-04-10,45-64,Male,USA,Not specified
FAERS-10273,SEMAGLUTIDE (WEGOVY),DIARRHEA,2021-09-05,45-64,Male,USA,Other
FAERS-10274,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-09-24,45-64,Male,USA,Not specified
FAERS-10275,TIRZEPATIDE (MOUNJARO),NAUSEA,2019-10-24,45-64,Female,USA,Other
FAERS-10276,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2023-04-07,18-44,Female,USA,Not specified
FAERS-10277,TIRZEPATIDE (ZEPBOUND),INJECTION SITE REACTION,2023-07-08,65-74,Female,Europe,Other
FAERS-10278,LIRAGLUTIDE (SAXENDA),GALLBLADDER DISEASE,2022-08-15,45-64,Female,USA,Hospitalization
FAERS-10279,EXENATIDE (BYDUREON),HYPOGLYCEMIA,2021-10-28,65-74,Female,USA,Disability
FAERS-10280,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2021-03-07,45-64,Female,USA,Other
FAERS-10281,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-05-25,65-74,Female,Europe,Not specified
FAERS-10282,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-03-05,45-64,Female,USA,Other
FAERS-10283,SEMAGLUTIDE (WEGOVY),FATIGUE,2019-01-27,75-84,Female,USA,Not specified
FAERS-10284,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-04-03,45-64,Female,USA,Other
FAERS-10285,TIRZEPATIDE (MOUNJARO),NAUSEA,2022-10-16,45-64,Female,USA,Other
FAERS-10286,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-09-10,45-64,Female,USA,Hospitalization
FAERS-10287,EXENATIDE (BYDUREON),DECREASED APPETITE,2019-03-08,65-74,Female,USA,Disability
FAERS-10288,EXENATIDE (BYETTA),ABDOMINAL PAIN,2023-08-19,45-64,Female,USA,Other
FAERS-10289,EXENATIDE (BYDUREON),CONSTIPATION,2023-01-03,45-64,Female,Europe,Other
FAERS-10290,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2019-07-21,45-64,Female,Europe,Other
FAERS-10291,SEMAGLUTIDE (OZEMPIC),HEADACHE,2018-04-28,65-74,Male,USA,Other
FAERS-10292,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-09-19,45-64,Female,Europe,Other
FAERS-10293,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2020-12-27,65-74,Male,USA,Other
FAERS-10294,SEMAGLUTIDE (WEGOVY),VOMITING,2021-09-11,18-44,Male,Europe,Other
FAERS-10295,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-06-02,65-74,Female,USA,Hospitalization
FAERS-10296,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2022-06-01,18-44,Female,USA,Other
FAERS-10297,DULAGLUTIDE (TRULICITY),FATIGUE,2022-11-13,45-64,Female,USA,Hospitalization
FAERS-10298,EXENATIDE (BYETTA),PANCREATITIS,2021-11-05,18-44,Male,USA,Other
FAERS-10299,LIRAGLUTIDE (SAXENDA),GALLBLADDER DISEASE,2023-02-05,18-44,Female,USA,Hospitalization
FAERS-10300,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2019-09-03,45-64,Female,USA,Other
FAERS-10301,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-12-18,65-74,Male,USA,Not specified
FAERS-10302,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2020-05-09,45-64,Male,USA,Other
FAERS-10303,SEMAGLUTIDE (WEGOVY),VOMITING,2019-05-08,45-64,Female,USA,Other
FAERS-10304,SEMAGLUTIDE (WEGOVY),FATIGUE,2018-07-11,45-64,Female,USA,Not specified
FAERS-10305,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-11-20,65-74,Female,USA,Hospitalization
FAERS-10306,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-06-10,75-84,Male,USA,Other
FAERS-10307,EXENATIDE (BYDUREON),FATIGUE,2023-07-12,45-64,Male,USA,Hospitalization
FAERS-10308,EXENATIDE (BYETTA),CONSTIPATION,2018-12-15,Unknown,Male,Europe,Not specified
FAERS-10309,LIRAGLUTIDE (VICTOZA),HYPOGLYCEMIA,2023-07-22,45-64,Female,Europe,Other
FAERS-10310,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-02-15,18-44,Female,Europe,Not specified
FAERS-10311,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-09-02,45-64,Female,Japan,Other
FAERS-10312,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2019-04-22,65-74,Female,USA,Other
FAERS-10313,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-06-26,45-64,Female,USA,Other
FAERS-10314,SEMAGLUTIDE (WEGOVY),NAUSEA,2022-10-08,18-44,Female,USA,Other
FAERS-10315,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2021-01-16,65-74,Female,USA,Hospitalization
FAERS-10316,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2020-05-11,85+,Male,Australia,Other
FAERS-10317,LIRAGLUTIDE (VICTOZA),FATIGUE,2022-02-10,45-64,Male,Europe,Hospitalization
FAERS-10318,EXENATIDE (BYDUREON),VOMITING,2020-12-08,65-74,Female,Europe,Other
FAERS-10319,EXENATIDE (BYETTA),DIARRHEA,2021-03-06,45-64,Female,USA,Other
FAERS-10320,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-07-01,18-44,Female,USA,Other
FAERS-10321,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2019-09-06,65-74,Female,USA,Other
FAERS-10322,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-06-20,18-44,Female,USA,Other
FAERS-10323,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2020-11-23,18-44,Female,USA,Not specified
FAERS-10324,SEMAGLUTIDE (WEGOVY),ASPIRATION,2020-02-06,45-64,Female,USA,Other
FAERS-10325,TIRZEPATIDE (MOUNJARO),DIARRHEA,2021-08-21,45-64,Female,USA,Other
FAERS-10326,TIRZEPATIDE (MOUNJARO),ASPIRATION,2021-03-11,75-84,Male,USA,Not specified
FAERS-10327,EXENATIDE (BYETTA),NAUSEA,2023-09-17,45-64,Male,USA,Other
FAERS-10328,DULAGLUTIDE (TRULICITY),DECREASED APPETITE,2019-01-26,45-64,Female,USA,Other
FAERS-10329,LIRAGLUTIDE (SAXENDA),NAUSEA,2022-08-18,18-44,Male,Europe,Other
FAERS-10330,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-01-25,45-64,Female,Other,Other
FAERS-10331,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-05-28,Unknown,Male,Europe,Not specified
FAERS-10332,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-04-07,45-64,Female,USA,Not specified
FAERS-10333,SEMAGLUTIDE (WEGOVY),HEADACHE,2020-03-26,45-64,Female,USA,Disability
FAERS-10334,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2022-06-23,18-44,Female,USA,Other
FAERS-10335,TIRZEPATIDE (MOUNJARO),HEADACHE,2023-03-25,75-84,Female,Japan,Other
FAERS-10336,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-04-05,Unknown,Female,USA,Other
FAERS-10337,LIRAGLUTIDE (VICTOZA),INJECTION SITE REACTION,2021-07-13,45-64,Female,USA,Other
FAERS-10338,EXENATIDE (BYDUREON),ALOPECIA,2022-06-15,65-74,Female,Europe,Not specified
FAERS-10339,LIRAGLUTIDE (SAXENDA),HEADACHE,2023-11-22,65-74,Female,USA,Other
FAERS-10340,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-08-09,65-74,Female,Other,Other
FAERS-10341,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-11-25,45-64,Male,Canada,Hospitalization
FAERS-10342,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-08-15,65-74,Female,USA,Hospitalization
FAERS-10343,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2022-03-28,18-44,Female,USA,Not specified
FAERS-10344,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2023-03-02,45-64,Male,USA,Other
FAERS-10345,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-01-07,45-64,Male,Europe,Other
FAERS-10346,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-02-28,18-44,Female,USA,Other
FAERS-10347,LIRAGLUTIDE (VICTOZA),FATIGUE,2019-06-10,18-44,Male,Europe,Hospitalization
FAERS-10348,LIRAGLUTIDE (VICTOZA),DIZZINESS,2022-03-15,45-64,Male,USA,Other
FAERS-10349,LIRAGLUTIDE (VICTOZA),DIZZINESS,2023-02-04,18-44,Female,Europe,Hospitalization
FAERS-10350,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-04-09,65-74,Female,USA,Other
FAERS-10351,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-01-28,45-64,Female,USA,Not specified
FAERS-10352,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2021-11-02,18-44,Female,USA,Other
FAERS-10353,SEMAGLUTIDE (WEGOVY),ALOPECIA,2022-02-17,18-44,Female,USA,Not specified
FAERS-10354,SEMAGLUTIDE (WEGOVY),NAUSEA,2023-07-12,45-64,Male,USA,Other
FAERS-10355,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-01-09,45-64,Unknown,USA,Disability
FAERS-10356,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-07-14,75-84,Female,USA,Other
FAERS-10357,TIRZEPATIDE (ZEPBOUND),DIZZINESS,2019-04-26,45-64,Male,USA,Life-threatening
FAERS-10358,LIRAGLUTIDE (SAXENDA),GALLBLADDER DISEASE,2019-12-14,45-64,Female,Europe,Other
FAERS-10359,LIRAGLUTIDE (VICTOZA),NAUSEA,2022-05-22,18-44,Female,USA,Other
FAERS-10360,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2020-06-17,18-44,Female,Europe,Other
FAERS-10361,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-12-04,18-44,Female,Europe,Other
FAERS-10362,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-10-21,65-74,Male,USA,Hospitalization
FAERS-10363,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2021-05-25,45-64,Female,USA,Hospitalization
FAERS-10364,SEMAGLUTIDE (WEGOVY),HEADACHE,2018-01-08,65-74,Male,USA,Hospitalization
FAERS-10365,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2018-12-24,75-84,Male,Other,Other
FAERS-10366,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2023-10-12,18-44,Female,USA,Hospitalization
FAERS-10367,EXENATIDE (BYDUREON),ASPIRATION,2023-02-15,18-44,Female,Other,Not specified
FAERS-10368,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2022-05-24,45-64,Male,USA,Other
FAERS-10369,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2023-09-25,Unknown,Unknown,Europe,Other
FAERS-10370,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-12-01,75-84,Male,USA,Not specified
FAERS-10371,SEMAGLUTIDE (OZEMPIC),NAUSEA,2019-09-08,45-64,Female,Europe,Other
FAERS-10372,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2018-04-28,Unknown,Male,USA,Other
FAERS-10373,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2019-03-21,45-64,Unknown,USA,Not specified
FAERS-10374,SEMAGLUTIDE (WEGOVY),VOMITING,2020-05-28,45-64,Female,Other,Other
FAERS-10375,TIRZEPATIDE (MOUNJARO),ALOPECIA,2021-02-07,45-64,Female,USA,Hospitalization
FAERS-10376,TIRZEPATIDE (MOUNJARO),ALOPECIA,2021-02-18,18-44,Male,USA,Other
FAERS-10377,LIRAGLUTIDE (VICTOZA),HYPOGLYCEMIA,2023-05-27,45-64,Female,USA,Other
FAERS-10378,EXENATIDE (BYETTA),NAUSEA,2020-06-13,65-74,Male,USA,Other
FAERS-10379,EXENATIDE (BYDUREON),PANCREATITIS,2023-09-24,65-74,Male,Other,Other
FAERS-10380,SEMAGLUTIDE (OZEMPIC),VOMITING,2019-04-05,18-44,Female,USA,Disability
FAERS-10381,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-02-01,45-64,Female,USA,Not specified
FAERS-10382,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-06-04,45-64,Female,USA,Hospitalization
FAERS-10383,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2021-01-13,18-44,Female,Europe,Other
FAERS-10384,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-01-20,18-44,Male,USA,Other
FAERS-10385,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2019-05-13,45-64,Female,USA,Hospitalization
FAERS-10386,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2023-01-13,65-74,Female,USA,Other
FAERS-10387,LIRAGLUTIDE (SAXENDA),FATIGUE,2021-05-06,65-74,Male,USA,Hospitalization
FAERS-10388,EXENATIDE (BYETTA),CONSTIPATION,2023-09-12,65-74,Female,USA,Other
FAERS-10389,LIRAGLUTIDE (VICTOZA),THYROID NEOPLASM,2023-12-02,18-44,Female,USA,Other
FAERS-10390,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-03-06,45-64,Unknown,USA,Disability
FAERS-10391,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-06-19,65-74,Female,USA,Other
FAERS-10392,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-05-06,18-44,Unknown,Canada,Other
FAERS-10393,SEMAGLUTIDE (WEGOVY),VOMITING,2018-10-07,18-44,Male,USA,Not specified
FAERS-10394,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2019-03-19,18-44,Female,Canada,Other
FAERS-10395,TIRZEPATIDE (MOUNJARO),DIARRHEA,2019-12-22,18-44,Female,USA,Other
FAERS-10396,TIRZEPATIDE (MOUNJARO),VOMITING,2023-11-16,45-64,Male,USA,Other
FAERS-10397,LIRAGLUTIDE (VICTOZA),INJECTION SITE REACTION,2021-11-19,45-64,Female,USA,Not specified
FAERS-10398,DULAGLUTIDE (TRULICITY),PANCREATITIS,2023-10-13,45-64,Male,Europe,Not specified
FAERS-10399,EXENATIDE (BYETTA),NAUSEA,2020-10-04,45-64,Female,Other,Not specified
FAERS-10400,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2020-02-27,65-74,Male,Other,Other
FAERS-10401,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2020-02-12,65-74,Female,USA,Other
FAERS-10402,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-07-16,0-17,Female,Europe,Not specified
FAERS-10403,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2022-11-08,45-64,Female,Europe,Life-threatening
FAERS-10404,SEMAGLUTIDE (WEGOVY),VOMITING,2023-02-11,65-74,Male,USA,Life-threatening
FAERS-10405,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2019-10-20,65-74,Female,Canada,Not specified
FAERS-10406,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2021-01-04,45-64,Female,USA,Other
FAERS-10407,LIRAGLUTIDE (VICTOZA),GALLBLADDER DISEASE,2022-05-08,45-64,Female,USA,Hospitalization
FAERS-10408,DULAGLUTIDE (TRULICITY),HEADACHE,2021-05-27,65-74,Male,USA,Other
FAERS-10409,EXENATIDE (BYETTA),FATIGUE,2023-08-28,18-44,Male,USA,Hospitalization
FAERS-10410,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-07-06,45-64,Female,USA,Other
FAERS-10411,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-05-19,18-44,Male,USA,Hospitalization
FAERS-10412,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-10-08,45-64,Male,USA,Other
FAERS-10413,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-08-19,65-74,Female,USA,Not specified
FAERS-10414,SEMAGLUTIDE (WEGOVY),FATIGUE,2022-09-26,18-44,Female,Europe,Other
FAERS-10415,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-03-07,18-44,Female,USA,Not specified
FAERS-10416,TIRZEPATIDE (MOUNJARO),DIARRHEA,2023-11-05,45-64,Unknown,USA,Not specified
FAERS-10417,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2022-09-11,65-74,Female,USA,Not specified
FAERS-10418,EXENATIDE (BYETTA),HYPOGLYCEMIA,2022-07-04,65-74,Female,USA,Other
FAERS-10419,LIRAGLUTIDE (VICTOZA),HEADACHE,2019-02-26,45-64,Female,USA,Other
FAERS-10420,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-10-16,45-64,Female,USA,Hospitalization
FAERS-10421,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2018-06-23,18-44,Female,Europe,Disability
FAERS-10422,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-05-10,75-84,Female,USA,Other
FAERS-10423,SEMAGLUTIDE (WEGOVY),FATIGUE,2020-12-15,45-64,Male,Canada,Other
FAERS-10424,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2021-07-24,65-74,Female,USA,Other
FAERS-10425,TIRZEPATIDE (MOUNJARO),FATIGUE,2019-12-17,45-64,Male,Europe,Other
FAERS-10426,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-04-27,45-64,Female,USA,Hospitalization
FAERS-10427,TIRZEPATIDE (ZEPBOUND),HYPOGLYCEMIA,2023-09-13,75-84,Female,USA,Other
FAERS-10428,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2023-08-19,18-44,Female,USA,Other
FAERS-10429,LIRAGLUTIDE (SAXENDA),DIARRHEA,2021-07-02,65-74,Female,Europe,Life-threatening
FAERS-10430,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-05-21,85+,Female,USA,Other
FAERS-10431,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-11-06,65-74,Female,USA,Other
FAERS-10432,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-11-09,18-44,Female,USA,Other
FAERS-10433,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2022-10-13,45-64,Male,USA,Other
FAERS-10434,SEMAGLUTIDE (WEGOVY),NAUSEA,2022-10-20,Unknown,Female,Europe,Other
FAERS-10435,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2021-05-09,45-64,Male,USA,Other
FAERS-10436,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2020-01-26,45-64,Male,USA,Not specified
FAERS-10437,EXENATIDE (BYETTA),GALLBLADDER DISEASE,2022-05-09,45-64,Male,USA,Not specified
FAERS-10438,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2020-12-23,18-44,Female,USA,Disability
FAERS-10439,EXENATIDE (BYETTA),DIZZINESS,2021-03-27,45-64,Female,USA,Other
FAERS-10440,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-09-25,45-64,Female,Europe,Not specified
FAERS-10441,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2020-05-14,65-74,Female,USA,Other
FAERS-10442,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-11-19,45-64,Male,Canada,Other
FAERS-10443,SEMAGLUTIDE (WEGOVY),DIZZINESS,2022-09-10,45-64,Male,USA,Other
FAERS-10444,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-08-05,18-44,Unknown,USA,Other
FAERS-10445,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2020-11-02,65-74,Female,USA,Hospitalization
FAERS-10446,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2022-02-05,65-74,Male,Europe,Other
FAERS-10447,EXENATIDE (BYDUREON),HYPOGLYCEMIA,2022-12-12,45-64,Female,USA,Not specified
FAERS-10448,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2023-04-23,45-64,Male,USA,Not specified
FAERS-10449,LIRAGLUTIDE (SAXENDA),DIARRHEA,2023-05-10,45-64,Female,USA,Other
FAERS-10450,SEMAGLUTIDE (OZEMPIC),FATIGUE,2020-08-12,45-64,Female,Europe,Other
FAERS-10451,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2020-03-07,65-74,Female,USA,Other
FAERS-10452,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2018-11-09,18-44,Female,Europe,Other
FAERS-10453,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-01-23,45-64,Male,USA,Hospitalization
FAERS-10454,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2020-11-21,18-44,Male,Europe,Hospitalization
FAERS-10455,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-07-27,18-44,Female,USA,Not specified
FAERS-10456,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-10-07,45-64,Male,Europe,Other
FAERS-10457,EXENATIDE (BYETTA),THYROID NEOPLASM,2022-04-23,45-64,Female,USA,Not specified
FAERS-10458,LIRAGLUTIDE (SAXENDA),CONSTIPATION,2022-08-05,18-44,Male,USA,Not specified
FAERS-10459,EXENATIDE (BYETTA),VOMITING,2022-05-09,65-74,Female,USA,Other
FAERS-10460,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-06-14,18-44,Male,USA,Other
FAERS-10461,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-03-11,65-74,Male,Canada,Other
FAERS-10462,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-03-04,45-64,Female,USA,Other
FAERS-10463,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-11-26,45-64,Female,Canada,Life-threatening
FAERS-10464,SEMAGLUTIDE (WEGOVY),DIARRHEA,2019-10-16,65-74,Unknown,Europe,Not specified
FAERS-10465,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2018-11-27,18-44,Female,USA,Other
FAERS-10466,TIRZEPATIDE (MOUNJARO),ASPIRATION,2021-02-09,45-64,Female,Canada,Other
FAERS-10467,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2022-11-28,45-64,Female,USA,Other
FAERS-10468,EXENATIDE (BYETTA),DECREASED APPETITE,2022-11-22,45-64,Female,Europe,Other
FAERS-10469,LIRAGLUTIDE (VICTOZA),SUICIDAL IDEATION,2022-03-17,45-64,Unknown,USA,Not specified
FAERS-10470,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2020-05-02,65-74,Male,USA,Other
FAERS-10471,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-10-15,45-64,Female,USA,Hospitalization
FAERS-10472,SEMAGLUTIDE (OZEMPIC),FATIGUE,2018-07-14,45-64,Unknown,Europe,Hospitalization
FAERS-10473,SEMAGLUTIDE (WEGOVY),HEADACHE,2022-09-18,65-74,Female,Other,Disability
FAERS-10474,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2020-08-11,75-84,Female,USA,Other
FAERS-10475,TIRZEPATIDE (MOUNJARO),DIZZINESS,2019-11-08,45-64,Female,Europe,Hospitalization
FAERS-10476,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2021-02-02,45-64,Female,USA,Not specified
FAERS-10477,DULAGLUTIDE (TRULICITY),DIARRHEA,2022-04-04,65-74,Female,USA,Not specified
FAERS-10478,DULAGLUTIDE (TRULICITY),CONSTIPATION,2023-01-21,65-74,Male,USA,Not specified
FAERS-10479,EXENATIDE (BYETTA),DIARRHEA,2022-08-01,65-74,Female,USA,Other
FAERS-10480,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-03-23,75-84,Female,USA,Other
FAERS-10481,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-09-13,18-44,Female,USA,Other
FAERS-10482,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-05-15,45-64,Male,USA,Not specified
FAERS-10483,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-09-28,45-64,Female,USA,Other
FAERS-10484,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2023-11-12,45-64,Male,USA,Not specified
FAERS-10485,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-11-11,65-74,Unknown,USA,Other
FAERS-10486,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-11-24,45-64,Female,Australia,Not specified
FAERS-10487,EXENATIDE (BYETTA),ABDOMINAL PAIN,2018-03-02,65-74,Female,USA,Other
FAERS-10488,LIRAGLUTIDE (VICTOZA),ABDOMINAL PAIN,2020-01-23,65-74,Unknown,Europe,Other
FAERS-10489,LIRAGLUTIDE (VICTOZA),INJECTION SITE REACTION,2023-12-18,18-44,Female,USA,Not specified
FAERS-10490,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-05-23,45-64,Male,Europe,Other
FAERS-10491,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2021-09-02,45-64,Female,Other,Hospitalization
FAERS-10492,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-11-23,45-64,Female,Canada,Other
FAERS-10493,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-04-10,45-64,Female,USA,Other
FAERS-10494,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2019-01-14,18-44,Female,Europe,Other
FAERS-10495,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2022-03-02,18-44,Female,USA,Life-threatening
FAERS-10496,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2022-08-26,18-44,Female,USA,Other
FAERS-10497,LIRAGLUTIDE (SAXENDA),VOMITING,2022-09-06,45-64,Female,Other,Other
FAERS-10498,EXENATIDE (BYETTA),GALLBLADDER DISEASE,2021-05-07,45-64,Female,Europe,Not specified
FAERS-10499,EXENATIDE (BYETTA),HEADACHE,2018-11-12,Unknown,Female,Other,Other
FAERS-10500,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2022-06-13,45-64,Female,Other,Not specified
FAERS-10501,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-06-17,45-64,Female,USA,Not specified
FAERS-10502,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-02-06,18-44,Female,USA,Not specified
FAERS-10503,SEMAGLUTIDE (WEGOVY),ALOPECIA,2022-04-28,45-64,Female,USA,Other
FAERS-10504,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-07-21,18-44,Female,Canada,Not specified
FAERS-10505,TIRZEPATIDE (MOUNJARO),VOMITING,2018-02-02,45-64,Male,Europe,Life-threatening
FAERS-10506,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-08-21,18-44,Female,Japan,Other
FAERS-10507,LIRAGLUTIDE (SAXENDA),NAUSEA,2022-12-19,45-64,Female,USA,Hospitalization
FAERS-10508,TIRZEPATIDE (ZEPBOUND),GALLBLADDER DISEASE,2022-05-25,45-64,Male,Europe,Not specified
FAERS-10509,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2020-07-26,45-64,Female,USA,Other
FAERS-10510,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-12-21,85+,Male,Europe,Other
FAERS-10511,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2018-10-13,45-64,Female,USA,Other
FAERS-10512,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2021-07-21,45-64,Female,Japan,Not specified
FAERS-10513,SEMAGLUTIDE (WEGOVY),DIARRHEA,2019-11-26,18-44,Female,USA,Other
FAERS-10514,SEMAGLUTIDE (WEGOVY),NAUSEA,2022-02-10,65-74,Unknown,USA,Other
FAERS-10515,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-11-21,18-44,Female,Other,Disability
FAERS-10516,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-11-10,18-44,Male,USA,Other
FAERS-10517,LIRAGLUTIDE (VICTOZA),HEADACHE,2018-04-26,45-64,Male,USA,Disability
FAERS-10518,EXENATIDE (BYDUREON),DIZZINESS,2021-08-15,45-64,Female,Europe,Other
FAERS-10519,LIRAGLUTIDE (SAXENDA),FATIGUE,2021-03-18,18-44,Female,USA,Disability
FAERS-10520,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-11-01,45-64,Female,Canada,Not specified
FAERS-10521,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-09-16,65-74,Male,USA,Other
FAERS-10522,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-03-15,45-64,Female,USA,Other
FAERS-10523,SEMAGLUTIDE (WEGOVY),VOMITING,2023-10-22,45-64,Male,USA,Life-threatening
FAERS-10524,SEMAGLUTIDE (WEGOVY),FATIGUE,2022-03-24,45-64,Male,Australia,Other
FAERS-10525,TIRZEPATIDE (MOUNJARO),ASPIRATION,2021-04-02,18-44,Female,USA,Other
FAERS-10526,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-01-21,65-74,Female,Japan,Other
FAERS-10527,EXENATIDE (BYDUREON),THYROID NEOPLASM,2022-10-06,45-64,Male,Europe,Other
FAERS-10528,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2021-04-17,45-64,Female,USA,Other
FAERS-10529,LIRAGLUTIDE (SAXENDA),FATIGUE,2020-03-08,45-64,Female,USA,Hospitalization
FAERS-10530,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-02-22,18-44,Male,USA,Disability
FAERS-10531,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2020-03-21,65-74,Female,USA,Not specified
FAERS-10532,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-01-19,18-44,Female,USA,Hospitalization
FAERS-10533,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-11-01,75-84,Female,USA,Not specified
FAERS-10534,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2022-08-28,65-74,Female,USA,Other
FAERS-10535,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2023-10-22,45-64,Male,USA,Other
FAERS-10536,TIRZEPATIDE (MOUNJARO),DIARRHEA,2019-07-13,45-64,Female,USA,Hospitalization
FAERS-10537,TIRZEPATIDE (ZEPBOUND),CONSTIPATION,2020-02-06,65-74,Female,USA,Other
FAERS-10538,EXENATIDE (BYETTA),DIZZINESS,2019-11-05,65-74,Female,Europe,Not specified
FAERS-10539,EXENATIDE (BYETTA),SUICIDAL IDEATION,2022-06-28,65-74,Female,USA,Hospitalization
FAERS-10540,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-10-26,18-44,Female,Europe,Other
FAERS-10541,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-04-28,45-64,Male,USA,Hospitalization
FAERS-10542,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-01-19,45-64,Male,USA,Other
FAERS-10543,SEMAGLUTIDE (WEGOVY),FATIGUE,2021-02-05,45-64,Male,Europe,Other
FAERS-10544,SEMAGLUTIDE (WEGOVY),HEADACHE,2022-11-13,45-64,Female,USA,Other
FAERS-10545,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2022-05-10,65-74,Female,USA,Other
FAERS-10546,TIRZEPATIDE (MOUNJARO),ALOPECIA,2019-04-15,45-64,Male,Canada,Other
FAERS-10547,LIRAGLUTIDE (VICTOZA),VOMITING,2022-11-23,45-64,Female,Europe,Hospitalization
FAERS-10548,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2023-07-03,0-17,Male,USA,Hospitalization
FAERS-10549,LIRAGLUTIDE (VICTOZA),GALLBLADDER DISEASE,2021-11-17,45-64,Female,Australia,Other
FAERS-10550,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-01-07,18-44,Female,USA,Not specified
FAERS-10551,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2022-12-08,45-64,Male,Europe,Other
FAERS-10552,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2019-05-25,45-64,Female,Other,Other
FAERS-10553,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-02-18,45-64,Male,USA,Other
FAERS-10554,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2021-10-07,75-84,Male,Other,Other
FAERS-10555,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2022-09-10,0-17,Male,USA,Other
FAERS-10556,TIRZEPATIDE (MOUNJARO),VOMITING,2023-05-23,45-64,Male,USA,Other
FAERS-10557,DULAGLUTIDE (TRULICITY),HEADACHE,2022-08-19,65-74,Female,Other,Not specified
FAERS-10558,DULAGLUTIDE (TRULICITY),VOMITING,2022-04-26,18-44,Female,Other,Other
FAERS-10559,LIRAGLUTIDE (SAXENDA),FATIGUE,2019-11-24,0-17,Female,USA,Not specified
FAERS-10560,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-05-06,75-84,Female,USA,Not specified
FAERS-10561,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-05-07,65-74,Female,USA,Disability
FAERS-10562,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2019-02-22,65-74,Female,Europe,Not specified
FAERS-10563,SEMAGLUTIDE (WEGOVY),FATIGUE,2023-06-20,0-17,Female,Other,Other
FAERS-10564,SEMAGLUTIDE (WEGOVY),ASPIRATION,2020-09-09,65-74,Female,USA,Other
FAERS-10565,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-01-17,18-44,Female,USA,Other
FAERS-10566,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2022-06-23,65-74,Female,USA,Hospitalization
FAERS-10567,EXENATIDE (BYDUREON),CONSTIPATION,2021-09-09,45-64,Male,USA,Disability
FAERS-10568,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2021-06-12,45-64,Male,USA,Not specified
FAERS-10569,LIRAGLUTIDE (SAXENDA),HYPOGLYCEMIA,2023-12-09,45-64,Unknown,Europe,Not specified
FAERS-10570,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-08-26,65-74,Male,Europe,Hospitalization
FAERS-10571,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-06-26,18-44,Female,USA,Other
FAERS-10572,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2020-04-27,65-74,Male,USA,Other
FAERS-10573,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2021-09-26,18-44,Female,USA,Other
FAERS-10574,SEMAGLUTIDE (WEGOVY),NAUSEA,2020-10-21,18-44,Female,Other,Other
FAERS-10575,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-12-15,65-74,Female,Europe,Not specified
FAERS-10576,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2020-06-14,45-64,Female,USA,Other
FAERS-10577,EXENATIDE (BYETTA),GALLBLADDER DISEASE,2021-11-10,65-74,Male,USA,Other
FAERS-10578,EXENATIDE (BYETTA),DIZZINESS,2021-10-17,45-64,Female,Canada,Not specified
FAERS-10579,DULAGLUTIDE (TRULICITY),DIARRHEA,2021-12-23,65-74,Male,USA,Other
FAERS-10580,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-01-01,45-64,Male,Australia,Other
FAERS-10581,SEMAGLUTIDE (OZEMPIC),FATIGUE,2019-07-10,Unknown,Male,USA,Disability
FAERS-10582,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2020-01-22,45-64,Male,USA,Other
FAERS-10583,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-09-15,65-74,Female,Canada,Hospitalization
FAERS-10584,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-10-14,45-64,Female,USA,Other
FAERS-10585,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-08-10,45-64,Male,USA,Other
FAERS-10586,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2023-06-10,45-64,Male,Europe,Other
FAERS-10587,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2023-05-20,45-64,Female,USA,Disability
FAERS-10588,TIRZEPATIDE (ZEPBOUND),HEADACHE,2020-12-24,18-44,Female,USA,Other
FAERS-10589,DULAGLUTIDE (TRULICITY),CONSTIPATION,2023-10-26,18-44,Female,USA,Other
FAERS-10590,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2020-02-06,45-64,Female,USA,Hospitalization
FAERS-10591,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-06-01,45-64,Female,Europe,Life-threatening
FAERS-10592,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2019-08-24,18-44,Unknown,USA,Hospitalization
FAERS-10593,SEMAGLUTIDE (WEGOVY),VOMITING,2023-08-12,18-44,Male,USA,Other
FAERS-10594,SEMAGLUTIDE (WEGOVY),ALOPECIA,2019-07-03,45-64,Female,Other,Other
FAERS-10595,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2018-12-08,65-74,Male,USA,Other
FAERS-10596,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-02-17,18-44,Unknown,USA,Other
FAERS-10597,LIRAGLUTIDE (VICTOZA),FATIGUE,2022-01-24,45-64,Male,USA,Not specified
FAERS-10598,EXENATIDE (BYETTA),DIARRHEA,2019-11-07,45-64,Male,USA,Not specified
FAERS-10599,LIRAGLUTIDE (VICTOZA),DIZZINESS,2019-04-01,45-64,Male,USA,Not specified
FAERS-10600,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-04-06,45-64,Female,USA,Other
FAERS-10601,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2019-06-21,45-64,Female,Europe,Life-threatening
FAERS-10602,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-11-25,18-44,Female,USA,Other
FAERS-10603,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-05-02,65-74,Male,USA,Other
FAERS-10604,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2020-06-11,45-64,Female,USA,Other
FAERS-10605,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2019-03-15,65-74,Female,USA,Other
FAERS-10606,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-03-01,45-64,Male,USA,Other
FAERS-10607,LIRAGLUTIDE (SAXENDA),ALOPECIA,2022-07-07,18-44,Female,Europe,Other
FAERS-10608,DULAGLUTIDE (TRULICITY),ALOPECIA,2021-02-17,18-44,Male,USA,Other
FAERS-10609,TIRZEPATIDE (ZEPBOUND),SUICIDAL IDEATION,2022-02-02,18-44,Female,USA,Other
FAERS-10610,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2021-06-08,45-64,Female,Europe,Other
FAERS-10611,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-02-15,75-84,Male,USA,Not specified
FAERS-10612,SEMAGLUTIDE (OZEMPIC),VOMITING,2021-12-02,45-64,Female,USA,Not specified
FAERS-10613,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2023-09-04,18-44,Male,USA,Hospitalization
FAERS-10614,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2022-03-18,45-64,Male,Europe,Other
FAERS-10615,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2022-11-14,18-44,Female,USA,Not specified
FAERS-10616,TIRZEPATIDE (MOUNJARO),DIARRHEA,2020-10-15,18-44,Female,USA,Not specified
FAERS-10617,LIRAGLUTIDE (SAXENDA),HEADACHE,2022-12-11,Unknown,Female,USA,Other
FAERS-10618,EXENATIDE (BYETTA),HEADACHE,2021-08-15,45-64,Female,Europe,Not specified
FAERS-10619,TIRZEPATIDE (ZEPBOUND),INJECTION SITE REACTION,2023-05-01,Unknown,Female,USA,Other
FAERS-10620,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-05-18,65-74,Male,Europe,Other
FAERS-10621,SEMAGLUTIDE (OZEMPIC),HEADACHE,2020-05-12,45-64,Male,USA,Not specified
FAERS-10622,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-04-24,18-44,Male,USA,Hospitalization
FAERS-10623,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-02-20,45-64,Female,Canada,Other
FAERS-10624,SEMAGLUTIDE (WEGOVY),NAUSEA,2023-06-12,65-74,Female,Europe,Not specified
FAERS-10625,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-10-01,75-84,Male,Europe,Other
FAERS-10626,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-06-17,18-44,Female,USA,Other
FAERS-10627,LIRAGLUTIDE (VICTOZA),NAUSEA,2022-09-03,65-74,Female,USA,Disability
FAERS-10628,LIRAGLUTIDE (SAXENDA),ALOPECIA,2023-09-13,18-44,Male,USA,Other
FAERS-10629,DULAGLUTIDE (TRULICITY),FATIGUE,2022-08-13,65-74,Male,USA,Other
FAERS-10630,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2019-07-11,45-64,Female,USA,Other
FAERS-10631,SEMAGLUTIDE (OZEMPIC),HEADACHE,2020-06-20,18-44,Female,USA,Other
FAERS-10632,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-10-05,18-44,Male,Europe,Other
FAERS-10633,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-02-04,18-44,Female,USA,Other
FAERS-10634,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-06-23,45-64,Male,Europe,Not specified
FAERS-10635,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2020-09-17,45-64,Male,Europe,Other
FAERS-10636,TIRZEPATIDE (MOUNJARO),HEADACHE,2022-07-19,45-64,Unknown,Europe,Not specified
FAERS-10637,EXENATIDE (BYETTA),NAUSEA,2022-01-15,18-44,Male,Europe,Other
FAERS-10638,TIRZEPATIDE (ZEPBOUND),VOMITING,2021-02-01,45-64,Female,Japan,Other
FAERS-10639,EXENATIDE (BYDUREON),GALLBLADDER DISEASE,2023-08-28,Unknown,Female,Europe,Other
FAERS-10640,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-01-08,18-44,Female,USA,Not specified
FAERS-10641,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-06-21,45-64,Female,USA,Other
FAERS-10642,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2021-07-27,Unknown,Male,USA,Not specified
FAERS-10643,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2021-03-03,75-84,Male,USA,Other
FAERS-10644,SEMAGLUTIDE (WEGOVY),FATIGUE,2021-10-05,45-64,Female,Europe,Other
FAERS-10645,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2022-10-18,45-64,Female,USA,Other
FAERS-10646,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2023-07-25,18-44,Female,Canada,Hospitalization
FAERS-10647,EXENATIDE (BYETTA),ASPIRATION,2019-06-27,45-64,Female,Australia,Not specified
FAERS-10648,EXENATIDE (BYDUREON),NAUSEA,2021-12-27,45-64,Unknown,Other,Not specified
FAERS-10649,EXENATIDE (BYDUREON),ABDOMINAL PAIN,2023-10-20,65-74,Male,USA,Other
FAERS-10650,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-12-25,18-44,Male,Europe,Other
FAERS-10651,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-08-16,45-64,Female,USA,Hospitalization
FAERS-10652,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2021-07-08,18-44,Female,USA,Other
FAERS-10653,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-10-16,65-74,Male,Japan,Other
FAERS-10654,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-07-24,65-74,Female,Europe,Other
FAERS-10655,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-01-17,65-74,Female,USA,Hospitalization
FAERS-10656,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2022-12-02,65-74,Female,USA,Other
FAERS-10657,EXENATIDE (BYETTA),ALOPECIA,2023-05-15,85+,Male,USA,Life-threatening
FAERS-10658,LIRAGLUTIDE (SAXENDA),DIZZINESS,2023-08-03,18-44,Female,USA,Other
FAERS-10659,TIRZEPATIDE (ZEPBOUND),CONSTIPATION,2021-06-15,45-64,Female,USA,Hospitalization
FAERS-10660,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2019-06-23,65-74,Female,Canada,Other
FAERS-10661,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-11-12,18-44,Female,USA,Hospitalization
FAERS-10662,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2020-09-13,65-74,Unknown,USA,Hospitalization
FAERS-10663,SEMAGLUTIDE (WEGOVY),DIARRHEA,2020-03-06,45-64,Female,Canada,Other
FAERS-10664,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-03-04,45-64,Female,Other,Not specified
FAERS-10665,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-08-18,0-17,Female,USA,Not specified
FAERS-10666,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-08-03,45-64,Male,Europe,Other
FAERS-10667,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2023-01-06,45-64,Female,USA,Hospitalization
FAERS-10668,EXENATIDE (BYDUREON),PANCREATITIS,2022-06-03,18-44,Male,USA,Hospitalization
FAERS-10669,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2022-10-26,18-44,Male,Europe,Other
FAERS-10670,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-06-12,65-74,Female,USA,Not specified
FAERS-10671,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-02-23,65-74,Female,USA,Not specified
FAERS-10672,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2019-10-24,45-64,Male,USA,Not specified
FAERS-10673,SEMAGLUTIDE (WEGOVY),FATIGUE,2023-12-10,18-44,Female,USA,Other
FAERS-10674,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-10-19,18-44,Female,USA,Other
FAERS-10675,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2020-05-07,45-64,Female,Canada,Hospitalization
FAERS-10676,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-07-14,45-64,Male,Europe,Hospitalization
FAERS-10677,LIRAGLUTIDE (SAXENDA),HEADACHE,2021-02-10,45-64,Male,USA,Other
FAERS-10678,EXENATIDE (BYETTA),PANCREATITIS,2023-10-01,0-17,Female,USA,Not specified
FAERS-10679,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2023-11-05,45-64,Female,Japan,Other
FAERS-10680,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-07-24,65-74,Female,USA,Hospitalization
FAERS-10681,SEMAGLUTIDE (OZEMPIC),FATIGUE,2018-10-22,45-64,Female,USA,Other
FAERS-10682,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-06-13,65-74,Male,USA,Other
FAERS-10683,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-05-23,45-64,Female,USA,Not specified
FAERS-10684,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2021-05-07,45-64,Male,Canada,Other
FAERS-10685,TIRZEPATIDE (MOUNJARO),DIARRHEA,2019-09-01,45-64,Male,USA,Other
FAERS-10686,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-05-25,18-44,Male,USA,Other
FAERS-10687,TIRZEPATIDE (ZEPBOUND),ALOPECIA,2023-08-13,75-84,Female,USA,Other
FAERS-10688,EXENATIDE (BYETTA),VOMITING,2023-06-15,45-64,Male,Europe,Not specified
FAERS-10689,TIRZEPATIDE (ZEPBOUND),FATIGUE,2021-04-11,45-64,Male,USA,Disability
FAERS-10690,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-03-09,45-64,Female,Europe,Hospitalization
FAERS-10691,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-05-05,45-64,Male,USA,Not specified
FAERS-10692,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-09-15,45-64,Male,USA,Hospitalization
FAERS-10693,SEMAGLUTIDE (WEGOVY),NAUSEA,2019-07-06,65-74,Male,USA,Other
FAERS-10694,SEMAGLUTIDE (WEGOVY),ASPIRATION,2021-06-27,45-64,Female,USA,Disability
FAERS-10695,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-10-05,65-74,Male,Japan,Hospitalization
FAERS-10696,TIRZEPATIDE (MOUNJARO),ALOPECIA,2022-08-16,45-64,Male,USA,Disability
FAERS-10697,LIRAGLUTIDE (VICTOZA),DIARRHEA,2020-11-11,65-74,Male,USA,Other
FAERS-10698,LIRAGLUTIDE (SAXENDA),HYPOGLYCEMIA,2022-03-10,18-44,Female,USA,Other
FAERS-10699,EXENATIDE (BYETTA),HEADACHE,2019-09-21,45-64,Female,Europe,Hospitalization
FAERS-10700,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2020-03-16,45-64,Female,USA,Other
FAERS-10701,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2021-06-18,65-74,Female,Europe,Other
FAERS-10702,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-02-19,45-64,Female,Europe,Other
FAERS-10703,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2021-10-04,18-44,Female,USA,Other
FAERS-10704,SEMAGLUTIDE (WEGOVY),DIZZINESS,2019-04-27,65-74,Male,USA,Hospitalization
FAERS-10705,TIRZEPATIDE (MOUNJARO),HEADACHE,2022-08-18,65-74,Female,Europe,Other
FAERS-10706,TIRZEPATIDE (MOUNJARO),DIZZINESS,2021-11-10,45-64,Male,Canada,Not specified
FAERS-10707,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2022-09-13,75-84,Unknown,USA,Not specified
FAERS-10708,LIRAGLUTIDE (SAXENDA),VOMITING,2022-06-04,65-74,Female,USA,Not specified
FAERS-10709,TIRZEPATIDE (ZEPBOUND),CONSTIPATION,2021-07-14,45-64,Female,USA,Other
FAERS-10710,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-07-05,45-64,Male,USA,Other
FAERS-10711,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2020-08-22,18-44,Male,USA,Other
FAERS-10712,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-12-20,18-44,Female,USA,Not specified
FAERS-10713,SEMAGLUTIDE (WEGOVY),DIZZINESS,2021-04-06,45-64,Female,Europe,Other
FAERS-10714,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-09-19,45-64,Female,Europe,Other
FAERS-10715,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-12-03,45-64,Female,USA,Hospitalization
FAERS-10716,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2022-02-17,Unknown,Unknown,Europe,Not specified
FAERS-10717,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2022-09-26,45-64,Female,Europe,Other
FAERS-10718,EXENATIDE (BYETTA),NAUSEA,2022-08-19,45-64,Female,USA,Other
FAERS-10719,DULAGLUTIDE (TRULICITY),PANCREATITIS,2022-10-24,Unknown,Male,USA,Other
FAERS-10720,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-11-10,45-64,Female,USA,Not specified
FAERS-10721,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-05-09,45-64,Male,USA,Hospitalization
FAERS-10722,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2020-10-24,65-74,Male,USA,Life-threatening
FAERS-10723,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-09-28,65-74,Male,Europe,Hospitalization
FAERS-10724,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-07-25,85+,Female,Europe,Other
FAERS-10725,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-01-21,65-74,Male,USA,Other
FAERS-10726,TIRZEPATIDE (MOUNJARO),ALOPECIA,2022-09-08,18-44,Female,USA,Other
FAERS-10727,EXENATIDE (BYDUREON),GALLBLADDER DISEASE,2021-08-13,45-64,Female,USA,Other
FAERS-10728,EXENATIDE (BYETTA),DECREASED APPETITE,2023-07-20,18-44,Female,USA,Not specified
FAERS-10729,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2021-11-24,45-64,Male,Europe,Other
FAERS-10730,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-06-18,65-74,Female,Europe,Hospitalization
FAERS-10731,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-06-08,18-44,Female,USA,Other
FAERS-10732,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-04-20,18-44,Female,USA,Other
FAERS-10733,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2022-11-19,18-44,Female,USA,Not specified
FAERS-10734,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2022-02-21,18-44,Male,USA,Other
FAERS-10735,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-05-06,65-74,Female,Europe,Other
FAERS-10736,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-05-06,18-44,Female,Other,Other
FAERS-10737,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2019-09-25,18-44,Female,USA,Other
FAERS-10738,EXENATIDE (BYETTA),DIZZINESS,2019-10-24,75-84,Female,USA,Other
FAERS-10739,DULAGLUTIDE (TRULICITY),NAUSEA,2018-07-09,45-64,Female,USA,Life-threatening
FAERS-10740,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-08-14,45-64,Male,Europe,Other
FAERS-10741,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-12-27,65-74,Male,USA,Other
FAERS-10742,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2021-01-21,45-64,Unknown,USA,Not specified
FAERS-10743,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-05-21,45-64,Female,USA,Disability
FAERS-10744,SEMAGLUTIDE (WEGOVY),HEADACHE,2021-02-21,85+,Female,USA,Other
FAERS-10745,TIRZEPATIDE (MOUNJARO),FATIGUE,2018-01-24,65-74,Female,USA,Not specified
FAERS-10746,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2022-08-01,45-64,Female,USA,Hospitalization
FAERS-10747,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2022-09-15,65-74,Female,USA,Not specified
FAERS-10748,EXENATIDE (BYETTA),DIARRHEA,2020-11-01,45-64,Female,USA,Other
FAERS-10749,EXENATIDE (BYETTA),NAUSEA,2018-05-27,45-64,Male,USA,Other
FAERS-10750,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2019-08-20,18-44,Female,Europe,Other
FAERS-10751,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-11-13,65-74,Female,Europe,Other
FAERS-10752,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-01-19,45-64,Male,Europe,Life-threatening
FAERS-10753,SEMAGLUTIDE (WEGOVY),VOMITING,2021-03-15,45-64,Female,USA,Other
FAERS-10754,SEMAGLUTIDE (WEGOVY),HEADACHE,2021-03-01,18-44,Female,USA,Not specified
FAERS-10755,TIRZEPATIDE (MOUNJARO),VOMITING,2022-05-14,0-17,Female,Europe,Other
FAERS-10756,TIRZEPATIDE (MOUNJARO),ALOPECIA,2021-08-14,45-64,Male,USA,Disability
FAERS-10757,LIRAGLUTIDE (VICTOZA),DIZZINESS,2023-11-27,18-44,Male,USA,Other
FAERS-10758,LIRAGLUTIDE (SAXENDA),HYPOGLYCEMIA,2023-10-12,45-64,Male,Other,Not specified
FAERS-10759,EXENATIDE (BYETTA),FATIGUE,2019-02-26,45-64,Female,USA,Hospitalization
FAERS-10760,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-01-21,75-84,Female,USA,Other
FAERS-10761,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-02-24,18-44,Female,Canada,Hospitalization
FAERS-10762,SEMAGLUTIDE (OZEMPIC),HEADACHE,2019-04-24,18-44,Male,USA,Other
FAERS-10763,SEMAGLUTIDE (WEGOVY),HEADACHE,2020-02-11,45-64,Female,Canada,Disability
FAERS-10764,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2019-10-16,45-64,Male,Canada,Hospitalization
FAERS-10765,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2021-08-24,18-44,Female,USA,Disability
FAERS-10766,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2022-05-05,45-64,Male,USA,Hospitalization
FAERS-10767,DULAGLUTIDE (TRULICITY),HYPOGLYCEMIA,2022-11-20,18-44,Male,Canada,Not specified
FAERS-10768,EXENATIDE (BYETTA),THYROID NEOPLASM,2022-04-19,65-74,Male,Canada,Other
FAERS-10769,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2021-10-08,65-74,Female,USA,Not specified
FAERS-10770,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-01-16,18-44,Female,USA,Other
FAERS-10771,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-02-15,45-64,Female,Europe,Other
FAERS-10772,SEMAGLUTIDE (OZEMPIC),VOMITING,2020-06-10,65-74,Female,USA,Disability
FAERS-10773,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2022-10-24,18-44,Female,USA,Other
FAERS-10774,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2020-06-21,45-64,Male,Europe,Other
FAERS-10775,TIRZEPATIDE (MOUNJARO),DIZZINESS,2021-01-10,65-74,Male,Canada,Other
FAERS-10776,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2023-02-20,75-84,Female,Europe,Not specified
FAERS-10777,EXENATIDE (BYDUREON),ASPIRATION,2019-07-12,45-64,Female,USA,Other
FAERS-10778,TIRZEPATIDE (ZEPBOUND),GALLBLADDER DISEASE,2023-04-05,18-44,Female,USA,Not specified
FAERS-10779,LIRAGLUTIDE (VICTOZA),HEADACHE,2023-12-07,45-64,Female,Europe,Other
FAERS-10780,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-01-03,45-64,Female,USA,Other
FAERS-10781,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-09-10,45-64,Female,USA,Other
FAERS-10782,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-04-15,45-64,Female,Other,Hospitalization
FAERS-10783,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2020-02-23,18-44,Female,USA,Hospitalization
FAERS-10784,SEMAGLUTIDE (WEGOVY),DIARRHEA,2021-11-18,18-44,Female,USA,Not specified
FAERS-10785,TIRZEPATIDE (MOUNJARO),FATIGUE,2020-01-28,45-64,Female,USA,Not specified
FAERS-10786,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2022-06-16,45-64,Male,USA,Other
FAERS-10787,EXENATIDE (BYDUREON),HEADACHE,2023-05-06,45-64,Female,USA,Other
FAERS-10788,LIRAGLUTIDE (VICTOZA),FATIGUE,2021-08-06,Unknown,Female,USA,Other
FAERS-10789,LIRAGLUTIDE (VICTOZA),INJECTION SITE REACTION,2022-11-26,45-64,Unknown,Europe,Life-threatening
FAERS-10790,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-03-07,18-44,Male,USA,Other
FAERS-10791,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-03-18,45-64,Male,USA,Other
FAERS-10792,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2022-06-05,45-64,Female,USA,Hospitalization
FAERS-10793,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2022-05-25,Unknown,Male,Europe,Not specified
FAERS-10794,SEMAGLUTIDE (WEGOVY),HEADACHE,2021-12-04,18-44,Female,Japan,Other
FAERS-10795,TIRZEPATIDE (MOUNJARO),ASPIRATION,2021-04-15,18-44,Female,USA,Other
FAERS-10796,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-05-07,45-64,Male,USA,Hospitalization
FAERS-10797,EXENATIDE (BYETTA),SUICIDAL IDEATION,2021-08-11,45-64,Female,Other,Other
FAERS-10798,EXENATIDE (BYETTA),THYROID NEOPLASM,2023-06-13,65-74,Female,USA,Other
FAERS-10799,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2020-08-24,45-64,Female,USA,Not specified
FAERS-10800,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2021-07-05,45-64,Female,Other,Not specified
FAERS-10801,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-06-03,18-44,Male,Other,Not specified
FAERS-10802,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-03-18,45-64,Male,USA,Other
FAERS-10803,SEMAGLUTIDE (WEGOVY),HEADACHE,2021-08-02,75-84,Male,Europe,Not specified
FAERS-10804,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2020-01-05,45-64,Female,Europe,Other
FAERS-10805,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-07-06,65-74,Female,Europe,Other
FAERS-10806,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-02-20,18-44,Male,USA,Other
FAERS-10807,EXENATIDE (BYETTA),FATIGUE,2023-02-12,45-64,Male,Europe,Other
FAERS-10808,EXENATIDE (BYETTA),NAUSEA,2022-12-05,18-44,Female,USA,Other
FAERS-10809,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2021-09-21,45-64,Female,USA,Not specified
FAERS-10810,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-09-11,65-74,Male,USA,Not specified
FAERS-10811,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-02-18,45-64,Male,Europe,Other
FAERS-10812,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-06-06,18-44,Female,USA,Hospitalization
FAERS-10813,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-09-28,18-44,Male,Canada,Other
FAERS-10814,SEMAGLUTIDE (WEGOVY),HEADACHE,2019-03-01,65-74,Male,USA,Other
FAERS-10815,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2022-06-06,45-64,Female,Canada,Other
FAERS-10816,TIRZEPATIDE (MOUNJARO),NAUSEA,2020-04-10,65-74,Male,Canada,Hospitalization
FAERS-10817,LIRAGLUTIDE (VICTOZA),THYROID NEOPLASM,2018-08-25,45-64,Female,USA,Other
FAERS-10818,LIRAGLUTIDE (VICTOZA),VOMITING,2019-05-02,65-74,Female,USA,Hospitalization
FAERS-10819,EXENATIDE (BYDUREON),NAUSEA,2022-04-06,18-44,Male,USA,Other
FAERS-10820,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-06-06,18-44,Female,USA,Not specified
FAERS-10821,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-01-17,45-64,Female,USA,Disability
FAERS-10822,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-02-07,45-64,Female,USA,Not specified
FAERS-10823,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-02-06,45-64,Female,USA,Not specified
FAERS-10824,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-06-04,45-64,Female,USA,Other
FAERS-10825,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-02-11,45-64,Female,USA,Other
FAERS-10826,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-04-18,45-64,Female,Europe,Other
FAERS-10827,DULAGLUTIDE (TRULICITY),CONSTIPATION,2022-03-01,18-44,Female,USA,Not specified
FAERS-10828,DULAGLUTIDE (TRULICITY),DECREASED APPETITE,2019-07-13,45-64,Female,Europe,Other
FAERS-10829,TIRZEPATIDE (ZEPBOUND),INJECTION SITE REACTION,2020-04-20,65-74,Male,USA,Not specified
FAERS-10830,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-10-19,18-44,Female,USA,Other
FAERS-10831,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-07-16,45-64,Female,USA,Other
FAERS-10832,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2020-03-01,45-64,Male,USA,Hospitalization
FAERS-10833,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-11-11,18-44,Female,Other,Life-threatening
FAERS-10834,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-08-07,18-44,Male,Europe,Other
FAERS-10835,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-01-25,45-64,Female,Europe,Hospitalization
FAERS-10836,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2021-08-02,75-84,Female,USA,Hospitalization
FAERS-10837,EXENATIDE (BYETTA),DECREASED APPETITE,2021-05-23,65-74,Female,USA,Other
FAERS-10838,TIRZEPATIDE (ZEPBOUND),HEADACHE,2022-09-28,45-64,Female,USA,Life-threatening
FAERS-10839,TIRZEPATIDE (ZEPBOUND),GALLBLADDER DISEASE,2021-05-11,45-64,Unknown,USA,Hospitalization
FAERS-10840,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-11-11,18-44,Female,Europe,Other
FAERS-10841,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2020-04-21,Unknown,Female,USA,Other
FAERS-10842,SEMAGLUTIDE (OZEMPIC),VOMITING,2020-09-11,45-64,Female,USA,Hospitalization
FAERS-10843,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2018-08-19,45-64,Female,USA,Hospitalization
FAERS-10844,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2022-12-22,45-64,Male,USA,Disability
FAERS-10845,TIRZEPATIDE (MOUNJARO),FATIGUE,2021-07-07,65-74,Female,USA,Other
FAERS-10846,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2021-01-10,65-74,Female,USA,Not specified
FAERS-10847,DULAGLUTIDE (TRULICITY),ALOPECIA,2022-10-11,45-64,Female,Europe,Other
FAERS-10848,EXENATIDE (BYETTA),ALOPECIA,2022-05-17,45-64,Male,Europe,Not specified
FAERS-10849,DULAGLUTIDE (TRULICITY),DECREASED APPETITE,2022-11-25,45-64,Female,USA,Other
FAERS-10850,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-11-27,45-64,Female,USA,Other
FAERS-10851,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-07-19,75-84,Female,USA,Other
FAERS-10852,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-05-28,18-44,Female,USA,Other
FAERS-10853,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2021-05-21,65-74,Male,USA,Life-threatening
FAERS-10854,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2018-05-15,18-44,Male,USA,Other
FAERS-10855,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2021-01-09,45-64,Female,USA,Other
FAERS-10856,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2023-01-02,45-64,Female,USA,Not specified
FAERS-10857,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2023-11-22,45-64,Male,Other,Not specified
FAERS-10858,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2023-02-17,65-74,Male,USA,Other
FAERS-10859,EXENATIDE (BYETTA),THYROID NEOPLASM,2020-02-25,75-84,Male,Canada,Not specified
FAERS-10860,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2020-07-07,45-64,Female,Europe,Hospitalization
FAERS-10861,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-08-18,85+,Female,USA,Other
FAERS-10862,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-03-12,45-64,Female,Europe,Other
FAERS-10863,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2018-12-22,45-64,Female,Japan,Other
FAERS-10864,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-11-23,75-84,Female,USA,Other
FAERS-10865,TIRZEPATIDE (MOUNJARO),ALOPECIA,2021-07-09,18-44,Female,Canada,Other
FAERS-10866,TIRZEPATIDE (MOUNJARO),ASPIRATION,2020-08-21,65-74,Male,Canada,Other
FAERS-10867,EXENATIDE (BYDUREON),GALLBLADDER DISEASE,2023-08-24,18-44,Female,Europe,Other
FAERS-10868,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2022-09-03,65-74,Female,Europe,Other
FAERS-10869,EXENATIDE (BYETTA),INJECTION SITE REACTION,2023-11-21,45-64,Male,Europe,Death
FAERS-10870,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-10-03,45-64,Male,USA,Hospitalization
FAERS-10871,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2020-10-22,65-74,Female,USA,Other
FAERS-10872,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2020-10-27,45-64,Female,USA,Other
FAERS-10873,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-10-08,18-44,Female,USA,Hospitalization
FAERS-10874,SEMAGLUTIDE (WEGOVY),NAUSEA,2019-08-07,45-64,Female,USA,Other
FAERS-10875,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2020-06-06,18-44,Female,USA,Not specified
FAERS-10876,TIRZEPATIDE (MOUNJARO),VOMITING,2022-11-16,65-74,Female,Japan,Hospitalization
FAERS-10877,EXENATIDE (BYDUREON),CONSTIPATION,2023-07-05,75-84,Female,USA,Other
FAERS-10878,LIRAGLUTIDE (VICTOZA),DIZZINESS,2021-07-26,Unknown,Male,Europe,Hospitalization
FAERS-10879,LIRAGLUTIDE (SAXENDA),THYROID NEOPLASM,2022-11-15,18-44,Female,USA,Hospitalization
FAERS-10880,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2020-07-23,65-74,Unknown,USA,Other
FAERS-10881,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-08-12,18-44,Female,USA,Not specified
FAERS-10882,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2018-05-17,85+,Female,Europe,Other
FAERS-10883,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2022-10-06,45-64,Female,Other,Other
FAERS-10884,SEMAGLUTIDE (WEGOVY),FATIGUE,2021-09-14,75-84,Female,USA,Hospitalization
FAERS-10885,TIRZEPATIDE (MOUNJARO),VOMITING,2023-12-12,18-44,Male,Canada,Not specified
FAERS-10886,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-06-14,65-74,Female,Europe,Not specified
FAERS-10887,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2023-11-26,45-64,Female,USA,Other
FAERS-10888,LIRAGLUTIDE (VICTOZA),DIARRHEA,2023-07-04,18-44,Male,USA,Not specified
FAERS-10889,DULAGLUTIDE (TRULICITY),NAUSEA,2022-12-28,45-64,Female,USA,Hospitalization
FAERS-10890,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-05-19,18-44,Male,Europe,Not specified
FAERS-10891,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-07-03,45-64,Unknown,USA,Other
FAERS-10892,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-02-13,18-44,Male,USA,Other
FAERS-10893,SEMAGLUTIDE (WEGOVY),ASPIRATION,2022-12-22,18-44,Male,USA,Other
FAERS-10894,SEMAGLUTIDE (WEGOVY),DIZZINESS,2018-10-15,45-64,Female,USA,Other
FAERS-10895,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2020-01-26,65-74,Female,USA,Other
FAERS-10896,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2021-07-09,18-44,Male,Other,Life-threatening
FAERS-10897,DULAGLUTIDE (TRULICITY),VOMITING,2021-11-05,65-74,Male,Europe,Hospitalization
FAERS-10898,DULAGLUTIDE (TRULICITY),ALOPECIA,2022-06-22,65-74,Female,Japan,Hospitalization
FAERS-10899,LIRAGLUTIDE (SAXENDA),FATIGUE,2022-07-03,45-64,Female,USA,Other
FAERS-10900,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2018-06-15,45-64,Female,USA,Other
FAERS-10901,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-02-10,65-74,Female,USA,Other
FAERS-10902,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-05-27,65-74,Male,Other,Other
FAERS-10903,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-09-14,45-64,Female,Japan,Other
FAERS-10904,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-09-01,65-74,Female,USA,Hospitalization
FAERS-10905,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2019-12-10,18-44,Male,USA,Other
FAERS-10906,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2021-03-07,65-74,Female,Europe,Death
FAERS-10907,EXENATIDE (BYDUREON),THYROID NEOPLASM,2018-07-04,18-44,Female,USA,Hospitalization
FAERS-10908,EXENATIDE (BYDUREON),FATIGUE,2022-08-10,45-64,Female,Other,Other
FAERS-10909,EXENATIDE (BYETTA),GALLBLADDER DISEASE,2021-03-05,45-64,Female,USA,Hospitalization
FAERS-10910,SEMAGLUTIDE (OZEMPIC),VOMITING,2020-11-05,18-44,Unknown,Canada,Other
FAERS-10911,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-08-05,45-64,Female,USA,Other
FAERS-10912,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-08-01,18-44,Male,Europe,Not specified
FAERS-10913,SEMAGLUTIDE (WEGOVY),HEADACHE,2019-01-04,18-44,Female,Europe,Other
FAERS-10914,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2022-09-10,Unknown,Female,Europe,Hospitalization
FAERS-10915,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-08-08,45-64,Female,Australia,Other
FAERS-10916,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-07-16,45-64,Male,USA,Hospitalization
FAERS-10917,EXENATIDE (BYETTA),ASPIRATION,2021-04-16,45-64,Female,USA,Other
FAERS-10918,LIRAGLUTIDE (VICTOZA),FATIGUE,2023-12-22,45-64,Female,Japan,Other
FAERS-10919,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2022-06-26,45-64,Female,Australia,Other
FAERS-10920,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2019-08-05,18-44,Male,Europe,Life-threatening
FAERS-10921,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-04-07,45-64,Female,Australia,Other
FAERS-10922,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2020-09-02,45-64,Male,Europe,Not specified
FAERS-10923,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2022-06-26,18-44,Male,USA,Other
FAERS-10924,SEMAGLUTIDE (WEGOVY),NAUSEA,2022-09-20,65-74,Male,USA,Other
FAERS-10925,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-02-04,75-84,Female,USA,Other
FAERS-10926,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-03-21,65-74,Male,USA,Hospitalization
FAERS-10927,LIRAGLUTIDE (VICTOZA),ASPIRATION,2022-12-28,18-44,Male,USA,Hospitalization
FAERS-10928,EXENATIDE (BYDUREON),GALLBLADDER DISEASE,2023-01-08,65-74,Male,USA,Not specified
FAERS-10929,DULAGLUTIDE (TRULICITY),PANCREATITIS,2023-06-21,45-64,Male,USA,Other
FAERS-10930,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-07-14,65-74,Female,USA,Not specified
FAERS-10931,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2021-01-23,45-64,Female,Australia,Not specified
FAERS-10932,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2020-01-13,18-44,Male,Other,Other
FAERS-10933,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2022-12-26,45-64,Female,USA,Other
FAERS-10934,SEMAGLUTIDE (WEGOVY),FATIGUE,2022-05-24,45-64,Female,Europe,Other
FAERS-10935,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-12-13,0-17,Male,USA,Other
FAERS-10936,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2022-11-13,45-64,Female,Europe,Other
FAERS-10937,LIRAGLUTIDE (SAXENDA),VOMITING,2023-09-18,45-64,Female,Europe,Other
FAERS-10938,TIRZEPATIDE (ZEPBOUND),FATIGUE,2018-09-19,45-64,Male,USA,Other
FAERS-10939,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2021-11-17,Unknown,Male,USA,Other
FAERS-10940,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-08-11,45-64,Male,USA,Not specified
FAERS-10941,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-09-28,Unknown,Female,Canada,Other
FAERS-10942,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-12-13,45-64,Female,Europe,Other
FAERS-10943,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-02-05,45-64,Female,Europe,Other
FAERS-10944,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-08-03,18-44,Male,Canada,Other
FAERS-10945,TIRZEPATIDE (MOUNJARO),FATIGUE,2021-08-21,45-64,Female,USA,Other
FAERS-10946,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-03-17,75-84,Female,Other,Hospitalization
FAERS-10947,EXENATIDE (BYDUREON),HYPOGLYCEMIA,2022-08-16,85+,Female,USA,Hospitalization
FAERS-10948,LIRAGLUTIDE (VICTOZA),THYROID NEOPLASM,2021-02-12,45-64,Female,USA,Other
FAERS-10949,TIRZEPATIDE (ZEPBOUND),FATIGUE,2021-01-26,18-44,Male,USA,Hospitalization
FAERS-10950,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2021-03-27,45-64,Female,USA,Other
FAERS-10951,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-05-19,45-64,Male,USA,Other
FAERS-10952,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2020-03-17,45-64,Female,Europe,Other
FAERS-10953,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2019-10-22,45-64,Male,Europe,Other
FAERS-10954,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2022-08-24,65-74,Male,USA,Other
FAERS-10955,TIRZEPATIDE (MOUNJARO),VOMITING,2023-05-18,18-44,Male,USA,Other
FAERS-10956,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-10-17,18-44,Female,USA,Death
FAERS-10957,DULAGLUTIDE (TRULICITY),FATIGUE,2023-05-26,18-44,Female,USA,Disability
FAERS-10958,EXENATIDE (BYDUREON),SUICIDAL IDEATION,2021-10-02,45-64,Male,USA,Other
FAERS-10959,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2021-02-04,18-44,Male,USA,Not specified
FAERS-10960,SEMAGLUTIDE (OZEMPIC),HEADACHE,2020-07-22,45-64,Male,Europe,Life-threatening
FAERS-10961,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-06-05,45-64,Male,USA,Other
FAERS-10962,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2020-10-19,45-64,Female,USA,Disability
FAERS-10963,SEMAGLUTIDE (WEGOVY),FATIGUE,2021-09-14,45-64,Female,USA,Hospitalization
FAERS-10964,SEMAGLUTIDE (WEGOVY),NAUSEA,2022-10-22,45-64,Female,USA,Hospitalization
FAERS-10965,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2021-11-17,45-64,Male,USA,Disability
FAERS-10966,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-07-18,45-64,Unknown,Europe,Other
FAERS-10967,TIRZEPATIDE (ZEPBOUND),ALOPECIA,2020-01-16,85+,Female,Europe,Other
FAERS-10968,LIRAGLUTIDE (SAXENDA),SUICIDAL IDEATION,2022-09-10,45-64,Female,USA,Hospitalization
FAERS-10969,EXENATIDE (BYDUREON),HEADACHE,2023-12-18,18-44,Male,Europe,Not specified
FAERS-10970,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-06-21,18-44,Female,Europe,Other
FAERS-10971,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-08-20,45-64,Male,Other,Other
FAERS-10972,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2018-01-22,18-44,Female,USA,Life-threatening
FAERS-10973,SEMAGLUTIDE (WEGOVY),HEADACHE,2019-11-21,45-64,Female,USA,Hospitalization
FAERS-10974,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-07-27,65-74,Female,Europe,Other
FAERS-10975,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2019-06-07,65-74,Female,Other,Other
FAERS-10976,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2021-02-27,18-44,Male,Japan,Other
FAERS-10977,LIRAGLUTIDE (SAXENDA),ALOPECIA,2018-08-23,18-44,Unknown,Other,Other
FAERS-10978,LIRAGLUTIDE (VICTOZA),NAUSEA,2021-09-16,Unknown,Female,USA,Life-threatening
FAERS-10979,LIRAGLUTIDE (VICTOZA),DECREASED APPETITE,2019-03-24,45-64,Female,USA,Hospitalization
FAERS-10980,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-04-28,45-64,Male,USA,Other
FAERS-10981,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-08-01,45-64,Female,USA,Not specified
FAERS-10982,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-07-09,75-84,Male,Australia,Hospitalization
FAERS-10983,SEMAGLUTIDE (WEGOVY),FATIGUE,2023-01-09,45-64,Female,USA,Not specified
FAERS-10984,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-01-24,45-64,Female,USA,Disability
FAERS-10985,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2021-02-21,75-84,Female,USA,Other
FAERS-10986,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-05-08,45-64,Male,Europe,Hospitalization
FAERS-10987,LIRAGLUTIDE (VICTOZA),THYROID NEOPLASM,2020-02-25,65-74,Female,USA,Other
FAERS-10988,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2019-01-13,45-64,Female,USA,Other
FAERS-10989,EXENATIDE (BYDUREON),VOMITING,2021-11-14,18-44,Female,USA,Hospitalization
FAERS-10990,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2019-07-08,45-64,Male,USA,Not specified
FAERS-10991,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2021-10-20,45-64,Female,USA,Hospitalization
FAERS-10992,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-02-04,45-64,Male,USA,Hospitalization
FAERS-10993,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2019-09-09,45-64,Female,Japan,Other
FAERS-10994,SEMAGLUTIDE (WEGOVY),FATIGUE,2018-03-10,45-64,Male,USA,Other
FAERS-10995,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-03-05,45-64,Female,USA,Other
FAERS-10996,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-03-02,45-64,Unknown,USA,Disability
FAERS-10997,EXENATIDE (BYETTA),SUICIDAL IDEATION,2023-02-11,45-64,Male,USA,Death
FAERS-10998,DULAGLUTIDE (TRULICITY),DECREASED APPETITE,2022-06-20,Unknown,Female,USA,Other
FAERS-10999,LIRAGLUTIDE (SAXENDA),DIARRHEA,2020-01-21,45-64,Female,USA,Disability
FAERS-11000,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-06-26,45-64,Male,Europe,Other
FAERS-11001,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2019-01-18,18-44,Unknown,USA,Hospitalization
FAERS-11002,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2018-01-07,18-44,Female,Europe,Disability
FAERS-11003,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-03-07,65-74,Female,USA,Hospitalization
FAERS-11004,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2021-02-11,75-84,Male,Europe,Not specified
FAERS-11005,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-10-14,18-44,Female,Europe,Not specified
FAERS-11006,TIRZEPATIDE (MOUNJARO),VOMITING,2020-07-23,18-44,Female,Europe,Other
FAERS-11007,EXENATIDE (BYETTA),HYPOGLYCEMIA,2022-09-10,45-64,Female,Europe,Other
FAERS-11008,LIRAGLUTIDE (SAXENDA),ABDOMINAL PAIN,2022-10-16,45-64,Male,USA,Disability
FAERS-11009,TIRZEPATIDE (ZEPBOUND),ALOPECIA,2021-11-25,65-74,Female,USA,Other
FAERS-11010,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-12-16,45-64,Male,USA,Other
FAERS-11011,SEMAGLUTIDE (OZEMPIC),HEADACHE,2020-04-15,45-64,Female,USA,Not specified
FAERS-11012,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-06-09,45-64,Female,USA,Other
FAERS-11013,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-08-17,18-44,Female,USA,Other
FAERS-11014,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2021-07-01,45-64,Female,Europe,Life-threatening
FAERS-11015,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2023-09-18,45-64,Female,USA,Other
FAERS-11016,TIRZEPATIDE (MOUNJARO),ALOPECIA,2018-04-11,75-84,Male,USA,Disability
FAERS-11017,LIRAGLUTIDE (SAXENDA),ABDOMINAL PAIN,2020-10-05,65-74,Female,Europe,Not specified
FAERS-11018,EXENATIDE (BYDUREON),INJECTION SITE REACTION,2023-07-13,75-84,Male,USA,Not specified
FAERS-11019,EXENATIDE (BYDUREON),NAUSEA,2023-04-08,45-64,Unknown,Other,Other
FAERS-11020,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-08-11,18-44,Female,USA,Other
FAERS-11021,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2020-08-28,18-44,Female,Europe,Other
FAERS-11022,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2018-11-27,45-64,Male,Australia,Other
FAERS-11023,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2022-05-11,45-64,Female,Europe,Other
FAERS-11024,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-10-21,18-44,Male,Other,Other
FAERS-11025,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-02-18,45-64,Female,USA,Other
FAERS-11026,TIRZEPATIDE (MOUNJARO),FATIGUE,2021-03-04,45-64,Female,USA,Other
FAERS-11027,LIRAGLUTIDE (VICTOZA),NAUSEA,2019-07-10,45-64,Female,USA,Disability
FAERS-11028,LIRAGLUTIDE (SAXENDA),DECREASED APPETITE,2020-07-13,18-44,Male,USA,Life-threatening
FAERS-11029,TIRZEPATIDE (ZEPBOUND),DIARRHEA,2023-04-05,45-64,Female,USA,Not specified
FAERS-11030,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-05-19,65-74,Female,USA,Disability
FAERS-11031,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-07-20,45-64,Male,Other,Not specified
FAERS-11032,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-12-03,75-84,Female,USA,Other
FAERS-11033,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2021-10-27,45-64,Female,Europe,Not specified
FAERS-11034,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-11-06,18-44,Female,Europe,Other
FAERS-11035,TIRZEPATIDE (MOUNJARO),VOMITING,2020-11-18,45-64,Male,Canada,Other
FAERS-11036,TIRZEPATIDE (MOUNJARO),ASPIRATION,2022-09-04,45-64,Female,USA,Not specified
FAERS-11037,TIRZEPATIDE (ZEPBOUND),INJECTION SITE REACTION,2020-04-17,45-64,Female,USA,Hospitalization
FAERS-11038,TIRZEPATIDE (ZEPBOUND),VOMITING,2023-04-13,45-64,Female,USA,Hospitalization
FAERS-11039,LIRAGLUTIDE (SAXENDA),VOMITING,2022-02-03,75-84,Male,Europe,Other
FAERS-11040,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-03-27,75-84,Male,Europe,Hospitalization
FAERS-11041,SEMAGLUTIDE (OZEMPIC),VOMITING,2019-01-22,45-64,Female,USA,Other
FAERS-11042,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-08-23,18-44,Female,Canada,Hospitalization
FAERS-11043,SEMAGLUTIDE (WEGOVY),DIZZINESS,2019-12-10,45-64,Female,Europe,Other
FAERS-11044,SEMAGLUTIDE (WEGOVY),DIZZINESS,2020-04-07,18-44,Female,USA,Hospitalization
FAERS-11045,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2022-04-04,Unknown,Male,USA,Other
FAERS-11046,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2019-06-11,18-44,Male,USA,Other
FAERS-11047,LIRAGLUTIDE (VICTOZA),DIZZINESS,2020-02-12,75-84,Female,USA,Other
FAERS-11048,TIRZEPATIDE (ZEPBOUND),GALLBLADDER DISEASE,2019-05-21,45-64,Female,USA,Other
FAERS-11049,TIRZEPATIDE (ZEPBOUND),VOMITING,2023-02-23,18-44,Male,USA,Other
FAERS-11050,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-11-23,65-74,Male,Other,Other
FAERS-11051,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-12-11,65-74,Male,USA,Not specified
FAERS-11052,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-09-21,18-44,Male,Japan,Other
FAERS-11053,SEMAGLUTIDE (WEGOVY),FATIGUE,2023-02-10,45-64,Male,USA,Disability
FAERS-11054,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-04-05,18-44,Male,USA,Other
FAERS-11055,TIRZEPATIDE (MOUNJARO),DIZZINESS,2021-06-05,18-44,Female,Other,Other
FAERS-11056,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-05-25,65-74,Female,Other,Hospitalization
FAERS-11057,EXENATIDE (BYDUREON),PANCREATITIS,2022-04-26,18-44,Female,Japan,Other
FAERS-11058,EXENATIDE (BYDUREON),CONSTIPATION,2022-02-28,65-74,Female,USA,Other
FAERS-11059,LIRAGLUTIDE (VICTOZA),NAUSEA,2020-09-27,Unknown,Female,USA,Other
FAERS-11060,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2020-04-08,45-64,Female,USA,Other
FAERS-11061,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2020-08-03,45-64,Female,Other,Not specified
FAERS-11062,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-07-25,45-64,Female,USA,Life-threatening
FAERS-11063,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2019-05-20,45-64,Female,USA,Other
FAERS-11064,SEMAGLUTIDE (WEGOVY),HEADACHE,2021-09-20,18-44,Female,USA,Other
FAERS-11065,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2018-09-24,65-74,Male,Japan,Other
FAERS-11066,TIRZEPATIDE (MOUNJARO),FATIGUE,2021-08-10,75-84,Female,Other,Other
FAERS-11067,EXENATIDE (BYETTA),VOMITING,2023-03-07,65-74,Unknown,USA,Other
FAERS-11068,LIRAGLUTIDE (SAXENDA),ALOPECIA,2022-06-23,65-74,Male,Europe,Hospitalization
FAERS-11069,DULAGLUTIDE (TRULICITY),ASPIRATION,2023-11-23,65-74,Male,USA,Other
FAERS-11070,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-05-08,45-64,Male,USA,Other
FAERS-11071,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-07-13,65-74,Male,Europe,Other
FAERS-11072,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2020-07-09,18-44,Female,Canada,Other
FAERS-11073,SEMAGLUTIDE (WEGOVY),FATIGUE,2023-12-28,45-64,Female,USA,Hospitalization
FAERS-11074,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-12-13,65-74,Male,USA,Other
FAERS-11075,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-07-17,18-44,Female,USA,Other
FAERS-11076,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2020-08-06,45-64,Male,USA,Other
FAERS-11077,TIRZEPATIDE (ZEPBOUND),HYPOGLYCEMIA,2020-04-09,65-74,Male,USA,Not specified
FAERS-11078,DULAGLUTIDE (TRULICITY),HYPOGLYCEMIA,2019-02-13,75-84,Male,USA,Hospitalization
FAERS-11079,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2019-01-09,45-64,Female,Europe,Other
FAERS-11080,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-01-13,45-64,Unknown,USA,Other
FAERS-11081,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2021-07-11,65-74,Female,USA,Other
FAERS-11082,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2022-07-20,Unknown,Female,Australia,Hospitalization
FAERS-11083,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2022-12-27,45-64,Male,USA,Not specified
FAERS-11084,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-04-12,45-64,Female,USA,Other
FAERS-11085,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2018-11-27,65-74,Female,Europe,Other
FAERS-11086,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-04-20,65-74,Female,Europe,Other
FAERS-11087,EXENATIDE (BYDUREON),DIZZINESS,2023-11-28,18-44,Female,Australia,Other
FAERS-11088,TIRZEPATIDE (ZEPBOUND),INJECTION SITE REACTION,2022-10-26,45-64,Male,USA,Not specified
FAERS-11089,EXENATIDE (BYETTA),NAUSEA,2023-08-06,45-64,Male,Europe,Not specified
FAERS-11090,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2020-11-23,45-64,Female,USA,Hospitalization
FAERS-11091,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-05-08,65-74,Male,Japan,Other
FAERS-11092,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-11-24,75-84,Female,Europe,Other
FAERS-11093,SEMAGLUTIDE (WEGOVY),ALOPECIA,2023-02-21,45-64,Male,USA,Other
FAERS-11094,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-07-26,65-74,Female,Europe,Disability
FAERS-11095,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2022-04-24,45-64,Male,USA,Not specified
FAERS-11096,TIRZEPATIDE (MOUNJARO),HEADACHE,2023-05-02,18-44,Male,USA,Other
FAERS-11097,LIRAGLUTIDE (VICTOZA),SUICIDAL IDEATION,2022-03-17,Unknown,Male,USA,Other
FAERS-11098,EXENATIDE (BYETTA),CONSTIPATION,2020-05-27,45-64,Female,USA,Disability
FAERS-11099,EXENATIDE (BYDUREON),HYPOGLYCEMIA,2023-12-02,45-64,Male,Europe,Other
FAERS-11100,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-08-21,Unknown,Male,Other,Not specified
FAERS-11101,SEMAGLUTIDE (OZEMPIC),FATIGUE,2021-12-07,45-64,Female,Other,Not specified
FAERS-11102,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-08-24,18-44,Female,Japan,Other
FAERS-11103,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2022-06-14,45-64,Female,Other,Other
FAERS-11104,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2021-12-07,65-74,Female,USA,Other
FAERS-11105,TIRZEPATIDE (MOUNJARO),HEADACHE,2023-01-28,18-44,Male,Europe,Not specified
FAERS-11106,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2022-03-07,45-64,Female,USA,Disability
FAERS-11107,EXENATIDE (BYDUREON),CONSTIPATION,2019-03-13,45-64,Female,Canada,Not specified
FAERS-11108,DULAGLUTIDE (TRULICITY),DECREASED APPETITE,2022-01-04,18-44,Male,USA,Not specified
FAERS-11109,EXENATIDE (BYDUREON),PANCREATITIS,2020-02-08,45-64,Male,Europe,Other
FAERS-11110,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-11-22,45-64,Male,Europe,Hospitalization
FAERS-11111,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-01-04,65-74,Female,USA,Hospitalization
FAERS-11112,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-10-16,45-64,Female,USA,Other
FAERS-11113,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2022-07-10,65-74,Male,USA,Other
FAERS-11114,SEMAGLUTIDE (WEGOVY),VOMITING,2020-12-01,18-44,Female,Europe,Other
FAERS-11115,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-09-23,65-74,Female,USA,Not specified
FAERS-11116,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2019-10-23,65-74,Male,Europe,Life-threatening
FAERS-11117,EXENATIDE (BYETTA),HYPOGLYCEMIA,2022-02-18,45-64,Male,USA,Other
FAERS-11118,TIRZEPATIDE (ZEPBOUND),VOMITING,2020-11-01,18-44,Male,Other,Other
FAERS-11119,TIRZEPATIDE (ZEPBOUND),THYROID NEOPLASM,2021-10-16,45-64,Female,Europe,Other
FAERS-11120,SEMAGLUTIDE (OZEMPIC),FATIGUE,2020-02-22,Unknown,Female,USA,Not specified
FAERS-11121,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-10-18,18-44,Male,Europe,Disability
FAERS-11122,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-07-21,18-44,Female,USA,Not specified
FAERS-11123,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2022-09-07,18-44,Male,USA,Hospitalization
FAERS-11124,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2021-11-21,Unknown,Female,USA,Not specified
FAERS-11125,TIRZEPATIDE (MOUNJARO),DIZZINESS,2021-01-20,45-64,Male,Other,Other
FAERS-11126,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-02-12,45-64,Female,USA,Not specified
FAERS-11127,LIRAGLUTIDE (SAXENDA),DIARRHEA,2023-04-13,65-74,Male,USA,Not specified
FAERS-11128,TIRZEPATIDE (ZEPBOUND),DIARRHEA,2022-09-12,65-74,Male,Europe,Other
FAERS-11129,LIRAGLUTIDE (SAXENDA),HEADACHE,2023-07-06,45-64,Female,USA,Other
FAERS-11130,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-08-19,85+,Female,USA,Hospitalization
FAERS-11131,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-12-09,45-64,Male,USA,Hospitalization
FAERS-11132,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-12-15,Unknown,Female,USA,Death
FAERS-11133,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2021-12-27,65-74,Female,USA,Disability
FAERS-11134,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-11-03,18-44,Male,Europe,Hospitalization
FAERS-11135,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-08-26,18-44,Female,USA,Not specified
FAERS-11136,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-09-22,45-64,Female,Europe,Not specified
FAERS-11137,EXENATIDE (BYETTA),DECREASED APPETITE,2023-12-14,45-64,Female,Japan,Other
FAERS-11138,EXENATIDE (BYDUREON),PANCREATITIS,2023-09-22,Unknown,Female,Japan,Other
FAERS-11139,EXENATIDE (BYETTA),HYPOGLYCEMIA,2023-03-03,18-44,Female,Europe,Other
FAERS-11140,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2020-02-11,45-64,Male,USA,Not specified
FAERS-11141,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-05-09,45-64,Female,USA,Disability
FAERS-11142,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-11-17,45-64,Male,USA,Not specified
FAERS-11143,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-10-15,45-64,Female,USA,Other
FAERS-11144,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2021-02-14,0-17,Female,USA,Other
FAERS-11145,TIRZEPATIDE (MOUNJARO),VOMITING,2022-03-25,45-64,Male,USA,Other
FAERS-11146,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2020-05-04,45-64,Male,USA,Not specified
FAERS-11147,EXENATIDE (BYDUREON),SUICIDAL IDEATION,2021-12-07,18-44,Female,USA,Hospitalization
FAERS-11148,LIRAGLUTIDE (SAXENDA),NAUSEA,2020-04-16,45-64,Female,Japan,Not specified
FAERS-11149,LIRAGLUTIDE (SAXENDA),DIARRHEA,2019-07-17,45-64,Female,Europe,Other
FAERS-11150,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-03-05,65-74,Male,Other,Other
FAERS-11151,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-10-24,45-64,Male,Europe,Hospitalization
FAERS-11152,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-12-17,45-64,Male,USA,Death
FAERS-11153,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2022-07-07,18-44,Male,Europe,Other
FAERS-11154,SEMAGLUTIDE (WEGOVY),ALOPECIA,2020-10-21,18-44,Female,USA,Other
FAERS-11155,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2023-07-01,18-44,Male,Other,Other
FAERS-11156,TIRZEPATIDE (MOUNJARO),VOMITING,2022-04-08,18-44,Female,USA,Other
FAERS-11157,DULAGLUTIDE (TRULICITY),VOMITING,2021-06-23,45-64,Male,USA,Other
FAERS-11158,LIRAGLUTIDE (SAXENDA),ASPIRATION,2021-05-16,18-44,Male,Europe,Other
FAERS-11159,EXENATIDE (BYETTA),VOMITING,2021-02-22,18-44,Female,USA,Hospitalization
FAERS-11160,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-10-17,65-74,Male,Europe,Other
FAERS-11161,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2019-11-24,45-64,Female,USA,Other
FAERS-11162,SEMAGLUTIDE (OZEMPIC),NAUSEA,2020-08-04,85+,Female,Europe,Hospitalization
FAERS-11163,SEMAGLUTIDE (WEGOVY),HEADACHE,2020-12-05,45-64,Female,Other,Hospitalization
FAERS-11164,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-09-12,45-64,Male,Canada,Not specified
FAERS-11165,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2021-09-26,65-74,Female,USA,Hospitalization
FAERS-11166,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-12-07,45-64,Male,USA,Other
FAERS-11167,DULAGLUTIDE (TRULICITY),FATIGUE,2021-09-13,45-64,Female,USA,Other
FAERS-11168,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2020-12-01,45-64,Male,USA,Not specified
FAERS-11169,EXENATIDE (BYETTA),HYPOGLYCEMIA,2020-12-09,45-64,Female,USA,Other
FAERS-11170,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2020-05-05,18-44,Male,USA,Other
FAERS-11171,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-01-21,45-64,Male,Europe,Other
FAERS-11172,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-12-05,45-64,Male,Europe,Other
FAERS-11173,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-04-24,45-64,Male,Europe,Not specified
FAERS-11174,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-10-04,Unknown,Female,Other,Other
FAERS-11175,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2022-04-27,75-84,Male,USA,Other
FAERS-11176,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2021-08-08,18-44,Female,Canada,Other
FAERS-11177,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2020-03-07,65-74,Male,USA,Other
FAERS-11178,EXENATIDE (BYDUREON),CONSTIPATION,2023-11-20,45-64,Male,Canada,Death
FAERS-11179,LIRAGLUTIDE (VICTOZA),VOMITING,2019-09-05,18-44,Female,Other,Other
FAERS-11180,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-11-02,45-64,Female,USA,Hospitalization
FAERS-11181,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-01-26,45-64,Female,USA,Hospitalization
FAERS-11182,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-10-15,45-64,Female,USA,Not specified
FAERS-11183,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2021-09-04,45-64,Male,USA,Hospitalization
FAERS-11184,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-01-08,45-64,Male,Canada,Hospitalization
FAERS-11185,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-07-22,18-44,Female,USA,Not specified
FAERS-11186,TIRZEPATIDE (MOUNJARO),ALOPECIA,2019-05-12,18-44,Male,USA,Hospitalization
FAERS-11187,LIRAGLUTIDE (SAXENDA),DIARRHEA,2022-03-14,75-84,Female,Canada,Other
FAERS-11188,EXENATIDE (BYETTA),CONSTIPATION,2022-05-12,45-64,Female,Europe,Not specified
FAERS-11189,LIRAGLUTIDE (SAXENDA),ASPIRATION,2023-02-26,45-64,Female,Europe,Hospitalization
FAERS-11190,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2021-12-26,18-44,Female,USA,Other
FAERS-11191,SEMAGLUTIDE (OZEMPIC),FATIGUE,2021-02-11,18-44,Female,Other,Not specified
FAERS-11192,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-07-20,45-64,Male,USA,Other
FAERS-11193,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2021-08-18,65-74,Female,USA,Other
FAERS-11194,SEMAGLUTIDE (WEGOVY),HEADACHE,2021-10-25,65-74,Female,USA,Other
FAERS-11195,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-01-12,45-64,Male,USA,Other
FAERS-11196,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-03-10,75-84,Male,USA,Other
FAERS-11197,EXENATIDE (BYETTA),THYROID NEOPLASM,2019-03-04,75-84,Male,Europe,Not specified
FAERS-11198,EXENATIDE (BYDUREON),DIARRHEA,2019-02-22,65-74,Female,USA,Other
FAERS-11199,DULAGLUTIDE (TRULICITY),SUICIDAL IDEATION,2019-02-01,65-74,Male,USA,Other
FAERS-11200,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-12-10,18-44,Male,Europe,Other
FAERS-11201,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2019-01-21,45-64,Female,USA,Hospitalization
FAERS-11202,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-08-18,45-64,Male,Europe,Other
FAERS-11203,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2023-05-03,45-64,Male,USA,Other
FAERS-11204,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2020-03-27,18-44,Male,USA,Other
FAERS-11205,TIRZEPATIDE (MOUNJARO),HEADACHE,2021-11-13,65-74,Female,USA,Not specified
FAERS-11206,TIRZEPATIDE (MOUNJARO),DIARRHEA,2019-02-12,65-74,Female,USA,Other
FAERS-11207,LIRAGLUTIDE (SAXENDA),NAUSEA,2022-05-07,45-64,Female,USA,Other
FAERS-11208,EXENATIDE (BYDUREON),ASPIRATION,2018-08-02,18-44,Male,USA,Hospitalization
FAERS-11209,TIRZEPATIDE (ZEPBOUND),THYROID NEOPLASM,2021-04-11,0-17,Female,USA,Other
FAERS-11210,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-12-17,Unknown,Female,USA,Hospitalization
FAERS-11211,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-01-10,18-44,Female,USA,Life-threatening
FAERS-11212,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2020-04-26,18-44,Female,Other,Other
FAERS-11213,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-10-21,65-74,Unknown,USA,Other
FAERS-11214,SEMAGLUTIDE (WEGOVY),ALOPECIA,2022-07-02,45-64,Male,USA,Not specified
FAERS-11215,TIRZEPATIDE (MOUNJARO),ALOPECIA,2019-03-19,45-64,Male,USA,Other
FAERS-11216,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-02-16,65-74,Male,Canada,Hospitalization
FAERS-11217,LIRAGLUTIDE (SAXENDA),DIARRHEA,2021-02-06,45-64,Male,USA,Other
FAERS-11218,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2022-03-04,45-64,Male,Canada,Not specified
FAERS-11219,DULAGLUTIDE (TRULICITY),NAUSEA,2023-03-15,65-74,Female,Canada,Other
FAERS-11220,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-05-22,75-84,Female,Europe,Hospitalization
FAERS-11221,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-03-28,18-44,Female,Europe,Hospitalization
FAERS-11222,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-11-03,45-64,Female,USA,Other
FAERS-11223,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2020-02-13,45-64,Female,USA,Other
FAERS-11224,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2022-12-24,45-64,Male,Other,Other
FAERS-11225,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2022-06-19,18-44,Male,USA,Hospitalization
FAERS-11226,TIRZEPATIDE (MOUNJARO),DIZZINESS,2021-08-07,45-64,Female,USA,Hospitalization
FAERS-11227,TIRZEPATIDE (ZEPBOUND),THYROID NEOPLASM,2019-02-09,45-64,Male,USA,Other
FAERS-11228,LIRAGLUTIDE (SAXENDA),SUICIDAL IDEATION,2023-03-27,45-64,Female,USA,Hospitalization
FAERS-11229,DULAGLUTIDE (TRULICITY),PANCREATITIS,2021-08-18,65-74,Male,USA,Other
FAERS-11230,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2021-01-18,45-64,Female,Europe,Other
FAERS-11231,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-12-24,18-44,Female,USA,Not specified
FAERS-11232,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-06-04,18-44,Female,Australia,Other
FAERS-11233,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-03-21,45-64,Female,Other,Other
FAERS-11234,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2021-09-25,18-44,Male,Other,Life-threatening
FAERS-11235,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2022-01-12,45-64,Female,Other,Not specified
FAERS-11236,TIRZEPATIDE (MOUNJARO),NAUSEA,2022-11-15,65-74,Female,Canada,Other
FAERS-11237,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2019-03-15,45-64,Female,Europe,Other
FAERS-11238,LIRAGLUTIDE (VICTOZA),HEADACHE,2022-11-14,18-44,Female,USA,Other
FAERS-11239,EXENATIDE (BYDUREON),DIZZINESS,2023-02-03,75-84,Female,Other,Other
FAERS-11240,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-02-21,45-64,Female,Europe,Other
FAERS-11241,SEMAGLUTIDE (OZEMPIC),HEADACHE,2020-08-18,18-44,Male,USA,Other
FAERS-11242,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-07-27,45-64,Male,Other,Other
FAERS-11243,SEMAGLUTIDE (WEGOVY),ALOPECIA,2022-05-22,45-64,Female,Europe,Other
FAERS-11244,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-07-02,65-74,Female,USA,Hospitalization
FAERS-11245,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-06-06,45-64,Female,Europe,Not specified
FAERS-11246,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-01-26,18-44,Unknown,USA,Not specified
FAERS-11247,DULAGLUTIDE (TRULICITY),DIARRHEA,2023-09-06,45-64,Unknown,USA,Other
FAERS-11248,TIRZEPATIDE (ZEPBOUND),INJECTION SITE REACTION,2021-11-09,18-44,Male,USA,Not specified
FAERS-11249,LIRAGLUTIDE (VICTOZA),THYROID NEOPLASM,2022-10-05,18-44,Male,USA,Hospitalization
FAERS-11250,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-03-15,75-84,Male,USA,Other
FAERS-11251,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2020-04-24,18-44,Female,USA,Other
FAERS-11252,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-11-01,65-74,Female,USA,Other
FAERS-11253,SEMAGLUTIDE (WEGOVY),HEADACHE,2019-05-09,18-44,Female,USA,Not specified
FAERS-11254,SEMAGLUTIDE (WEGOVY),VOMITING,2021-08-26,45-64,Female,Europe,Hospitalization
FAERS-11255,TIRZEPATIDE (MOUNJARO),VOMITING,2021-06-21,75-84,Male,Europe,Not specified
FAERS-11256,TIRZEPATIDE (MOUNJARO),ALOPECIA,2022-10-28,18-44,Male,USA,Hospitalization
FAERS-11257,LIRAGLUTIDE (SAXENDA),THYROID NEOPLASM,2020-12-09,45-64,Female,USA,Not specified
FAERS-11258,LIRAGLUTIDE (VICTOZA),DIZZINESS,2020-06-04,45-64,Female,Europe,Not specified
FAERS-11259,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2021-08-07,18-44,Female,Australia,Not specified
FAERS-11260,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-09-13,45-64,Male,Europe,Not specified
FAERS-11261,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-02-19,18-44,Female,Europe,Other
FAERS-11262,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-08-14,18-44,Male,Europe,Other
FAERS-11263,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2020-06-12,45-64,Male,USA,Not specified
FAERS-11264,SEMAGLUTIDE (WEGOVY),ALOPECIA,2021-07-10,45-64,Female,Other,Other
FAERS-11265,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2019-06-14,75-84,Female,USA,Other
FAERS-11266,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-02-01,18-44,Female,USA,Other
FAERS-11267,TIRZEPATIDE (ZEPBOUND),INJECTION SITE REACTION,2020-02-13,18-44,Female,USA,Other
FAERS-11268,LIRAGLUTIDE (VICTOZA),FATIGUE,2023-11-03,18-44,Male,USA,Other
FAERS-11269,EXENATIDE (BYDUREON),HYPOGLYCEMIA,2020-08-16,65-74,Male,USA,Hospitalization
FAERS-11270,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-04-19,18-44,Female,USA,Hospitalization
FAERS-11271,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-03-27,65-74,Female,USA,Not specified
FAERS-11272,SEMAGLUTIDE (OZEMPIC),NAUSEA,2018-08-04,45-64,Female,USA,Not specified
FAERS-11273,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2019-06-16,45-64,Male,USA,Other
FAERS-11274,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-02-27,45-64,Female,Europe,Other
FAERS-11275,TIRZEPATIDE (MOUNJARO),DIZZINESS,2019-06-28,18-44,Male,USA,Other
FAERS-11276,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2021-09-01,18-44,Male,Japan,Not specified
FAERS-11277,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2019-06-23,65-74,Male,Australia,Other
FAERS-11278,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2019-03-25,18-44,Male,USA,Other
FAERS-11279,DULAGLUTIDE (TRULICITY),DIZZINESS,2022-08-09,45-64,Female,USA,Other
FAERS-11280,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2019-09-27,18-44,Male,USA,Not specified
FAERS-11281,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-01-07,65-74,Male,USA,Hospitalization
FAERS-11282,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2020-10-25,65-74,Male,USA,Other
FAERS-11283,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2020-09-04,65-74,Male,USA,Not specified
FAERS-11284,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2022-07-07,45-64,Unknown,Canada,Hospitalization
FAERS-11285,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2019-08-04,45-64,Female,USA,Other
FAERS-11286,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2022-08-12,65-74,Male,USA,Other
FAERS-11287,EXENATIDE (BYETTA),VOMITING,2022-01-15,45-64,Male,USA,Other
FAERS-11288,TIRZEPATIDE (ZEPBOUND),NAUSEA,2020-03-20,45-64,Female,USA,Other
FAERS-11289,EXENATIDE (BYETTA),FATIGUE,2023-04-04,45-64,Female,USA,Hospitalization
FAERS-11290,SEMAGLUTIDE (OZEMPIC),NAUSEA,2020-10-23,45-64,Male,USA,Other
FAERS-11291,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-04-06,18-44,Female,Canada,Other
FAERS-11292,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2019-09-23,45-64,Female,Europe,Other
FAERS-11293,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2022-03-06,65-74,Female,USA,Other
FAERS-11294,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2018-05-03,85+,Female,USA,Life-threatening
FAERS-11295,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2018-04-16,0-17,Female,USA,Hospitalization
FAERS-11296,TIRZEPATIDE (MOUNJARO),ALOPECIA,2022-03-25,45-64,Unknown,Europe,Hospitalization
FAERS-11297,TIRZEPATIDE (ZEPBOUND),VOMITING,2021-09-09,65-74,Male,USA,Other
FAERS-11298,LIRAGLUTIDE (SAXENDA),GALLBLADDER DISEASE,2023-11-28,18-44,Female,Europe,Not specified
FAERS-11299,EXENATIDE (BYETTA),FATIGUE,2020-07-28,45-64,Female,USA,Disability
FAERS-11300,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-07-12,45-64,Male,USA,Disability
FAERS-11301,SEMAGLUTIDE (OZEMPIC),VOMITING,2021-11-22,75-84,Female,USA,Other
FAERS-11302,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-06-11,Unknown,Female,USA,Other
FAERS-11303,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-06-27,Unknown,Male,USA,Other
FAERS-11304,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2021-01-16,45-64,Female,Europe,Not specified
FAERS-11305,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-03-10,45-64,Female,USA,Other
FAERS-11306,TIRZEPATIDE (MOUNJARO),VOMITING,2023-02-02,45-64,Female,USA,Other
FAERS-11307,TIRZEPATIDE (ZEPBOUND),HYPOGLYCEMIA,2021-05-26,45-64,Male,USA,Not specified
FAERS-11308,EXENATIDE (BYDUREON),THYROID NEOPLASM,2020-12-07,45-64,Female,Europe,Other
FAERS-11309,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2022-07-14,18-44,Female,USA,Other
FAERS-11310,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2020-07-22,65-74,Female,USA,Not specified
FAERS-11311,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2021-04-10,18-44,Female,USA,Other
FAERS-11312,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-07-04,75-84,Female,USA,Hospitalization
FAERS-11313,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-07-15,45-64,Female,Europe,Other
FAERS-11314,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2021-03-20,18-44,Female,Other,Not specified
FAERS-11315,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-05-02,45-64,Female,USA,Other
FAERS-11316,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-08-27,45-64,Male,Europe,Hospitalization
FAERS-11317,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2023-10-16,Unknown,Male,USA,Other
FAERS-11318,TIRZEPATIDE (ZEPBOUND),DIARRHEA,2023-09-05,45-64,Female,Europe,Other
FAERS-11319,DULAGLUTIDE (TRULICITY),DIARRHEA,2022-12-01,65-74,Female,USA,Not specified
FAERS-11320,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-09-04,18-44,Male,USA,Other
FAERS-11321,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-05-13,18-44,Female,USA,Other
FAERS-11322,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-08-28,18-44,Female,USA,Other
FAERS-11323,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-04-06,18-44,Male,USA,Other
FAERS-11324,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2019-10-16,18-44,Female,USA,Other
FAERS-11325,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2023-03-01,45-64,Female,USA,Other
FAERS-11326,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-11-20,45-64,Female,USA,Other
FAERS-11327,LIRAGLUTIDE (SAXENDA),THYROID NEOPLASM,2023-06-17,45-64,Female,USA,Not specified
FAERS-11328,EXENATIDE (BYETTA),CONSTIPATION,2020-03-12,65-74,Female,USA,Other
FAERS-11329,EXENATIDE (BYETTA),PANCREATITIS,2023-05-13,65-74,Female,USA,Hospitalization
FAERS-11330,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2020-12-17,45-64,Female,USA,Other
FAERS-11331,SEMAGLUTIDE (OZEMPIC),FATIGUE,2021-10-27,18-44,Male,Other,Other
FAERS-11332,SEMAGLUTIDE (OZEMPIC),NAUSEA,2019-11-16,65-74,Male,USA,Other
FAERS-11333,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2019-03-24,65-74,Female,Europe,Not specified
FAERS-11334,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2019-12-03,45-64,Male,USA,Other
FAERS-11335,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2019-08-13,45-64,Male,USA,Hospitalization
FAERS-11336,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-04-07,45-64,Male,USA,Other
FAERS-11337,DULAGLUTIDE (TRULICITY),ALOPECIA,2022-11-04,65-74,Male,USA,Disability
FAERS-11338,LIRAGLUTIDE (VICTOZA),ASPIRATION,2019-03-22,45-64,Female,USA,Other
FAERS-11339,EXENATIDE (BYDUREON),DIZZINESS,2022-06-12,45-64,Female,USA,Other
FAERS-11340,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-02-19,18-44,Male,USA,Hospitalization
FAERS-11341,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-06-01,45-64,Male,USA,Disability
FAERS-11342,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2019-03-10,75-84,Male,Europe,Hospitalization
FAERS-11343,SEMAGLUTIDE (WEGOVY),HEADACHE,2021-01-18,65-74,Female,USA,Other
FAERS-11344,SEMAGLUTIDE (WEGOVY),VOMITING,2018-06-14,45-64,Female,USA,Other
FAERS-11345,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-11-02,65-74,Male,USA,Disability
FAERS-11346,TIRZEPATIDE (MOUNJARO),VOMITING,2023-01-12,75-84,Female,Europe,Not specified
FAERS-11347,DULAGLUTIDE (TRULICITY),DIZZINESS,2023-05-24,45-64,Male,USA,Hospitalization
FAERS-11348,TIRZEPATIDE (ZEPBOUND),FATIGUE,2023-04-01,18-44,Female,USA,Not specified
FAERS-11349,TIRZEPATIDE (ZEPBOUND),ALOPECIA,2022-12-01,65-74,Female,Canada,Other
FAERS-11350,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-03-04,65-74,Female,USA,Other
FAERS-11351,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2021-01-08,Unknown,Female,USA,Disability
FAERS-11352,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-10-02,18-44,Female,Canada,Not specified
FAERS-11353,SEMAGLUTIDE (WEGOVY),NAUSEA,2019-03-10,65-74,Female,USA,Hospitalization
FAERS-11354,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2022-08-22,45-64,Male,USA,Hospitalization
FAERS-11355,TIRZEPATIDE (MOUNJARO),VOMITING,2023-06-28,18-44,Female,USA,Disability
FAERS-11356,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2022-09-09,75-84,Female,USA,Other
FAERS-11357,EXENATIDE (BYETTA),FATIGUE,2022-05-03,18-44,Female,Europe,Disability
FAERS-11358,LIRAGLUTIDE (VICTOZA),SUICIDAL IDEATION,2019-12-27,45-64,Male,USA,Other
FAERS-11359,TIRZEPATIDE (ZEPBOUND),THYROID NEOPLASM,2019-08-27,45-64,Female,USA,Hospitalization
FAERS-11360,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-10-13,45-64,Female,USA,Other
FAERS-11361,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2020-07-18,45-64,Male,USA,Hospitalization
FAERS-11362,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-06-27,45-64,Male,USA,Not specified
FAERS-11363,SEMAGLUTIDE (WEGOVY),ALOPECIA,2023-07-28,45-64,Female,USA,Other
FAERS-11364,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2021-12-22,65-74,Male,USA,Other
FAERS-11365,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-05-06,45-64,Female,Europe,Not specified
FAERS-11366,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2021-11-09,Unknown,Male,Japan,Hospitalization
FAERS-11367,LIRAGLUTIDE (VICTOZA),ALOPECIA,2021-05-22,45-64,Female,USA,Other
FAERS-11368,EXENATIDE (BYDUREON),ALOPECIA,2021-05-28,45-64,Male,USA,Life-threatening
FAERS-11369,DULAGLUTIDE (TRULICITY),NAUSEA,2022-09-07,0-17,Male,USA,Other
FAERS-11370,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-08-06,18-44,Female,USA,Other
FAERS-11371,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2020-10-21,18-44,Female,USA,Hospitalization
FAERS-11372,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-01-18,18-44,Female,Canada,Other
FAERS-11373,SEMAGLUTIDE (WEGOVY),VOMITING,2022-06-18,65-74,Male,USA,Other
FAERS-11374,SEMAGLUTIDE (WEGOVY),DIZZINESS,2022-04-07,45-64,Male,USA,Other
FAERS-11375,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-03-01,65-74,Female,USA,Other
FAERS-11376,TIRZEPATIDE (MOUNJARO),ALOPECIA,2022-05-20,45-64,Female,Europe,Hospitalization
FAERS-11377,LIRAGLUTIDE (SAXENDA),NAUSEA,2022-06-17,75-84,Female,USA,Other
FAERS-11378,EXENATIDE (BYDUREON),FATIGUE,2023-01-22,45-64,Male,USA,Other
FAERS-11379,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2023-10-17,45-64,Female,Other,Not specified
FAERS-11380,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-01-20,65-74,Female,USA,Other
FAERS-11381,SEMAGLUTIDE (OZEMPIC),FATIGUE,2021-04-11,45-64,Male,Europe,Other
FAERS-11382,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2019-04-15,45-64,Female,Europe,Other
FAERS-11383,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-11-16,45-64,Female,USA,Other
FAERS-11384,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2019-09-08,45-64,Female,Europe,Other
FAERS-11385,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2021-06-04,45-64,Male,USA,Hospitalization
FAERS-11386,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-03-15,Unknown,Female,USA,Hospitalization
FAERS-11387,TIRZEPATIDE (ZEPBOUND),HYPOGLYCEMIA,2019-01-27,65-74,Female,USA,Other
FAERS-11388,EXENATIDE (BYDUREON),DIARRHEA,2021-07-12,18-44,Female,USA,Hospitalization
FAERS-11389,EXENATIDE (BYDUREON),HEADACHE,2023-10-20,65-74,Male,Canada,Other
FAERS-11390,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2021-07-21,18-44,Female,USA,Other
FAERS-11391,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2020-10-27,45-64,Female,USA,Not specified
FAERS-11392,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-07-11,65-74,Female,USA,Other
FAERS-11393,SEMAGLUTIDE (WEGOVY),FATIGUE,2021-06-02,45-64,Female,USA,Other
FAERS-11394,SEMAGLUTIDE (WEGOVY),ASPIRATION,2021-06-25,45-64,Female,USA,Life-threatening
FAERS-11395,TIRZEPATIDE (MOUNJARO),DIARRHEA,2020-09-09,65-74,Female,Other,Other
FAERS-11396,TIRZEPATIDE (MOUNJARO),DIZZINESS,2021-08-08,18-44,Male,USA,Not specified
FAERS-11397,LIRAGLUTIDE (SAXENDA),ASPIRATION,2020-05-05,18-44,Female,USA,Hospitalization
FAERS-11398,EXENATIDE (BYETTA),SUICIDAL IDEATION,2023-09-18,65-74,Male,Japan,Other
FAERS-11399,TIRZEPATIDE (ZEPBOUND),FATIGUE,2023-07-24,65-74,Female,USA,Other
FAERS-11400,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-02-15,45-64,Female,Europe,Not specified
FAERS-11401,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-06-26,18-44,Male,USA,Hospitalization
FAERS-11402,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2021-11-24,65-74,Male,USA,Other
FAERS-11403,SEMAGLUTIDE (WEGOVY),ALOPECIA,2021-12-26,45-64,Male,Japan,Other
FAERS-11404,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-11-01,45-64,Female,USA,Other
FAERS-11405,TIRZEPATIDE (MOUNJARO),HEADACHE,2022-08-27,65-74,Male,USA,Death
FAERS-11406,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-12-24,18-44,Female,USA,Disability
FAERS-11407,DULAGLUTIDE (TRULICITY),VOMITING,2021-05-20,45-64,Male,USA,Other
FAERS-11408,EXENATIDE (BYETTA),CONSTIPATION,2023-04-10,45-64,Female,Other,Other
FAERS-11409,DULAGLUTIDE (TRULICITY),ALOPECIA,2019-02-25,45-64,Female,USA,Other
FAERS-11410,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2020-06-22,45-64,Male,USA,Hospitalization
FAERS-11411,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-08-20,45-64,Female,USA,Other
FAERS-11412,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-01-18,45-64,Female,Canada,Other
FAERS-11413,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-01-09,45-64,Female,USA,Other
FAERS-11414,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2020-03-18,45-64,Male,USA,Disability
FAERS-11415,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-01-24,75-84,Female,USA,Hospitalization
FAERS-11416,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-02-21,65-74,Male,USA,Hospitalization
FAERS-11417,LIRAGLUTIDE (VICTOZA),GALLBLADDER DISEASE,2023-04-10,18-44,Male,USA,Not specified
FAERS-11418,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2018-01-25,18-44,Female,Australia,Not specified
FAERS-11419,TIRZEPATIDE (ZEPBOUND),FATIGUE,2018-11-25,65-74,Male,USA,Other
FAERS-11420,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-12-09,65-74,Female,USA,Not specified
FAERS-11421,SEMAGLUTIDE (OZEMPIC),VOMITING,2018-12-27,45-64,Female,Europe,Other
FAERS-11422,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-05-26,18-44,Female,USA,Other
FAERS-11423,SEMAGLUTIDE (WEGOVY),FATIGUE,2021-11-19,18-44,Male,USA,Other
FAERS-11424,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2022-12-18,18-44,Female,USA,Other
FAERS-11425,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-12-04,Unknown,Female,Other,Other
FAERS-11426,TIRZEPATIDE (MOUNJARO),HEADACHE,2022-02-21,18-44,Female,USA,Other
FAERS-11427,LIRAGLUTIDE (VICTOZA),ALOPECIA,2023-08-19,Unknown,Male,USA,Other
FAERS-11428,LIRAGLUTIDE (VICTOZA),GALLBLADDER DISEASE,2023-01-25,65-74,Female,Europe,Other
FAERS-11429,DULAGLUTIDE (TRULICITY),PANCREATITIS,2022-07-28,45-64,Male,USA,Hospitalization
FAERS-11430,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-11-08,65-74,Female,USA,Other
FAERS-11431,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2019-02-14,45-64,Female,Other,Other
FAERS-11432,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2020-08-28,65-74,Male,Europe,Not specified
FAERS-11433,SEMAGLUTIDE (WEGOVY),NAUSEA,2022-12-28,45-64,Male,Europe,Other
FAERS-11434,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-11-09,45-64,Female,USA,Other
FAERS-11435,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-04-26,45-64,Female,USA,Other
FAERS-11436,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-12-24,45-64,Male,USA,Not specified
FAERS-11437,LIRAGLUTIDE (VICTOZA),DIARRHEA,2020-08-03,65-74,Female,USA,Not specified
FAERS-11438,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2021-01-20,18-44,Female,USA,Other
FAERS-11439,LIRAGLUTIDE (VICTOZA),VOMITING,2018-04-09,45-64,Female,USA,Other
FAERS-11440,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-05-18,45-64,Female,USA,Other
FAERS-11441,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-05-19,18-44,Male,Europe,Hospitalization
FAERS-11442,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-10-20,45-64,Female,USA,Other
FAERS-11443,SEMAGLUTIDE (WEGOVY),ALOPECIA,2020-04-07,65-74,Female,USA,Hospitalization
FAERS-11444,SEMAGLUTIDE (WEGOVY),ALOPECIA,2021-01-05,18-44,Male,Canada,Other
FAERS-11445,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2019-09-13,45-64,Male,USA,Other
FAERS-11446,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2022-10-27,45-64,Male,USA,Disability
FAERS-11447,LIRAGLUTIDE (VICTOZA),THYROID NEOPLASM,2022-08-23,65-74,Female,Europe,Other
FAERS-11448,EXENATIDE (BYDUREON),DIARRHEA,2023-08-25,65-74,Female,USA,Other
FAERS-11449,EXENATIDE (BYDUREON),HYPOGLYCEMIA,2020-06-06,45-64,Female,Japan,Not specified
FAERS-11450,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-06-04,18-44,Female,USA,Not specified
FAERS-11451,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2022-11-16,45-64,Male,USA,Other
FAERS-11452,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-01-28,45-64,Male,USA,Other
FAERS-11453,SEMAGLUTIDE (WEGOVY),FATIGUE,2023-11-25,45-64,Female,USA,Other
FAERS-11454,SEMAGLUTIDE (WEGOVY),VOMITING,2023-03-28,45-64,Female,Europe,Not specified
FAERS-11455,TIRZEPATIDE (MOUNJARO),VOMITING,2023-06-04,65-74,Male,USA,Not specified
FAERS-11456,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-11-28,65-74,Female,Europe,Not specified
FAERS-11457,EXENATIDE (BYDUREON),DIARRHEA,2018-11-13,Unknown,Female,USA,Other
FAERS-11458,EXENATIDE (BYDUREON),DECREASED APPETITE,2023-02-06,18-44,Female,USA,Other
FAERS-11459,LIRAGLUTIDE (SAXENDA),DIZZINESS,2023-01-10,45-64,Female,USA,Other
FAERS-11460,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-08-03,45-64,Female,Europe,Hospitalization
FAERS-11461,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-03-26,65-74,Male,USA,Hospitalization
FAERS-11462,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-11-21,45-64,Female,Australia,Not specified
FAERS-11463,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2021-05-06,65-74,Female,USA,Other
FAERS-11464,SEMAGLUTIDE (WEGOVY),HEADACHE,2020-05-09,45-64,Female,USA,Other
FAERS-11465,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2022-08-27,45-64,Female,USA,Other
FAERS-11466,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2022-04-23,18-44,Female,USA,Other
FAERS-11467,EXENATIDE (BYDUREON),ALOPECIA,2022-12-26,65-74,Male,Europe,Other
FAERS-11468,EXENATIDE (BYETTA),ALOPECIA,2019-11-21,18-44,Female,USA,Death
FAERS-11469,LIRAGLUTIDE (VICTOZA),HYPOGLYCEMIA,2023-06-23,45-64,Female,Europe,Hospitalization
FAERS-11470,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-02-06,65-74,Male,USA,Not specified
FAERS-11471,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-08-19,45-64,Male,USA,Other
FAERS-11472,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-06-16,45-64,Female,USA,Other
FAERS-11473,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-09-04,Unknown,Female,Europe,Other
FAERS-11474,SEMAGLUTIDE (WEGOVY),ALOPECIA,2022-05-20,75-84,Female,USA,Not specified
FAERS-11475,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2019-06-26,18-44,Unknown,Europe,Not specified
FAERS-11476,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-03-15,45-64,Female,Europe,Hospitalization
FAERS-11477,LIRAGLUTIDE (VICTOZA),CONSTIPATION,2023-07-03,18-44,Male,USA,Other
FAERS-11478,LIRAGLUTIDE (VICTOZA),DECREASED APPETITE,2021-08-18,65-74,Female,USA,Other
FAERS-11479,EXENATIDE (BYDUREON),CONSTIPATION,2020-02-13,45-64,Female,USA,Hospitalization
FAERS-11480,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-12-28,18-44,Female,Canada,Other
FAERS-11481,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-04-20,18-44,Female,Europe,Life-threatening
FAERS-11482,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-07-03,45-64,Female,USA,Other
FAERS-11483,SEMAGLUTIDE (WEGOVY),DIARRHEA,2021-11-06,18-44,Male,USA,Other
FAERS-11484,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2023-07-06,45-64,Female,USA,Life-threatening
FAERS-11485,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2022-02-21,65-74,Female,USA,Not specified
FAERS-11486,TIRZEPATIDE (MOUNJARO),ALOPECIA,2021-08-01,18-44,Male,USA,Other
FAERS-11487,EXENATIDE (BYDUREON),GALLBLADDER DISEASE,2022-10-26,65-74,Male,USA,Not specified
FAERS-11488,DULAGLUTIDE (TRULICITY),FATIGUE,2023-02-26,65-74,Female,Europe,Life-threatening
FAERS-11489,DULAGLUTIDE (TRULICITY),HEADACHE,2021-12-19,45-64,Female,USA,Other
FAERS-11490,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-01-04,45-64,Female,USA,Not specified
FAERS-11491,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-11-10,18-44,Female,USA,Other
FAERS-11492,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-05-21,45-64,Male,USA,Hospitalization
FAERS-11493,SEMAGLUTIDE (WEGOVY),VOMITING,2020-09-04,65-74,Female,USA,Hospitalization
FAERS-11494,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-10-08,45-64,Female,USA,Not specified
FAERS-11495,TIRZEPATIDE (MOUNJARO),ASPIRATION,2018-06-12,75-84,Female,USA,Hospitalization
FAERS-11496,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-12-03,65-74,Female,USA,Other
FAERS-11497,EXENATIDE (BYDUREON),INJECTION SITE REACTION,2021-11-24,45-64,Male,Other,Not specified
FAERS-11498,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2022-09-28,65-74,Female,Other,Other
FAERS-11499,EXENATIDE (BYDUREON),ALOPECIA,2021-12-23,45-64,Female,Europe,Other
FAERS-11500,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-05-01,45-64,Female,Japan,Other
FAERS-11501,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-11-11,45-64,Male,USA,Hospitalization
FAERS-11502,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-10-27,45-64,Male,USA,Other
FAERS-11503,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-06-11,45-64,Female,USA,Other
FAERS-11504,SEMAGLUTIDE (WEGOVY),ALOPECIA,2022-03-22,18-44,Female,USA,Other
FAERS-11505,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2022-06-03,45-64,Female,USA,Disability
FAERS-11506,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-01-05,45-64,Male,USA,Other
FAERS-11507,LIRAGLUTIDE (VICTOZA),DIZZINESS,2023-05-18,45-64,Female,Europe,Other
FAERS-11508,LIRAGLUTIDE (VICTOZA),GALLBLADDER DISEASE,2019-07-07,45-64,Female,Australia,Disability
FAERS-11509,TIRZEPATIDE (ZEPBOUND),HEADACHE,2023-07-18,18-44,Male,Europe,Other
FAERS-11510,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-02-22,45-64,Female,USA,Not specified
FAERS-11511,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2021-07-16,65-74,Male,USA,Other
FAERS-11512,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-01-18,75-84,Male,Canada,Not specified
FAERS-11513,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2022-07-14,45-64,Female,USA,Other
FAERS-11514,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-10-19,45-64,Male,USA,Other
FAERS-11515,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-02-12,45-64,Male,USA,Hospitalization
FAERS-11516,TIRZEPATIDE (MOUNJARO),DIZZINESS,2020-03-15,65-74,Female,USA,Other
FAERS-11517,LIRAGLUTIDE (VICTOZA),DIARRHEA,2021-01-07,75-84,Female,USA,Other
FAERS-11518,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2023-09-21,45-64,Unknown,Europe,Hospitalization
FAERS-11519,EXENATIDE (BYETTA),SUICIDAL IDEATION,2023-02-01,65-74,Female,USA,Other
FAERS-11520,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-07-09,45-64,Female,USA,Not specified
FAERS-11521,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-08-16,65-74,Female,Other,Not specified
FAERS-11522,SEMAGLUTIDE (OZEMPIC),VOMITING,2018-07-23,65-74,Female,Europe,Not specified
FAERS-11523,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-10-25,45-64,Female,USA,Other
FAERS-11524,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2020-08-07,45-64,Female,USA,Other
FAERS-11525,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-05-11,45-64,Female,Europe,Other
FAERS-11526,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2022-03-05,65-74,Female,USA,Other
FAERS-11527,TIRZEPATIDE (ZEPBOUND),CONSTIPATION,2023-03-19,45-64,Female,USA,Other
FAERS-11528,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2019-10-10,45-64,Male,Europe,Not specified
FAERS-11529,LIRAGLUTIDE (SAXENDA),DIZZINESS,2022-05-12,18-44,Male,USA,Other
FAERS-11530,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2020-06-21,Unknown,Female,USA,Life-threatening
FAERS-11531,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-03-28,45-64,Female,Canada,Other
FAERS-11532,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2021-05-07,65-74,Male,Australia,Disability
FAERS-11533,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-08-19,65-74,Female,USA,Not specified
FAERS-11534,SEMAGLUTIDE (WEGOVY),ASPIRATION,2022-04-24,65-74,Female,Europe,Disability
FAERS-11535,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2019-09-18,45-64,Male,USA,Not specified
FAERS-11536,TIRZEPATIDE (MOUNJARO),HEADACHE,2022-04-09,18-44,Female,USA,Other
FAERS-11537,LIRAGLUTIDE (VICTOZA),DECREASED APPETITE,2022-01-20,45-64,Male,Europe,Other
FAERS-11538,LIRAGLUTIDE (SAXENDA),VOMITING,2023-09-10,18-44,Female,USA,Hospitalization
FAERS-11539,LIRAGLUTIDE (VICTOZA),ABDOMINAL PAIN,2023-01-11,65-74,Female,USA,Other
FAERS-11540,SEMAGLUTIDE (OZEMPIC),VOMITING,2019-10-07,45-64,Female,USA,Other
FAERS-11541,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-08-25,0-17,Female,Japan,Other
FAERS-11542,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-07-20,45-64,Female,Other,Other
FAERS-11543,SEMAGLUTIDE (WEGOVY),DIZZINESS,2022-05-28,45-64,Female,USA,Other
FAERS-11544,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2019-03-16,45-64,Female,USA,Hospitalization
FAERS-11545,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-11-10,45-64,Female,USA,Hospitalization
FAERS-11546,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2020-02-25,45-64,Female,Europe,Disability
FAERS-11547,LIRAGLUTIDE (SAXENDA),FATIGUE,2021-10-07,45-64,Female,USA,Other
FAERS-11548,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2020-11-06,18-44,Female,USA,Other
FAERS-11549,EXENATIDE (BYETTA),THYROID NEOPLASM,2021-05-16,45-64,Female,Europe,Not specified
FAERS-11550,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-06-15,45-64,Male,Europe,Other
FAERS-11551,SEMAGLUTIDE (OZEMPIC),HEADACHE,2019-07-12,65-74,Male,Australia,Other
FAERS-11552,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2020-11-23,45-64,Male,Europe,Other
FAERS-11553,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-12-07,18-44,Female,USA,Other
FAERS-11554,SEMAGLUTIDE (WEGOVY),DIZZINESS,2020-12-16,45-64,Male,USA,Not specified
FAERS-11555,TIRZEPATIDE (MOUNJARO),DIZZINESS,2021-12-16,75-84,Female,Europe,Other
FAERS-11556,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2021-09-12,45-64,Male,USA,Other
FAERS-11557,LIRAGLUTIDE (SAXENDA),VOMITING,2023-07-27,18-44,Female,USA,Life-threatening
FAERS-11558,LIRAGLUTIDE (VICTOZA),DIZZINESS,2021-09-25,45-64,Female,USA,Other
FAERS-11559,EXENATIDE (BYETTA),HEADACHE,2019-12-23,45-64,Male,Europe,Other
FAERS-11560,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2020-06-15,45-64,Female,Europe,Disability
FAERS-11561,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-01-05,18-44,Unknown,USA,Hospitalization
FAERS-11562,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-09-12,45-64,Female,USA,Hospitalization
FAERS-11563,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2023-08-10,18-44,Female,Europe,Other
FAERS-11564,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-09-06,65-74,Female,Other,Other
FAERS-11565,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2023-02-25,18-44,Female,USA,Other
FAERS-11566,TIRZEPATIDE (MOUNJARO),ALOPECIA,2020-06-03,45-64,Female,Other,Death
FAERS-11567,EXENATIDE (BYETTA),PANCREATITIS,2021-01-13,45-64,Female,Europe,Other
FAERS-11568,TIRZEPATIDE (ZEPBOUND),DIZZINESS,2020-04-19,45-64,Male,USA,Other
FAERS-11569,LIRAGLUTIDE (SAXENDA),HEADACHE,2023-12-28,45-64,Male,Europe,Other
FAERS-11570,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-01-25,18-44,Male,USA,Hospitalization
FAERS-11571,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-04-10,18-44,Female,Japan,Life-threatening
FAERS-11572,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2018-08-04,18-44,Female,Europe,Not specified
FAERS-11573,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2021-08-15,45-64,Female,Europe,Other
FAERS-11574,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2020-10-24,45-64,Female,USA,Other
FAERS-11575,TIRZEPATIDE (MOUNJARO),DIARRHEA,2021-06-14,18-44,Female,Europe,Disability
FAERS-11576,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2019-08-01,65-74,Female,USA,Hospitalization
FAERS-11577,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2023-07-28,65-74,Female,Australia,Other
FAERS-11578,LIRAGLUTIDE (VICTOZA),THYROID NEOPLASM,2022-05-24,18-44,Female,USA,Other
FAERS-11579,LIRAGLUTIDE (SAXENDA),NAUSEA,2022-03-23,65-74,Male,USA,Other
FAERS-11580,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-10-14,45-64,Male,Europe,Not specified
FAERS-11581,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-11-06,18-44,Female,USA,Other
FAERS-11582,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2021-06-27,65-74,Male,USA,Other
FAERS-11583,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2018-03-14,65-74,Male,Canada,Hospitalization
FAERS-11584,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2018-04-03,45-64,Female,USA,Other
FAERS-11585,TIRZEPATIDE (MOUNJARO),VOMITING,2023-08-05,85+,Female,USA,Not specified
FAERS-11586,TIRZEPATIDE (MOUNJARO),ALOPECIA,2021-06-22,0-17,Female,Canada,Other
FAERS-11587,EXENATIDE (BYETTA),DECREASED APPETITE,2022-03-08,18-44,Female,Europe,Other
FAERS-11588,LIRAGLUTIDE (VICTOZA),CONSTIPATION,2023-02-08,18-44,Male,USA,Disability
FAERS-11589,LIRAGLUTIDE (VICTOZA),INJECTION SITE REACTION,2022-09-19,45-64,Female,USA,Not specified
FAERS-11590,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2020-12-28,65-74,Male,USA,Hospitalization
FAERS-11591,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2020-03-21,45-64,Male,USA,Hospitalization
FAERS-11592,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-06-07,18-44,Male,USA,Other
FAERS-11593,SEMAGLUTIDE (WEGOVY),ALOPECIA,2022-09-15,45-64,Female,USA,Hospitalization
FAERS-11594,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2023-05-11,65-74,Female,USA,Not specified
FAERS-11595,TIRZEPATIDE (MOUNJARO),FATIGUE,2021-09-09,45-64,Female,Europe,Hospitalization
FAERS-11596,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2020-08-27,45-64,Female,USA,Hospitalization
FAERS-11597,EXENATIDE (BYETTA),INJECTION SITE REACTION,2022-02-28,18-44,Male,USA,Not specified
FAERS-11598,LIRAGLUTIDE (VICTOZA),GALLBLADDER DISEASE,2023-04-25,75-84,Unknown,USA,Hospitalization
FAERS-11599,EXENATIDE (BYDUREON),INJECTION SITE REACTION,2022-01-26,45-64,Female,USA,Other
FAERS-11600,SEMAGLUTIDE (OZEMPIC),HEADACHE,2020-11-06,45-64,Unknown,USA,Other
FAERS-11601,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-10-14,18-44,Female,Europe,Not specified
FAERS-11602,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-07-16,75-84,Female,USA,Other
FAERS-11603,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-05-07,75-84,Male,USA,Not specified
FAERS-11604,SEMAGLUTIDE (WEGOVY),DIZZINESS,2020-03-25,75-84,Male,USA,Not specified
FAERS-11605,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2021-10-07,Unknown,Female,USA,Other
FAERS-11606,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2021-12-24,18-44,Female,USA,Other
FAERS-11607,EXENATIDE (BYDUREON),DIARRHEA,2018-02-17,45-64,Female,Europe,Other
FAERS-11608,TIRZEPATIDE (ZEPBOUND),ALOPECIA,2023-09-24,45-64,Male,USA,Other
FAERS-11609,LIRAGLUTIDE (VICTOZA),VOMITING,2021-01-13,Unknown,Female,USA,Not specified
FAERS-11610,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-08-25,45-64,Female,USA,Other
FAERS-11611,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-04-28,18-44,Female,Other,Not specified
FAERS-11612,SEMAGLUTIDE (OZEMPIC),FATIGUE,2019-05-27,45-64,Female,USA,Other
FAERS-11613,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2023-06-03,18-44,Female,USA,Hospitalization
FAERS-11614,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2021-05-04,45-64,Female,USA,Not specified
FAERS-11615,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2022-11-13,45-64,Female,USA,Hospitalization
FAERS-11616,TIRZEPATIDE (MOUNJARO),VOMITING,2019-04-12,65-74,Female,USA,Other
FAERS-11617,EXENATIDE (BYDUREON),ASPIRATION,2021-08-28,45-64,Female,Europe,Other
FAERS-11618,EXENATIDE (BYETTA),NAUSEA,2021-01-07,45-64,Female,Europe,Other
FAERS-11619,TIRZEPATIDE (ZEPBOUND),DIZZINESS,2018-08-28,45-64,Male,USA,Not specified
FAERS-11620,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-01-11,45-64,Female,Other,Other
FAERS-11621,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-09-21,45-64,Female,USA,Other
FAERS-11622,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-06-12,45-64,Female,Europe,Other
FAERS-11623,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2019-12-03,65-74,Male,Europe,Other
FAERS-11624,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2021-12-16,45-64,Male,USA,Other
FAERS-11625,TIRZEPATIDE (MOUNJARO),ALOPECIA,2021-02-07,65-74,Female,Other,Other
FAERS-11626,TIRZEPATIDE (MOUNJARO),ASPIRATION,2022-07-20,45-64,Female,Europe,Other
FAERS-11627,LIRAGLUTIDE (VICTOZA),VOMITING,2023-03-23,65-74,Female,Europe,Other
FAERS-11628,LIRAGLUTIDE (SAXENDA),GALLBLADDER DISEASE,2023-05-20,75-84,Male,Other,Other
FAERS-11629,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2020-05-01,18-44,Female,USA,Other
FAERS-11630,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-04-05,Unknown,Male,USA,Hospitalization
FAERS-11631,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-09-19,18-44,Female,Europe,Disability
FAERS-11632,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-07-24,45-64,Female,USA,Other
FAERS-11633,SEMAGLUTIDE (WEGOVY),ALOPECIA,2021-04-11,45-64,Female,USA,Other
FAERS-11634,SEMAGLUTIDE (WEGOVY),VOMITING,2023-09-19,45-64,Male,Europe,Hospitalization
FAERS-11635,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2021-10-08,65-74,Female,USA,Other
FAERS-11636,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2022-10-27,45-64,Female,Other,Hospitalization
FAERS-11637,EXENATIDE (BYETTA),HYPOGLYCEMIA,2018-08-18,45-64,Male,Other,Other
FAERS-11638,LIRAGLUTIDE (SAXENDA),FATIGUE,2023-05-19,45-64,Male,USA,Other
FAERS-11639,EXENATIDE (BYDUREON),NAUSEA,2020-07-07,45-64,Female,Europe,Other
FAERS-11640,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-09-14,45-64,Male,USA,Hospitalization
FAERS-11641,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-12-25,45-64,Male,USA,Other
FAERS-11642,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-12-07,Unknown,Female,USA,Other
FAERS-11643,SEMAGLUTIDE (WEGOVY),DIZZINESS,2022-08-24,65-74,Male,USA,Hospitalization
FAERS-11644,SEMAGLUTIDE (WEGOVY),VOMITING,2021-07-13,75-84,Female,Australia,Other
FAERS-11645,TIRZEPATIDE (MOUNJARO),DIARRHEA,2023-05-16,45-64,Male,USA,Hospitalization
FAERS-11646,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2019-08-25,18-44,Female,USA,Hospitalization
FAERS-11647,LIRAGLUTIDE (SAXENDA),NAUSEA,2021-03-01,45-64,Unknown,USA,Not specified
FAERS-11648,EXENATIDE (BYETTA),NAUSEA,2022-06-28,45-64,Male,Europe,Hospitalization
FAERS-11649,LIRAGLUTIDE (VICTOZA),CONSTIPATION,2021-11-05,45-64,Male,USA,Other
FAERS-11650,SEMAGLUTIDE (OZEMPIC),HEADACHE,2020-03-27,65-74,Female,Canada,Not specified
FAERS-11651,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-05-10,18-44,Female,Other,Hospitalization
FAERS-11652,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2020-03-20,45-64,Male,USA,Not specified
FAERS-11653,SEMAGLUTIDE (WEGOVY),ASPIRATION,2021-02-22,75-84,Female,USA,Other
FAERS-11654,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2020-07-02,45-64,Male,Europe,Other
FAERS-11655,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-10-04,75-84,Female,Japan,Not specified
FAERS-11656,TIRZEPATIDE (MOUNJARO),VOMITING,2023-09-13,45-64,Female,USA,Other
FAERS-11657,EXENATIDE (BYDUREON),CONSTIPATION,2023-07-13,45-64,Female,USA,Other
FAERS-11658,TIRZEPATIDE (ZEPBOUND),FATIGUE,2021-08-26,45-64,Male,USA,Other
FAERS-11659,EXENATIDE (BYDUREON),DECREASED APPETITE,2021-10-24,45-64,Male,Australia,Not specified
FAERS-11660,SEMAGLUTIDE (OZEMPIC),HEADACHE,2018-05-13,45-64,Female,USA,Death
FAERS-11661,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-09-28,18-44,Female,Canada,Life-threatening
FAERS-11662,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-04-23,45-64,Female,USA,Other
FAERS-11663,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2018-07-07,45-64,Female,USA,Not specified
FAERS-11664,SEMAGLUTIDE (WEGOVY),VOMITING,2023-06-06,45-64,Female,Europe,Not specified
FAERS-11665,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2020-04-20,45-64,Female,USA,Other
FAERS-11666,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2022-04-21,45-64,Female,Canada,Other
FAERS-11667,LIRAGLUTIDE (SAXENDA),GALLBLADDER DISEASE,2023-04-27,18-44,Female,USA,Other
FAERS-11668,LIRAGLUTIDE (SAXENDA),DIZZINESS,2021-11-23,45-64,Female,Europe,Disability
FAERS-11669,EXENATIDE (BYDUREON),VOMITING,2022-03-24,18-44,Female,USA,Other
FAERS-11670,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-10-09,75-84,Female,USA,Hospitalization
FAERS-11671,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-08-07,65-74,Female,Other,Hospitalization
FAERS-11672,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-03-03,45-64,Male,USA,Other
FAERS-11673,SEMAGLUTIDE (WEGOVY),ALOPECIA,2020-10-25,18-44,Female,USA,Hospitalization
FAERS-11674,SEMAGLUTIDE (WEGOVY),ASPIRATION,2021-10-01,65-74,Male,USA,Not specified
FAERS-11675,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2020-11-02,75-84,Female,USA,Other
FAERS-11676,TIRZEPATIDE (MOUNJARO),DIARRHEA,2020-11-24,45-64,Male,USA,Other
FAERS-11677,DULAGLUTIDE (TRULICITY),VOMITING,2020-06-02,18-44,Female,USA,Hospitalization
FAERS-11678,TIRZEPATIDE (ZEPBOUND),GALLBLADDER DISEASE,2023-06-02,45-64,Female,USA,Hospitalization
FAERS-11679,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2021-10-04,0-17,Male,USA,Not specified
FAERS-11680,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-08-19,18-44,Female,USA,Other
FAERS-11681,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-10-09,45-64,Female,Europe,Other
FAERS-11682,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-06-08,45-64,Female,USA,Hospitalization
FAERS-11683,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-06-24,18-44,Female,Other,Hospitalization
FAERS-11684,SEMAGLUTIDE (WEGOVY),ALOPECIA,2022-04-13,18-44,Female,Europe,Hospitalization
FAERS-11685,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-08-15,18-44,Female,Canada,Not specified
FAERS-11686,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2022-04-07,45-64,Female,USA,Other
FAERS-11687,EXENATIDE (BYETTA),CONSTIPATION,2023-09-28,65-74,Female,USA,Other
FAERS-11688,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2022-08-10,45-64,Female,USA,Not specified
FAERS-11689,EXENATIDE (BYETTA),HYPOGLYCEMIA,2022-09-14,18-44,Male,Canada,Death
FAERS-11690,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-12-22,45-64,Female,Europe,Other
FAERS-11691,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2021-08-08,45-64,Female,USA,Not specified
FAERS-11692,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-12-21,75-84,Male,Australia,Not specified
FAERS-11693,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-01-11,65-74,Male,USA,Not specified
FAERS-11694,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2020-02-12,65-74,Male,USA,Other
FAERS-11695,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2020-05-04,65-74,Female,USA,Not specified
FAERS-11696,TIRZEPATIDE (MOUNJARO),DIARRHEA,2023-07-06,65-74,Male,USA,Other
FAERS-11697,EXENATIDE (BYDUREON),HYPOGLYCEMIA,2023-11-05,Unknown,Female,Japan,Not specified
FAERS-11698,TIRZEPATIDE (ZEPBOUND),INJECTION SITE REACTION,2020-01-19,18-44,Female,USA,Other
FAERS-11699,LIRAGLUTIDE (SAXENDA),ASPIRATION,2023-11-19,45-64,Male,Canada,Other
FAERS-11700,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-11-13,18-44,Female,USA,Not specified
FAERS-11701,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-05-23,75-84,Female,USA,Other
FAERS-11702,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-10-14,45-64,Unknown,USA,Not specified
FAERS-11703,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-01-16,18-44,Female,Other,Other
FAERS-11704,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-06-02,45-64,Female,USA,Other
FAERS-11705,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2018-10-01,45-64,Female,USA,Other
FAERS-11706,TIRZEPATIDE (MOUNJARO),NAUSEA,2018-11-09,45-64,Female,USA,Other
FAERS-11707,LIRAGLUTIDE (SAXENDA),GALLBLADDER DISEASE,2023-03-12,45-64,Unknown,USA,Other
FAERS-11708,EXENATIDE (BYETTA),CONSTIPATION,2022-11-11,45-64,Male,USA,Not specified
FAERS-11709,TIRZEPATIDE (ZEPBOUND),NAUSEA,2020-02-05,18-44,Female,USA,Other
FAERS-11710,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-06-28,18-44,Male,Europe,Not specified
FAERS-11711,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-06-26,45-64,Female,Other,Other
FAERS-11712,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-03-03,18-44,Male,Japan,Other
FAERS-11713,SEMAGLUTIDE (WEGOVY),VOMITING,2023-07-11,45-64,Female,USA,Other
FAERS-11714,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-08-10,65-74,Female,USA,Other
FAERS-11715,TIRZEPATIDE (MOUNJARO),DIZZINESS,2019-04-09,65-74,Female,USA,Hospitalization
FAERS-11716,TIRZEPATIDE (MOUNJARO),HEADACHE,2019-03-28,Unknown,Female,Europe,Other
FAERS-11717,LIRAGLUTIDE (VICTOZA),DIARRHEA,2022-05-07,45-64,Female,USA,Other
FAERS-11718,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2021-03-03,45-64,Female,Other,Hospitalization
FAERS-11719,DULAGLUTIDE (TRULICITY),PANCREATITIS,2019-12-15,65-74,Female,Europe,Hospitalization
FAERS-11720,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-11-20,18-44,Female,Japan,Other
FAERS-11721,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-08-12,45-64,Female,USA,Other
FAERS-11722,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-01-23,45-64,Unknown,USA,Other
FAERS-11723,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2023-08-28,45-64,Female,Europe,Not specified
FAERS-11724,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2018-03-26,18-44,Female,USA,Other
FAERS-11725,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-11-06,45-64,Female,USA,Life-threatening
FAERS-11726,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2021-04-01,18-44,Male,USA,Other
FAERS-11727,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2022-12-16,75-84,Female,USA,Other
FAERS-11728,LIRAGLUTIDE (VICTOZA),FATIGUE,2023-12-16,45-64,Female,USA,Other
FAERS-11729,LIRAGLUTIDE (VICTOZA),CONSTIPATION,2018-05-21,75-84,Female,USA,Life-threatening
FAERS-11730,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2019-05-11,45-64,Female,USA,Other
FAERS-11731,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2019-08-12,65-74,Female,Other,Other
FAERS-11732,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2021-08-26,45-64,Male,Canada,Other
FAERS-11733,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-11-19,65-74,Female,Japan,Not specified
FAERS-11734,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2022-08-01,45-64,Male,Europe,Other
FAERS-11735,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2022-08-20,45-64,Male,USA,Not specified
FAERS-11736,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2020-05-23,65-74,Male,USA,Hospitalization
FAERS-11737,TIRZEPATIDE (ZEPBOUND),FATIGUE,2022-09-05,18-44,Male,USA,Other
FAERS-11738,LIRAGLUTIDE (SAXENDA),FATIGUE,2023-04-20,45-64,Female,USA,Other
FAERS-11739,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2021-07-14,65-74,Male,Europe,Other
FAERS-11740,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2018-11-25,45-64,Male,USA,Other
FAERS-11741,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-03-20,65-74,Unknown,USA,Other
FAERS-11742,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-05-06,75-84,Female,USA,Other
FAERS-11743,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2022-03-11,18-44,Male,USA,Not specified
FAERS-11744,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2020-10-27,18-44,Female,USA,Other
FAERS-11745,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-12-23,45-64,Female,USA,Other
FAERS-11746,TIRZEPATIDE (MOUNJARO),FATIGUE,2020-12-08,75-84,Male,USA,Hospitalization
FAERS-11747,LIRAGLUTIDE (SAXENDA),THYROID NEOPLASM,2022-09-02,45-64,Female,Europe,Other
FAERS-11748,EXENATIDE (BYDUREON),ALOPECIA,2020-03-04,45-64,Female,USA,Other
FAERS-11749,LIRAGLUTIDE (SAXENDA),CONSTIPATION,2022-12-08,18-44,Female,USA,Other
FAERS-11750,SEMAGLUTIDE (OZEMPIC),NAUSEA,2020-06-11,65-74,Female,Other,Other
FAERS-11751,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2018-12-23,45-64,Female,USA,Other
FAERS-11752,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-06-23,18-44,Male,USA,Hospitalization
FAERS-11753,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2020-01-21,45-64,Female,USA,Other
FAERS-11754,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2020-10-09,45-64,Female,USA,Other
FAERS-11755,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2018-10-21,45-64,Male,USA,Other
FAERS-11756,TIRZEPATIDE (MOUNJARO),ALOPECIA,2019-04-07,18-44,Male,USA,Other
FAERS-11757,EXENATIDE (BYDUREON),INJECTION SITE REACTION,2023-06-15,65-74,Female,Canada,Hospitalization
FAERS-11758,EXENATIDE (BYDUREON),CONSTIPATION,2018-01-07,65-74,Female,USA,Not specified
FAERS-11759,LIRAGLUTIDE (SAXENDA),CONSTIPATION,2023-10-25,75-84,Female,USA,Life-threatening
FAERS-11760,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-04-03,45-64,Male,Other,Other
FAERS-11761,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-01-10,65-74,Female,Canada,Other
FAERS-11762,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-07-24,85+,Male,USA,Not specified
FAERS-11763,SEMAGLUTIDE (WEGOVY),VOMITING,2023-05-05,45-64,Male,Europe,Other
FAERS-11764,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-12-22,65-74,Female,USA,Other
FAERS-11765,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2023-08-28,75-84,Male,USA,Not specified
FAERS-11766,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2019-12-05,45-64,Male,USA,Disability
FAERS-11767,DULAGLUTIDE (TRULICITY),DECREASED APPETITE,2021-01-19,18-44,Female,Europe,Not specified
FAERS-11768,EXENATIDE (BYDUREON),VOMITING,2022-05-01,65-74,Male,USA,Other
FAERS-11769,LIRAGLUTIDE (VICTOZA),CONSTIPATION,2023-07-18,45-64,Male,Europe,Not specified
FAERS-11770,SEMAGLUTIDE (OZEMPIC),FATIGUE,2021-10-12,18-44,Female,USA,Other
FAERS-11771,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-03-11,18-44,Female,USA,Other
FAERS-11772,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2021-05-05,18-44,Female,USA,Not specified
FAERS-11773,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2021-10-09,45-64,Female,USA,Not specified
FAERS-11774,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-03-02,45-64,Female,Europe,Other
FAERS-11775,TIRZEPATIDE (MOUNJARO),ASPIRATION,2022-12-06,Unknown,Male,USA,Not specified
FAERS-11776,TIRZEPATIDE (MOUNJARO),HEADACHE,2021-07-04,Unknown,Female,Europe,Not specified
FAERS-11777,EXENATIDE (BYETTA),NAUSEA,2022-03-24,18-44,Male,Australia,Disability
FAERS-11778,EXENATIDE (BYDUREON),ALOPECIA,2021-07-17,45-64,Male,Europe,Other
FAERS-11779,DULAGLUTIDE (TRULICITY),CONSTIPATION,2019-11-21,45-64,Female,Europe,Other
FAERS-11780,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-09-26,65-74,Male,USA,Hospitalization
FAERS-11781,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2021-04-18,18-44,Female,USA,Other
FAERS-11782,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2020-11-03,18-44,Male,USA,Hospitalization
FAERS-11783,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2018-10-10,18-44,Female,Europe,Other
FAERS-11784,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2022-10-02,45-64,Female,Japan,Other
FAERS-11785,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-07-25,45-64,Female,USA,Other
FAERS-11786,TIRZEPATIDE (MOUNJARO),VOMITING,2023-08-01,45-64,Female,USA,Other
FAERS-11787,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2020-12-21,18-44,Male,USA,Not specified
FAERS-11788,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2021-09-25,45-64,Female,USA,Other
FAERS-11789,DULAGLUTIDE (TRULICITY),CONSTIPATION,2023-01-17,45-64,Male,USA,Other
FAERS-11790,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-11-24,45-64,Female,USA,Hospitalization
FAERS-11791,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-03-02,45-64,Female,Japan,Other
FAERS-11792,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2020-08-08,18-44,Male,Europe,Hospitalization
FAERS-11793,SEMAGLUTIDE (WEGOVY),ALOPECIA,2018-03-08,65-74,Female,Europe,Other
FAERS-11794,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-02-04,65-74,Male,USA,Life-threatening
FAERS-11795,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-12-14,Unknown,Female,USA,Hospitalization
FAERS-11796,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-05-14,45-64,Female,USA,Other
FAERS-11797,DULAGLUTIDE (TRULICITY),VOMITING,2022-09-08,18-44,Female,Europe,Not specified
FAERS-11798,LIRAGLUTIDE (VICTOZA),DIARRHEA,2021-09-12,18-44,Female,Europe,Other
FAERS-11799,DULAGLUTIDE (TRULICITY),VOMITING,2022-04-07,65-74,Male,USA,Hospitalization
FAERS-11800,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-02-17,45-64,Male,USA,Other
FAERS-11801,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-08-26,0-17,Female,USA,Disability
FAERS-11802,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-11-18,45-64,Male,USA,Not specified
FAERS-11803,SEMAGLUTIDE (WEGOVY),VOMITING,2023-08-17,45-64,Female,USA,Not specified
FAERS-11804,SEMAGLUTIDE (WEGOVY),VOMITING,2022-04-27,18-44,Female,USA,Other
FAERS-11805,TIRZEPATIDE (MOUNJARO),VOMITING,2018-11-24,45-64,Female,Europe,Not specified
FAERS-11806,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2019-10-26,45-64,Female,Europe,Other
FAERS-11807,DULAGLUTIDE (TRULICITY),DIZZINESS,2021-02-14,65-74,Male,USA,Other
FAERS-11808,DULAGLUTIDE (TRULICITY),VOMITING,2022-06-09,18-44,Female,USA,Other
FAERS-11809,DULAGLUTIDE (TRULICITY),DECREASED APPETITE,2022-05-28,Unknown,Male,Europe,Not specified
FAERS-11810,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-11-20,45-64,Female,Europe,Other
FAERS-11811,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-09-17,18-44,Male,Europe,Other
FAERS-11812,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-04-11,45-64,Female,Canada,Not specified
FAERS-11813,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2020-06-17,18-44,Male,Other,Other
FAERS-11814,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2022-03-26,45-64,Female,USA,Other
FAERS-11815,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2021-08-19,45-64,Female,USA,Other
FAERS-11816,TIRZEPATIDE (MOUNJARO),VOMITING,2022-11-27,65-74,Male,USA,Other
FAERS-11817,EXENATIDE (BYDUREON),ALOPECIA,2023-08-18,45-64,Female,Europe,Other
FAERS-11818,LIRAGLUTIDE (SAXENDA),DIZZINESS,2023-01-03,18-44,Female,Europe,Death
FAERS-11819,LIRAGLUTIDE (SAXENDA),ASPIRATION,2021-10-14,45-64,Unknown,USA,Disability
FAERS-11820,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-07-11,45-64,Unknown,USA,Hospitalization
FAERS-11821,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-05-04,45-64,Female,USA,Other
FAERS-11822,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2020-11-19,65-74,Female,Europe,Hospitalization
FAERS-11823,SEMAGLUTIDE (WEGOVY),VOMITING,2020-04-20,Unknown,Female,USA,Other
FAERS-11824,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2018-10-11,75-84,Female,USA,Other
FAERS-11825,TIRZEPATIDE (MOUNJARO),DIARRHEA,2018-03-03,85+,Female,USA,Other
FAERS-11826,TIRZEPATIDE (MOUNJARO),DIZZINESS,2020-07-08,Unknown,Female,USA,Other
FAERS-11827,EXENATIDE (BYETTA),DIARRHEA,2020-05-14,18-44,Male,USA,Other
FAERS-11828,EXENATIDE (BYETTA),SUICIDAL IDEATION,2021-08-15,45-64,Male,Europe,Life-threatening
FAERS-11829,DULAGLUTIDE (TRULICITY),SUICIDAL IDEATION,2020-11-16,65-74,Male,Europe,Other
FAERS-11830,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2021-08-20,45-64,Male,USA,Disability
FAERS-11831,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2020-07-07,18-44,Female,Europe,Disability
FAERS-11832,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-08-01,45-64,Female,Canada,Other
FAERS-11833,SEMAGLUTIDE (WEGOVY),HEADACHE,2018-10-12,45-64,Male,Europe,Other
FAERS-11834,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-06-08,45-64,Female,USA,Other
FAERS-11835,TIRZEPATIDE (MOUNJARO),ASPIRATION,2022-09-20,18-44,Male,USA,Other
FAERS-11836,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2020-12-06,18-44,Female,USA,Hospitalization
FAERS-11837,EXENATIDE (BYDUREON),HEADACHE,2020-03-28,18-44,Female,USA,Other
FAERS-11838,LIRAGLUTIDE (VICTOZA),CONSTIPATION,2019-01-19,45-64,Female,USA,Other
FAERS-11839,EXENATIDE (BYDUREON),DIARRHEA,2020-04-20,45-64,Female,Canada,Other
FAERS-11840,SEMAGLUTIDE (OZEMPIC),VOMITING,2019-08-18,18-44,Female,USA,Other
FAERS-11841,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2018-03-25,18-44,Female,USA,Other
FAERS-11842,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2020-08-05,45-64,Female,USA,Not specified
FAERS-11843,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2022-08-06,45-64,Female,Europe,Other
FAERS-11844,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2023-03-01,18-44,Female,USA,Other
FAERS-11845,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-09-15,45-64,Female,USA,Not specified
FAERS-11846,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-05-17,45-64,Female,Europe,Not specified
FAERS-11847,LIRAGLUTIDE (VICTOZA),FATIGUE,2022-06-27,45-64,Female,USA,Other
FAERS-11848,EXENATIDE (BYETTA),ASPIRATION,2022-01-07,45-64,Male,USA,Other
FAERS-11849,EXENATIDE (BYDUREON),INJECTION SITE REACTION,2020-05-13,45-64,Female,Europe,Other
FAERS-11850,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-08-12,18-44,Female,USA,Not specified
FAERS-11851,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-02-10,45-64,Male,Australia,Other
FAERS-11852,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2019-05-12,65-74,Female,Canada,Not specified
FAERS-11853,SEMAGLUTIDE (WEGOVY),HEADACHE,2019-06-07,18-44,Unknown,Europe,Other
FAERS-11854,SEMAGLUTIDE (WEGOVY),FATIGUE,2022-01-01,18-44,Male,Europe,Other
FAERS-11855,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-06-20,45-64,Female,USA,Other
FAERS-11856,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-07-25,65-74,Female,Canada,Other
FAERS-11857,EXENATIDE (BYDUREON),ALOPECIA,2023-07-11,65-74,Female,USA,Other
FAERS-11858,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2020-10-13,45-64,Male,Europe,Other
FAERS-11859,LIRAGLUTIDE (VICTOZA),NAUSEA,2022-07-26,45-64,Female,USA,Not specified
FAERS-11860,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2018-02-06,45-64,Male,Japan,Not specified
FAERS-11861,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-11-16,45-64,Male,USA,Hospitalization
FAERS-11862,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-08-09,65-74,Male,Europe,Other
FAERS-11863,SEMAGLUTIDE (WEGOVY),HEADACHE,2021-03-22,65-74,Female,USA,Other
FAERS-11864,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2023-04-27,45-64,Male,USA,Hospitalization
FAERS-11865,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-07-02,45-64,Female,USA,Not specified
FAERS-11866,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2020-04-08,65-74,Male,USA,Other
FAERS-11867,LIRAGLUTIDE (VICTOZA),ASPIRATION,2021-10-11,45-64,Female,USA,Other
FAERS-11868,LIRAGLUTIDE (VICTOZA),DIARRHEA,2021-01-14,45-64,Female,USA,Other
FAERS-11869,DULAGLUTIDE (TRULICITY),DIARRHEA,2019-04-16,45-64,Male,Australia,Not specified
FAERS-11870,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-05-08,75-84,Female,USA,Other
FAERS-11871,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2019-02-03,18-44,Male,USA,Other
FAERS-11872,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-12-21,45-64,Female,USA,Life-threatening
FAERS-11873,SEMAGLUTIDE (WEGOVY),NAUSEA,2023-11-22,45-64,Male,USA,Not specified
FAERS-11874,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2021-02-02,45-64,Male,USA,Not specified
FAERS-11875,TIRZEPATIDE (MOUNJARO),VOMITING,2023-07-27,18-44,Male,Japan,Not specified
FAERS-11876,TIRZEPATIDE (MOUNJARO),VOMITING,2023-05-05,45-64,Female,USA,Hospitalization
FAERS-11877,EXENATIDE (BYETTA),SUICIDAL IDEATION,2022-04-23,18-44,Female,USA,Other
FAERS-11878,DULAGLUTIDE (TRULICITY),SUICIDAL IDEATION,2021-09-10,45-64,Female,Europe,Other
FAERS-11879,EXENATIDE (BYDUREON),ALOPECIA,2023-11-11,45-64,Female,Europe,Disability
FAERS-11880,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-03-04,45-64,Male,USA,Not specified
FAERS-11881,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2021-04-23,65-74,Male,USA,Other
FAERS-11882,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-05-23,75-84,Female,Europe,Disability
FAERS-11883,SEMAGLUTIDE (WEGOVY),FATIGUE,2019-01-27,18-44,Male,USA,Not specified
FAERS-11884,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-12-28,18-44,Female,Europe,Other
FAERS-11885,TIRZEPATIDE (MOUNJARO),DIARRHEA,2021-10-28,45-64,Female,USA,Other
FAERS-11886,TIRZEPATIDE (MOUNJARO),NAUSEA,2022-06-05,65-74,Female,USA,Hospitalization
FAERS-11887,LIRAGLUTIDE (VICTOZA),ABDOMINAL PAIN,2023-07-02,45-64,Female,Japan,Other
FAERS-11888,EXENATIDE (BYDUREON),GALLBLADDER DISEASE,2019-09-07,45-64,Female,USA,Disability
FAERS-11889,LIRAGLUTIDE (SAXENDA),DECREASED APPETITE,2021-09-19,65-74,Female,USA,Other
FAERS-11890,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-12-19,45-64,Female,Europe,Other
FAERS-11891,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-11-26,65-74,Male,USA,Hospitalization
FAERS-11892,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-06-27,45-64,Female,Canada,Other
FAERS-11893,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2020-10-09,45-64,Female,USA,Other
FAERS-11894,SEMAGLUTIDE (WEGOVY),NAUSEA,2020-01-14,18-44,Male,Europe,Hospitalization
FAERS-11895,TIRZEPATIDE (MOUNJARO),VOMITING,2023-01-17,65-74,Female,Canada,Not specified
FAERS-11896,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2022-08-19,65-74,Female,Europe,Disability
FAERS-11897,EXENATIDE (BYDUREON),HEADACHE,2021-12-11,65-74,Female,Japan,Life-threatening
FAERS-11898,EXENATIDE (BYDUREON),CONSTIPATION,2023-01-04,45-64,Male,USA,Hospitalization
FAERS-11899,EXENATIDE (BYDUREON),INJECTION SITE REACTION,2020-07-07,18-44,Male,USA,Other
FAERS-11900,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-11-03,65-74,Male,Other,Hospitalization
FAERS-11901,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2019-05-06,18-44,Female,Other,Hospitalization
FAERS-11902,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-02-16,18-44,Female,Europe,Other
FAERS-11903,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-04-18,18-44,Female,USA,Not specified
FAERS-11904,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2023-02-06,75-84,Female,Other,Hospitalization
FAERS-11905,TIRZEPATIDE (MOUNJARO),DIARRHEA,2023-11-12,65-74,Female,USA,Hospitalization
FAERS-11906,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2023-07-07,65-74,Female,Europe,Life-threatening
FAERS-11907,EXENATIDE (BYETTA),DIZZINESS,2023-04-27,65-74,Female,USA,Other
FAERS-11908,DULAGLUTIDE (TRULICITY),HEADACHE,2023-01-15,45-64,Male,USA,Death
FAERS-11909,EXENATIDE (BYETTA),GALLBLADDER DISEASE,2021-01-11,Unknown,Female,USA,Not specified
FAERS-11910,SEMAGLUTIDE (OZEMPIC),VOMITING,2019-03-16,65-74,Female,USA,Other
FAERS-11911,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2018-11-11,65-74,Male,USA,Other
FAERS-11912,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-11-05,45-64,Male,USA,Other
FAERS-11913,SEMAGLUTIDE (WEGOVY),ALOPECIA,2023-09-12,Unknown,Male,Europe,Hospitalization
FAERS-11914,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2021-12-03,45-64,Male,Other,Not specified
FAERS-11915,TIRZEPATIDE (MOUNJARO),ASPIRATION,2019-05-25,45-64,Female,USA,Other
FAERS-11916,TIRZEPATIDE (MOUNJARO),ASPIRATION,2020-05-10,18-44,Male,Europe,Not specified
FAERS-11917,EXENATIDE (BYETTA),INJECTION SITE REACTION,2023-12-18,75-84,Male,Europe,Other
FAERS-11918,EXENATIDE (BYETTA),DECREASED APPETITE,2021-07-03,18-44,Female,Australia,Other
FAERS-11919,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2018-08-02,18-44,Male,Australia,Other
FAERS-11920,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-04-03,45-64,Male,USA,Other
FAERS-11921,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-08-07,75-84,Female,USA,Other
FAERS-11922,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2020-07-01,65-74,Female,Europe,Other
FAERS-11923,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-04-02,45-64,Female,Europe,Other
FAERS-11924,SEMAGLUTIDE (WEGOVY),DIZZINESS,2020-10-14,45-64,Female,USA,Not specified
FAERS-11925,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-11-20,18-44,Female,USA,Other
FAERS-11926,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2019-03-27,45-64,Male,USA,Other
FAERS-11927,TIRZEPATIDE (ZEPBOUND),THYROID NEOPLASM,2020-01-24,18-44,Female,USA,Hospitalization
FAERS-11928,DULAGLUTIDE (TRULICITY),DIARRHEA,2022-12-04,18-44,Female,USA,Not specified
FAERS-11929,TIRZEPATIDE (ZEPBOUND),HYPOGLYCEMIA,2022-02-28,45-64,Female,USA,Other
FAERS-11930,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-11-05,45-64,Female,USA,Disability
FAERS-11931,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-05-14,65-74,Female,Europe,Hospitalization
FAERS-11932,SEMAGLUTIDE (OZEMPIC),NAUSEA,2019-08-17,45-64,Male,Canada,Other
FAERS-11933,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2021-01-16,65-74,Male,USA,Other
FAERS-11934,SEMAGLUTIDE (WEGOVY),HEADACHE,2021-12-28,45-64,Male,USA,Other
FAERS-11935,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-01-25,45-64,Male,USA,Disability
FAERS-11936,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-02-09,18-44,Female,USA,Other
FAERS-11937,EXENATIDE (BYETTA),ABDOMINAL PAIN,2021-07-01,18-44,Female,USA,Hospitalization
FAERS-11938,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2022-09-28,45-64,Female,Europe,Other
FAERS-11939,EXENATIDE (BYETTA),ASPIRATION,2023-06-25,45-64,Unknown,USA,Other
FAERS-11940,SEMAGLUTIDE (OZEMPIC),HEADACHE,2019-05-24,45-64,Male,USA,Other
FAERS-11941,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-10-19,65-74,Female,USA,Other
FAERS-11942,SEMAGLUTIDE (OZEMPIC),VOMITING,2018-06-12,45-64,Male,USA,Other
FAERS-11943,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2018-02-04,45-64,Male,Other,Other
FAERS-11944,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-12-03,45-64,Male,USA,Hospitalization
FAERS-11945,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2020-06-04,45-64,Female,USA,Hospitalization
FAERS-11946,TIRZEPATIDE (MOUNJARO),NAUSEA,2022-08-07,45-64,Male,USA,Hospitalization
FAERS-11947,LIRAGLUTIDE (VICTOZA),DIZZINESS,2023-04-02,18-44,Male,USA,Other
FAERS-11948,LIRAGLUTIDE (SAXENDA),HEADACHE,2023-04-26,45-64,Female,USA,Other
FAERS-11949,LIRAGLUTIDE (SAXENDA),VOMITING,2018-12-12,45-64,Male,USA,Not specified
FAERS-11950,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-10-01,45-64,Male,Europe,Other
FAERS-11951,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2020-04-07,65-74,Male,USA,Hospitalization
FAERS-11952,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2019-12-07,45-64,Male,USA,Other
FAERS-11953,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2022-03-16,65-74,Female,USA,Other
FAERS-11954,SEMAGLUTIDE (WEGOVY),DIARRHEA,2021-02-25,18-44,Male,Europe,Life-threatening
FAERS-11955,TIRZEPATIDE (MOUNJARO),VOMITING,2020-12-17,45-64,Female,Europe,Other
FAERS-11956,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-10-11,45-64,Female,USA,Not specified
FAERS-11957,LIRAGLUTIDE (VICTOZA),SUICIDAL IDEATION,2021-03-20,45-64,Female,USA,Not specified
FAERS-11958,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2023-01-07,45-64,Male,Europe,Other
FAERS-11959,DULAGLUTIDE (TRULICITY),ALOPECIA,2023-03-02,45-64,Male,USA,Disability
FAERS-11960,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-10-23,75-84,Male,USA,Other
FAERS-11961,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2019-01-17,45-64,Female,USA,Not specified
FAERS-11962,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-02-09,18-44,Female,USA,Other
FAERS-11963,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-03-26,65-74,Male,USA,Other
FAERS-11964,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2021-11-18,18-44,Male,USA,Hospitalization
FAERS-11965,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2021-01-25,45-64,Female,Other,Hospitalization
FAERS-11966,TIRZEPATIDE (MOUNJARO),NAUSEA,2018-06-06,45-64,Male,Europe,Other
FAERS-11967,EXENATIDE (BYDUREON),HEADACHE,2019-09-21,18-44,Male,Other,Other
FAERS-11968,EXENATIDE (BYDUREON),INJECTION SITE REACTION,2021-11-04,45-64,Female,Other,Other
FAERS-11969,EXENATIDE (BYETTA),DIZZINESS,2023-10-22,65-74,Male,USA,Other
FAERS-11970,SEMAGLUTIDE (OZEMPIC),FATIGUE,2020-05-17,45-64,Female,USA,Other
FAERS-11971,SEMAGLUTIDE (OZEMPIC),NAUSEA,2018-10-02,45-64,Male,USA,Hospitalization
FAERS-11972,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-09-09,18-44,Male,USA,Other
FAERS-11973,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2021-04-11,45-64,Male,USA,Other
FAERS-11974,SEMAGLUTIDE (WEGOVY),NAUSEA,2023-09-23,45-64,Male,USA,Hospitalization
FAERS-11975,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2022-08-20,45-64,Male,USA,Other
FAERS-11976,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-09-06,65-74,Female,Other,Hospitalization
FAERS-11977,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2023-02-18,18-44,Male,USA,Not specified
FAERS-11978,EXENATIDE (BYDUREON),NAUSEA,2020-08-16,45-64,Male,Canada,Not specified
FAERS-11979,LIRAGLUTIDE (VICTOZA),FATIGUE,2019-05-08,45-64,Female,USA,Life-threatening
FAERS-11980,SEMAGLUTIDE (OZEMPIC),VOMITING,2020-10-21,45-64,Female,USA,Other
FAERS-11981,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-12-05,45-64,Male,USA,Other
FAERS-11982,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-02-15,45-64,Male,USA,Not specified
FAERS-11983,SEMAGLUTIDE (WEGOVY),ALOPECIA,2021-06-25,45-64,Unknown,USA,Other
FAERS-11984,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2021-09-22,18-44,Female,Europe,Death
FAERS-11985,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2022-05-14,65-74,Female,Europe,Other
FAERS-11986,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2023-01-25,45-64,Female,USA,Disability
FAERS-11987,TIRZEPATIDE (ZEPBOUND),GALLBLADDER DISEASE,2023-06-24,45-64,Female,USA,Not specified
FAERS-11988,DULAGLUTIDE (TRULICITY),DIZZINESS,2021-11-02,45-64,Female,USA,Not specified
FAERS-11989,LIRAGLUTIDE (SAXENDA),ABDOMINAL PAIN,2021-09-09,75-84,Male,Europe,Other
FAERS-11990,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-02-04,18-44,Female,Europe,Other
FAERS-11991,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2018-04-08,45-64,Female,USA,Other
FAERS-11992,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-04-02,18-44,Male,USA,Not specified
FAERS-11993,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-09-16,65-74,Female,Japan,Other
FAERS-11994,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2021-09-24,45-64,Female,USA,Not specified
FAERS-11995,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-01-19,18-44,Male,Europe,Hospitalization
FAERS-11996,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-04-23,18-44,Male,USA,Other
FAERS-11997,DULAGLUTIDE (TRULICITY),DIZZINESS,2022-12-14,45-64,Female,Europe,Not specified
FAERS-11998,EXENATIDE (BYETTA),DECREASED APPETITE,2023-02-10,45-64,Female,USA,Other
FAERS-11999,TIRZEPATIDE (ZEPBOUND),SUICIDAL IDEATION,2021-04-13,45-64,Female,USA,Other
FAERS-12000,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2020-12-06,18-44,Male,Other,Not specified
FAERS-12001,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-07-03,45-64,Male,USA,Hospitalization
FAERS-12002,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2022-07-24,45-64,Female,USA,Hospitalization
FAERS-12003,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-07-14,18-44,Female,USA,Not specified
FAERS-12004,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2021-01-02,45-64,Male,Europe,Not specified
FAERS-12005,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2021-10-03,18-44,Female,USA,Not specified
FAERS-12006,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-04-04,45-64,Female,USA,Not specified
FAERS-12007,LIRAGLUTIDE (VICTOZA),ABDOMINAL PAIN,2022-07-19,45-64,Male,USA,Hospitalization
FAERS-12008,EXENATIDE (BYDUREON),SUICIDAL IDEATION,2022-09-27,45-64,Female,Japan,Other
FAERS-12009,EXENATIDE (BYDUREON),THYROID NEOPLASM,2023-08-25,18-44,Male,USA,Disability
FAERS-12010,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-03-14,45-64,Female,USA,Hospitalization
FAERS-12011,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-08-23,45-64,Female,USA,Other
FAERS-12012,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-05-10,18-44,Female,USA,Other
FAERS-12013,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-07-25,65-74,Female,USA,Other
FAERS-12014,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-11-10,75-84,Female,USA,Not specified
FAERS-12015,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-08-03,65-74,Female,Europe,Not specified
FAERS-12016,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-04-05,45-64,Female,USA,Other
FAERS-12017,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2023-04-06,65-74,Female,USA,Not specified
FAERS-12018,TIRZEPATIDE (ZEPBOUND),CONSTIPATION,2020-07-13,65-74,Female,USA,Other
FAERS-12019,TIRZEPATIDE (ZEPBOUND),GALLBLADDER DISEASE,2021-02-15,45-64,Unknown,USA,Other
FAERS-12020,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2021-12-08,18-44,Female,Europe,Other
FAERS-12021,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2020-09-05,45-64,Female,USA,Other
FAERS-12022,SEMAGLUTIDE (OZEMPIC),HEADACHE,2018-06-14,18-44,Female,USA,Not specified
FAERS-12023,SEMAGLUTIDE (WEGOVY),DIARRHEA,2021-09-26,18-44,Female,USA,Not specified
FAERS-12024,SEMAGLUTIDE (WEGOVY),DIARRHEA,2021-05-03,45-64,Female,Europe,Other
FAERS-12025,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-01-18,45-64,Female,USA,Other
FAERS-12026,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2020-09-11,45-64,Female,USA,Other
FAERS-12027,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2020-05-28,18-44,Male,USA,Other
FAERS-12028,EXENATIDE (BYDUREON),ASPIRATION,2023-01-01,65-74,Female,USA,Other
FAERS-12029,EXENATIDE (BYETTA),HYPOGLYCEMIA,2019-07-17,45-64,Female,USA,Disability
FAERS-12030,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-01-02,18-44,Female,Europe,Not specified
FAERS-12031,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-02-28,18-44,Female,USA,Other
FAERS-12032,SEMAGLUTIDE (OZEMPIC),NAUSEA,2020-10-15,45-64,Male,USA,Other
FAERS-12033,SEMAGLUTIDE (WEGOVY),DIZZINESS,2021-08-15,18-44,Female,USA,Other
FAERS-12034,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2020-07-25,18-44,Female,USA,Not specified
FAERS-12035,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2019-08-24,45-64,Male,USA,Other
FAERS-12036,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-10-03,45-64,Male,USA,Other
FAERS-12037,LIRAGLUTIDE (SAXENDA),NAUSEA,2023-04-07,75-84,Female,USA,Other
FAERS-12038,TIRZEPATIDE (ZEPBOUND),ASPIRATION,2020-06-13,75-84,Male,Europe,Hospitalization
FAERS-12039,EXENATIDE (BYETTA),ASPIRATION,2023-11-04,45-64,Male,Other,Hospitalization
FAERS-12040,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-11-11,45-64,Male,USA,Hospitalization
FAERS-12041,SEMAGLUTIDE (OZEMPIC),FATIGUE,2020-02-22,45-64,Male,USA,Other
FAERS-12042,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-01-05,45-64,Female,USA,Not specified
FAERS-12043,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-01-08,18-44,Female,USA,Other
FAERS-12044,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-08-24,65-74,Female,USA,Other
FAERS-12045,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2020-02-16,18-44,Male,USA,Not specified
FAERS-12046,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-07-06,65-74,Male,USA,Other
FAERS-12047,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2020-07-28,45-64,Female,USA,Not specified
FAERS-12048,EXENATIDE (BYETTA),ABDOMINAL PAIN,2023-07-01,18-44,Female,USA,Other
FAERS-12049,EXENATIDE (BYETTA),INJECTION SITE REACTION,2022-12-21,75-84,Male,Europe,Other
FAERS-12050,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-08-08,Unknown,Female,Europe,Not specified
FAERS-12051,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-07-18,65-74,Female,USA,Hospitalization
FAERS-12052,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-02-13,18-44,Male,USA,Other
FAERS-12053,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-11-09,18-44,Male,Other,Other
FAERS-12054,SEMAGLUTIDE (WEGOVY),DIARRHEA,2019-10-05,18-44,Female,Australia,Other
FAERS-12055,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2022-11-09,45-64,Female,USA,Disability
FAERS-12056,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-03-02,45-64,Female,Canada,Not specified
FAERS-12057,TIRZEPATIDE (ZEPBOUND),THYROID NEOPLASM,2021-12-20,45-64,Male,Europe,Other
FAERS-12058,LIRAGLUTIDE (SAXENDA),FATIGUE,2021-12-20,45-64,Male,Canada,Other
FAERS-12059,EXENATIDE (BYDUREON),VOMITING,2022-01-23,18-44,Male,USA,Other
FAERS-12060,SEMAGLUTIDE (OZEMPIC),VOMITING,2021-08-07,75-84,Male,USA,Other
FAERS-12061,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2021-02-20,18-44,Female,USA,Hospitalization
FAERS-12062,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-03-28,Unknown,Female,USA,Other
FAERS-12063,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-06-17,45-64,Female,USA,Other
FAERS-12064,SEMAGLUTIDE (WEGOVY),FATIGUE,2022-01-13,65-74,Female,USA,Other
FAERS-12065,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-11-28,65-74,Female,Europe,Other
FAERS-12066,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-01-22,45-64,Female,Europe,Hospitalization
FAERS-12067,LIRAGLUTIDE (SAXENDA),ASPIRATION,2021-03-17,18-44,Female,Canada,Other
FAERS-12068,EXENATIDE (BYETTA),GALLBLADDER DISEASE,2020-04-21,18-44,Female,USA,Not specified
FAERS-12069,EXENATIDE (BYDUREON),HEADACHE,2023-04-18,45-64,Male,USA,Not specified
FAERS-12070,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2019-11-11,75-84,Male,USA,Death
FAERS-12071,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-07-06,65-74,Female,USA,Not specified
FAERS-12072,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2021-10-26,75-84,Male,Europe,Other
FAERS-12073,SEMAGLUTIDE (WEGOVY),VOMITING,2023-06-12,65-74,Female,USA,Hospitalization
FAERS-12074,SEMAGLUTIDE (WEGOVY),DIZZINESS,2022-01-20,45-64,Female,Australia,Other
FAERS-12075,TIRZEPATIDE (MOUNJARO),FATIGUE,2020-11-20,45-64,Female,USA,Hospitalization
FAERS-12076,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2019-08-20,45-64,Female,Japan,Other
FAERS-12077,TIRZEPATIDE (ZEPBOUND),CONSTIPATION,2023-02-27,65-74,Male,USA,Other
FAERS-12078,DULAGLUTIDE (TRULICITY),PANCREATITIS,2021-02-07,45-64,Female,USA,Other
FAERS-12079,LIRAGLUTIDE (SAXENDA),DIZZINESS,2023-02-08,18-44,Female,Europe,Other
FAERS-12080,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-03-23,45-64,Male,USA,Not specified
FAERS-12081,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-03-15,45-64,Female,USA,Other
FAERS-12082,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-10-24,Unknown,Female,USA,Not specified
FAERS-12083,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2022-09-28,0-17,Female,USA,Other
FAERS-12084,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-07-14,65-74,Female,USA,Hospitalization
FAERS-12085,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2021-08-09,65-74,Female,Europe,Other
FAERS-12086,TIRZEPATIDE (MOUNJARO),DIARRHEA,2023-11-09,45-64,Male,USA,Other
FAERS-12087,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2023-10-10,45-64,Female,Canada,Life-threatening
FAERS-12088,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2022-06-01,45-64,Male,USA,Hospitalization
FAERS-12089,TIRZEPATIDE (ZEPBOUND),ASPIRATION,2020-11-08,18-44,Female,USA,Hospitalization
FAERS-12090,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2019-06-28,45-64,Female,Other,Other
FAERS-12091,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-07-18,45-64,Female,USA,Other
FAERS-12092,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-07-19,45-64,Male,USA,Other
FAERS-12093,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2023-07-15,18-44,Female,Europe,Not specified
FAERS-12094,SEMAGLUTIDE (WEGOVY),ALOPECIA,2023-03-12,65-74,Male,USA,Not specified
FAERS-12095,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-02-17,45-64,Female,USA,Disability
FAERS-12096,TIRZEPATIDE (MOUNJARO),ALOPECIA,2020-02-05,45-64,Female,USA,Disability
FAERS-12097,LIRAGLUTIDE (VICTOZA),SUICIDAL IDEATION,2019-12-01,45-64,Female,USA,Not specified
FAERS-12098,EXENATIDE (BYETTA),ABDOMINAL PAIN,2022-01-18,45-64,Male,Europe,Life-threatening
FAERS-12099,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2020-06-16,45-64,Female,USA,Other
FAERS-12100,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2020-03-28,Unknown,Female,USA,Other
FAERS-12101,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-12-15,18-44,Male,Europe,Other
FAERS-12102,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-12-15,18-44,Male,USA,Not specified
FAERS-12103,SEMAGLUTIDE (WEGOVY),DIZZINESS,2021-12-24,18-44,Female,USA,Disability
FAERS-12104,SEMAGLUTIDE (WEGOVY),HEADACHE,2018-03-06,45-64,Male,Europe,Life-threatening
FAERS-12105,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2020-02-24,65-74,Male,USA,Other
FAERS-12106,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2022-03-08,65-74,Male,USA,Not specified
FAERS-12107,LIRAGLUTIDE (SAXENDA),DECREASED APPETITE,2023-04-11,45-64,Male,USA,Other
FAERS-12108,LIRAGLUTIDE (SAXENDA),ABDOMINAL PAIN,2023-08-08,18-44,Female,USA,Life-threatening
FAERS-12109,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2021-08-20,75-84,Female,USA,Other
FAERS-12110,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-01-06,65-74,Female,Europe,Other
FAERS-12111,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-09-16,18-44,Male,Europe,Other
FAERS-12112,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-09-08,45-64,Female,USA,Hospitalization
FAERS-12113,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-12-26,45-64,Unknown,USA,Other
FAERS-12114,SEMAGLUTIDE (WEGOVY),NAUSEA,2023-08-20,18-44,Male,USA,Not specified
FAERS-12115,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2021-11-07,45-64,Female,Canada,Other
FAERS-12116,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2020-09-13,65-74,Female,USA,Not specified
FAERS-12117,TIRZEPATIDE (ZEPBOUND),CONSTIPATION,2022-10-28,45-64,Male,Japan,Other
FAERS-12118,LIRAGLUTIDE (SAXENDA),VOMITING,2020-12-19,18-44,Female,USA,Not specified
FAERS-12119,TIRZEPATIDE (ZEPBOUND),NAUSEA,2023-10-24,18-44,Female,Europe,Other
FAERS-12120,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-04-02,45-64,Female,Europe,Other
FAERS-12121,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2020-10-16,0-17,Female,USA,Hospitalization
FAERS-12122,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2020-04-06,18-44,Male,USA,Hospitalization
FAERS-12123,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2022-01-04,45-64,Female,USA,Other
FAERS-12124,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2019-03-02,18-44,Male,USA,Hospitalization
FAERS-12125,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-08-08,45-64,Female,Europe,Disability
FAERS-12126,TIRZEPATIDE (MOUNJARO),DIZZINESS,2021-06-07,65-74,Male,USA,Other
FAERS-12127,EXENATIDE (BYDUREON),CONSTIPATION,2022-03-25,45-64,Female,USA,Other
FAERS-12128,LIRAGLUTIDE (VICTOZA),VOMITING,2022-03-11,45-64,Female,Europe,Not specified
FAERS-12129,EXENATIDE (BYETTA),DECREASED APPETITE,2019-10-07,Unknown,Male,USA,Other
FAERS-12130,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2019-12-24,85+,Female,Europe,Other
FAERS-12131,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2019-12-19,18-44,Female,USA,Other
FAERS-12132,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-07-12,18-44,Female,USA,Other
FAERS-12133,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-05-03,45-64,Female,USA,Not specified
FAERS-12134,SEMAGLUTIDE (WEGOVY),ALOPECIA,2021-06-20,18-44,Unknown,Australia,Life-threatening
FAERS-12135,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2019-12-24,45-64,Male,USA,Not specified
FAERS-12136,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2019-05-17,65-74,Male,USA,Other
FAERS-12137,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2022-11-01,45-64,Female,Europe,Disability
FAERS-12138,EXENATIDE (BYDUREON),SUICIDAL IDEATION,2021-07-16,18-44,Male,USA,Other
FAERS-12139,EXENATIDE (BYDUREON),HYPOGLYCEMIA,2021-10-22,45-64,Female,USA,Other
FAERS-12140,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2021-02-05,45-64,Female,Australia,Not specified
FAERS-12141,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-09-04,45-64,Male,USA,Hospitalization
FAERS-12142,SEMAGLUTIDE (OZEMPIC),NAUSEA,2019-07-09,75-84,Female,USA,Other
FAERS-12143,SEMAGLUTIDE (WEGOVY),VOMITING,2022-12-22,18-44,Female,USA,Other
FAERS-12144,SEMAGLUTIDE (WEGOVY),VOMITING,2021-01-15,45-64,Female,USA,Hospitalization
FAERS-12145,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-06-03,45-64,Male,USA,Not specified
FAERS-12146,TIRZEPATIDE (MOUNJARO),ALOPECIA,2022-04-26,45-64,Female,Other,Other
FAERS-12147,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2022-09-22,18-44,Female,USA,Other
FAERS-12148,DULAGLUTIDE (TRULICITY),DECREASED APPETITE,2022-06-07,45-64,Female,USA,Not specified
FAERS-12149,LIRAGLUTIDE (VICTOZA),DIZZINESS,2023-07-13,18-44,Female,Australia,Other
FAERS-12150,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2020-08-01,45-64,Male,USA,Hospitalization
FAERS-12151,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2021-10-01,45-64,Female,USA,Other
FAERS-12152,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2019-05-02,18-44,Female,Europe,Hospitalization
FAERS-12153,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2019-12-19,45-64,Female,Australia,Other
FAERS-12154,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2020-12-03,45-64,Male,USA,Other
FAERS-12155,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-11-27,18-44,Female,USA,Other
FAERS-12156,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-04-21,75-84,Female,USA,Hospitalization
FAERS-12157,DULAGLUTIDE (TRULICITY),DIZZINESS,2022-05-04,45-64,Female,USA,Other
FAERS-12158,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2022-10-09,18-44,Female,Other,Other
FAERS-12159,LIRAGLUTIDE (VICTOZA),INJECTION SITE REACTION,2022-10-20,45-64,Male,Europe,Other
FAERS-12160,SEMAGLUTIDE (OZEMPIC),HEADACHE,2019-05-06,18-44,Female,Europe,Not specified
FAERS-12161,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2019-08-27,75-84,Male,USA,Not specified
FAERS-12162,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-11-01,18-44,Female,Europe,Other
FAERS-12163,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2022-02-08,18-44,Female,Japan,Other
FAERS-12164,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-10-15,45-64,Female,USA,Not specified
FAERS-12165,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-09-21,18-44,Female,USA,Other
FAERS-12166,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2019-09-13,45-64,Male,Europe,Not specified
FAERS-12167,LIRAGLUTIDE (SAXENDA),HEADACHE,2023-09-17,18-44,Male,Australia,Other
FAERS-12168,LIRAGLUTIDE (VICTOZA),HEADACHE,2018-03-02,45-64,Female,USA,Not specified
FAERS-12169,LIRAGLUTIDE (SAXENDA),HEADACHE,2023-03-27,45-64,Male,Europe,Death
FAERS-12170,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-03-17,45-64,Female,Europe,Not specified
FAERS-12171,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-09-05,45-64,Female,USA,Other
FAERS-12172,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-11-02,45-64,Unknown,Australia,Other
FAERS-12173,SEMAGLUTIDE (WEGOVY),DIZZINESS,2019-10-14,18-44,Male,Japan,Hospitalization
FAERS-12174,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-11-26,45-64,Female,USA,Other
FAERS-12175,TIRZEPATIDE (MOUNJARO),HEADACHE,2023-10-26,45-64,Female,USA,Not specified
FAERS-12176,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-07-23,45-64,Male,USA,Other
FAERS-12177,EXENATIDE (BYETTA),GALLBLADDER DISEASE,2021-05-15,45-64,Female,Australia,Other
FAERS-12178,LIRAGLUTIDE (VICTOZA),VOMITING,2020-06-19,18-44,Female,USA,Other
FAERS-12179,EXENATIDE (BYDUREON),GALLBLADDER DISEASE,2022-04-09,45-64,Male,USA,Other
FAERS-12180,SEMAGLUTIDE (OZEMPIC),HEADACHE,2020-05-13,45-64,Female,Canada,Other
FAERS-12181,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2021-10-27,65-74,Female,USA,Hospitalization
FAERS-12182,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-12-08,18-44,Female,USA,Other
FAERS-12183,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2023-12-14,45-64,Female,Other,Hospitalization
FAERS-12184,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-01-09,65-74,Female,USA,Other
FAERS-12185,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-06-09,45-64,Female,Europe,Other
FAERS-12186,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-04-23,45-64,Female,USA,Other
FAERS-12187,TIRZEPATIDE (ZEPBOUND),ALOPECIA,2023-12-03,45-64,Female,USA,Other
FAERS-12188,LIRAGLUTIDE (VICTOZA),DECREASED APPETITE,2018-09-24,45-64,Female,USA,Hospitalization
FAERS-12189,DULAGLUTIDE (TRULICITY),HYPOGLYCEMIA,2021-09-28,45-64,Male,USA,Not specified
FAERS-12190,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-05-18,65-74,Female,Japan,Other
FAERS-12191,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-12-20,45-64,Female,Europe,Other
FAERS-12192,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-06-11,45-64,Female,Europe,Other
FAERS-12193,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2020-10-22,65-74,Male,USA,Death
FAERS-12194,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-12-02,65-74,Unknown,USA,Other
FAERS-12195,TIRZEPATIDE (MOUNJARO),VOMITING,2023-09-25,18-44,Female,USA,Other
FAERS-12196,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-03-04,18-44,Male,USA,Other
FAERS-12197,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2018-11-21,45-64,Female,USA,Other
FAERS-12198,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2023-07-22,Unknown,Male,USA,Not specified
FAERS-12199,EXENATIDE (BYDUREON),SUICIDAL IDEATION,2021-07-09,45-64,Female,USA,Life-threatening
FAERS-12200,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-08-11,75-84,Male,Canada,Other
FAERS-12201,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-04-26,45-64,Female,Europe,Other
FAERS-12202,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-07-13,45-64,Male,Europe,Other
FAERS-12203,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2019-07-21,18-44,Female,Europe,Other
FAERS-12204,SEMAGLUTIDE (WEGOVY),DIZZINESS,2022-03-28,18-44,Male,Europe,Death
FAERS-12205,TIRZEPATIDE (MOUNJARO),DIARRHEA,2021-08-23,45-64,Female,Europe,Other
FAERS-12206,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2018-02-06,18-44,Male,USA,Other
FAERS-12207,TIRZEPATIDE (ZEPBOUND),VOMITING,2021-09-21,75-84,Female,Europe,Other
FAERS-12208,TIRZEPATIDE (ZEPBOUND),NAUSEA,2022-07-16,65-74,Female,USA,Other
FAERS-12209,EXENATIDE (BYETTA),DIARRHEA,2023-08-26,65-74,Male,USA,Not specified
FAERS-12210,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-03-21,45-64,Male,Europe,Not specified
FAERS-12211,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-04-24,65-74,Female,USA,Other
FAERS-12212,SEMAGLUTIDE (OZEMPIC),FATIGUE,2021-09-02,18-44,Male,USA,Other
FAERS-12213,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-03-10,65-74,Male,Other,Hospitalization
FAERS-12214,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2021-05-02,45-64,Male,USA,Hospitalization
FAERS-12215,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-12-05,18-44,Female,USA,Not specified
FAERS-12216,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2023-08-10,18-44,Male,USA,Other
FAERS-12217,EXENATIDE (BYETTA),ALOPECIA,2023-02-15,65-74,Female,Australia,Other
FAERS-12218,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2023-08-06,18-44,Male,USA,Hospitalization
FAERS-12219,EXENATIDE (BYETTA),HEADACHE,2021-01-21,45-64,Female,Canada,Other
FAERS-12220,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-05-11,18-44,Female,Other,Other
FAERS-12221,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2021-09-17,45-64,Unknown,Other,Not specified
FAERS-12222,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-01-28,65-74,Male,USA,Not specified
FAERS-12223,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-08-16,45-64,Male,USA,Other
FAERS-12224,SEMAGLUTIDE (WEGOVY),FATIGUE,2021-05-22,18-44,Female,Other,Not specified
FAERS-12225,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2022-06-23,45-64,Female,USA,Hospitalization
FAERS-12226,TIRZEPATIDE (MOUNJARO),DIZZINESS,2018-11-21,18-44,Female,USA,Other
FAERS-12227,EXENATIDE (BYDUREON),DECREASED APPETITE,2022-09-17,18-44,Female,USA,Other
FAERS-12228,EXENATIDE (BYETTA),INJECTION SITE REACTION,2022-09-25,65-74,Female,USA,Life-threatening
FAERS-12229,EXENATIDE (BYDUREON),DIZZINESS,2023-08-04,45-64,Unknown,USA,Other
FAERS-12230,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2019-12-20,18-44,Female,USA,Other
FAERS-12231,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2020-09-21,65-74,Male,USA,Disability
FAERS-12232,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2020-02-21,45-64,Male,Europe,Other
FAERS-12233,SEMAGLUTIDE (WEGOVY),FATIGUE,2022-03-17,45-64,Female,Australia,Not specified
FAERS-12234,SEMAGLUTIDE (WEGOVY),ASPIRATION,2020-01-27,65-74,Female,USA,Hospitalization
FAERS-12235,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2022-08-14,18-44,Male,USA,Other
FAERS-12236,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-11-16,18-44,Female,USA,Other
FAERS-12237,TIRZEPATIDE (ZEPBOUND),NAUSEA,2023-05-02,18-44,Male,USA,Not specified
FAERS-12238,LIRAGLUTIDE (VICTOZA),ASPIRATION,2023-10-17,45-64,Male,USA,Other
FAERS-12239,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2020-06-10,65-74,Female,USA,Other
FAERS-12240,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2018-12-25,45-64,Female,USA,Not specified
FAERS-12241,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-05-11,65-74,Female,USA,Not specified
FAERS-12242,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-07-14,45-64,Male,USA,Not specified
FAERS-12243,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2022-06-10,45-64,Male,USA,Not specified
FAERS-12244,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2023-01-26,45-64,Female,Australia,Other
FAERS-12245,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2021-10-16,45-64,Female,Japan,Hospitalization
FAERS-12246,TIRZEPATIDE (MOUNJARO),DIZZINESS,2021-04-10,45-64,Female,USA,Other
FAERS-12247,DULAGLUTIDE (TRULICITY),HEADACHE,2022-01-17,45-64,Female,USA,Disability
FAERS-12248,DULAGLUTIDE (TRULICITY),HEADACHE,2022-11-22,45-64,Female,USA,Other
FAERS-12249,EXENATIDE (BYETTA),VOMITING,2021-02-19,18-44,Female,USA,Other
FAERS-12250,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2019-07-23,45-64,Male,USA,Other
FAERS-12251,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-03-13,65-74,Female,USA,Hospitalization
FAERS-12252,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-06-05,45-64,Male,Australia,Not specified
FAERS-12253,SEMAGLUTIDE (WEGOVY),ALOPECIA,2019-08-15,45-64,Female,Other,Other
FAERS-12254,SEMAGLUTIDE (WEGOVY),VOMITING,2020-02-04,65-74,Female,USA,Other
FAERS-12255,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-07-05,45-64,Male,USA,Other
FAERS-12256,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2022-08-02,18-44,Female,USA,Not specified
FAERS-12257,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2022-11-10,45-64,Female,USA,Other
FAERS-12258,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2020-06-16,65-74,Male,Europe,Not specified
FAERS-12259,EXENATIDE (BYDUREON),HEADACHE,2020-12-11,75-84,Male,USA,Other
FAERS-12260,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-08-06,45-64,Male,USA,Other
FAERS-12261,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2021-01-03,45-64,Female,Canada,Other
FAERS-12262,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-08-08,75-84,Female,USA,Hospitalization
FAERS-12263,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-06-01,18-44,Female,USA,Other
FAERS-12264,SEMAGLUTIDE (WEGOVY),VOMITING,2023-02-04,45-64,Female,Europe,Other
FAERS-12265,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2019-11-03,45-64,Female,Canada,Other
FAERS-12266,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-08-02,65-74,Male,USA,Not specified
FAERS-12267,LIRAGLUTIDE (VICTOZA),CONSTIPATION,2021-01-01,18-44,Male,USA,Not specified
FAERS-12268,LIRAGLUTIDE (SAXENDA),ASPIRATION,2022-05-18,65-74,Female,Canada,Other
FAERS-12269,EXENATIDE (BYDUREON),ABDOMINAL PAIN,2022-10-18,65-74,Male,USA,Other
FAERS-12270,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-02-14,45-64,Male,USA,Not specified
FAERS-12271,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-04-26,45-64,Female,Japan,Other
FAERS-12272,SEMAGLUTIDE (OZEMPIC),HEADACHE,2018-06-02,18-44,Female,Europe,Life-threatening
FAERS-12273,SEMAGLUTIDE (WEGOVY),ALOPECIA,2019-05-07,45-64,Female,Europe,Not specified
FAERS-12274,SEMAGLUTIDE (WEGOVY),ALOPECIA,2023-04-11,65-74,Female,USA,Not specified
FAERS-12275,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-01-24,45-64,Female,USA,Other
FAERS-12276,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2023-09-17,45-64,Unknown,Other,Disability
FAERS-12277,LIRAGLUTIDE (SAXENDA),THYROID NEOPLASM,2023-11-28,45-64,Male,Japan,Other
FAERS-12278,LIRAGLUTIDE (VICTOZA),HEADACHE,2023-12-02,45-64,Male,Europe,Other
FAERS-12279,DULAGLUTIDE (TRULICITY),DIZZINESS,2020-03-24,45-64,Female,USA,Not specified
FAERS-12280,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2019-08-21,45-64,Male,Europe,Other
FAERS-12281,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2019-02-04,45-64,Female,Canada,Other
FAERS-12282,SEMAGLUTIDE (OZEMPIC),FATIGUE,2020-05-23,45-64,Female,Europe,Not specified
FAERS-12283,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2018-12-20,18-44,Female,USA,Other
FAERS-12284,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2019-03-01,65-74,Female,Europe,Not specified
FAERS-12285,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-06-28,18-44,Female,Europe,Not specified
FAERS-12286,TIRZEPATIDE (MOUNJARO),NAUSEA,2019-06-04,65-74,Female,Europe,Other
FAERS-12287,EXENATIDE (BYDUREON),ASPIRATION,2022-10-09,65-74,Male,Europe,Other
FAERS-12288,EXENATIDE (BYETTA),PANCREATITIS,2019-08-23,45-64,Male,Europe,Disability
FAERS-12289,LIRAGLUTIDE (VICTOZA),HYPOGLYCEMIA,2022-06-21,45-64,Female,Europe,Hospitalization
FAERS-12290,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2021-11-20,65-74,Male,USA,Disability
FAERS-12291,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2019-05-12,65-74,Male,Canada,Hospitalization
FAERS-12292,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-05-03,18-44,Male,USA,Hospitalization
FAERS-12293,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2022-10-20,45-64,Male,USA,Not specified
FAERS-12294,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2021-10-11,45-64,Female,USA,Hospitalization
FAERS-12295,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2022-10-01,18-44,Male,Other,Other
FAERS-12296,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2019-09-13,45-64,Female,Europe,Other
FAERS-12297,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2022-12-22,65-74,Female,Other,Hospitalization
FAERS-12298,LIRAGLUTIDE (VICTOZA),DECREASED APPETITE,2023-06-28,45-64,Male,USA,Disability
FAERS-12299,TIRZEPATIDE (ZEPBOUND),GALLBLADDER DISEASE,2021-01-07,45-64,Female,Europe,Life-threatening
FAERS-12300,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2021-03-13,18-44,Female,Other,Death
FAERS-12301,SEMAGLUTIDE (OZEMPIC),VOMITING,2020-10-23,45-64,Male,USA,Other
FAERS-12302,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2018-01-19,18-44,Male,USA,Hospitalization
FAERS-12303,SEMAGLUTIDE (WEGOVY),ASPIRATION,2018-09-18,45-64,Female,USA,Not specified
FAERS-12304,SEMAGLUTIDE (WEGOVY),FATIGUE,2019-07-15,18-44,Male,Japan,Disability
FAERS-12305,TIRZEPATIDE (MOUNJARO),DIARRHEA,2023-08-11,75-84,Male,Europe,Other
FAERS-12306,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-03-03,45-64,Unknown,USA,Life-threatening
FAERS-12307,EXENATIDE (BYDUREON),DIZZINESS,2023-04-14,45-64,Male,USA,Other
FAERS-12308,LIRAGLUTIDE (VICTOZA),ALOPECIA,2022-02-09,65-74,Male,USA,Other
FAERS-12309,DULAGLUTIDE (TRULICITY),ASPIRATION,2019-06-27,45-64,Male,Japan,Life-threatening
FAERS-12310,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-02-21,45-64,Male,USA,Other
FAERS-12311,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-09-19,18-44,Female,Japan,Not specified
FAERS-12312,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-09-14,45-64,Female,USA,Disability
FAERS-12313,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2021-12-15,45-64,Male,USA,Other
FAERS-12314,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2018-01-25,45-64,Male,USA,Not specified
FAERS-12315,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2022-04-03,18-44,Female,Europe,Other
FAERS-12316,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-09-09,75-84,Female,USA,Other
FAERS-12317,LIRAGLUTIDE (SAXENDA),SUICIDAL IDEATION,2023-08-06,45-64,Unknown,USA,Hospitalization
FAERS-12318,LIRAGLUTIDE (VICTOZA),HEADACHE,2023-04-05,45-64,Female,USA,Other
FAERS-12319,LIRAGLUTIDE (VICTOZA),VOMITING,2022-12-05,18-44,Male,Other,Not specified
FAERS-12320,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-10-20,65-74,Male,Other,Other
FAERS-12321,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2019-11-07,45-64,Female,Europe,Not specified
FAERS-12322,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2020-08-16,65-74,Male,Canada,Other
FAERS-12323,SEMAGLUTIDE (WEGOVY),ASPIRATION,2020-03-17,45-64,Male,USA,Hospitalization
FAERS-12324,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2022-01-12,18-44,Male,USA,Other
FAERS-12325,TIRZEPATIDE (MOUNJARO),DIZZINESS,2021-10-04,75-84,Female,USA,Other
FAERS-12326,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2023-02-14,65-74,Female,Europe,Other
FAERS-12327,EXENATIDE (BYDUREON),THYROID NEOPLASM,2018-03-19,18-44,Male,Canada,Other
FAERS-12328,EXENATIDE (BYETTA),CONSTIPATION,2023-09-27,75-84,Male,USA,Other
FAERS-12329,EXENATIDE (BYETTA),GALLBLADDER DISEASE,2020-02-14,18-44,Female,Europe,Other
FAERS-12330,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-07-15,45-64,Female,USA,Not specified
FAERS-12331,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2020-10-17,18-44,Male,USA,Not specified
FAERS-12332,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-05-21,18-44,Female,Europe,Hospitalization
FAERS-12333,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-12-08,45-64,Male,USA,Other
FAERS-12334,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2020-03-13,45-64,Female,USA,Hospitalization
FAERS-12335,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2020-07-22,18-44,Male,USA,Hospitalization
FAERS-12336,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2021-03-04,45-64,Female,Europe,Other
FAERS-12337,EXENATIDE (BYETTA),DIZZINESS,2023-11-20,75-84,Female,USA,Hospitalization
FAERS-12338,EXENATIDE (BYETTA),ASPIRATION,2023-02-22,18-44,Male,USA,Other
FAERS-12339,EXENATIDE (BYDUREON),GALLBLADDER DISEASE,2023-12-10,18-44,Female,Europe,Not specified
FAERS-12340,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-04-08,18-44,Female,USA,Other
FAERS-12341,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2019-06-28,65-74,Female,USA,Other
FAERS-12342,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-12-13,18-44,Unknown,USA,Not specified
FAERS-12343,SEMAGLUTIDE (WEGOVY),HEADACHE,2022-12-26,45-64,Male,USA,Not specified
FAERS-12344,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2020-04-14,75-84,Female,USA,Other
FAERS-12345,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-09-13,65-74,Female,Australia,Not specified
FAERS-12346,TIRZEPATIDE (MOUNJARO),VOMITING,2021-06-01,18-44,Male,USA,Other
FAERS-12347,TIRZEPATIDE (ZEPBOUND),HEADACHE,2021-02-27,75-84,Female,Japan,Other
FAERS-12348,DULAGLUTIDE (TRULICITY),DIZZINESS,2021-08-06,45-64,Female,USA,Hospitalization
FAERS-12349,LIRAGLUTIDE (VICTOZA),NAUSEA,2023-10-04,65-74,Male,USA,Other
FAERS-12350,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-11-18,75-84,Male,Other,Other
FAERS-12351,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-06-10,65-74,Female,Europe,Disability
FAERS-12352,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-02-22,45-64,Female,Europe,Not specified
FAERS-12353,SEMAGLUTIDE (WEGOVY),NAUSEA,2022-06-06,45-64,Female,USA,Hospitalization
FAERS-12354,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-05-11,45-64,Female,USA,Life-threatening
FAERS-12355,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2021-09-26,85+,Male,Canada,Other
FAERS-12356,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2019-04-21,45-64,Female,USA,Not specified
FAERS-12357,EXENATIDE (BYDUREON),ASPIRATION,2021-12-27,45-64,Female,USA,Hospitalization
FAERS-12358,DULAGLUTIDE (TRULICITY),HYPOGLYCEMIA,2021-04-15,18-44,Female,Europe,Hospitalization
FAERS-12359,LIRAGLUTIDE (SAXENDA),ASPIRATION,2023-03-27,45-64,Male,Europe,Other
FAERS-12360,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-01-02,18-44,Female,USA,Hospitalization
FAERS-12361,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2021-06-15,65-74,Male,USA,Other
FAERS-12362,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-12-26,18-44,Male,USA,Hospitalization
FAERS-12363,SEMAGLUTIDE (WEGOVY),ASPIRATION,2019-03-02,65-74,Female,USA,Disability
FAERS-12364,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-03-24,45-64,Female,USA,Hospitalization
FAERS-12365,TIRZEPATIDE (MOUNJARO),DIZZINESS,2020-03-24,45-64,Female,USA,Other
FAERS-12366,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-03-06,65-74,Female,Europe,Life-threatening
FAERS-12367,EXENATIDE (BYDUREON),ALOPECIA,2022-10-06,45-64,Female,USA,Hospitalization
FAERS-12368,LIRAGLUTIDE (SAXENDA),SUICIDAL IDEATION,2020-06-08,45-64,Female,Europe,Hospitalization
FAERS-12369,DULAGLUTIDE (TRULICITY),HYPOGLYCEMIA,2019-01-18,45-64,Unknown,USA,Not specified
FAERS-12370,SEMAGLUTIDE (OZEMPIC),NAUSEA,2019-09-26,18-44,Female,Europe,Life-threatening
FAERS-12371,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2020-02-12,45-64,Male,USA,Other
FAERS-12372,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-11-06,Unknown,Male,Other,Other
FAERS-12373,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-05-18,45-64,Female,USA,Not specified
FAERS-12374,SEMAGLUTIDE (WEGOVY),ALOPECIA,2020-04-07,45-64,Male,Europe,Not specified
FAERS-12375,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2018-02-25,18-44,Male,Europe,Other
FAERS-12376,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2023-03-23,18-44,Female,Europe,Not specified
FAERS-12377,EXENATIDE (BYDUREON),DIZZINESS,2019-03-27,18-44,Female,USA,Not specified
FAERS-12378,LIRAGLUTIDE (SAXENDA),CONSTIPATION,2023-12-16,45-64,Female,USA,Not specified
FAERS-12379,LIRAGLUTIDE (VICTOZA),VOMITING,2022-08-09,45-64,Female,USA,Hospitalization
FAERS-12380,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-02-21,45-64,Male,Canada,Other
FAERS-12381,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2020-11-02,65-74,Male,Europe,Other
FAERS-12382,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-07-03,45-64,Female,Europe,Other
FAERS-12383,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2019-03-21,45-64,Female,USA,Other
FAERS-12384,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2022-11-11,45-64,Female,USA,Other
FAERS-12385,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-04-19,45-64,Female,USA,Other
FAERS-12386,TIRZEPATIDE (MOUNJARO),HEADACHE,2018-03-01,45-64,Male,USA,Other
FAERS-12387,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2022-03-24,45-64,Male,Canada,Other
FAERS-12388,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2021-10-13,75-84,Female,Europe,Other
FAERS-12389,EXENATIDE (BYETTA),DECREASED APPETITE,2020-03-14,45-64,Female,USA,Other
FAERS-12390,SEMAGLUTIDE (OZEMPIC),FATIGUE,2020-11-13,18-44,Female,Europe,Other
FAERS-12391,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-08-21,75-84,Female,Other,Other
FAERS-12392,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-12-23,65-74,Female,Australia,Other
FAERS-12393,SEMAGLUTIDE (WEGOVY),VOMITING,2020-09-22,18-44,Female,USA,Other
FAERS-12394,SEMAGLUTIDE (WEGOVY),HEADACHE,2020-10-03,45-64,Male,USA,Other
FAERS-12395,TIRZEPATIDE (MOUNJARO),NAUSEA,2021-11-15,45-64,Female,USA,Other
FAERS-12396,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2023-08-13,0-17,Male,USA,Other
FAERS-12397,EXENATIDE (BYETTA),DECREASED APPETITE,2022-05-03,45-64,Female,USA,Other
FAERS-12398,LIRAGLUTIDE (VICTOZA),GALLBLADDER DISEASE,2023-01-01,45-64,Female,USA,Other
FAERS-12399,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2021-05-19,18-44,Male,USA,Other
FAERS-12400,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-06-05,45-64,Male,Canada,Other
FAERS-12401,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-01-06,45-64,Male,USA,Other
FAERS-12402,SEMAGLUTIDE (OZEMPIC),VOMITING,2021-04-03,45-64,Female,Europe,Not specified
FAERS-12403,SEMAGLUTIDE (WEGOVY),DIZZINESS,2022-06-20,75-84,Female,USA,Other
FAERS-12404,SEMAGLUTIDE (WEGOVY),ASPIRATION,2021-05-28,45-64,Female,USA,Not specified
FAERS-12405,TIRZEPATIDE (MOUNJARO),ASPIRATION,2019-05-20,65-74,Male,USA,Hospitalization
FAERS-12406,TIRZEPATIDE (MOUNJARO),HEADACHE,2023-05-09,45-64,Male,USA,Other
FAERS-12407,LIRAGLUTIDE (SAXENDA),CONSTIPATION,2022-11-27,65-74,Female,USA,Other
FAERS-12408,EXENATIDE (BYETTA),DIARRHEA,2019-12-16,18-44,Female,USA,Other
FAERS-12409,LIRAGLUTIDE (VICTOZA),THYROID NEOPLASM,2022-05-04,45-64,Female,Europe,Other
FAERS-12410,SEMAGLUTIDE (OZEMPIC),VOMITING,2019-12-06,0-17,Female,USA,Hospitalization
FAERS-12411,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-04-10,18-44,Male,Canada,Other
FAERS-12412,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-03-02,45-64,Female,USA,Other
FAERS-12413,SEMAGLUTIDE (WEGOVY),NAUSEA,2023-03-24,45-64,Female,USA,Other
FAERS-12414,SEMAGLUTIDE (WEGOVY),HEADACHE,2021-03-25,65-74,Male,Europe,Hospitalization
FAERS-12415,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2022-10-13,45-64,Female,Canada,Disability
FAERS-12416,TIRZEPATIDE (MOUNJARO),HEADACHE,2022-07-26,45-64,Female,Other,Hospitalization
FAERS-12417,EXENATIDE (BYETTA),DIZZINESS,2021-05-23,75-84,Male,USA,Other
FAERS-12418,DULAGLUTIDE (TRULICITY),CONSTIPATION,2018-04-10,18-44,Female,USA,Not specified
FAERS-12419,LIRAGLUTIDE (VICTOZA),SUICIDAL IDEATION,2023-04-10,18-44,Female,USA,Other
FAERS-12420,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2020-08-23,45-64,Female,USA,Other
FAERS-12421,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-01-02,45-64,Female,USA,Other
FAERS-12422,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2020-05-13,75-84,Male,Europe,Other
FAERS-12423,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2022-08-15,18-44,Female,USA,Not specified
FAERS-12424,SEMAGLUTIDE (WEGOVY),VOMITING,2023-01-05,45-64,Unknown,USA,Disability
FAERS-12425,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-10-09,65-74,Female,USA,Other
FAERS-12426,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-03-07,45-64,Male,Canada,Disability
FAERS-12427,EXENATIDE (BYETTA),THYROID NEOPLASM,2020-07-19,45-64,Male,USA,Not specified
FAERS-12428,LIRAGLUTIDE (VICTOZA),CONSTIPATION,2021-08-03,0-17,Male,USA,Other
FAERS-12429,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2018-07-05,45-64,Female,Australia,Other
FAERS-12430,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-03-09,45-64,Female,USA,Other
FAERS-12431,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-09-25,18-44,Female,Japan,Other
FAERS-12432,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-03-02,18-44,Male,Europe,Hospitalization
FAERS-12433,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-01-03,18-44,Unknown,USA,Other
FAERS-12434,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-01-15,18-44,Female,USA,Not specified
FAERS-12435,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2022-02-27,75-84,Male,Canada,Not specified
FAERS-12436,TIRZEPATIDE (MOUNJARO),DIZZINESS,2019-10-28,45-64,Male,USA,Death
FAERS-12437,LIRAGLUTIDE (SAXENDA),NAUSEA,2023-03-26,45-64,Female,USA,Other
FAERS-12438,EXENATIDE (BYDUREON),DIARRHEA,2021-01-26,45-64,Female,USA,Not specified
FAERS-12439,EXENATIDE (BYDUREON),PANCREATITIS,2023-12-24,45-64,Female,Europe,Hospitalization
FAERS-12440,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-03-04,18-44,Male,USA,Hospitalization
FAERS-12441,SEMAGLUTIDE (OZEMPIC),VOMITING,2018-12-12,18-44,Female,Other,Not specified
FAERS-12442,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-02-15,65-74,Female,USA,Not specified
FAERS-12443,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-10-05,45-64,Female,Europe,Other
FAERS-12444,SEMAGLUTIDE (WEGOVY),HEADACHE,2022-12-25,45-64,Male,USA,Hospitalization
FAERS-12445,TIRZEPATIDE (MOUNJARO),VOMITING,2023-04-08,18-44,Female,Australia,Other
FAERS-12446,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2019-03-13,18-44,Female,USA,Other
FAERS-12447,EXENATIDE (BYDUREON),ALOPECIA,2020-04-24,45-64,Female,Europe,Other
FAERS-12448,EXENATIDE (BYDUREON),HEADACHE,2021-01-10,18-44,Unknown,USA,Other
FAERS-12449,EXENATIDE (BYETTA),FATIGUE,2022-03-01,45-64,Female,USA,Not specified
FAERS-12450,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-06-07,45-64,Female,USA,Other
FAERS-12451,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-11-07,18-44,Female,USA,Life-threatening
FAERS-12452,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-08-16,65-74,Female,USA,Other
FAERS-12453,SEMAGLUTIDE (WEGOVY),DIARRHEA,2019-07-12,75-84,Female,USA,Other
FAERS-12454,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-03-05,45-64,Male,USA,Other
FAERS-12455,TIRZEPATIDE (MOUNJARO),VOMITING,2021-01-05,45-64,Female,Japan,Other
FAERS-12456,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2020-11-24,45-64,Female,USA,Not specified
FAERS-12457,EXENATIDE (BYDUREON),GALLBLADDER DISEASE,2023-01-14,65-74,Female,Europe,Other
FAERS-12458,LIRAGLUTIDE (SAXENDA),DECREASED APPETITE,2021-04-07,45-64,Male,Europe,Other
FAERS-12459,LIRAGLUTIDE (VICTOZA),DECREASED APPETITE,2022-04-23,65-74,Male,USA,Not specified
FAERS-12460,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-03-26,45-64,Male,USA,Hospitalization
FAERS-12461,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-03-28,45-64,Female,USA,Other
FAERS-12462,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2019-10-04,45-64,Female,Canada,Other
FAERS-12463,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2023-11-01,45-64,Female,Other,Hospitalization
FAERS-12464,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2021-09-16,45-64,Female,Australia,Other
FAERS-12465,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2021-07-24,45-64,Female,USA,Other
FAERS-12466,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2022-02-20,45-64,Female,USA,Hospitalization
FAERS-12467,DULAGLUTIDE (TRULICITY),ALOPECIA,2022-01-10,18-44,Male,USA,Life-threatening
FAERS-12468,LIRAGLUTIDE (SAXENDA),HEADACHE,2023-10-25,65-74,Male,Europe,Not specified
FAERS-12469,TIRZEPATIDE (ZEPBOUND),VOMITING,2021-10-20,65-74,Female,Europe,Not specified
FAERS-12470,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-02-24,45-64,Male,USA,Other
FAERS-12471,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-03-23,65-74,Female,USA,Hospitalization
FAERS-12472,SEMAGLUTIDE (OZEMPIC),NAUSEA,2020-07-07,75-84,Female,USA,Not specified
FAERS-12473,SEMAGLUTIDE (WEGOVY),NAUSEA,2020-09-08,45-64,Male,USA,Other
FAERS-12474,SEMAGLUTIDE (WEGOVY),NAUSEA,2023-10-06,45-64,Female,Japan,Other
FAERS-12475,TIRZEPATIDE (MOUNJARO),HEADACHE,2022-03-27,45-64,Male,USA,Other
FAERS-12476,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-04-28,18-44,Male,Europe,Other
FAERS-12477,DULAGLUTIDE (TRULICITY),DECREASED APPETITE,2021-12-03,65-74,Male,Europe,Other
FAERS-12478,EXENATIDE (BYDUREON),VOMITING,2023-07-06,45-64,Female,Europe,Other
FAERS-12479,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2023-04-05,45-64,Female,USA,Other
FAERS-12480,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2019-09-28,18-44,Male,USA,Other
FAERS-12481,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-02-17,45-64,Male,Europe,Other
FAERS-12482,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-08-16,65-74,Female,USA,Other
FAERS-12483,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2022-01-21,45-64,Female,USA,Not specified
FAERS-12484,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-10-05,18-44,Female,USA,Other
FAERS-12485,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2019-10-14,45-64,Female,USA,Other
FAERS-12486,TIRZEPATIDE (MOUNJARO),HEADACHE,2022-12-22,18-44,Female,USA,Hospitalization
FAERS-12487,EXENATIDE (BYDUREON),ALOPECIA,2023-07-18,18-44,Female,USA,Other
FAERS-12488,LIRAGLUTIDE (VICTOZA),DIZZINESS,2021-05-20,45-64,Female,USA,Other
FAERS-12489,EXENATIDE (BYETTA),ASPIRATION,2022-11-21,18-44,Male,USA,Hospitalization
FAERS-12490,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2018-05-21,45-64,Male,Canada,Other
FAERS-12491,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2019-08-19,45-64,Female,Other,Other
FAERS-12492,SEMAGLUTIDE (OZEMPIC),FATIGUE,2021-11-16,45-64,Female,USA,Other
FAERS-12493,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2019-09-07,45-64,Female,USA,Not specified
FAERS-12494,SEMAGLUTIDE (WEGOVY),ALOPECIA,2021-08-17,65-74,Male,USA,Not specified
FAERS-12495,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2019-07-10,45-64,Female,Europe,Other
FAERS-12496,TIRZEPATIDE (MOUNJARO),HEADACHE,2020-11-17,45-64,Male,Europe,Not specified
FAERS-12497,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2020-03-15,18-44,Female,Other,Hospitalization
FAERS-12498,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2020-09-27,45-64,Male,Europe,Other
FAERS-12499,EXENATIDE (BYETTA),VOMITING,2022-11-26,18-44,Female,USA,Hospitalization
FAERS-12500,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-08-09,45-64,Female,USA,Not specified
FAERS-12501,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2020-03-15,18-44,Male,Other,Other
FAERS-12502,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-11-13,18-44,Male,Europe,Hospitalization
FAERS-12503,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-06-13,65-74,Female,USA,Other
FAERS-12504,SEMAGLUTIDE (WEGOVY),HEADACHE,2022-05-14,65-74,Male,USA,Other
FAERS-12505,TIRZEPATIDE (MOUNJARO),NAUSEA,2022-09-16,65-74,Female,Japan,Life-threatening
FAERS-12506,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2020-06-23,65-74,Male,USA,Hospitalization
FAERS-12507,LIRAGLUTIDE (VICTOZA),ABDOMINAL PAIN,2022-01-13,45-64,Female,USA,Other
FAERS-12508,EXENATIDE (BYDUREON),PANCREATITIS,2023-03-10,45-64,Female,USA,Not specified
FAERS-12509,DULAGLUTIDE (TRULICITY),DIARRHEA,2022-07-28,65-74,Male,Japan,Other
FAERS-12510,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2020-10-01,45-64,Male,Australia,Other
FAERS-12511,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2018-08-10,45-64,Female,USA,Other
FAERS-12512,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-10-14,45-64,Female,USA,Other
FAERS-12513,SEMAGLUTIDE (WEGOVY),VOMITING,2018-02-05,65-74,Male,USA,Other
FAERS-12514,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2023-01-01,18-44,Male,Europe,Other
FAERS-12515,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2019-12-25,45-64,Female,Australia,Other
FAERS-12516,TIRZEPATIDE (MOUNJARO),ASPIRATION,2020-05-18,45-64,Female,USA,Other
FAERS-12517,EXENATIDE (BYDUREON),ABDOMINAL PAIN,2022-03-06,45-64,Male,Europe,Other
FAERS-12518,LIRAGLUTIDE (SAXENDA),DIARRHEA,2019-02-17,65-74,Male,Canada,Other
FAERS-12519,LIRAGLUTIDE (SAXENDA),DIZZINESS,2022-11-02,45-64,Male,Japan,Other
FAERS-12520,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2020-06-21,18-44,Female,USA,Disability
FAERS-12521,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-05-04,45-64,Female,Europe,Not specified
FAERS-12522,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-08-07,18-44,Female,Europe,Other
FAERS-12523,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-01-08,45-64,Male,USA,Disability
FAERS-12524,SEMAGLUTIDE (WEGOVY),HEADACHE,2020-11-17,45-64,Female,USA,Not specified
FAERS-12525,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-03-26,45-64,Male,USA,Not specified
FAERS-12526,TIRZEPATIDE (MOUNJARO),VOMITING,2018-09-14,65-74,Female,USA,Death
FAERS-12527,EXENATIDE (BYDUREON),VOMITING,2021-11-07,18-44,Female,USA,Not specified
FAERS-12528,EXENATIDE (BYDUREON),CONSTIPATION,2022-02-12,65-74,Female,USA,Other
FAERS-12529,DULAGLUTIDE (TRULICITY),CONSTIPATION,2022-12-13,45-64,Female,USA,Not specified
FAERS-12530,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2020-07-05,45-64,Female,Other,Other
FAERS-12531,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-06-02,65-74,Female,USA,Other
FAERS-12532,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-09-11,65-74,Female,USA,Other
FAERS-12533,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-03-04,45-64,Male,Australia,Other
FAERS-12534,SEMAGLUTIDE (WEGOVY),HEADACHE,2020-05-13,45-64,Female,Japan,Other
FAERS-12535,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-11-20,65-74,Male,Europe,Other
FAERS-12536,TIRZEPATIDE (MOUNJARO),HEADACHE,2023-08-11,45-64,Female,Canada,Other
FAERS-12537,EXENATIDE (BYETTA),PANCREATITIS,2023-01-06,45-64,Female,Europe,Hospitalization
FAERS-12538,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2022-11-27,45-64,Female,Europe,Hospitalization
FAERS-12539,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2022-02-15,45-64,Female,Japan,Hospitalization
FAERS-12540,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-02-26,45-64,Male,Other,Other
FAERS-12541,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-09-04,45-64,Female,USA,Hospitalization
FAERS-12542,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-09-04,45-64,Male,USA,Other
FAERS-12543,SEMAGLUTIDE (WEGOVY),HEADACHE,2019-06-19,45-64,Unknown,Europe,Hospitalization
FAERS-12544,SEMAGLUTIDE (WEGOVY),ALOPECIA,2023-12-19,65-74,Female,Japan,Other
FAERS-12545,TIRZEPATIDE (MOUNJARO),DIARRHEA,2021-09-28,18-44,Female,USA,Other
FAERS-12546,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2022-11-11,18-44,Female,USA,Other
FAERS-12547,EXENATIDE (BYETTA),INJECTION SITE REACTION,2023-11-11,65-74,Female,Europe,Disability
FAERS-12548,EXENATIDE (BYDUREON),GALLBLADDER DISEASE,2023-02-01,65-74,Male,USA,Other
FAERS-12549,EXENATIDE (BYETTA),DIARRHEA,2023-06-04,45-64,Female,USA,Other
FAERS-12550,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-02-28,45-64,Female,USA,Other
FAERS-12551,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2020-08-07,45-64,Male,USA,Other
FAERS-12552,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2020-07-05,75-84,Female,USA,Not specified
FAERS-12553,SEMAGLUTIDE (WEGOVY),VOMITING,2022-04-12,45-64,Female,USA,Other
FAERS-12554,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-07-03,45-64,Female,USA,Other
FAERS-12555,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-07-08,45-64,Male,Europe,Other
FAERS-12556,TIRZEPATIDE (MOUNJARO),HEADACHE,2021-04-13,45-64,Female,USA,Not specified
FAERS-12557,EXENATIDE (BYETTA),NAUSEA,2022-08-01,18-44,Female,USA,Not specified
FAERS-12558,EXENATIDE (BYETTA),DIZZINESS,2021-04-10,Unknown,Female,USA,Life-threatening
FAERS-12559,TIRZEPATIDE (ZEPBOUND),GALLBLADDER DISEASE,2021-01-04,18-44,Male,Europe,Other
FAERS-12560,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-11-10,75-84,Male,Canada,Other
FAERS-12561,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-09-01,Unknown,Female,USA,Hospitalization
FAERS-12562,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2021-09-28,0-17,Male,USA,Hospitalization
FAERS-12563,SEMAGLUTIDE (WEGOVY),DIZZINESS,2022-10-11,45-64,Female,USA,Other
FAERS-12564,SEMAGLUTIDE (WEGOVY),ASPIRATION,2022-05-23,45-64,Female,USA,Other
FAERS-12565,TIRZEPATIDE (MOUNJARO),ASPIRATION,2018-03-06,65-74,Female,Europe,Other
FAERS-12566,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2021-06-25,45-64,Female,USA,Not specified
FAERS-12567,TIRZEPATIDE (ZEPBOUND),SUICIDAL IDEATION,2023-08-05,18-44,Female,USA,Not specified
FAERS-12568,TIRZEPATIDE (ZEPBOUND),HYPOGLYCEMIA,2023-09-04,65-74,Male,Other,Other
FAERS-12569,DULAGLUTIDE (TRULICITY),SUICIDAL IDEATION,2018-05-07,65-74,Female,Europe,Other
FAERS-12570,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-11-24,65-74,Female,USA,Other
FAERS-12571,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-01-27,65-74,Male,USA,Other
FAERS-12572,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-06-07,0-17,Male,Japan,Other
FAERS-12573,SEMAGLUTIDE (WEGOVY),DIZZINESS,2021-06-09,45-64,Male,USA,Other
FAERS-12574,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-04-03,75-84,Male,Europe,Other
FAERS-12575,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-02-01,45-64,Female,USA,Hospitalization
FAERS-12576,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2022-03-09,45-64,Female,USA,Other
FAERS-12577,LIRAGLUTIDE (VICTOZA),SUICIDAL IDEATION,2022-02-21,45-64,Male,USA,Not specified
FAERS-12578,LIRAGLUTIDE (VICTOZA),INJECTION SITE REACTION,2023-08-05,45-64,Female,USA,Other
FAERS-12579,LIRAGLUTIDE (SAXENDA),SUICIDAL IDEATION,2019-08-27,45-64,Male,USA,Other
FAERS-12580,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-04-06,45-64,Male,Canada,Other
FAERS-12581,SEMAGLUTIDE (OZEMPIC),VOMITING,2021-07-04,65-74,Male,USA,Other
FAERS-12582,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-03-02,45-64,Male,USA,Not specified
FAERS-12583,SEMAGLUTIDE (WEGOVY),DIARRHEA,2020-07-24,18-44,Female,Europe,Hospitalization
FAERS-12584,SEMAGLUTIDE (WEGOVY),HEADACHE,2018-08-16,18-44,Female,USA,Other
FAERS-12585,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-01-01,18-44,Male,USA,Other
FAERS-12586,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2022-03-06,45-64,Male,Europe,Hospitalization
FAERS-12587,LIRAGLUTIDE (VICTOZA),HEADACHE,2023-11-13,45-64,Male,USA,Other
FAERS-12588,LIRAGLUTIDE (VICTOZA),DIARRHEA,2023-05-24,65-74,Male,Canada,Other
FAERS-12589,TIRZEPATIDE (ZEPBOUND),THYROID NEOPLASM,2023-08-27,18-44,Male,Europe,Hospitalization
FAERS-12590,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-05-10,18-44,Male,Other,Not specified
FAERS-12591,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2021-03-11,18-44,Female,USA,Death
FAERS-12592,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-11-24,45-64,Male,Other,Hospitalization
FAERS-12593,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2023-07-20,65-74,Female,Europe,Hospitalization
FAERS-12594,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2020-03-16,45-64,Female,USA,Other
FAERS-12595,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-11-05,45-64,Male,USA,Other
FAERS-12596,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2021-03-04,45-64,Female,USA,Hospitalization
FAERS-12597,EXENATIDE (BYDUREON),VOMITING,2019-07-18,75-84,Female,Japan,Not specified
FAERS-12598,EXENATIDE (BYDUREON),ABDOMINAL PAIN,2022-07-26,45-64,Female,USA,Not specified
FAERS-12599,EXENATIDE (BYETTA),DECREASED APPETITE,2023-09-17,18-44,Female,Other,Other
FAERS-12600,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-02-19,18-44,Female,USA,Hospitalization
FAERS-12601,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-01-02,45-64,Female,USA,Other
FAERS-12602,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-04-13,65-74,Female,Europe,Other
FAERS-12603,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2020-09-09,18-44,Male,USA,Other
FAERS-12604,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2020-09-14,75-84,Male,USA,Other
FAERS-12605,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-04-24,18-44,Female,USA,Other
FAERS-12606,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2021-04-25,65-74,Female,USA,Disability
FAERS-12607,TIRZEPATIDE (ZEPBOUND),NAUSEA,2023-07-15,45-64,Female,Europe,Disability
FAERS-12608,TIRZEPATIDE (ZEPBOUND),DIZZINESS,2022-02-04,0-17,Female,Europe,Other
FAERS-12609,DULAGLUTIDE (TRULICITY),ALOPECIA,2021-12-21,18-44,Female,Canada,Life-threatening
FAERS-12610,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-11-18,45-64,Male,USA,Not specified
FAERS-12611,SEMAGLUTIDE (OZEMPIC),HEADACHE,2018-12-11,45-64,Female,USA,Other
FAERS-12612,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-08-09,75-84,Female,Canada,Other
FAERS-12613,SEMAGLUTIDE (WEGOVY),NAUSEA,2022-05-22,18-44,Female,Europe,Disability
FAERS-12614,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2021-02-17,65-74,Female,USA,Not specified
FAERS-12615,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2021-09-05,45-64,Female,USA,Other
FAERS-12616,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2021-11-01,45-64,Unknown,USA,Hospitalization
FAERS-12617,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2021-10-20,18-44,Female,USA,Other
FAERS-12618,LIRAGLUTIDE (SAXENDA),HEADACHE,2020-01-04,45-64,Female,USA,Hospitalization
FAERS-12619,LIRAGLUTIDE (VICTOZA),ABDOMINAL PAIN,2023-02-23,45-64,Male,USA,Other
FAERS-12620,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-01-05,45-64,Female,USA,Not specified
FAERS-12621,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-12-11,18-44,Male,Canada,Not specified
FAERS-12622,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-03-08,65-74,Female,Other,Other
FAERS-12623,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2023-09-05,0-17,Male,USA,Other
FAERS-12624,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2022-11-11,45-64,Female,Australia,Other
FAERS-12625,TIRZEPATIDE (MOUNJARO),NAUSEA,2018-08-20,45-64,Female,USA,Life-threatening
FAERS-12626,TIRZEPATIDE (MOUNJARO),NAUSEA,2022-09-05,45-64,Male,USA,Other
FAERS-12627,TIRZEPATIDE (ZEPBOUND),VOMITING,2023-10-24,65-74,Female,USA,Not specified
FAERS-12628,EXENATIDE (BYDUREON),HYPOGLYCEMIA,2021-09-23,45-64,Male,Europe,Other
FAERS-12629,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2023-12-25,45-64,Male,Other,Other
FAERS-12630,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-08-14,18-44,Female,Europe,Not specified
FAERS-12631,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-06-08,45-64,Female,USA,Hospitalization
FAERS-12632,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-08-28,65-74,Female,USA,Hospitalization
FAERS-12633,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2021-03-06,45-64,Female,USA,Not specified
FAERS-12634,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2023-07-15,65-74,Male,USA,Not specified
FAERS-12635,TIRZEPATIDE (MOUNJARO),FATIGUE,2021-12-26,65-74,Female,USA,Other
FAERS-12636,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-08-14,18-44,Unknown,Other,Not specified
FAERS-12637,DULAGLUTIDE (TRULICITY),FATIGUE,2022-02-22,65-74,Female,USA,Life-threatening
FAERS-12638,TIRZEPATIDE (ZEPBOUND),DIZZINESS,2019-09-10,45-64,Male,Other,Other
FAERS-12639,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2021-04-10,Unknown,Male,USA,Hospitalization
FAERS-12640,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-03-03,65-74,Female,USA,Other
FAERS-12641,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2020-05-19,65-74,Female,Europe,Other
FAERS-12642,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-02-25,45-64,Female,Europe,Hospitalization
FAERS-12643,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2019-03-15,45-64,Female,USA,Other
FAERS-12644,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-05-17,45-64,Male,USA,Not specified
FAERS-12645,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-07-18,18-44,Male,USA,Hospitalization
FAERS-12646,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2019-02-02,18-44,Female,USA,Death
FAERS-12647,LIRAGLUTIDE (VICTOZA),ALOPECIA,2019-12-06,45-64,Male,Europe,Other
FAERS-12648,TIRZEPATIDE (ZEPBOUND),DIARRHEA,2022-01-27,45-64,Male,Europe,Not specified
FAERS-12649,DULAGLUTIDE (TRULICITY),DIARRHEA,2019-01-07,65-74,Female,USA,Life-threatening
FAERS-12650,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-10-02,18-44,Female,USA,Hospitalization
FAERS-12651,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-02-08,18-44,Male,USA,Hospitalization
FAERS-12652,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-07-02,65-74,Female,USA,Other
FAERS-12653,SEMAGLUTIDE (WEGOVY),VOMITING,2023-06-22,45-64,Female,Japan,Other
FAERS-12654,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2022-05-28,Unknown,Female,USA,Not specified
FAERS-12655,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2022-02-07,45-64,Female,Japan,Not specified
FAERS-12656,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2022-03-18,45-64,Male,USA,Other
FAERS-12657,DULAGLUTIDE (TRULICITY),FATIGUE,2023-12-08,0-17,Male,USA,Other
FAERS-12658,DULAGLUTIDE (TRULICITY),VOMITING,2022-03-05,18-44,Female,USA,Not specified
FAERS-12659,EXENATIDE (BYDUREON),DIZZINESS,2022-02-18,65-74,Female,USA,Disability
FAERS-12660,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-01-06,18-44,Female,USA,Other
FAERS-12661,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-09-02,45-64,Female,USA,Hospitalization
FAERS-12662,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2020-07-06,45-64,Male,Europe,Life-threatening
FAERS-12663,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-07-18,45-64,Male,Other,Other
FAERS-12664,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2021-11-12,45-64,Female,USA,Hospitalization
FAERS-12665,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-12-24,18-44,Female,Other,Not specified
FAERS-12666,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2021-05-27,18-44,Male,USA,Hospitalization
FAERS-12667,TIRZEPATIDE (ZEPBOUND),NAUSEA,2023-11-17,75-84,Male,USA,Other
FAERS-12668,LIRAGLUTIDE (VICTOZA),ABDOMINAL PAIN,2022-04-19,18-44,Female,USA,Hospitalization
FAERS-12669,EXENATIDE (BYETTA),SUICIDAL IDEATION,2023-12-14,45-64,Male,USA,Other
FAERS-12670,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2020-06-03,65-74,Male,USA,Other
FAERS-12671,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-07-23,65-74,Female,Other,Other
FAERS-12672,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2021-02-03,65-74,Female,USA,Hospitalization
FAERS-12673,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-03-16,18-44,Female,Japan,Other
FAERS-12674,SEMAGLUTIDE (WEGOVY),ALOPECIA,2022-09-11,65-74,Female,USA,Other
FAERS-12675,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-08-11,65-74,Male,Europe,Not specified
FAERS-12676,TIRZEPATIDE (MOUNJARO),DIARRHEA,2019-06-09,45-64,Female,USA,Life-threatening
FAERS-12677,EXENATIDE (BYDUREON),NAUSEA,2023-01-05,45-64,Female,USA,Other
FAERS-12678,LIRAGLUTIDE (SAXENDA),HYPOGLYCEMIA,2021-08-15,65-74,Unknown,Europe,Hospitalization
FAERS-12679,LIRAGLUTIDE (SAXENDA),VOMITING,2022-02-12,18-44,Female,USA,Other
FAERS-12680,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2020-11-24,45-64,Female,USA,Hospitalization
FAERS-12681,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-08-10,45-64,Unknown,USA,Not specified
FAERS-12682,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2020-01-06,45-64,Male,USA,Other
FAERS-12683,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-08-06,65-74,Female,USA,Other
FAERS-12684,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2020-08-21,Unknown,Female,USA,Not specified
FAERS-12685,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-06-07,18-44,Female,Canada,Other
FAERS-12686,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-04-17,45-64,Female,USA,Other
FAERS-12687,EXENATIDE (BYETTA),SUICIDAL IDEATION,2018-05-17,45-64,Female,Europe,Not specified
FAERS-12688,EXENATIDE (BYETTA),THYROID NEOPLASM,2021-06-25,45-64,Male,USA,Disability
FAERS-12689,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2023-08-07,18-44,Female,Europe,Other
FAERS-12690,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-05-25,75-84,Male,Canada,Hospitalization
FAERS-12691,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-09-20,45-64,Male,USA,Not specified
FAERS-12692,SEMAGLUTIDE (OZEMPIC),FATIGUE,2019-12-28,45-64,Male,USA,Hospitalization
FAERS-12693,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2020-07-24,45-64,Male,USA,Not specified
FAERS-12694,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2023-03-16,18-44,Male,USA,Hospitalization
FAERS-12695,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2022-10-04,65-74,Female,Europe,Not specified
FAERS-12696,TIRZEPATIDE (MOUNJARO),VOMITING,2023-06-04,18-44,Female,USA,Other
FAERS-12697,EXENATIDE (BYETTA),GALLBLADDER DISEASE,2019-07-19,45-64,Male,USA,Hospitalization
FAERS-12698,EXENATIDE (BYETTA),SUICIDAL IDEATION,2021-10-26,18-44,Male,USA,Other
FAERS-12699,TIRZEPATIDE (ZEPBOUND),THYROID NEOPLASM,2022-02-02,65-74,Male,USA,Other
FAERS-12700,SEMAGLUTIDE (OZEMPIC),NAUSEA,2018-04-26,18-44,Female,Canada,Not specified
FAERS-12701,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-01-02,18-44,Female,USA,Other
FAERS-12702,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-07-19,18-44,Female,USA,Disability
FAERS-12703,SEMAGLUTIDE (WEGOVY),VOMITING,2021-04-18,65-74,Male,USA,Hospitalization
FAERS-12704,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2021-01-06,45-64,Female,Europe,Not specified
FAERS-12705,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-04-24,45-64,Unknown,USA,Other
FAERS-12706,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-02-06,45-64,Unknown,USA,Not specified
FAERS-12707,TIRZEPATIDE (ZEPBOUND),ALOPECIA,2023-07-02,18-44,Female,USA,Hospitalization
FAERS-12708,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2022-03-18,45-64,Female,Europe,Other
FAERS-12709,LIRAGLUTIDE (SAXENDA),THYROID NEOPLASM,2022-01-15,45-64,Male,Europe,Other
FAERS-12710,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-06-25,45-64,Male,USA,Other
FAERS-12711,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-10-27,18-44,Female,Europe,Not specified
FAERS-12712,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-05-27,18-44,Female,Japan,Disability
FAERS-12713,SEMAGLUTIDE (WEGOVY),NAUSEA,2020-03-12,18-44,Female,USA,Not specified
FAERS-12714,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2019-03-26,18-44,Female,USA,Other
FAERS-12715,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2022-12-08,45-64,Female,USA,Not specified
FAERS-12716,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2023-10-17,65-74,Female,USA,Not specified
FAERS-12717,EXENATIDE (BYETTA),ABDOMINAL PAIN,2020-03-10,65-74,Female,Europe,Not specified
FAERS-12718,DULAGLUTIDE (TRULICITY),ASPIRATION,2018-10-24,45-64,Male,Europe,Other
FAERS-12719,EXENATIDE (BYDUREON),CONSTIPATION,2021-03-19,18-44,Female,USA,Hospitalization
FAERS-12720,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-10-05,65-74,Female,Japan,Not specified
FAERS-12721,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-05-19,18-44,Female,USA,Other
FAERS-12722,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-11-03,65-74,Female,USA,Other
FAERS-12723,SEMAGLUTIDE (WEGOVY),ASPIRATION,2020-07-15,45-64,Unknown,USA,Hospitalization
FAERS-12724,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-05-16,45-64,Male,USA,Other
FAERS-12725,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2019-03-23,45-64,Female,USA,Hospitalization
FAERS-12726,TIRZEPATIDE (MOUNJARO),DIZZINESS,2018-10-06,18-44,Female,USA,Other
FAERS-12727,EXENATIDE (BYETTA),ASPIRATION,2020-02-03,45-64,Male,USA,Other
FAERS-12728,LIRAGLUTIDE (VICTOZA),SUICIDAL IDEATION,2023-03-04,45-64,Male,USA,Other
FAERS-12729,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2022-10-15,45-64,Male,Canada,Other
FAERS-12730,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-03-05,45-64,Male,Europe,Not specified
FAERS-12731,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-12-18,18-44,Female,USA,Other
FAERS-12732,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-08-02,65-74,Female,USA,Other
FAERS-12733,SEMAGLUTIDE (WEGOVY),DIZZINESS,2020-03-19,65-74,Male,USA,Other
FAERS-12734,SEMAGLUTIDE (WEGOVY),HEADACHE,2019-06-15,45-64,Female,USA,Other
FAERS-12735,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2021-09-26,85+,Male,Canada,Other
FAERS-12736,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-06-23,45-64,Female,USA,Other
FAERS-12737,DULAGLUTIDE (TRULICITY),DIARRHEA,2021-03-22,65-74,Male,USA,Other
FAERS-12738,LIRAGLUTIDE (VICTOZA),GALLBLADDER DISEASE,2021-06-03,75-84,Female,USA,Other
FAERS-12739,DULAGLUTIDE (TRULICITY),DIARRHEA,2023-09-06,18-44,Male,USA,Other
FAERS-12740,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-08-06,75-84,Female,Europe,Other
FAERS-12741,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2019-03-26,65-74,Female,USA,Life-threatening
FAERS-12742,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2018-01-20,18-44,Female,USA,Other
FAERS-12743,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2021-01-09,18-44,Female,USA,Not specified
FAERS-12744,SEMAGLUTIDE (WEGOVY),ASPIRATION,2021-03-03,65-74,Male,USA,Other
FAERS-12745,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2018-02-19,18-44,Female,USA,Disability
FAERS-12746,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2021-08-03,18-44,Female,USA,Hospitalization
FAERS-12747,EXENATIDE (BYETTA),CONSTIPATION,2018-09-05,65-74,Female,USA,Other
FAERS-12748,EXENATIDE (BYDUREON),NAUSEA,2023-01-16,45-64,Female,Japan,Not specified
FAERS-12749,LIRAGLUTIDE (VICTOZA),GALLBLADDER DISEASE,2018-10-11,18-44,Female,Australia,Disability
FAERS-12750,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-04-22,45-64,Male,Europe,Hospitalization
FAERS-12751,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-10-09,65-74,Female,USA,Other
FAERS-12752,SEMAGLUTIDE (OZEMPIC),VOMITING,2019-06-09,45-64,Male,USA,Not specified
FAERS-12753,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2022-07-17,75-84,Male,USA,Other
FAERS-12754,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2022-05-20,65-74,Female,USA,Other
FAERS-12755,TIRZEPATIDE (MOUNJARO),DIZZINESS,2019-06-28,18-44,Male,USA,Other
FAERS-12756,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-10-19,45-64,Unknown,Europe,Death
FAERS-12757,LIRAGLUTIDE (SAXENDA),DECREASED APPETITE,2021-05-25,18-44,Male,USA,Other
FAERS-12758,DULAGLUTIDE (TRULICITY),DIARRHEA,2020-07-19,45-64,Female,USA,Other
FAERS-12759,EXENATIDE (BYETTA),INJECTION SITE REACTION,2022-12-08,18-44,Female,USA,Other
FAERS-12760,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-04-17,45-64,Female,USA,Other
FAERS-12761,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-04-17,18-44,Male,Other,Not specified
FAERS-12762,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2019-12-09,45-64,Female,USA,Disability
FAERS-12763,SEMAGLUTIDE (WEGOVY),ALOPECIA,2023-08-18,45-64,Female,USA,Hospitalization
FAERS-12764,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2021-02-10,18-44,Female,USA,Disability
FAERS-12765,TIRZEPATIDE (MOUNJARO),FATIGUE,2019-12-13,65-74,Male,USA,Hospitalization
FAERS-12766,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2021-07-28,65-74,Female,USA,Other
FAERS-12767,EXENATIDE (BYDUREON),SUICIDAL IDEATION,2023-02-12,65-74,Female,Japan,Other
FAERS-12768,EXENATIDE (BYDUREON),VOMITING,2018-01-05,45-64,Female,USA,Other
FAERS-12769,EXENATIDE (BYDUREON),DIARRHEA,2021-12-15,65-74,Male,USA,Other
FAERS-12770,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2021-07-02,45-64,Male,USA,Other
FAERS-12771,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-04-07,45-64,Female,Japan,Hospitalization
FAERS-12772,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-02-18,45-64,Male,Europe,Not specified
FAERS-12773,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-11-09,18-44,Female,Canada,Other
FAERS-12774,SEMAGLUTIDE (WEGOVY),DIZZINESS,2021-04-17,65-74,Female,USA,Other
FAERS-12775,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2020-07-07,65-74,Male,USA,Other
FAERS-12776,TIRZEPATIDE (MOUNJARO),ALOPECIA,2022-08-13,45-64,Female,Canada,Hospitalization
FAERS-12777,LIRAGLUTIDE (SAXENDA),ALOPECIA,2022-10-05,45-64,Female,Europe,Hospitalization
FAERS-12778,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2023-02-18,18-44,Female,USA,Not specified
FAERS-12779,EXENATIDE (BYDUREON),INJECTION SITE REACTION,2019-02-13,18-44,Female,USA,Other
FAERS-12780,SEMAGLUTIDE (OZEMPIC),HEADACHE,2020-10-19,85+,Female,USA,Life-threatening
FAERS-12781,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-03-16,65-74,Male,Other,Hospitalization
FAERS-12782,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-04-15,45-64,Female,Europe,Hospitalization
FAERS-12783,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2021-05-06,75-84,Female,Europe,Other
FAERS-12784,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2022-11-08,18-44,Female,USA,Not specified
FAERS-12785,TIRZEPATIDE (MOUNJARO),VOMITING,2023-10-23,65-74,Female,USA,Hospitalization
FAERS-12786,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2018-07-20,65-74,Female,USA,Life-threatening
FAERS-12787,EXENATIDE (BYETTA),PANCREATITIS,2023-09-06,45-64,Male,USA,Not specified
FAERS-12788,LIRAGLUTIDE (SAXENDA),CONSTIPATION,2023-01-23,75-84,Female,USA,Hospitalization
FAERS-12789,EXENATIDE (BYDUREON),DECREASED APPETITE,2021-09-28,65-74,Female,USA,Not specified
FAERS-12790,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-06-21,45-64,Female,Europe,Other
FAERS-12791,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-05-25,65-74,Female,USA,Other
FAERS-12792,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-04-15,18-44,Female,USA,Other
FAERS-12793,SEMAGLUTIDE (WEGOVY),VOMITING,2022-01-15,18-44,Female,USA,Not specified
FAERS-12794,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-02-15,45-64,Female,USA,Life-threatening
FAERS-12795,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-05-27,18-44,Female,USA,Other
FAERS-12796,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-09-17,65-74,Male,Canada,Other
FAERS-12797,LIRAGLUTIDE (SAXENDA),THYROID NEOPLASM,2019-07-18,18-44,Female,USA,Hospitalization
FAERS-12798,EXENATIDE (BYETTA),DECREASED APPETITE,2019-08-13,65-74,Female,USA,Other
FAERS-12799,TIRZEPATIDE (ZEPBOUND),HEADACHE,2019-01-21,45-64,Female,USA,Other
FAERS-12800,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2021-05-07,75-84,Male,Japan,Other
FAERS-12801,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-11-27,45-64,Male,USA,Not specified
FAERS-12802,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-11-05,18-44,Male,Europe,Other
FAERS-12803,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2019-03-08,45-64,Female,USA,Other
FAERS-12804,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-12-02,18-44,Female,USA,Other
FAERS-12805,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2021-07-11,65-74,Male,Japan,Hospitalization
FAERS-12806,TIRZEPATIDE (MOUNJARO),ALOPECIA,2022-07-09,45-64,Male,USA,Other
FAERS-12807,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2021-01-08,65-74,Female,Europe,Not specified
FAERS-12808,EXENATIDE (BYDUREON),ABDOMINAL PAIN,2021-12-19,65-74,Female,USA,Other
FAERS-12809,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2020-04-05,45-64,Female,USA,Disability
FAERS-12810,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-07-10,45-64,Female,Europe,Other
FAERS-12811,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-11-06,45-64,Female,USA,Hospitalization
FAERS-12812,SEMAGLUTIDE (OZEMPIC),NAUSEA,2020-07-19,18-44,Female,USA,Other
FAERS-12813,SEMAGLUTIDE (WEGOVY),NAUSEA,2023-10-14,45-64,Male,USA,Life-threatening
FAERS-12814,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-11-27,45-64,Unknown,Japan,Life-threatening
FAERS-12815,TIRZEPATIDE (MOUNJARO),ASPIRATION,2020-09-24,45-64,Female,USA,Other
FAERS-12816,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-06-25,45-64,Female,USA,Other
FAERS-12817,LIRAGLUTIDE (SAXENDA),DIARRHEA,2023-05-20,18-44,Male,USA,Not specified
FAERS-12818,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2022-03-05,45-64,Female,Other,Other
FAERS-12819,TIRZEPATIDE (ZEPBOUND),NAUSEA,2022-08-13,18-44,Male,Europe,Hospitalization
FAERS-12820,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-11-08,65-74,Male,Europe,Not specified
FAERS-12821,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2019-04-17,65-74,Female,USA,Not specified
FAERS-12822,SEMAGLUTIDE (OZEMPIC),FATIGUE,2020-10-20,18-44,Female,USA,Other
FAERS-12823,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-12-05,65-74,Female,USA,Other
FAERS-12824,SEMAGLUTIDE (WEGOVY),NAUSEA,2022-04-11,45-64,Female,USA,Not specified
FAERS-12825,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-02-20,75-84,Unknown,USA,Not specified
FAERS-12826,TIRZEPATIDE (MOUNJARO),HEADACHE,2023-09-27,45-64,Male,Australia,Hospitalization
FAERS-12827,LIRAGLUTIDE (SAXENDA),GALLBLADDER DISEASE,2021-11-01,18-44,Male,USA,Other
FAERS-12828,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2022-11-24,75-84,Female,USA,Other
FAERS-12829,LIRAGLUTIDE (SAXENDA),SUICIDAL IDEATION,2022-02-23,0-17,Male,Australia,Life-threatening
FAERS-12830,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2021-07-04,18-44,Male,Europe,Hospitalization
FAERS-12831,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-06-02,45-64,Female,USA,Disability
FAERS-12832,SEMAGLUTIDE (OZEMPIC),VOMITING,2020-06-27,45-64,Female,Other,Other
FAERS-12833,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-04-15,45-64,Male,USA,Hospitalization
FAERS-12834,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2021-08-10,18-44,Male,Other,Other
FAERS-12835,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-07-28,45-64,Female,USA,Hospitalization
FAERS-12836,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2022-08-14,Unknown,Female,Canada,Other
FAERS-12837,EXENATIDE (BYETTA),VOMITING,2022-06-03,45-64,Male,Japan,Other
FAERS-12838,LIRAGLUTIDE (VICTOZA),THYROID NEOPLASM,2021-07-07,18-44,Female,USA,Not specified
FAERS-12839,TIRZEPATIDE (ZEPBOUND),DIZZINESS,2021-09-24,18-44,Female,USA,Hospitalization
FAERS-12840,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-10-13,18-44,Female,USA,Other
FAERS-12841,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-08-01,45-64,Female,USA,Hospitalization
FAERS-12842,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-05-04,18-44,Female,USA,Other
FAERS-12843,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-03-06,Unknown,Male,Japan,Hospitalization
FAERS-12844,SEMAGLUTIDE (WEGOVY),HEADACHE,2020-12-24,45-64,Female,USA,Hospitalization
FAERS-12845,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-11-23,75-84,Female,USA,Other
FAERS-12846,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2020-12-11,45-64,Male,USA,Hospitalization
FAERS-12847,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2023-06-24,45-64,Female,Canada,Other
FAERS-12848,LIRAGLUTIDE (VICTOZA),NAUSEA,2023-09-17,18-44,Unknown,USA,Not specified
FAERS-12849,DULAGLUTIDE (TRULICITY),FATIGUE,2023-01-20,45-64,Female,USA,Life-threatening
FAERS-12850,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-12-27,65-74,Female,USA,Other
FAERS-12851,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2022-03-26,45-64,Male,USA,Other
FAERS-12852,SEMAGLUTIDE (OZEMPIC),VOMITING,2018-03-26,45-64,Male,USA,Other
FAERS-12853,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2021-08-26,18-44,Female,USA,Other
FAERS-12854,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2022-01-16,18-44,Male,USA,Other
FAERS-12855,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2023-01-28,65-74,Male,Europe,Other
FAERS-12856,TIRZEPATIDE (MOUNJARO),ASPIRATION,2019-02-10,65-74,Female,Canada,Other
FAERS-12857,TIRZEPATIDE (ZEPBOUND),ALOPECIA,2021-08-26,45-64,Female,USA,Other
FAERS-12858,DULAGLUTIDE (TRULICITY),DIARRHEA,2022-01-12,45-64,Male,Europe,Disability
FAERS-12859,TIRZEPATIDE (ZEPBOUND),DIARRHEA,2019-08-27,45-64,Female,USA,Other
FAERS-12860,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-01-13,18-44,Female,USA,Disability
FAERS-12861,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2019-09-21,18-44,Female,USA,Hospitalization
FAERS-12862,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2019-04-19,45-64,Male,USA,Hospitalization
FAERS-12863,SEMAGLUTIDE (WEGOVY),DIARRHEA,2018-06-05,18-44,Female,USA,Hospitalization
FAERS-12864,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2023-10-15,18-44,Male,Australia,Other
FAERS-12865,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-01-02,65-74,Female,Europe,Other
FAERS-12866,TIRZEPATIDE (MOUNJARO),HEADACHE,2023-08-10,18-44,Female,USA,Other
FAERS-12867,LIRAGLUTIDE (SAXENDA),ALOPECIA,2021-12-18,Unknown,Female,USA,Not specified
FAERS-12868,LIRAGLUTIDE (SAXENDA),DECREASED APPETITE,2022-11-18,75-84,Male,USA,Hospitalization
FAERS-12869,EXENATIDE (BYETTA),DIZZINESS,2023-05-25,45-64,Female,USA,Other
FAERS-12870,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2021-02-16,18-44,Male,Europe,Other
FAERS-12871,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-02-26,45-64,Female,USA,Other
FAERS-12872,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2021-11-05,45-64,Male,USA,Other
FAERS-12873,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-06-17,45-64,Male,USA,Other
FAERS-12874,SEMAGLUTIDE (WEGOVY),VOMITING,2020-12-21,75-84,Female,USA,Not specified
FAERS-12875,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2022-10-02,65-74,Male,USA,Other
FAERS-12876,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2021-10-09,45-64,Male,USA,Hospitalization
FAERS-12877,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2023-12-15,65-74,Female,USA,Other
FAERS-12878,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2022-09-21,18-44,Female,USA,Other
FAERS-12879,DULAGLUTIDE (TRULICITY),HYPOGLYCEMIA,2022-07-11,65-74,Male,Europe,Other
FAERS-12880,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-11-22,18-44,Female,Europe,Other
FAERS-12881,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-04-24,75-84,Female,USA,Other
FAERS-12882,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-11-04,65-74,Male,USA,Other
FAERS-12883,SEMAGLUTIDE (WEGOVY),DIARRHEA,2020-03-23,45-64,Female,USA,Other
FAERS-12884,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-07-10,18-44,Female,USA,Other
FAERS-12885,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2020-07-26,45-64,Male,USA,Not specified
FAERS-12886,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2020-08-08,45-64,Female,USA,Other
FAERS-12887,EXENATIDE (BYDUREON),DIARRHEA,2018-04-22,65-74,Female,Europe,Death
FAERS-12888,EXENATIDE (BYETTA),VOMITING,2020-03-17,45-64,Male,USA,Other
FAERS-12889,LIRAGLUTIDE (VICTOZA),CONSTIPATION,2022-10-01,45-64,Female,USA,Other
FAERS-12890,SEMAGLUTIDE (OZEMPIC),FATIGUE,2021-06-05,65-74,Female,USA,Not specified
FAERS-12891,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-02-07,75-84,Male,USA,Other
FAERS-12892,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2021-04-07,18-44,Female,USA,Other
FAERS-12893,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2020-03-16,65-74,Unknown,Europe,Other
FAERS-12894,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-01-13,18-44,Male,Canada,Other
FAERS-12895,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2020-06-02,45-64,Female,USA,Disability
FAERS-12896,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-03-21,45-64,Male,USA,Other
FAERS-12897,EXENATIDE (BYDUREON),SUICIDAL IDEATION,2019-08-09,45-64,Female,USA,Hospitalization
FAERS-12898,EXENATIDE (BYDUREON),SUICIDAL IDEATION,2021-07-05,45-64,Female,USA,Other
FAERS-12899,TIRZEPATIDE (ZEPBOUND),SUICIDAL IDEATION,2020-07-07,45-64,Male,Europe,Not specified
FAERS-12900,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-05-14,45-64,Female,Europe,Other
FAERS-12901,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-02-17,45-64,Male,USA,Not specified
FAERS-12902,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-09-23,45-64,Female,USA,Other
FAERS-12903,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2022-01-19,65-74,Male,Japan,Other
FAERS-12904,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-11-07,65-74,Male,USA,Hospitalization
FAERS-12905,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-10-09,65-74,Male,USA,Not specified
FAERS-12906,TIRZEPATIDE (MOUNJARO),VOMITING,2023-09-26,18-44,Female,USA,Other
FAERS-12907,EXENATIDE (BYDUREON),SUICIDAL IDEATION,2021-05-01,18-44,Female,USA,Hospitalization
FAERS-12908,TIRZEPATIDE (ZEPBOUND),CONSTIPATION,2023-03-07,45-64,Female,Other,Not specified
FAERS-12909,EXENATIDE (BYETTA),DECREASED APPETITE,2023-11-06,45-64,Female,USA,Other
FAERS-12910,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-09-17,65-74,Female,USA,Hospitalization
FAERS-12911,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-06-22,18-44,Female,USA,Other
FAERS-12912,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2019-12-07,18-44,Female,USA,Other
FAERS-12913,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2023-10-18,45-64,Female,USA,Not specified
FAERS-12914,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2021-08-20,45-64,Female,USA,Other
FAERS-12915,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-10-28,45-64,Female,USA,Not specified
FAERS-12916,TIRZEPATIDE (MOUNJARO),DIARRHEA,2019-03-14,45-64,Male,Europe,Hospitalization
FAERS-12917,DULAGLUTIDE (TRULICITY),DIARRHEA,2023-11-17,18-44,Male,Japan,Other
FAERS-12918,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2021-06-16,45-64,Female,USA,Other
FAERS-12919,LIRAGLUTIDE (VICTOZA),ABDOMINAL PAIN,2022-06-17,45-64,Male,USA,Other
FAERS-12920,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-07-13,45-64,Male,Europe,Other
FAERS-12921,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2021-09-19,18-44,Female,Canada,Other
FAERS-12922,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2020-07-18,0-17,Female,Europe,Not specified
FAERS-12923,SEMAGLUTIDE (WEGOVY),NAUSEA,2023-12-03,65-74,Female,Europe,Other
FAERS-12924,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-05-05,45-64,Male,USA,Not specified
FAERS-12925,TIRZEPATIDE (MOUNJARO),FATIGUE,2021-01-18,45-64,Male,Europe,Other
FAERS-12926,TIRZEPATIDE (MOUNJARO),HEADACHE,2023-04-09,18-44,Female,Canada,Other
FAERS-12927,TIRZEPATIDE (ZEPBOUND),HEADACHE,2022-10-16,45-64,Male,USA,Hospitalization
FAERS-12928,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2021-05-17,18-44,Male,USA,Hospitalization
FAERS-12929,LIRAGLUTIDE (SAXENDA),ASPIRATION,2023-08-10,45-64,Female,Europe,Not specified
FAERS-12930,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-10-09,18-44,Male,USA,Other
FAERS-12931,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2020-07-01,45-64,Female,USA,Life-threatening
FAERS-12932,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2018-04-03,45-64,Female,Europe,Other
FAERS-12933,SEMAGLUTIDE (WEGOVY),HEADACHE,2022-01-15,Unknown,Male,USA,Disability
FAERS-12934,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2022-08-10,18-44,Male,Europe,Other
FAERS-12935,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2021-09-14,45-64,Female,USA,Other
FAERS-12936,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-12-05,45-64,Female,USA,Not specified
FAERS-12937,LIRAGLUTIDE (SAXENDA),ALOPECIA,2023-02-19,45-64,Female,USA,Other
FAERS-12938,LIRAGLUTIDE (VICTOZA),DIZZINESS,2023-06-24,18-44,Unknown,USA,Other
FAERS-12939,EXENATIDE (BYDUREON),DIZZINESS,2021-09-07,45-64,Female,Europe,Hospitalization
FAERS-12940,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-04-22,18-44,Male,USA,Not specified
FAERS-12941,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-02-15,18-44,Male,Europe,Other
FAERS-12942,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-10-10,65-74,Female,Europe,Other
FAERS-12943,SEMAGLUTIDE (WEGOVY),HEADACHE,2020-08-24,65-74,Female,Japan,Hospitalization
FAERS-12944,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2018-03-06,18-44,Female,Australia,Disability
FAERS-12945,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-07-11,45-64,Male,Europe,Not specified
FAERS-12946,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2022-09-09,65-74,Female,USA,Not specified
FAERS-12947,DULAGLUTIDE (TRULICITY),HEADACHE,2021-06-11,45-64,Male,Europe,Disability
FAERS-12948,EXENATIDE (BYETTA),VOMITING,2022-08-24,65-74,Female,USA,Disability
FAERS-12949,EXENATIDE (BYETTA),VOMITING,2022-05-12,45-64,Male,USA,Other
FAERS-12950,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-09-09,65-74,Female,USA,Other
FAERS-12951,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2018-08-13,18-44,Male,USA,Hospitalization
FAERS-12952,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-11-20,45-64,Male,USA,Hospitalization
FAERS-12953,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2019-10-21,65-74,Female,Europe,Other
FAERS-12954,SEMAGLUTIDE (WEGOVY),FATIGUE,2022-03-27,45-64,Female,Europe,Not specified
FAERS-12955,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-10-02,45-64,Female,USA,Not specified
FAERS-12956,TIRZEPATIDE (MOUNJARO),NAUSEA,2022-03-13,45-64,Male,Europe,Other
FAERS-12957,LIRAGLUTIDE (VICTOZA),CONSTIPATION,2021-05-20,65-74,Female,Japan,Not specified
FAERS-12958,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2022-07-28,45-64,Female,USA,Other
FAERS-12959,EXENATIDE (BYDUREON),SUICIDAL IDEATION,2021-08-15,Unknown,Male,USA,Disability
FAERS-12960,SEMAGLUTIDE (OZEMPIC),VOMITING,2020-06-11,18-44,Female,Canada,Other
FAERS-12961,SEMAGLUTIDE (OZEMPIC),NAUSEA,2018-03-21,65-74,Male,Europe,Hospitalization
FAERS-12962,SEMAGLUTIDE (OZEMPIC),FATIGUE,2021-05-09,45-64,Female,USA,Hospitalization
FAERS-12963,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2021-05-16,45-64,Male,Other,Not specified
FAERS-12964,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-06-28,45-64,Female,Australia,Hospitalization
FAERS-12965,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2021-09-20,Unknown,Male,USA,Hospitalization
FAERS-12966,TIRZEPATIDE (MOUNJARO),NAUSEA,2021-01-28,45-64,Female,USA,Not specified
FAERS-12967,LIRAGLUTIDE (VICTOZA),DIZZINESS,2021-05-09,45-64,Female,USA,Other
FAERS-12968,DULAGLUTIDE (TRULICITY),HEADACHE,2023-07-24,45-64,Female,Other,Not specified
FAERS-12969,LIRAGLUTIDE (SAXENDA),ALOPECIA,2021-04-25,18-44,Male,USA,Other
FAERS-12970,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-12-06,65-74,Female,Australia,Other
FAERS-12971,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-09-25,18-44,Female,USA,Other
FAERS-12972,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-12-22,18-44,Female,USA,Other
FAERS-12973,SEMAGLUTIDE (WEGOVY),DIARRHEA,2021-12-12,65-74,Male,USA,Hospitalization
FAERS-12974,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-01-15,65-74,Female,USA,Not specified
FAERS-12975,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2021-12-04,65-74,Female,Europe,Other
FAERS-12976,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-05-24,45-64,Male,USA,Not specified
FAERS-12977,EXENATIDE (BYETTA),VOMITING,2020-03-03,18-44,Male,USA,Other
FAERS-12978,TIRZEPATIDE (ZEPBOUND),GALLBLADDER DISEASE,2023-02-08,45-64,Female,Australia,Other
FAERS-12979,LIRAGLUTIDE (SAXENDA),SUICIDAL IDEATION,2023-05-27,45-64,Female,Canada,Other
FAERS-12980,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2019-12-28,65-74,Male,Europe,Hospitalization
FAERS-12981,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-01-26,45-64,Unknown,Other,Life-threatening
FAERS-12982,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-11-19,45-64,Female,Europe,Other
FAERS-12983,SEMAGLUTIDE (WEGOVY),ALOPECIA,2022-02-20,18-44,Female,USA,Other
FAERS-12984,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-12-13,45-64,Female,USA,Not specified
FAERS-12985,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2023-03-05,65-74,Female,USA,Other
FAERS-12986,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-04-24,45-64,Female,USA,Other
FAERS-12987,DULAGLUTIDE (TRULICITY),HEADACHE,2018-08-28,65-74,Female,USA,Other
FAERS-12988,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2021-01-20,45-64,Male,USA,Life-threatening
FAERS-12989,LIRAGLUTIDE (VICTOZA),ALOPECIA,2023-07-10,45-64,Female,Canada,Hospitalization
FAERS-12990,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-03-13,65-74,Male,USA,Disability
FAERS-12991,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-10-21,65-74,Female,Japan,Other
FAERS-12992,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-05-26,18-44,Male,Europe,Hospitalization
FAERS-12993,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-09-11,18-44,Female,Other,Hospitalization
FAERS-12994,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-05-25,65-74,Male,Europe,Other
FAERS-12995,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2022-09-08,65-74,Female,USA,Other
FAERS-12996,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-05-13,65-74,Female,USA,Other
FAERS-12997,EXENATIDE (BYDUREON),VOMITING,2020-02-04,45-64,Male,Europe,Other
FAERS-12998,EXENATIDE (BYETTA),HYPOGLYCEMIA,2019-12-01,45-64,Female,USA,Other
FAERS-12999,EXENATIDE (BYETTA),PANCREATITIS,2019-04-02,18-44,Female,USA,Other
FAERS-13000,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-04-03,45-64,Male,Europe,Other
FAERS-13001,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-09-14,45-64,Female,USA,Life-threatening
FAERS-13002,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-02-02,65-74,Female,USA,Other
FAERS-13003,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-01-14,45-64,Female,USA,Other
FAERS-13004,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2022-04-26,0-17,Female,Europe,Other
FAERS-13005,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2021-01-06,45-64,Female,USA,Disability
FAERS-13006,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2022-06-23,45-64,Female,Other,Hospitalization
FAERS-13007,LIRAGLUTIDE (SAXENDA),ASPIRATION,2021-03-01,18-44,Male,USA,Other
FAERS-13008,DULAGLUTIDE (TRULICITY),NAUSEA,2022-01-04,45-64,Male,Europe,Not specified
FAERS-13009,DULAGLUTIDE (TRULICITY),HYPOGLYCEMIA,2019-03-09,18-44,Female,USA,Hospitalization
FAERS-13010,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-01-12,18-44,Unknown,USA,Other
FAERS-13011,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2018-02-04,18-44,Female,USA,Other
FAERS-13012,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2020-03-12,45-64,Male,USA,Death
FAERS-13013,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-05-11,Unknown,Female,USA,Not specified
FAERS-13014,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2022-05-25,45-64,Male,USA,Not specified
FAERS-13015,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-07-07,45-64,Male,USA,Other
FAERS-13016,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2021-08-21,65-74,Female,USA,Other
FAERS-13017,EXENATIDE (BYDUREON),ASPIRATION,2022-06-06,65-74,Male,USA,Other
FAERS-13018,LIRAGLUTIDE (VICTOZA),GALLBLADDER DISEASE,2023-07-12,65-74,Male,Europe,Not specified
FAERS-13019,EXENATIDE (BYETTA),SUICIDAL IDEATION,2020-04-28,45-64,Female,USA,Other
FAERS-13020,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-06-08,75-84,Female,USA,Other
FAERS-13021,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-05-25,45-64,Male,Canada,Other
FAERS-13022,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-12-14,45-64,Male,USA,Hospitalization
FAERS-13023,SEMAGLUTIDE (WEGOVY),DIZZINESS,2020-05-07,65-74,Female,USA,Not specified
FAERS-13024,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2021-06-16,Unknown,Female,USA,Hospitalization
FAERS-13025,TIRZEPATIDE (MOUNJARO),DIZZINESS,2020-11-18,65-74,Female,USA,Not specified
FAERS-13026,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2021-12-14,18-44,Female,USA,Other
FAERS-13027,EXENATIDE (BYETTA),NAUSEA,2021-08-19,65-74,Female,USA,Other
FAERS-13028,EXENATIDE (BYETTA),DIZZINESS,2021-06-28,65-74,Female,Europe,Disability
FAERS-13029,EXENATIDE (BYETTA),VOMITING,2022-02-01,45-64,Female,Europe,Other
FAERS-13030,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-01-04,18-44,Male,USA,Other
FAERS-13031,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2018-03-13,65-74,Female,Japan,Other
FAERS-13032,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-04-19,18-44,Unknown,Other,Other
FAERS-13033,SEMAGLUTIDE (WEGOVY),ALOPECIA,2023-12-19,45-64,Male,USA,Not specified
FAERS-13034,SEMAGLUTIDE (WEGOVY),DIZZINESS,2021-04-20,45-64,Female,USA,Hospitalization
FAERS-13035,TIRZEPATIDE (MOUNJARO),DIARRHEA,2023-01-07,75-84,Female,USA,Other
FAERS-13036,TIRZEPATIDE (MOUNJARO),HEADACHE,2019-11-14,45-64,Female,Other,Other
FAERS-13037,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2023-01-14,45-64,Male,USA,Other
FAERS-13038,EXENATIDE (BYETTA),CONSTIPATION,2023-02-06,45-64,Female,USA,Other
FAERS-13039,EXENATIDE (BYETTA),NAUSEA,2021-10-02,45-64,Female,USA,Other
FAERS-13040,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-11-14,18-44,Male,USA,Not specified
FAERS-13041,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2019-01-27,18-44,Female,USA,Other
FAERS-13042,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-08-20,45-64,Female,Other,Disability
FAERS-13043,SEMAGLUTIDE (WEGOVY),VOMITING,2018-05-19,18-44,Female,USA,Other
FAERS-13044,SEMAGLUTIDE (WEGOVY),DIZZINESS,2021-03-02,45-64,Female,USA,Life-threatening
FAERS-13045,TIRZEPATIDE (MOUNJARO),HEADACHE,2021-09-02,65-74,Female,Japan,Other
FAERS-13046,TIRZEPATIDE (MOUNJARO),VOMITING,2019-04-09,45-64,Male,USA,Other
FAERS-13047,EXENATIDE (BYDUREON),ASPIRATION,2019-06-07,45-64,Male,USA,Hospitalization
FAERS-13048,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2023-10-04,45-64,Female,USA,Disability
FAERS-13049,EXENATIDE (BYETTA),GALLBLADDER DISEASE,2023-02-26,18-44,Female,USA,Other
FAERS-13050,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2021-01-05,18-44,Female,USA,Other
FAERS-13051,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-11-03,65-74,Male,Australia,Other
FAERS-13052,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2021-08-23,65-74,Female,USA,Hospitalization
FAERS-13053,SEMAGLUTIDE (WEGOVY),ASPIRATION,2021-07-10,18-44,Female,Europe,Not specified
FAERS-13054,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2018-11-16,18-44,Female,Other,Other
FAERS-13055,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-03-08,45-64,Female,Europe,Other
FAERS-13056,TIRZEPATIDE (MOUNJARO),DIARRHEA,2019-06-07,45-64,Male,Europe,Other
FAERS-13057,DULAGLUTIDE (TRULICITY),DIZZINESS,2021-05-27,45-64,Female,USA,Other
FAERS-13058,LIRAGLUTIDE (VICTOZA),THYROID NEOPLASM,2023-01-05,18-44,Female,Europe,Other
FAERS-13059,LIRAGLUTIDE (SAXENDA),FATIGUE,2022-12-20,65-74,Female,USA,Other
FAERS-13060,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-10-08,65-74,Female,USA,Not specified
FAERS-13061,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-08-12,18-44,Unknown,Europe,Not specified
FAERS-13062,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-03-15,18-44,Female,USA,Other
FAERS-13063,SEMAGLUTIDE (WEGOVY),VOMITING,2021-06-01,18-44,Female,Europe,Other
FAERS-13064,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-11-09,45-64,Female,USA,Hospitalization
FAERS-13065,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2023-03-09,Unknown,Female,USA,Hospitalization
FAERS-13066,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2018-11-27,45-64,Female,Canada,Other
FAERS-13067,EXENATIDE (BYETTA),DIZZINESS,2019-03-18,45-64,Unknown,Europe,Hospitalization
FAERS-13068,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2023-11-06,18-44,Female,USA,Hospitalization
FAERS-13069,LIRAGLUTIDE (VICTOZA),HEADACHE,2022-08-11,18-44,Female,USA,Not specified
FAERS-13070,SEMAGLUTIDE (OZEMPIC),FATIGUE,2018-05-03,45-64,Female,USA,Hospitalization
FAERS-13071,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-02-23,45-64,Female,USA,Hospitalization
FAERS-13072,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-06-25,45-64,Female,Australia,Not specified
FAERS-13073,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-01-26,18-44,Female,USA,Not specified
FAERS-13074,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2022-01-20,45-64,Female,USA,Other
FAERS-13075,TIRZEPATIDE (MOUNJARO),FATIGUE,2019-05-04,18-44,Female,USA,Other
FAERS-13076,TIRZEPATIDE (MOUNJARO),ASPIRATION,2022-03-26,65-74,Male,USA,Other
FAERS-13077,TIRZEPATIDE (ZEPBOUND),ASPIRATION,2022-12-21,45-64,Female,USA,Hospitalization
FAERS-13078,TIRZEPATIDE (ZEPBOUND),DIARRHEA,2020-07-08,45-64,Female,Japan,Other
FAERS-13079,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2023-08-18,45-64,Female,USA,Other
FAERS-13080,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-12-15,18-44,Male,Europe,Other
FAERS-13081,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2018-06-18,18-44,Female,USA,Other
FAERS-13082,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-01-18,45-64,Female,USA,Other
FAERS-13083,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-10-21,65-74,Male,USA,Hospitalization
FAERS-13084,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2021-07-03,65-74,Female,Europe,Other
FAERS-13085,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2021-08-02,45-64,Male,USA,Hospitalization
FAERS-13086,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2022-02-10,45-64,Male,USA,Other
FAERS-13087,EXENATIDE (BYETTA),NAUSEA,2020-12-13,45-64,Female,USA,Other
FAERS-13088,LIRAGLUTIDE (VICTOZA),DIZZINESS,2023-08-28,65-74,Male,USA,Not specified
FAERS-13089,LIRAGLUTIDE (SAXENDA),ALOPECIA,2020-03-09,65-74,Female,Europe,Life-threatening
FAERS-13090,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-05-04,0-17,Male,USA,Other
FAERS-13091,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-06-15,75-84,Female,USA,Other
FAERS-13092,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-07-01,75-84,Female,Europe,Life-threatening
FAERS-13093,SEMAGLUTIDE (WEGOVY),DIARRHEA,2020-03-20,45-64,Male,Europe,Other
FAERS-13094,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2019-11-18,45-64,Male,USA,Not specified
FAERS-13095,TIRZEPATIDE (MOUNJARO),DIARRHEA,2023-10-14,45-64,Male,USA,Other
FAERS-13096,TIRZEPATIDE (MOUNJARO),ASPIRATION,2019-05-06,45-64,Female,USA,Other
FAERS-13097,LIRAGLUTIDE (VICTOZA),NAUSEA,2020-02-12,18-44,Female,Japan,Other
FAERS-13098,EXENATIDE (BYETTA),DIARRHEA,2023-01-13,45-64,Female,USA,Disability
FAERS-13099,LIRAGLUTIDE (VICTOZA),ALOPECIA,2020-03-17,65-74,Unknown,USA,Hospitalization
FAERS-13100,SEMAGLUTIDE (OZEMPIC),HEADACHE,2018-02-22,75-84,Female,USA,Other
FAERS-13101,SEMAGLUTIDE (OZEMPIC),VOMITING,2020-10-16,18-44,Male,USA,Hospitalization
FAERS-13102,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-07-04,18-44,Male,Europe,Other
FAERS-13103,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-02-17,45-64,Female,Europe,Other
FAERS-13104,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-03-08,45-64,Male,USA,Hospitalization
FAERS-13105,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-02-13,45-64,Female,USA,Other
FAERS-13106,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2021-05-15,75-84,Female,USA,Other
FAERS-13107,LIRAGLUTIDE (VICTOZA),HYPOGLYCEMIA,2023-04-22,65-74,Male,USA,Other
FAERS-13108,TIRZEPATIDE (ZEPBOUND),ASPIRATION,2021-07-11,45-64,Unknown,USA,Hospitalization
FAERS-13109,LIRAGLUTIDE (VICTOZA),DECREASED APPETITE,2018-10-06,45-64,Female,USA,Other
FAERS-13110,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-12-20,45-64,Female,USA,Hospitalization
FAERS-13111,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-08-01,18-44,Male,USA,Other
FAERS-13112,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2020-11-16,45-64,Male,USA,Hospitalization
FAERS-13113,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2022-12-10,18-44,Female,USA,Other
FAERS-13114,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-10-10,18-44,Female,USA,Disability
FAERS-13115,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-04-19,75-84,Male,Europe,Other
FAERS-13116,TIRZEPATIDE (MOUNJARO),HEADACHE,2019-03-09,45-64,Female,Europe,Other
FAERS-13117,EXENATIDE (BYETTA),DECREASED APPETITE,2019-08-25,45-64,Female,USA,Not specified
FAERS-13118,EXENATIDE (BYDUREON),ABDOMINAL PAIN,2022-06-19,45-64,Female,Europe,Hospitalization
FAERS-13119,LIRAGLUTIDE (SAXENDA),ASPIRATION,2023-11-28,75-84,Male,USA,Hospitalization
FAERS-13120,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2020-08-28,45-64,Female,USA,Other
FAERS-13121,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2020-05-11,65-74,Male,USA,Not specified
FAERS-13122,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2021-07-11,65-74,Male,Other,Not specified
FAERS-13123,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2022-10-14,45-64,Female,USA,Life-threatening
FAERS-13124,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2019-05-14,65-74,Male,USA,Other
FAERS-13125,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2021-07-18,75-84,Female,Other,Not specified
FAERS-13126,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2023-08-14,18-44,Female,Canada,Other
FAERS-13127,LIRAGLUTIDE (VICTOZA),DIZZINESS,2021-04-09,18-44,Male,USA,Other
FAERS-13128,LIRAGLUTIDE (SAXENDA),SUICIDAL IDEATION,2023-11-12,18-44,Female,USA,Not specified
FAERS-13129,LIRAGLUTIDE (VICTOZA),DIARRHEA,2023-12-28,18-44,Female,USA,Other
FAERS-13130,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-08-28,0-17,Female,Other,Not specified
FAERS-13131,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-04-08,65-74,Male,Europe,Other
FAERS-13132,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-03-25,18-44,Female,Europe,Other
FAERS-13133,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-12-09,65-74,Male,USA,Other
FAERS-13134,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2018-04-14,45-64,Female,Europe,Other
FAERS-13135,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2021-01-04,65-74,Female,Europe,Hospitalization
FAERS-13136,TIRZEPATIDE (MOUNJARO),DIARRHEA,2023-12-22,65-74,Male,Europe,Other
FAERS-13137,EXENATIDE (BYETTA),ASPIRATION,2023-04-07,18-44,Female,Europe,Not specified
FAERS-13138,LIRAGLUTIDE (VICTOZA),HYPOGLYCEMIA,2023-03-23,45-64,Female,USA,Other
FAERS-13139,DULAGLUTIDE (TRULICITY),FATIGUE,2018-06-21,65-74,Male,USA,Other
FAERS-13140,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2020-09-12,45-64,Female,Japan,Not specified
FAERS-13141,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2020-10-12,65-74,Male,Canada,Other
FAERS-13142,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-01-03,45-64,Male,USA,Hospitalization
FAERS-13143,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2022-12-23,45-64,Female,Europe,Other
FAERS-13144,SEMAGLUTIDE (WEGOVY),HEADACHE,2022-12-24,18-44,Female,Europe,Hospitalization
FAERS-13145,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2019-07-13,18-44,Male,USA,Not specified
FAERS-13146,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2022-02-09,45-64,Female,USA,Other
FAERS-13147,LIRAGLUTIDE (VICTOZA),FATIGUE,2018-11-01,45-64,Female,USA,Hospitalization
FAERS-13148,DULAGLUTIDE (TRULICITY),FATIGUE,2023-08-18,45-64,Male,USA,Other
FAERS-13149,TIRZEPATIDE (ZEPBOUND),THYROID NEOPLASM,2023-02-13,45-64,Male,USA,Not specified
FAERS-13150,SEMAGLUTIDE (OZEMPIC),FATIGUE,2019-02-04,45-64,Female,USA,Other
FAERS-13151,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2019-10-19,45-64,Female,Other,Other
FAERS-13152,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2020-04-06,45-64,Female,Europe,Other
FAERS-13153,SEMAGLUTIDE (WEGOVY),FATIGUE,2023-09-07,18-44,Male,USA,Other
FAERS-13154,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-12-05,45-64,Male,USA,Other
FAERS-13155,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2022-09-06,75-84,Unknown,USA,Other
FAERS-13156,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-06-18,45-64,Male,Japan,Hospitalization
FAERS-13157,EXENATIDE (BYDUREON),PANCREATITIS,2022-04-01,65-74,Female,USA,Not specified
FAERS-13158,LIRAGLUTIDE (VICTOZA),NAUSEA,2023-03-16,65-74,Male,USA,Other
FAERS-13159,DULAGLUTIDE (TRULICITY),DIZZINESS,2022-12-23,65-74,Male,USA,Hospitalization
FAERS-13160,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2019-04-01,65-74,Female,USA,Not specified
FAERS-13161,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-08-05,18-44,Female,USA,Not specified
FAERS-13162,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-03-16,45-64,Female,USA,Other
FAERS-13163,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2023-09-10,75-84,Female,USA,Hospitalization
FAERS-13164,SEMAGLUTIDE (WEGOVY),DIARRHEA,2020-10-02,65-74,Female,Japan,Hospitalization
FAERS-13165,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-03-07,18-44,Male,USA,Other
FAERS-13166,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2023-08-28,18-44,Female,USA,Not specified
FAERS-13167,EXENATIDE (BYDUREON),HYPOGLYCEMIA,2023-07-04,45-64,Female,Europe,Other
FAERS-13168,EXENATIDE (BYETTA),DIZZINESS,2021-07-13,18-44,Female,USA,Other
FAERS-13169,DULAGLUTIDE (TRULICITY),PANCREATITIS,2023-04-10,45-64,Female,USA,Other
FAERS-13170,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-05-05,45-64,Female,USA,Not specified
FAERS-13171,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2020-12-06,65-74,Male,USA,Hospitalization
FAERS-13172,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-08-01,18-44,Male,Other,Other
FAERS-13173,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-11-19,45-64,Female,Europe,Hospitalization
FAERS-13174,SEMAGLUTIDE (WEGOVY),ASPIRATION,2019-12-27,45-64,Female,USA,Not specified
FAERS-13175,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2022-12-07,18-44,Male,USA,Other
FAERS-13176,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2023-04-08,65-74,Female,Canada,Other
FAERS-13177,EXENATIDE (BYETTA),FATIGUE,2020-05-19,18-44,Female,USA,Other
FAERS-13178,EXENATIDE (BYETTA),VOMITING,2022-07-21,18-44,Male,Canada,Other
FAERS-13179,LIRAGLUTIDE (SAXENDA),DECREASED APPETITE,2019-08-23,18-44,Male,Canada,Hospitalization
FAERS-13180,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-09-11,45-64,Male,USA,Other
FAERS-13181,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2019-01-02,65-74,Unknown,USA,Not specified
FAERS-13182,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-01-03,65-74,Female,USA,Other
FAERS-13183,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2022-06-09,65-74,Male,USA,Disability
FAERS-13184,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-11-23,65-74,Female,Europe,Other
FAERS-13185,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2020-10-23,45-64,Female,Europe,Other
FAERS-13186,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-10-02,65-74,Male,USA,Other
FAERS-13187,EXENATIDE (BYETTA),DIZZINESS,2018-05-28,18-44,Female,USA,Not specified
FAERS-13188,TIRZEPATIDE (ZEPBOUND),DIARRHEA,2023-02-11,45-64,Female,USA,Other
FAERS-13189,EXENATIDE (BYETTA),INJECTION SITE REACTION,2018-05-23,45-64,Male,Europe,Disability
FAERS-13190,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2020-11-01,45-64,Male,USA,Other
FAERS-13191,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-06-28,18-44,Male,USA,Not specified
FAERS-13192,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-08-28,45-64,Female,Europe,Hospitalization
FAERS-13193,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-01-12,65-74,Male,Europe,Other
FAERS-13194,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2022-08-07,45-64,Female,USA,Other
FAERS-13195,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-12-10,45-64,Male,USA,Hospitalization
FAERS-13196,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2021-01-25,18-44,Unknown,Europe,Other
FAERS-13197,DULAGLUTIDE (TRULICITY),ALOPECIA,2022-07-28,45-64,Female,USA,Not specified
FAERS-13198,EXENATIDE (BYDUREON),HEADACHE,2021-09-22,65-74,Male,Japan,Other
FAERS-13199,TIRZEPATIDE (ZEPBOUND),VOMITING,2020-07-06,45-64,Female,Europe,Other
FAERS-13200,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-10-23,45-64,Female,Europe,Other
FAERS-13201,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-03-18,45-64,Female,Other,Not specified
FAERS-13202,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-10-19,65-74,Female,USA,Other
FAERS-13203,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2022-08-05,45-64,Male,USA,Other
FAERS-13204,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-09-12,65-74,Female,USA,Not specified
FAERS-13205,TIRZEPATIDE (MOUNJARO),HEADACHE,2023-05-04,45-64,Female,Japan,Other
FAERS-13206,TIRZEPATIDE (MOUNJARO),VOMITING,2022-10-03,75-84,Female,USA,Not specified
FAERS-13207,LIRAGLUTIDE (VICTOZA),DIZZINESS,2023-09-18,75-84,Female,USA,Other
FAERS-13208,EXENATIDE (BYDUREON),VOMITING,2023-06-25,Unknown,Female,USA,Hospitalization
FAERS-13209,EXENATIDE (BYDUREON),DIZZINESS,2022-08-18,45-64,Female,USA,Not specified
FAERS-13210,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-03-19,45-64,Unknown,USA,Disability
FAERS-13211,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2019-09-13,65-74,Male,USA,Not specified
FAERS-13212,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-11-20,45-64,Female,Other,Other
FAERS-13213,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2020-02-21,18-44,Female,USA,Other
FAERS-13214,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2022-01-05,65-74,Male,Other,Not specified
FAERS-13215,TIRZEPATIDE (MOUNJARO),ALOPECIA,2021-10-15,65-74,Female,USA,Other
FAERS-13216,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2022-06-16,65-74,Female,Other,Not specified
FAERS-13217,EXENATIDE (BYDUREON),VOMITING,2022-10-12,45-64,Male,USA,Not specified
FAERS-13218,EXENATIDE (BYDUREON),ALOPECIA,2023-04-12,45-64,Male,USA,Other
FAERS-13219,LIRAGLUTIDE (SAXENDA),ASPIRATION,2021-07-18,18-44,Male,USA,Not specified
FAERS-13220,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-05-17,45-64,Female,USA,Disability
FAERS-13221,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2021-09-14,65-74,Male,Australia,Other
FAERS-13222,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-09-11,65-74,Male,Other,Other
FAERS-13223,SEMAGLUTIDE (WEGOVY),NAUSEA,2022-09-20,45-64,Female,USA,Other
FAERS-13224,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-11-27,65-74,Female,Europe,Other
FAERS-13225,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2022-09-02,65-74,Female,Other,Other
FAERS-13226,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-01-20,65-74,Male,USA,Life-threatening
FAERS-13227,LIRAGLUTIDE (SAXENDA),GALLBLADDER DISEASE,2020-03-25,18-44,Female,USA,Other
FAERS-13228,LIRAGLUTIDE (VICTOZA),HEADACHE,2022-03-28,45-64,Female,Japan,Not specified
FAERS-13229,LIRAGLUTIDE (SAXENDA),ABDOMINAL PAIN,2022-04-18,65-74,Male,USA,Not specified
FAERS-13230,SEMAGLUTIDE (OZEMPIC),VOMITING,2021-11-05,18-44,Female,USA,Other
FAERS-13231,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-02-10,45-64,Male,Europe,Disability
FAERS-13232,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-11-22,18-44,Female,USA,Other
FAERS-13233,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2021-02-26,65-74,Female,Europe,Other
FAERS-13234,SEMAGLUTIDE (WEGOVY),ASPIRATION,2018-03-13,18-44,Male,USA,Other
FAERS-13235,TIRZEPATIDE (MOUNJARO),ASPIRATION,2022-03-26,65-74,Male,USA,Other
FAERS-13236,TIRZEPATIDE (MOUNJARO),VOMITING,2020-12-22,18-44,Female,USA,Other
FAERS-13237,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2018-10-27,18-44,Female,USA,Not specified
FAERS-13238,TIRZEPATIDE (ZEPBOUND),HEADACHE,2023-06-27,45-64,Male,Europe,Other
FAERS-13239,EXENATIDE (BYDUREON),CONSTIPATION,2020-03-18,45-64,Male,Europe,Not specified
FAERS-13240,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-03-28,18-44,Female,USA,Hospitalization
FAERS-13241,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-12-06,45-64,Female,Europe,Other
FAERS-13242,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-02-17,18-44,Female,USA,Not specified
FAERS-13243,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2019-10-08,45-64,Male,USA,Hospitalization
FAERS-13244,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-06-03,18-44,Female,USA,Other
FAERS-13245,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-10-18,18-44,Male,Europe,Hospitalization
FAERS-13246,TIRZEPATIDE (MOUNJARO),ALOPECIA,2020-02-06,75-84,Female,USA,Not specified
FAERS-13247,LIRAGLUTIDE (VICTOZA),ABDOMINAL PAIN,2022-01-10,18-44,Female,Japan,Other
FAERS-13248,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2023-07-10,45-64,Male,USA,Other
FAERS-13249,EXENATIDE (BYDUREON),DIARRHEA,2021-08-12,18-44,Female,USA,Other
FAERS-13250,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-05-19,45-64,Female,USA,Hospitalization
FAERS-13251,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-11-10,18-44,Female,USA,Other
FAERS-13252,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2018-11-28,45-64,Female,USA,Life-threatening
FAERS-13253,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2021-07-05,45-64,Male,USA,Other
FAERS-13254,SEMAGLUTIDE (WEGOVY),VOMITING,2023-06-26,45-64,Female,USA,Hospitalization
FAERS-13255,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2020-10-03,65-74,Female,Europe,Other
FAERS-13256,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2019-09-08,45-64,Female,USA,Other
FAERS-13257,TIRZEPATIDE (ZEPBOUND),ALOPECIA,2022-01-12,45-64,Female,USA,Hospitalization
FAERS-13258,EXENATIDE (BYETTA),DECREASED APPETITE,2023-12-20,45-64,Female,USA,Not specified
FAERS-13259,TIRZEPATIDE (ZEPBOUND),GALLBLADDER DISEASE,2018-03-01,18-44,Male,USA,Hospitalization
FAERS-13260,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-01-07,65-74,Female,USA,Other
FAERS-13261,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-08-25,45-64,Male,USA,Other
FAERS-13262,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-04-09,65-74,Male,USA,Other
FAERS-13263,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-03-08,45-64,Male,USA,Other
FAERS-13264,SEMAGLUTIDE (WEGOVY),HEADACHE,2022-03-15,18-44,Male,USA,Life-threatening
FAERS-13265,TIRZEPATIDE (MOUNJARO),NAUSEA,2021-02-18,65-74,Male,USA,Other
FAERS-13266,TIRZEPATIDE (MOUNJARO),DIARRHEA,2021-04-06,18-44,Female,USA,Hospitalization
FAERS-13267,EXENATIDE (BYETTA),INJECTION SITE REACTION,2021-02-24,45-64,Male,Europe,Other
FAERS-13268,DULAGLUTIDE (TRULICITY),CONSTIPATION,2022-02-21,65-74,Male,USA,Not specified
FAERS-13269,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2022-12-10,65-74,Female,USA,Other
FAERS-13270,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2019-12-23,18-44,Male,USA,Hospitalization
FAERS-13271,SEMAGLUTIDE (OZEMPIC),NAUSEA,2020-09-12,45-64,Male,USA,Not specified
FAERS-13272,SEMAGLUTIDE (OZEMPIC),NAUSEA,2019-04-15,45-64,Female,USA,Hospitalization
FAERS-13273,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2019-05-26,65-74,Female,USA,Other
FAERS-13274,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2022-06-11,75-84,Female,USA,Other
FAERS-13275,TIRZEPATIDE (MOUNJARO),VOMITING,2021-12-22,18-44,Female,USA,Not specified
FAERS-13276,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-04-19,45-64,Female,Europe,Other
FAERS-13277,TIRZEPATIDE (ZEPBOUND),DIARRHEA,2021-04-01,45-64,Female,Japan,Other
FAERS-13278,DULAGLUTIDE (TRULICITY),CONSTIPATION,2022-05-27,18-44,Female,Canada,Not specified
FAERS-13279,LIRAGLUTIDE (VICTOZA),INJECTION SITE REACTION,2023-11-13,18-44,Female,Europe,Not specified
FAERS-13280,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2021-12-07,65-74,Female,USA,Hospitalization
FAERS-13281,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2019-05-06,18-44,Female,USA,Other
FAERS-13282,SEMAGLUTIDE (OZEMPIC),VOMITING,2021-09-24,18-44,Female,USA,Other
FAERS-13283,SEMAGLUTIDE (WEGOVY),ASPIRATION,2021-07-18,45-64,Female,Europe,Not specified
FAERS-13284,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2021-09-25,45-64,Female,USA,Not specified
FAERS-13285,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-04-13,45-64,Male,Europe,Other
FAERS-13286,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-03-25,18-44,Male,Other,Not specified
FAERS-13287,EXENATIDE (BYETTA),VOMITING,2021-04-09,45-64,Female,USA,Hospitalization
FAERS-13288,LIRAGLUTIDE (SAXENDA),NAUSEA,2019-08-06,65-74,Female,USA,Hospitalization
FAERS-13289,LIRAGLUTIDE (VICTOZA),ABDOMINAL PAIN,2019-12-19,18-44,Male,USA,Other
FAERS-13290,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-09-20,45-64,Female,USA,Other
FAERS-13291,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-10-20,45-64,Male,USA,Other
FAERS-13292,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-02-09,45-64,Female,USA,Other
FAERS-13293,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2019-10-18,45-64,Female,USA,Other
FAERS-13294,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2020-11-28,65-74,Male,USA,Not specified
FAERS-13295,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2020-02-06,45-64,Male,Other,Other
FAERS-13296,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-07-04,45-64,Female,Europe,Other
FAERS-13297,LIRAGLUTIDE (SAXENDA),DIZZINESS,2019-04-17,18-44,Female,USA,Not specified
FAERS-13298,EXENATIDE (BYDUREON),DIZZINESS,2023-03-23,45-64,Female,USA,Hospitalization
FAERS-13299,LIRAGLUTIDE (VICTOZA),DIZZINESS,2021-11-23,18-44,Male,Other,Life-threatening
FAERS-13300,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2019-04-03,65-74,Female,USA,Other
FAERS-13301,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2018-12-20,45-64,Female,Europe,Not specified
FAERS-13302,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-06-17,45-64,Female,Europe,Disability
FAERS-13303,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2022-10-18,65-74,Female,USA,Other
FAERS-13304,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-03-05,45-64,Male,Europe,Not specified
FAERS-13305,TIRZEPATIDE (MOUNJARO),ALOPECIA,2019-10-23,65-74,Male,Europe,Other
FAERS-13306,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-05-27,65-74,Male,Europe,Other
FAERS-13307,DULAGLUTIDE (TRULICITY),ASPIRATION,2020-04-13,65-74,Male,Europe,Not specified
FAERS-13308,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2021-04-24,45-64,Female,USA,Other
FAERS-13309,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2022-01-25,18-44,Female,Europe,Not specified
FAERS-13310,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-11-19,45-64,Female,Europe,Other
FAERS-13311,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2020-05-24,45-64,Female,USA,Hospitalization
FAERS-13312,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-11-25,45-64,Female,Europe,Not specified
FAERS-13313,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2022-02-07,75-84,Female,USA,Disability
FAERS-13314,SEMAGLUTIDE (WEGOVY),DIZZINESS,2022-02-16,18-44,Female,USA,Other
FAERS-13315,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2020-03-21,Unknown,Female,USA,Life-threatening
FAERS-13316,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2023-12-08,45-64,Female,USA,Not specified
FAERS-13317,TIRZEPATIDE (ZEPBOUND),HYPOGLYCEMIA,2021-01-04,75-84,Male,USA,Not specified
FAERS-13318,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2023-05-05,45-64,Male,USA,Other
FAERS-13319,EXENATIDE (BYDUREON),NAUSEA,2021-12-20,45-64,Male,Europe,Other
FAERS-13320,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-07-22,45-64,Female,USA,Hospitalization
FAERS-13321,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2021-05-16,Unknown,Male,Europe,Other
FAERS-13322,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2018-05-27,45-64,Male,USA,Other
FAERS-13323,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2019-03-13,45-64,Male,USA,Not specified
FAERS-13324,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2021-06-20,65-74,Male,USA,Other
FAERS-13325,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2020-08-13,45-64,Male,USA,Other
FAERS-13326,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-10-12,45-64,Unknown,USA,Disability
FAERS-13327,EXENATIDE (BYETTA),GALLBLADDER DISEASE,2023-04-20,45-64,Male,USA,Other
FAERS-13328,EXENATIDE (BYETTA),ALOPECIA,2022-03-10,65-74,Male,USA,Hospitalization
FAERS-13329,DULAGLUTIDE (TRULICITY),DECREASED APPETITE,2020-05-22,45-64,Male,USA,Other
FAERS-13330,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2019-12-17,75-84,Male,USA,Other
FAERS-13331,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-05-06,18-44,Male,USA,Other
FAERS-13332,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-06-01,18-44,Female,Australia,Other
FAERS-13333,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2020-09-21,65-74,Male,Canada,Not specified
FAERS-13334,SEMAGLUTIDE (WEGOVY),FATIGUE,2023-08-27,45-64,Female,USA,Other
FAERS-13335,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-05-11,45-64,Female,USA,Disability
FAERS-13336,TIRZEPATIDE (MOUNJARO),DIZZINESS,2021-02-26,65-74,Female,USA,Other
FAERS-13337,LIRAGLUTIDE (VICTOZA),NAUSEA,2020-09-15,65-74,Female,USA,Disability
FAERS-13338,LIRAGLUTIDE (SAXENDA),THYROID NEOPLASM,2021-07-14,65-74,Female,USA,Other
FAERS-13339,EXENATIDE (BYETTA),DIZZINESS,2022-11-01,18-44,Male,Europe,Not specified
FAERS-13340,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-02-03,45-64,Male,Europe,Hospitalization
FAERS-13341,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-08-04,65-74,Male,Other,Other
FAERS-13342,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-02-18,45-64,Female,USA,Other
FAERS-13343,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2021-10-24,18-44,Male,USA,Other
FAERS-13344,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-07-19,45-64,Female,USA,Other
FAERS-13345,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-11-11,Unknown,Female,USA,Other
FAERS-13346,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2021-01-05,45-64,Female,USA,Not specified
FAERS-13347,EXENATIDE (BYDUREON),ASPIRATION,2022-12-18,65-74,Female,USA,Other
FAERS-13348,LIRAGLUTIDE (SAXENDA),ALOPECIA,2021-11-28,18-44,Female,Europe,Other
FAERS-13349,LIRAGLUTIDE (SAXENDA),SUICIDAL IDEATION,2021-05-17,Unknown,Female,USA,Not specified
FAERS-13350,SEMAGLUTIDE (OZEMPIC),VOMITING,2021-04-25,45-64,Female,USA,Other
FAERS-13351,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-04-01,65-74,Female,USA,Other
FAERS-13352,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-07-20,65-74,Female,USA,Other
FAERS-13353,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2022-09-28,45-64,Male,Europe,Other
FAERS-13354,SEMAGLUTIDE (WEGOVY),ASPIRATION,2021-08-02,65-74,Female,USA,Not specified
FAERS-13355,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2021-05-10,45-64,Male,USA,Other
FAERS-13356,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2021-12-23,45-64,Female,Europe,Other
FAERS-13357,TIRZEPATIDE (ZEPBOUND),HEADACHE,2021-07-03,45-64,Male,USA,Other
FAERS-13358,EXENATIDE (BYDUREON),ASPIRATION,2021-05-28,45-64,Male,USA,Other
FAERS-13359,DULAGLUTIDE (TRULICITY),ASPIRATION,2020-07-15,18-44,Female,USA,Other
FAERS-13360,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-08-27,45-64,Female,USA,Other
FAERS-13361,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-11-08,85+,Female,USA,Not specified
FAERS-13362,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2020-12-15,65-74,Male,USA,Other
FAERS-13363,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-08-14,65-74,Female,Europe,Other
FAERS-13364,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2022-08-12,45-64,Male,Other,Hospitalization
FAERS-13365,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-04-21,45-64,Male,USA,Other
FAERS-13366,TIRZEPATIDE (MOUNJARO),VOMITING,2018-05-24,45-64,Female,USA,Hospitalization
FAERS-13367,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2021-05-11,45-64,Female,USA,Other
FAERS-13368,LIRAGLUTIDE (SAXENDA),DECREASED APPETITE,2023-11-05,45-64,Male,Other,Not specified
FAERS-13369,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2018-01-09,45-64,Female,Europe,Other
FAERS-13370,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2020-05-19,45-64,Male,USA,Not specified
FAERS-13371,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-09-19,65-74,Male,USA,Other
FAERS-13372,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-06-17,45-64,Male,USA,Disability
FAERS-13373,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2021-05-16,65-74,Male,USA,Other
FAERS-13374,SEMAGLUTIDE (WEGOVY),ASPIRATION,2022-01-09,45-64,Female,USA,Other
FAERS-13375,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-09-05,45-64,Female,Canada,Other
FAERS-13376,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-10-12,45-64,Male,USA,Hospitalization
FAERS-13377,EXENATIDE (BYDUREON),DIZZINESS,2020-12-06,45-64,Male,USA,Other
FAERS-13378,LIRAGLUTIDE (VICTOZA),FATIGUE,2023-11-08,65-74,Female,USA,Other
FAERS-13379,DULAGLUTIDE (TRULICITY),DIARRHEA,2020-02-18,18-44,Male,USA,Other
FAERS-13380,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-02-09,45-64,Female,USA,Other
FAERS-13381,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-03-01,45-64,Male,USA,Death
FAERS-13382,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-03-24,45-64,Male,Canada,Disability
FAERS-13383,SEMAGLUTIDE (WEGOVY),FATIGUE,2022-12-22,45-64,Female,Other,Other
FAERS-13384,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-02-07,45-64,Female,Canada,Hospitalization
FAERS-13385,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2020-09-12,45-64,Female,USA,Disability
FAERS-13386,TIRZEPATIDE (MOUNJARO),ASPIRATION,2019-04-20,Unknown,Female,USA,Not specified
FAERS-13387,EXENATIDE (BYETTA),GALLBLADDER DISEASE,2021-10-26,18-44,Male,USA,Other
FAERS-13388,EXENATIDE (BYETTA),FATIGUE,2023-09-13,45-64,Female,Other,Other
FAERS-13389,EXENATIDE (BYETTA),SUICIDAL IDEATION,2023-03-07,Unknown,Male,USA,Other
FAERS-13390,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-02-18,18-44,Male,USA,Not specified
FAERS-13391,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2019-05-28,65-74,Unknown,Other,Other
FAERS-13392,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-02-23,45-64,Unknown,USA,Other
FAERS-13393,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-10-24,45-64,Female,Other,Not specified
FAERS-13394,SEMAGLUTIDE (WEGOVY),DIARRHEA,2021-02-10,45-64,Male,Japan,Other
FAERS-13395,TIRZEPATIDE (MOUNJARO),VOMITING,2021-01-03,18-44,Male,USA,Other
FAERS-13396,TIRZEPATIDE (MOUNJARO),NAUSEA,2021-02-22,18-44,Male,USA,Other
FAERS-13397,TIRZEPATIDE (ZEPBOUND),DIZZINESS,2021-06-11,65-74,Female,USA,Other
FAERS-13398,EXENATIDE (BYDUREON),SUICIDAL IDEATION,2023-05-04,45-64,Female,USA,Other
FAERS-13399,EXENATIDE (BYDUREON),THYROID NEOPLASM,2022-10-09,45-64,Male,USA,Other
FAERS-13400,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-02-01,45-64,Male,USA,Other
FAERS-13401,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-02-01,45-64,Female,USA,Hospitalization
FAERS-13402,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2020-11-09,65-74,Female,USA,Hospitalization
FAERS-13403,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2023-03-22,45-64,Male,Europe,Hospitalization
FAERS-13404,SEMAGLUTIDE (WEGOVY),ALOPECIA,2023-10-19,45-64,Female,USA,Other
FAERS-13405,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-12-03,18-44,Male,USA,Other
FAERS-13406,TIRZEPATIDE (MOUNJARO),NAUSEA,2022-11-12,45-64,Male,Europe,Other
FAERS-13407,LIRAGLUTIDE (VICTOZA),HEADACHE,2018-11-22,45-64,Female,USA,Other
FAERS-13408,LIRAGLUTIDE (SAXENDA),HEADACHE,2020-08-04,45-64,Female,USA,Hospitalization
FAERS-13409,LIRAGLUTIDE (SAXENDA),VOMITING,2021-09-26,45-64,Female,Europe,Other
FAERS-13410,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2018-07-02,18-44,Female,USA,Other
FAERS-13411,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-06-28,65-74,Female,USA,Other
FAERS-13412,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-06-02,45-64,Female,Europe,Other
FAERS-13413,SEMAGLUTIDE (WEGOVY),NAUSEA,2022-06-14,65-74,Female,Other,Other
FAERS-13414,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2022-06-14,18-44,Male,USA,Not specified
FAERS-13415,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2021-07-12,45-64,Female,Japan,Other
FAERS-13416,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2020-11-02,Unknown,Female,USA,Other
FAERS-13417,LIRAGLUTIDE (VICTOZA),ASPIRATION,2023-12-28,18-44,Female,Canada,Disability
FAERS-13418,DULAGLUTIDE (TRULICITY),NAUSEA,2023-02-25,45-64,Female,USA,Other
FAERS-13419,TIRZEPATIDE (ZEPBOUND),CONSTIPATION,2023-09-19,18-44,Male,Europe,Other
FAERS-13420,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-05-03,65-74,Female,Other,Other
FAERS-13421,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-04-10,18-44,Female,Europe,Other
FAERS-13422,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-04-21,45-64,Female,Other,Hospitalization
FAERS-13423,SEMAGLUTIDE (WEGOVY),HEADACHE,2022-09-09,65-74,Male,Europe,Not specified
FAERS-13424,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2021-06-13,45-64,Female,Europe,Other
FAERS-13425,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-11-06,65-74,Female,Europe,Not specified
FAERS-13426,TIRZEPATIDE (MOUNJARO),DIARRHEA,2023-02-17,65-74,Female,Japan,Disability
FAERS-13427,LIRAGLUTIDE (VICTOZA),GALLBLADDER DISEASE,2021-12-10,18-44,Female,USA,Other
FAERS-13428,DULAGLUTIDE (TRULICITY),FATIGUE,2023-05-11,45-64,Female,USA,Not specified
FAERS-13429,LIRAGLUTIDE (VICTOZA),FATIGUE,2022-06-05,45-64,Male,USA,Hospitalization
FAERS-13430,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-12-11,18-44,Female,USA,Other
FAERS-13431,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-05-03,45-64,Female,USA,Not specified
FAERS-13432,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-03-14,45-64,Unknown,USA,Other
FAERS-13433,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2022-07-09,65-74,Female,Europe,Other
FAERS-13434,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-11-14,45-64,Female,USA,Other
FAERS-13435,TIRZEPATIDE (MOUNJARO),VOMITING,2023-01-26,45-64,Female,USA,Hospitalization
FAERS-13436,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-07-26,45-64,Female,USA,Disability
FAERS-13437,TIRZEPATIDE (ZEPBOUND),VOMITING,2020-05-05,65-74,Female,Europe,Hospitalization
FAERS-13438,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2022-08-13,65-74,Male,Europe,Other
FAERS-13439,TIRZEPATIDE (ZEPBOUND),HEADACHE,2018-02-26,45-64,Male,Europe,Other
FAERS-13440,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-09-01,18-44,Male,USA,Hospitalization
FAERS-13441,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-09-13,65-74,Female,USA,Other
FAERS-13442,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-01-12,18-44,Male,USA,Other
FAERS-13443,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-12-27,45-64,Female,USA,Not specified
FAERS-13444,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-07-23,18-44,Male,USA,Not specified
FAERS-13445,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-06-14,45-64,Male,Europe,Other
FAERS-13446,TIRZEPATIDE (MOUNJARO),DIZZINESS,2018-02-12,45-64,Female,USA,Not specified
FAERS-13447,EXENATIDE (BYDUREON),ASPIRATION,2020-01-22,65-74,Female,USA,Other
FAERS-13448,LIRAGLUTIDE (SAXENDA),SUICIDAL IDEATION,2020-05-07,45-64,Male,USA,Not specified
FAERS-13449,LIRAGLUTIDE (SAXENDA),GALLBLADDER DISEASE,2018-09-20,45-64,Male,Europe,Other
FAERS-13450,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-12-19,45-64,Male,Europe,Not specified
FAERS-13451,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2020-11-23,18-44,Female,USA,Other
FAERS-13452,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-07-09,45-64,Female,USA,Other
FAERS-13453,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2022-11-19,65-74,Female,USA,Other
FAERS-13454,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2023-08-01,45-64,Female,USA,Other
FAERS-13455,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2022-05-08,45-64,Female,Europe,Not specified
FAERS-13456,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2021-10-06,45-64,Female,USA,Not specified
FAERS-13457,EXENATIDE (BYDUREON),NAUSEA,2019-07-23,45-64,Female,Canada,Other
FAERS-13458,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2019-01-04,45-64,Female,USA,Hospitalization
FAERS-13459,LIRAGLUTIDE (SAXENDA),DIZZINESS,2022-05-08,45-64,Female,Europe,Other
FAERS-13460,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2020-06-15,45-64,Female,USA,Not specified
FAERS-13461,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-11-16,18-44,Male,USA,Other
FAERS-13462,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-06-05,45-64,Female,USA,Disability
FAERS-13463,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-11-24,45-64,Female,USA,Other
FAERS-13464,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2022-09-04,45-64,Female,USA,Other
FAERS-13465,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-11-21,18-44,Female,USA,Hospitalization
FAERS-13466,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2023-11-10,18-44,Male,Europe,Other
FAERS-13467,LIRAGLUTIDE (SAXENDA),NAUSEA,2023-11-23,18-44,Female,USA,Hospitalization
FAERS-13468,EXENATIDE (BYDUREON),THYROID NEOPLASM,2023-04-10,45-64,Female,Europe,Hospitalization
FAERS-13469,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2020-05-12,45-64,Unknown,USA,Other
FAERS-13470,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-01-03,18-44,Male,USA,Other
FAERS-13471,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-01-13,18-44,Female,Europe,Other
FAERS-13472,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-03-17,45-64,Male,USA,Other
FAERS-13473,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-10-26,45-64,Female,USA,Other
FAERS-13474,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2021-04-12,65-74,Female,USA,Not specified
FAERS-13475,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-12-17,45-64,Male,Canada,Other
FAERS-13476,TIRZEPATIDE (MOUNJARO),NAUSEA,2020-02-07,18-44,Male,USA,Disability
FAERS-13477,LIRAGLUTIDE (SAXENDA),ALOPECIA,2020-10-15,65-74,Female,USA,Not specified
FAERS-13478,LIRAGLUTIDE (SAXENDA),DIARRHEA,2021-11-08,45-64,Unknown,USA,Other
FAERS-13479,EXENATIDE (BYDUREON),ALOPECIA,2019-12-09,45-64,Female,Europe,Other
FAERS-13480,SEMAGLUTIDE (OZEMPIC),NAUSEA,2018-01-15,45-64,Female,Canada,Other
FAERS-13481,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-03-13,45-64,Female,Europe,Not specified
FAERS-13482,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-04-24,Unknown,Male,Australia,Other
FAERS-13483,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-09-13,45-64,Female,USA,Other
FAERS-13484,SEMAGLUTIDE (WEGOVY),HEADACHE,2020-03-03,18-44,Male,USA,Other
FAERS-13485,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-10-16,45-64,Male,USA,Other
FAERS-13486,TIRZEPATIDE (MOUNJARO),HEADACHE,2022-05-13,65-74,Male,USA,Not specified
FAERS-13487,LIRAGLUTIDE (SAXENDA),HYPOGLYCEMIA,2021-04-06,45-64,Female,USA,Other
FAERS-13488,LIRAGLUTIDE (SAXENDA),ABDOMINAL PAIN,2023-09-22,75-84,Male,USA,Not specified
FAERS-13489,EXENATIDE (BYDUREON),PANCREATITIS,2023-11-11,18-44,Female,USA,Hospitalization
FAERS-13490,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-08-27,65-74,Female,USA,Not specified
FAERS-13491,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-08-03,45-64,Male,Europe,Other
FAERS-13492,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-04-08,18-44,Female,USA,Other
FAERS-13493,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2022-07-01,65-74,Male,USA,Disability
FAERS-13494,SEMAGLUTIDE (WEGOVY),FATIGUE,2023-01-24,65-74,Female,USA,Other
FAERS-13495,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-08-13,45-64,Female,USA,Hospitalization
FAERS-13496,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-11-14,0-17,Female,USA,Death
FAERS-13497,TIRZEPATIDE (ZEPBOUND),FATIGUE,2021-01-22,18-44,Female,Europe,Other
FAERS-13498,EXENATIDE (BYETTA),GALLBLADDER DISEASE,2022-07-28,45-64,Male,Canada,Other
FAERS-13499,LIRAGLUTIDE (SAXENDA),ALOPECIA,2022-02-13,18-44,Female,USA,Hospitalization
FAERS-13500,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-05-26,45-64,Male,Europe,Other
FAERS-13501,SEMAGLUTIDE (OZEMPIC),NAUSEA,2018-05-05,45-64,Female,USA,Other
FAERS-13502,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2019-09-03,18-44,Female,USA,Other
FAERS-13503,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2020-07-15,45-64,Male,Other,Not specified
FAERS-13504,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2019-04-21,18-44,Female,Japan,Not specified
FAERS-13505,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-03-06,65-74,Male,USA,Hospitalization
FAERS-13506,TIRZEPATIDE (MOUNJARO),HEADACHE,2022-05-17,75-84,Male,Europe,Hospitalization
FAERS-13507,EXENATIDE (BYETTA),CONSTIPATION,2022-05-07,65-74,Female,USA,Other
FAERS-13508,EXENATIDE (BYETTA),DIZZINESS,2023-02-16,0-17,Female,USA,Other
FAERS-13509,LIRAGLUTIDE (SAXENDA),GALLBLADDER DISEASE,2018-03-24,18-44,Female,USA,Hospitalization
FAERS-13510,SEMAGLUTIDE (OZEMPIC),NAUSEA,2020-02-19,65-74,Male,Japan,Other
FAERS-13511,SEMAGLUTIDE (OZEMPIC),FATIGUE,2018-04-11,45-64,Female,USA,Not specified
FAERS-13512,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-12-01,45-64,Female,USA,Disability
FAERS-13513,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2021-03-09,45-64,Female,Canada,Not specified
FAERS-13514,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2022-04-25,0-17,Male,USA,Other
FAERS-13515,TIRZEPATIDE (MOUNJARO),HEADACHE,2021-09-15,45-64,Male,USA,Other
FAERS-13516,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2018-05-08,45-64,Female,Canada,Other
FAERS-13517,EXENATIDE (BYDUREON),SUICIDAL IDEATION,2022-04-27,75-84,Female,USA,Hospitalization
FAERS-13518,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2023-12-27,18-44,Male,USA,Other
FAERS-13519,DULAGLUTIDE (TRULICITY),PANCREATITIS,2023-06-04,65-74,Female,Other,Other
FAERS-13520,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2021-08-24,45-64,Female,USA,Not specified
FAERS-13521,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-05-06,45-64,Unknown,USA,Other
FAERS-13522,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-12-10,65-74,Female,Australia,Not specified
FAERS-13523,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2023-08-13,18-44,Male,USA,Other
FAERS-13524,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-09-19,45-64,Female,USA,Other
FAERS-13525,TIRZEPATIDE (MOUNJARO),DIARRHEA,2021-11-01,45-64,Female,USA,Other
FAERS-13526,TIRZEPATIDE (MOUNJARO),HEADACHE,2022-06-24,45-64,Male,Europe,Other
FAERS-13527,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2023-12-28,45-64,Female,Japan,Other
FAERS-13528,LIRAGLUTIDE (VICTOZA),FATIGUE,2022-08-15,75-84,Female,USA,Not specified
FAERS-13529,DULAGLUTIDE (TRULICITY),DIZZINESS,2022-07-05,45-64,Female,USA,Other
FAERS-13530,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-02-22,45-64,Female,Europe,Other
FAERS-13531,SEMAGLUTIDE (OZEMPIC),NAUSEA,2020-10-14,45-64,Male,USA,Life-threatening
FAERS-13532,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-05-07,18-44,Female,Japan,Life-threatening
FAERS-13533,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2020-10-08,75-84,Male,Europe,Other
FAERS-13534,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-07-19,65-74,Female,Canada,Not specified
FAERS-13535,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-03-07,18-44,Female,USA,Other
FAERS-13536,TIRZEPATIDE (MOUNJARO),HEADACHE,2019-09-11,45-64,Female,USA,Other
FAERS-13537,EXENATIDE (BYDUREON),SUICIDAL IDEATION,2021-09-11,18-44,Female,Australia,Other
FAERS-13538,DULAGLUTIDE (TRULICITY),ALOPECIA,2022-09-26,45-64,Male,Other,Hospitalization
FAERS-13539,LIRAGLUTIDE (VICTOZA),GALLBLADDER DISEASE,2018-04-15,85+,Female,USA,Other
FAERS-13540,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-07-18,Unknown,Female,Europe,Other
FAERS-13541,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2020-10-05,45-64,Male,USA,Life-threatening
FAERS-13542,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2019-12-11,18-44,Female,Japan,Other
FAERS-13543,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2022-09-26,75-84,Female,Europe,Other
FAERS-13544,SEMAGLUTIDE (WEGOVY),FATIGUE,2020-12-03,45-64,Female,USA,Other
FAERS-13545,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-02-16,45-64,Female,USA,Not specified
FAERS-13546,TIRZEPATIDE (MOUNJARO),HEADACHE,2020-03-18,45-64,Male,USA,Other
FAERS-13547,TIRZEPATIDE (ZEPBOUND),FATIGUE,2022-05-11,18-44,Male,USA,Other
FAERS-13548,LIRAGLUTIDE (VICTOZA),ASPIRATION,2023-02-24,18-44,Male,Europe,Not specified
FAERS-13549,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2022-03-22,75-84,Male,USA,Not specified
FAERS-13550,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-06-21,65-74,Male,USA,Other
FAERS-13551,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2021-05-06,45-64,Female,Europe,Not specified
FAERS-13552,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-05-24,65-74,Male,USA,Other
FAERS-13553,SEMAGLUTIDE (WEGOVY),ASPIRATION,2022-08-05,18-44,Male,Other,Not specified
FAERS-13554,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2021-02-28,18-44,Female,USA,Other
FAERS-13555,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2019-12-22,45-64,Male,USA,Other
FAERS-13556,TIRZEPATIDE (MOUNJARO),FATIGUE,2021-12-04,18-44,Female,USA,Other
FAERS-13557,DULAGLUTIDE (TRULICITY),DIZZINESS,2022-06-03,65-74,Female,USA,Other
FAERS-13558,TIRZEPATIDE (ZEPBOUND),DIARRHEA,2019-04-23,45-64,Female,Europe,Hospitalization
FAERS-13559,EXENATIDE (BYETTA),HYPOGLYCEMIA,2020-08-19,0-17,Male,USA,Other
FAERS-13560,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-06-11,65-74,Male,Other,Not specified
FAERS-13561,SEMAGLUTIDE (OZEMPIC),VOMITING,2019-10-06,65-74,Female,USA,Not specified
FAERS-13562,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2022-02-26,45-64,Female,USA,Not specified
FAERS-13563,SEMAGLUTIDE (WEGOVY),ASPIRATION,2022-03-13,45-64,Female,Europe,Hospitalization
FAERS-13564,SEMAGLUTIDE (WEGOVY),DIZZINESS,2020-11-19,45-64,Female,Europe,Not specified
FAERS-13565,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-07-23,75-84,Female,USA,Other
FAERS-13566,TIRZEPATIDE (MOUNJARO),FATIGUE,2021-11-11,65-74,Male,USA,Not specified
FAERS-13567,EXENATIDE (BYETTA),ASPIRATION,2021-08-04,45-64,Male,Other,Other
FAERS-13568,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2022-01-27,65-74,Male,USA,Life-threatening
FAERS-13569,EXENATIDE (BYETTA),NAUSEA,2018-05-05,65-74,Male,USA,Other
FAERS-13570,SEMAGLUTIDE (OZEMPIC),HEADACHE,2018-05-01,45-64,Male,USA,Other
FAERS-13571,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-03-13,45-64,Male,USA,Other
FAERS-13572,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-01-08,45-64,Male,USA,Other
FAERS-13573,SEMAGLUTIDE (WEGOVY),DIZZINESS,2021-11-02,18-44,Female,Europe,Not specified
FAERS-13574,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2019-08-06,18-44,Male,Australia,Not specified
FAERS-13575,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2021-10-26,75-84,Male,Other,Hospitalization
FAERS-13576,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-04-11,18-44,Male,Japan,Other
FAERS-13577,EXENATIDE (BYDUREON),ABDOMINAL PAIN,2022-11-25,65-74,Male,USA,Other
FAERS-13578,DULAGLUTIDE (TRULICITY),DECREASED APPETITE,2023-06-08,75-84,Female,USA,Not specified
FAERS-13579,TIRZEPATIDE (ZEPBOUND),ALOPECIA,2021-12-25,18-44,Female,USA,Disability
FAERS-13580,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2018-01-23,18-44,Male,USA,Not specified
FAERS-13581,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-05-10,45-64,Female,USA,Hospitalization
FAERS-13582,SEMAGLUTIDE (OZEMPIC),FATIGUE,2021-01-23,18-44,Female,USA,Not specified
FAERS-13583,SEMAGLUTIDE (WEGOVY),DIARRHEA,2020-12-24,18-44,Female,USA,Hospitalization
FAERS-13584,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-10-07,75-84,Female,USA,Other
FAERS-13585,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2023-12-25,45-64,Female,USA,Other
FAERS-13586,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2022-12-08,65-74,Female,USA,Other
FAERS-13587,LIRAGLUTIDE (VICTOZA),ABDOMINAL PAIN,2020-08-08,65-74,Female,Canada,Other
FAERS-13588,LIRAGLUTIDE (VICTOZA),DIZZINESS,2020-05-04,65-74,Male,USA,Not specified
FAERS-13589,LIRAGLUTIDE (VICTOZA),ABDOMINAL PAIN,2022-04-23,45-64,Male,USA,Not specified
FAERS-13590,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2019-01-05,18-44,Male,USA,Other
FAERS-13591,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2021-06-11,18-44,Male,Europe,Other
FAERS-13592,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-01-09,65-74,Female,USA,Life-threatening
FAERS-13593,SEMAGLUTIDE (WEGOVY),ASPIRATION,2021-02-03,65-74,Female,Australia,Other
FAERS-13594,SEMAGLUTIDE (WEGOVY),DIARRHEA,2020-01-16,65-74,Female,USA,Other
FAERS-13595,TIRZEPATIDE (MOUNJARO),VOMITING,2023-06-01,18-44,Male,Other,Other
FAERS-13596,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-02-20,65-74,Male,Other,Other
FAERS-13597,DULAGLUTIDE (TRULICITY),VOMITING,2022-02-13,45-64,Female,USA,Other
FAERS-13598,LIRAGLUTIDE (VICTOZA),DIARRHEA,2021-01-27,45-64,Female,Other,Other
FAERS-13599,TIRZEPATIDE (ZEPBOUND),INJECTION SITE REACTION,2023-11-12,18-44,Female,Europe,Not specified
FAERS-13600,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2018-07-03,18-44,Male,Canada,Other
FAERS-13601,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-06-22,18-44,Female,Europe,Other
FAERS-13602,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2020-07-01,45-64,Male,USA,Not specified
FAERS-13603,SEMAGLUTIDE (WEGOVY),FATIGUE,2019-05-25,65-74,Female,USA,Other
FAERS-13604,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2022-09-17,65-74,Female,USA,Other
FAERS-13605,TIRZEPATIDE (MOUNJARO),VOMITING,2023-11-04,45-64,Male,Europe,Other
FAERS-13606,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2023-12-12,45-64,Female,USA,Hospitalization
FAERS-13607,EXENATIDE (BYDUREON),GALLBLADDER DISEASE,2022-11-19,45-64,Female,Other,Other
FAERS-13608,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2022-01-16,45-64,Male,USA,Not specified
FAERS-13609,EXENATIDE (BYDUREON),FATIGUE,2019-11-28,65-74,Female,Other,Other
FAERS-13610,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2018-09-08,18-44,Male,USA,Other
FAERS-13611,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-08-17,18-44,Female,USA,Other
FAERS-13612,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-05-20,Unknown,Female,USA,Other
FAERS-13613,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2022-07-13,65-74,Male,USA,Other
FAERS-13614,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2023-02-03,45-64,Male,USA,Other
FAERS-13615,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-04-10,18-44,Female,Europe,Other
FAERS-13616,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2020-03-01,45-64,Female,Europe,Other
FAERS-13617,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2023-04-25,65-74,Male,USA,Other
FAERS-13618,DULAGLUTIDE (TRULICITY),FATIGUE,2022-09-16,18-44,Female,USA,Hospitalization
FAERS-13619,LIRAGLUTIDE (VICTOZA),SUICIDAL IDEATION,2020-02-05,18-44,Male,USA,Other
FAERS-13620,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-11-02,75-84,Female,USA,Not specified
FAERS-13621,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2018-10-19,Unknown,Female,Europe,Not specified
FAERS-13622,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2020-09-16,45-64,Female,USA,Hospitalization
FAERS-13623,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-04-17,45-64,Male,Europe,Disability
FAERS-13624,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2021-10-10,18-44,Female,USA,Other
FAERS-13625,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2019-10-19,18-44,Female,Europe,Not specified
FAERS-13626,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2022-08-23,Unknown,Female,USA,Disability
FAERS-13627,TIRZEPATIDE (ZEPBOUND),FATIGUE,2022-06-21,65-74,Male,USA,Other
FAERS-13628,TIRZEPATIDE (ZEPBOUND),DIARRHEA,2021-06-13,18-44,Male,Canada,Other
FAERS-13629,DULAGLUTIDE (TRULICITY),SUICIDAL IDEATION,2022-09-19,Unknown,Male,USA,Other
FAERS-13630,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-09-01,18-44,Female,USA,Other
FAERS-13631,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-04-19,45-64,Female,Europe,Hospitalization
FAERS-13632,SEMAGLUTIDE (OZEMPIC),FATIGUE,2018-09-13,45-64,Male,USA,Other
FAERS-13633,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2023-05-10,45-64,Female,USA,Other
FAERS-13634,SEMAGLUTIDE (WEGOVY),NAUSEA,2020-09-18,18-44,Unknown,Europe,Not specified
FAERS-13635,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2019-06-02,18-44,Female,USA,Disability
FAERS-13636,TIRZEPATIDE (MOUNJARO),VOMITING,2022-07-22,65-74,Male,USA,Other
FAERS-13637,EXENATIDE (BYETTA),ALOPECIA,2020-10-14,75-84,Female,USA,Hospitalization
FAERS-13638,TIRZEPATIDE (ZEPBOUND),NAUSEA,2022-12-04,45-64,Female,USA,Not specified
FAERS-13639,EXENATIDE (BYETTA),ALOPECIA,2021-11-22,45-64,Female,Europe,Other
FAERS-13640,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-05-03,65-74,Female,USA,Not specified
FAERS-13641,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-02-28,18-44,Male,Europe,Not specified
FAERS-13642,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-12-23,18-44,Male,Other,Disability
FAERS-13643,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2021-08-02,18-44,Female,Europe,Other
FAERS-13644,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2023-07-15,45-64,Male,USA,Hospitalization
FAERS-13645,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2020-05-26,45-64,Female,USA,Not specified
FAERS-13646,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-08-11,45-64,Male,USA,Other
FAERS-13647,DULAGLUTIDE (TRULICITY),DIZZINESS,2020-08-09,65-74,Female,USA,Other
FAERS-13648,EXENATIDE (BYDUREON),HEADACHE,2023-04-20,75-84,Female,USA,Hospitalization
FAERS-13649,LIRAGLUTIDE (VICTOZA),GALLBLADDER DISEASE,2023-07-10,85+,Female,USA,Hospitalization
FAERS-13650,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-04-03,18-44,Male,Europe,Other
FAERS-13651,SEMAGLUTIDE (OZEMPIC),HEADACHE,2019-01-03,45-64,Female,USA,Hospitalization
FAERS-13652,SEMAGLUTIDE (OZEMPIC),HEADACHE,2019-06-08,45-64,Male,USA,Other
FAERS-13653,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-07-15,45-64,Male,USA,Other
FAERS-13654,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-05-17,45-64,Female,USA,Other
FAERS-13655,TIRZEPATIDE (MOUNJARO),VOMITING,2019-01-15,18-44,Female,USA,Other
FAERS-13656,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-11-16,18-44,Female,Other,Other
FAERS-13657,LIRAGLUTIDE (SAXENDA),DIZZINESS,2021-02-04,65-74,Female,Australia,Not specified
FAERS-13658,TIRZEPATIDE (ZEPBOUND),HYPOGLYCEMIA,2023-05-20,45-64,Female,Europe,Hospitalization
FAERS-13659,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2021-10-14,45-64,Female,Europe,Other
FAERS-13660,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-07-23,18-44,Female,USA,Not specified
FAERS-13661,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-01-27,18-44,Female,USA,Disability
FAERS-13662,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2019-10-23,18-44,Male,Australia,Other
FAERS-13663,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-12-04,45-64,Female,USA,Not specified
FAERS-13664,SEMAGLUTIDE (WEGOVY),DIZZINESS,2022-10-28,45-64,Female,USA,Other
FAERS-13665,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-04-26,75-84,Male,USA,Other
FAERS-13666,TIRZEPATIDE (MOUNJARO),HEADACHE,2023-04-27,45-64,Female,Canada,Other
FAERS-13667,DULAGLUTIDE (TRULICITY),DECREASED APPETITE,2023-04-09,45-64,Female,USA,Other
FAERS-13668,TIRZEPATIDE (ZEPBOUND),ASPIRATION,2018-01-12,45-64,Female,USA,Other
FAERS-13669,EXENATIDE (BYDUREON),VOMITING,2019-12-04,65-74,Female,USA,Other
FAERS-13670,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2020-06-25,45-64,Female,USA,Other
FAERS-13671,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2021-02-10,18-44,Female,Europe,Other
FAERS-13672,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2020-12-08,45-64,Female,Europe,Other
FAERS-13673,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-07-24,45-64,Unknown,Europe,Other
FAERS-13674,SEMAGLUTIDE (WEGOVY),DIARRHEA,2019-01-20,45-64,Female,Canada,Not specified
FAERS-13675,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-02-22,18-44,Male,USA,Other
FAERS-13676,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-08-07,65-74,Female,USA,Other
FAERS-13677,LIRAGLUTIDE (SAXENDA),THYROID NEOPLASM,2023-04-01,65-74,Female,USA,Hospitalization
FAERS-13678,EXENATIDE (BYDUREON),HEADACHE,2021-07-27,18-44,Female,USA,Other
FAERS-13679,TIRZEPATIDE (ZEPBOUND),INJECTION SITE REACTION,2022-07-16,45-64,Female,Europe,Hospitalization
FAERS-13680,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-08-22,18-44,Male,Europe,Not specified
FAERS-13681,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-06-11,75-84,Male,Other,Other
FAERS-13682,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-03-05,18-44,Unknown,Europe,Hospitalization
FAERS-13683,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2021-08-13,18-44,Female,USA,Hospitalization
FAERS-13684,SEMAGLUTIDE (WEGOVY),DIZZINESS,2020-05-25,Unknown,Male,USA,Hospitalization
FAERS-13685,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-10-19,45-64,Female,USA,Hospitalization
FAERS-13686,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2020-10-22,45-64,Male,USA,Hospitalization
FAERS-13687,EXENATIDE (BYETTA),INJECTION SITE REACTION,2023-03-21,45-64,Unknown,USA,Not specified
FAERS-13688,DULAGLUTIDE (TRULICITY),ASPIRATION,2022-10-28,18-44,Female,USA,Other
FAERS-13689,LIRAGLUTIDE (SAXENDA),SUICIDAL IDEATION,2022-05-09,18-44,Male,USA,Other
FAERS-13690,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-12-24,65-74,Male,Japan,Other
FAERS-13691,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-04-08,65-74,Female,USA,Hospitalization
FAERS-13692,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-02-27,45-64,Female,USA,Other
FAERS-13693,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-07-23,45-64,Female,Europe,Not specified
FAERS-13694,SEMAGLUTIDE (WEGOVY),ALOPECIA,2023-10-04,45-64,Female,USA,Other
FAERS-13695,TIRZEPATIDE (MOUNJARO),NAUSEA,2022-02-14,65-74,Female,Other,Life-threatening
FAERS-13696,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2020-09-10,45-64,Female,USA,Hospitalization
FAERS-13697,TIRZEPATIDE (ZEPBOUND),DIARRHEA,2023-08-25,45-64,Female,USA,Disability
FAERS-13698,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2023-10-11,65-74,Male,Europe,Other
FAERS-13699,TIRZEPATIDE (ZEPBOUND),HEADACHE,2021-02-03,45-64,Male,Europe,Hospitalization
FAERS-13700,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2020-09-14,Unknown,Female,USA,Hospitalization
FAERS-13701,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2019-06-18,75-84,Female,USA,Other
FAERS-13702,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2018-07-08,18-44,Male,USA,Hospitalization
FAERS-13703,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2021-11-18,45-64,Female,USA,Hospitalization
FAERS-13704,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2019-08-22,85+,Female,USA,Other
FAERS-13705,TIRZEPATIDE (MOUNJARO),FATIGUE,2021-06-25,18-44,Female,USA,Not specified
FAERS-13706,TIRZEPATIDE (MOUNJARO),HEADACHE,2019-08-28,18-44,Male,USA,Hospitalization
FAERS-13707,LIRAGLUTIDE (SAXENDA),DIARRHEA,2022-03-16,45-64,Female,USA,Other
FAERS-13708,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2022-12-11,18-44,Female,USA,Other
FAERS-13709,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2018-02-20,18-44,Female,Canada,Other
FAERS-13710,SEMAGLUTIDE (OZEMPIC),HEADACHE,2020-12-02,18-44,Male,USA,Hospitalization
FAERS-13711,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2018-12-21,Unknown,Male,USA,Other
FAERS-13712,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-11-09,65-74,Female,Europe,Disability
FAERS-13713,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2023-03-28,65-74,Female,Other,Not specified
FAERS-13714,SEMAGLUTIDE (WEGOVY),NAUSEA,2020-07-27,45-64,Female,Europe,Not specified
FAERS-13715,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2021-04-07,45-64,Female,Europe,Not specified
FAERS-13716,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-07-13,45-64,Male,Australia,Other
FAERS-13717,DULAGLUTIDE (TRULICITY),NAUSEA,2021-01-04,45-64,Male,Europe,Other
FAERS-13718,EXENATIDE (BYDUREON),VOMITING,2023-03-17,45-64,Male,Australia,Hospitalization
FAERS-13719,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2022-07-20,18-44,Male,Europe,Other
FAERS-13720,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-03-23,18-44,Female,USA,Other
FAERS-13721,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-01-11,18-44,Male,Europe,Other
FAERS-13722,SEMAGLUTIDE (OZEMPIC),HEADACHE,2020-05-24,Unknown,Female,USA,Hospitalization
FAERS-13723,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-12-28,65-74,Female,USA,Other
FAERS-13724,SEMAGLUTIDE (WEGOVY),DIZZINESS,2021-03-27,18-44,Male,USA,Other
FAERS-13725,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-09-06,45-64,Male,USA,Other
FAERS-13726,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2023-01-09,Unknown,Male,USA,Not specified
FAERS-13727,LIRAGLUTIDE (SAXENDA),ALOPECIA,2023-08-04,45-64,Female,USA,Not specified
FAERS-13728,DULAGLUTIDE (TRULICITY),VOMITING,2020-10-08,65-74,Female,Europe,Other
FAERS-13729,EXENATIDE (BYDUREON),PANCREATITIS,2022-03-02,45-64,Male,Europe,Other
FAERS-13730,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-02-04,45-64,Female,USA,Other
FAERS-13731,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-06-15,Unknown,Female,USA,Other
FAERS-13732,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2019-07-01,65-74,Male,Canada,Other
FAERS-13733,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-01-26,65-74,Female,USA,Other
FAERS-13734,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-04-13,45-64,Female,USA,Other
FAERS-13735,TIRZEPATIDE (MOUNJARO),DIZZINESS,2021-07-22,45-64,Male,USA,Other
FAERS-13736,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-04-01,45-64,Female,USA,Other
FAERS-13737,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2023-10-20,65-74,Female,Europe,Other
FAERS-13738,DULAGLUTIDE (TRULICITY),HEADACHE,2022-06-23,65-74,Female,USA,Other
FAERS-13739,TIRZEPATIDE (ZEPBOUND),ASPIRATION,2022-09-17,65-74,Male,USA,Other
FAERS-13740,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-10-17,18-44,Female,USA,Other
FAERS-13741,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-08-13,45-64,Female,Europe,Other
FAERS-13742,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-08-19,65-74,Female,USA,Other
FAERS-13743,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-05-11,45-64,Female,Europe,Other
FAERS-13744,SEMAGLUTIDE (WEGOVY),ASPIRATION,2019-01-15,45-64,Female,USA,Other
FAERS-13745,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-06-10,18-44,Female,USA,Other
FAERS-13746,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2022-01-26,45-64,Female,USA,Other
FAERS-13747,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2022-11-21,45-64,Female,Japan,Other
FAERS-13748,EXENATIDE (BYETTA),INJECTION SITE REACTION,2023-06-17,45-64,Female,Europe,Not specified
FAERS-13749,DULAGLUTIDE (TRULICITY),FATIGUE,2022-09-03,18-44,Female,USA,Other
FAERS-13750,SEMAGLUTIDE (OZEMPIC),FATIGUE,2018-12-07,Unknown,Male,USA,Hospitalization
FAERS-13751,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-07-04,45-64,Female,Europe,Not specified
FAERS-13752,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-08-17,65-74,Male,USA,Other
FAERS-13753,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2022-05-01,18-44,Male,Europe,Disability
FAERS-13754,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2022-11-25,45-64,Female,USA,Hospitalization
FAERS-13755,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2023-07-11,18-44,Unknown,USA,Disability
FAERS-13756,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2019-10-15,45-64,Female,USA,Life-threatening
FAERS-13757,EXENATIDE (BYETTA),DECREASED APPETITE,2022-02-10,18-44,Female,USA,Other
FAERS-13758,EXENATIDE (BYETTA),PANCREATITIS,2021-12-15,18-44,Male,USA,Not specified
FAERS-13759,TIRZEPATIDE (ZEPBOUND),ASPIRATION,2021-04-14,18-44,Male,USA,Not specified
FAERS-13760,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-07-04,75-84,Female,USA,Other
FAERS-13761,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-03-16,45-64,Female,USA,Other
FAERS-13762,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-02-05,18-44,Female,USA,Life-threatening
FAERS-13763,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-06-13,Unknown,Female,Europe,Other
FAERS-13764,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2021-06-11,45-64,Male,USA,Not specified
FAERS-13765,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-07-01,45-64,Male,USA,Other
FAERS-13766,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-04-21,45-64,Female,USA,Hospitalization
FAERS-13767,DULAGLUTIDE (TRULICITY),SUICIDAL IDEATION,2022-07-02,18-44,Female,USA,Hospitalization
FAERS-13768,LIRAGLUTIDE (VICTOZA),DECREASED APPETITE,2022-03-14,65-74,Female,USA,Not specified
FAERS-13769,EXENATIDE (BYETTA),NAUSEA,2021-06-22,75-84,Male,USA,Hospitalization
FAERS-13770,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-01-24,65-74,Male,USA,Hospitalization
FAERS-13771,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-05-10,18-44,Male,USA,Other
FAERS-13772,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-12-03,45-64,Female,Japan,Other
FAERS-13773,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-02-24,18-44,Female,USA,Other
FAERS-13774,SEMAGLUTIDE (WEGOVY),HEADACHE,2018-06-08,45-64,Female,USA,Hospitalization
FAERS-13775,TIRZEPATIDE (MOUNJARO),VOMITING,2023-03-05,18-44,Female,Canada,Other
FAERS-13776,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2019-05-20,45-64,Male,USA,Other
FAERS-13777,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2022-03-02,45-64,Female,USA,Other
FAERS-13778,LIRAGLUTIDE (VICTOZA),DIARRHEA,2018-02-06,45-64,Female,Europe,Other
FAERS-13779,EXENATIDE (BYETTA),HEADACHE,2021-10-11,65-74,Male,Europe,Hospitalization
FAERS-13780,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-01-21,45-64,Male,USA,Other
FAERS-13781,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-06-06,45-64,Male,USA,Other
FAERS-13782,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-09-09,45-64,Female,USA,Hospitalization
FAERS-13783,SEMAGLUTIDE (WEGOVY),NAUSEA,2022-08-25,45-64,Female,USA,Not specified
FAERS-13784,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2022-03-18,18-44,Female,USA,Other
FAERS-13785,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-07-22,18-44,Female,USA,Other
FAERS-13786,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2018-04-28,65-74,Male,USA,Other
FAERS-13787,EXENATIDE (BYDUREON),FATIGUE,2021-09-01,45-64,Male,Europe,Other
FAERS-13788,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2022-10-27,85+,Female,USA,Other
FAERS-13789,TIRZEPATIDE (ZEPBOUND),DIARRHEA,2020-05-05,45-64,Male,USA,Other
FAERS-13790,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-01-03,Unknown,Female,USA,Other
FAERS-13791,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-01-23,45-64,Female,USA,Hospitalization
FAERS-13792,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-02-12,45-64,Female,USA,Life-threatening
FAERS-13793,SEMAGLUTIDE (WEGOVY),FATIGUE,2023-01-10,45-64,Female,USA,Disability
FAERS-13794,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2021-12-05,45-64,Female,USA,Other
FAERS-13795,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2019-10-01,18-44,Male,Other,Hospitalization
FAERS-13796,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2018-03-01,65-74,Female,Europe,Other
FAERS-13797,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2023-04-23,45-64,Female,Europe,Other
FAERS-13798,LIRAGLUTIDE (VICTOZA),NAUSEA,2023-06-20,18-44,Female,USA,Other
FAERS-13799,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2023-11-08,45-64,Female,Europe,Not specified
FAERS-13800,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-03-12,45-64,Female,USA,Life-threatening
FAERS-13801,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-01-10,45-64,Female,USA,Hospitalization
FAERS-13802,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2018-11-28,45-64,Female,USA,Other
FAERS-13803,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-04-28,Unknown,Male,Australia,Other
FAERS-13804,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-08-13,65-74,Female,Europe,Other
FAERS-13805,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2022-06-16,65-74,Female,USA,Other
FAERS-13806,TIRZEPATIDE (MOUNJARO),ALOPECIA,2021-05-20,45-64,Female,USA,Other
FAERS-13807,EXENATIDE (BYETTA),FATIGUE,2019-06-17,45-64,Female,USA,Other
FAERS-13808,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2018-10-19,45-64,Female,USA,Other
FAERS-13809,LIRAGLUTIDE (VICTOZA),CONSTIPATION,2021-10-04,45-64,Male,USA,Hospitalization
FAERS-13810,SEMAGLUTIDE (OZEMPIC),VOMITING,2021-12-28,45-64,Male,Europe,Hospitalization
FAERS-13811,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-12-11,45-64,Female,USA,Other
FAERS-13812,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2019-11-07,18-44,Female,USA,Hospitalization
FAERS-13813,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-09-01,65-74,Male,USA,Not specified
FAERS-13814,SEMAGLUTIDE (WEGOVY),NAUSEA,2020-10-16,18-44,Female,USA,Other
FAERS-13815,TIRZEPATIDE (MOUNJARO),DIARRHEA,2020-10-17,45-64,Male,USA,Not specified
FAERS-13816,TIRZEPATIDE (MOUNJARO),ASPIRATION,2022-02-28,75-84,Female,USA,Other
FAERS-13817,LIRAGLUTIDE (SAXENDA),HYPOGLYCEMIA,2021-07-01,45-64,Female,USA,Other
FAERS-13818,EXENATIDE (BYETTA),ABDOMINAL PAIN,2023-11-16,45-64,Male,Europe,Not specified
FAERS-13819,LIRAGLUTIDE (VICTOZA),VOMITING,2022-05-12,45-64,Female,USA,Not specified
FAERS-13820,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-10-17,65-74,Female,Canada,Other
FAERS-13821,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-05-09,45-64,Female,USA,Other
FAERS-13822,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-02-20,45-64,Male,USA,Not specified
FAERS-13823,SEMAGLUTIDE (WEGOVY),DIARRHEA,2021-01-23,75-84,Unknown,Other,Other
FAERS-13824,SEMAGLUTIDE (WEGOVY),DIZZINESS,2019-12-19,18-44,Female,Europe,Disability
FAERS-13825,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-09-10,18-44,Female,USA,Other
FAERS-13826,TIRZEPATIDE (MOUNJARO),FATIGUE,2021-02-12,18-44,Female,Europe,Other
FAERS-13827,DULAGLUTIDE (TRULICITY),DIARRHEA,2019-08-01,18-44,Female,Canada,Other
FAERS-13828,LIRAGLUTIDE (SAXENDA),DIZZINESS,2019-01-05,45-64,Female,Other,Other
FAERS-13829,DULAGLUTIDE (TRULICITY),DIZZINESS,2021-11-06,45-64,Male,USA,Not specified
FAERS-13830,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2021-11-06,65-74,Female,USA,Other
FAERS-13831,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-02-05,65-74,Female,Canada,Other
FAERS-13832,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-08-18,45-64,Female,Europe,Other
FAERS-13833,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-10-28,45-64,Male,Europe,Other
FAERS-13834,SEMAGLUTIDE (WEGOVY),FATIGUE,2023-02-17,45-64,Female,USA,Not specified
FAERS-13835,TIRZEPATIDE (MOUNJARO),DIARRHEA,2020-03-22,65-74,Female,USA,Other
FAERS-13836,TIRZEPATIDE (MOUNJARO),HEADACHE,2023-10-09,45-64,Male,Japan,Other
FAERS-13837,EXENATIDE (BYDUREON),DIZZINESS,2020-12-27,65-74,Male,USA,Other
FAERS-13838,LIRAGLUTIDE (SAXENDA),HYPOGLYCEMIA,2022-11-06,18-44,Male,USA,Not specified
FAERS-13839,EXENATIDE (BYETTA),HEADACHE,2023-04-24,65-74,Male,Europe,Life-threatening
FAERS-13840,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-03-26,65-74,Female,USA,Other
FAERS-13841,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-11-25,45-64,Female,USA,Other
FAERS-13842,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-03-01,45-64,Female,Other,Other
FAERS-13843,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-12-01,45-64,Male,USA,Other
FAERS-13844,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2021-11-23,18-44,Male,USA,Other
FAERS-13845,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2019-08-16,65-74,Male,Other,Other
FAERS-13846,TIRZEPATIDE (MOUNJARO),ALOPECIA,2021-10-16,18-44,Male,USA,Disability
FAERS-13847,LIRAGLUTIDE (VICTOZA),ALOPECIA,2020-06-27,18-44,Female,Europe,Not specified
FAERS-13848,DULAGLUTIDE (TRULICITY),ASPIRATION,2018-12-05,18-44,Female,Europe,Other
FAERS-13849,LIRAGLUTIDE (SAXENDA),ABDOMINAL PAIN,2022-10-26,45-64,Female,Europe,Other
FAERS-13850,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2021-09-18,45-64,Male,USA,Not specified
FAERS-13851,SEMAGLUTIDE (OZEMPIC),VOMITING,2021-11-15,65-74,Female,Europe,Disability
FAERS-13852,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2018-05-17,65-74,Female,USA,Other
FAERS-13853,SEMAGLUTIDE (WEGOVY),ASPIRATION,2020-12-06,65-74,Female,Europe,Other
FAERS-13854,SEMAGLUTIDE (WEGOVY),VOMITING,2021-08-23,45-64,Male,USA,Other
FAERS-13855,TIRZEPATIDE (MOUNJARO),NAUSEA,2022-06-19,65-74,Female,USA,Not specified
FAERS-13856,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2022-01-21,45-64,Male,USA,Other
FAERS-13857,LIRAGLUTIDE (SAXENDA),CONSTIPATION,2023-04-19,18-44,Female,USA,Other
FAERS-13858,EXENATIDE (BYDUREON),VOMITING,2023-03-18,65-74,Female,USA,Disability
FAERS-13859,LIRAGLUTIDE (SAXENDA),HYPOGLYCEMIA,2023-02-02,45-64,Male,Canada,Other
FAERS-13860,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-04-11,18-44,Female,USA,Other
FAERS-13861,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-02-11,45-64,Female,USA,Not specified
FAERS-13862,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-11-10,45-64,Female,USA,Other
FAERS-13863,SEMAGLUTIDE (WEGOVY),FATIGUE,2021-06-11,45-64,Female,USA,Not specified
FAERS-13864,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2019-02-10,45-64,Male,Europe,Other
FAERS-13865,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2020-06-06,75-84,Male,USA,Other
FAERS-13866,TIRZEPATIDE (MOUNJARO),DIARRHEA,2023-08-22,65-74,Female,USA,Other
FAERS-13867,EXENATIDE (BYDUREON),THYROID NEOPLASM,2021-02-20,18-44,Female,USA,Other
FAERS-13868,LIRAGLUTIDE (VICTOZA),VOMITING,2021-03-02,65-74,Female,USA,Not specified
FAERS-13869,TIRZEPATIDE (ZEPBOUND),ALOPECIA,2022-05-15,45-64,Female,USA,Disability
FAERS-13870,SEMAGLUTIDE (OZEMPIC),FATIGUE,2020-12-12,65-74,Male,Other,Other
FAERS-13871,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-05-01,65-74,Male,USA,Other
FAERS-13872,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-01-19,18-44,Female,USA,Other
FAERS-13873,SEMAGLUTIDE (WEGOVY),DIARRHEA,2021-11-06,65-74,Female,Japan,Other
FAERS-13874,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-08-20,45-64,Male,USA,Not specified
FAERS-13875,TIRZEPATIDE (MOUNJARO),VOMITING,2021-07-01,65-74,Female,Japan,Hospitalization
FAERS-13876,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-12-24,18-44,Female,USA,Not specified
FAERS-13877,LIRAGLUTIDE (SAXENDA),ALOPECIA,2022-11-20,65-74,Female,USA,Other
FAERS-13878,LIRAGLUTIDE (VICTOZA),ASPIRATION,2020-03-04,45-64,Female,USA,Other
FAERS-13879,LIRAGLUTIDE (VICTOZA),NAUSEA,2020-02-08,18-44,Male,Europe,Hospitalization
FAERS-13880,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-10-02,65-74,Female,USA,Other
FAERS-13881,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-06-06,65-74,Female,Europe,Death
FAERS-13882,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-02-22,18-44,Female,USA,Disability
FAERS-13883,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2019-03-08,85+,Female,Europe,Other
FAERS-13884,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-12-23,45-64,Female,Other,Not specified
FAERS-13885,TIRZEPATIDE (MOUNJARO),ASPIRATION,2022-10-03,18-44,Female,USA,Other
FAERS-13886,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-01-04,65-74,Female,USA,Disability
FAERS-13887,LIRAGLUTIDE (VICTOZA),ALOPECIA,2023-05-19,18-44,Female,USA,Other
FAERS-13888,TIRZEPATIDE (ZEPBOUND),THYROID NEOPLASM,2021-01-27,18-44,Female,USA,Other
FAERS-13889,DULAGLUTIDE (TRULICITY),PANCREATITIS,2022-04-03,45-64,Female,Canada,Not specified
FAERS-13890,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-11-17,18-44,Female,Europe,Other
FAERS-13891,SEMAGLUTIDE (OZEMPIC),VOMITING,2019-12-25,Unknown,Female,Other,Other
FAERS-13892,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-04-02,18-44,Male,Canada,Other
FAERS-13893,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2021-10-28,18-44,Male,USA,Not specified
FAERS-13894,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-04-07,45-64,Male,Europe,Other
FAERS-13895,TIRZEPATIDE (MOUNJARO),VOMITING,2023-01-19,45-64,Female,USA,Other
FAERS-13896,TIRZEPATIDE (MOUNJARO),ASPIRATION,2020-04-10,45-64,Male,USA,Disability
FAERS-13897,TIRZEPATIDE (ZEPBOUND),ALOPECIA,2021-12-18,45-64,Female,Europe,Other
FAERS-13898,EXENATIDE (BYETTA),CONSTIPATION,2022-01-27,65-74,Male,USA,Other
FAERS-13899,LIRAGLUTIDE (VICTOZA),DIARRHEA,2022-11-12,65-74,Male,USA,Other
FAERS-13900,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2020-02-19,45-64,Male,Canada,Not specified
FAERS-13901,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2020-04-14,85+,Female,USA,Other
FAERS-13902,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-11-07,18-44,Female,USA,Hospitalization
FAERS-13903,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-06-17,18-44,Male,USA,Other
FAERS-13904,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2023-05-04,65-74,Female,Europe,Other
FAERS-13905,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-06-06,18-44,Male,USA,Other
FAERS-13906,TIRZEPATIDE (MOUNJARO),FATIGUE,2018-02-04,18-44,Male,USA,Other
FAERS-13907,LIRAGLUTIDE (SAXENDA),ABDOMINAL PAIN,2023-12-07,18-44,Female,USA,Other
FAERS-13908,TIRZEPATIDE (ZEPBOUND),VOMITING,2023-04-13,45-64,Male,USA,Hospitalization
FAERS-13909,EXENATIDE (BYETTA),DIZZINESS,2021-12-21,45-64,Female,Europe,Other
FAERS-13910,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-07-17,65-74,Male,USA,Other
FAERS-13911,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2022-02-09,75-84,Unknown,Other,Not specified
FAERS-13912,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2021-06-28,65-74,Female,USA,Other
FAERS-13913,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2018-02-03,65-74,Male,USA,Other
FAERS-13914,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2023-09-13,Unknown,Male,Europe,Other
FAERS-13915,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-08-24,45-64,Male,USA,Not specified
FAERS-13916,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2023-01-19,65-74,Male,USA,Other
FAERS-13917,EXENATIDE (BYDUREON),DIZZINESS,2018-12-20,18-44,Female,USA,Other
FAERS-13918,DULAGLUTIDE (TRULICITY),DECREASED APPETITE,2020-12-26,65-74,Male,USA,Other
FAERS-13919,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2020-12-16,65-74,Female,USA,Not specified
FAERS-13920,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-12-22,45-64,Male,USA,Other
FAERS-13921,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2021-05-20,18-44,Female,USA,Other
FAERS-13922,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-12-16,45-64,Male,USA,Not specified
FAERS-13923,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2020-01-01,45-64,Female,USA,Hospitalization
FAERS-13924,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-11-15,65-74,Unknown,Australia,Disability
FAERS-13925,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2021-03-08,45-64,Female,Europe,Other
FAERS-13926,TIRZEPATIDE (MOUNJARO),VOMITING,2020-05-24,45-64,Male,USA,Other
FAERS-13927,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2019-01-15,45-64,Female,USA,Other
FAERS-13928,TIRZEPATIDE (ZEPBOUND),DIARRHEA,2021-02-24,65-74,Male,Europe,Other
FAERS-13929,TIRZEPATIDE (ZEPBOUND),SUICIDAL IDEATION,2021-05-03,65-74,Female,Australia,Other
FAERS-13930,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-04-11,18-44,Female,USA,Other
FAERS-13931,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2020-04-16,65-74,Female,Canada,Life-threatening
FAERS-13932,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-09-04,45-64,Female,USA,Other
FAERS-13933,SEMAGLUTIDE (WEGOVY),NAUSEA,2022-12-16,18-44,Female,USA,Hospitalization
FAERS-13934,SEMAGLUTIDE (WEGOVY),VOMITING,2023-09-28,45-64,Male,Europe,Not specified
FAERS-13935,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2021-12-01,18-44,Female,Europe,Other
FAERS-13936,TIRZEPATIDE (MOUNJARO),HEADACHE,2023-05-09,18-44,Female,USA,Other
FAERS-13937,EXENATIDE (BYDUREON),VOMITING,2019-10-15,18-44,Female,USA,Other
FAERS-13938,LIRAGLUTIDE (SAXENDA),DIARRHEA,2023-11-17,65-74,Female,USA,Not specified
FAERS-13939,EXENATIDE (BYDUREON),ALOPECIA,2023-08-10,Unknown,Male,USA,Other
FAERS-13940,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-02-21,65-74,Female,USA,Hospitalization
FAERS-13941,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-09-27,45-64,Male,USA,Hospitalization
FAERS-13942,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-10-14,65-74,Female,USA,Other
FAERS-13943,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2023-04-18,18-44,Female,USA,Not specified
FAERS-13944,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2021-11-17,45-64,Female,USA,Hospitalization
FAERS-13945,TIRZEPATIDE (MOUNJARO),VOMITING,2023-08-01,65-74,Female,USA,Not specified
FAERS-13946,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2020-09-25,65-74,Male,USA,Hospitalization
FAERS-13947,EXENATIDE (BYDUREON),FATIGUE,2021-10-08,65-74,Female,Europe,Life-threatening
FAERS-13948,DULAGLUTIDE (TRULICITY),ALOPECIA,2023-09-08,65-74,Female,USA,Other
FAERS-13949,LIRAGLUTIDE (SAXENDA),DIZZINESS,2021-08-28,45-64,Female,USA,Other
FAERS-13950,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-11-28,45-64,Male,Canada,Other
FAERS-13951,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2021-05-03,45-64,Male,USA,Other
FAERS-13952,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-10-12,45-64,Female,USA,Hospitalization
FAERS-13953,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-01-06,18-44,Male,Europe,Other
FAERS-13954,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2019-12-13,45-64,Unknown,USA,Other
FAERS-13955,TIRZEPATIDE (MOUNJARO),ASPIRATION,2021-04-01,45-64,Female,USA,Other
FAERS-13956,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-01-24,18-44,Unknown,Europe,Other
FAERS-13957,LIRAGLUTIDE (SAXENDA),VOMITING,2022-12-16,45-64,Male,USA,Other
FAERS-13958,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2022-01-02,45-64,Female,USA,Other
FAERS-13959,LIRAGLUTIDE (SAXENDA),SUICIDAL IDEATION,2021-04-07,65-74,Female,Japan,Hospitalization
FAERS-13960,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-12-13,18-44,Male,USA,Life-threatening
FAERS-13961,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-04-16,45-64,Female,Canada,Other
FAERS-13962,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-12-16,65-74,Male,USA,Not specified
FAERS-13963,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2022-03-21,65-74,Male,USA,Disability
FAERS-13964,SEMAGLUTIDE (WEGOVY),ASPIRATION,2020-04-25,18-44,Female,USA,Disability
FAERS-13965,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-06-13,45-64,Female,USA,Other
FAERS-13966,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-01-09,18-44,Female,Canada,Other
FAERS-13967,DULAGLUTIDE (TRULICITY),VOMITING,2023-11-22,45-64,Female,USA,Hospitalization
FAERS-13968,DULAGLUTIDE (TRULICITY),HEADACHE,2022-05-12,45-64,Male,Other,Not specified
FAERS-13969,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2022-12-18,65-74,Female,USA,Other
FAERS-13970,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2020-03-21,45-64,Female,USA,Not specified
FAERS-13971,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-10-07,85+,Female,USA,Other
FAERS-13972,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-04-20,45-64,Female,USA,Other
FAERS-13973,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-11-07,45-64,Female,Europe,Hospitalization
FAERS-13974,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-11-14,18-44,Male,USA,Not specified
FAERS-13975,TIRZEPATIDE (MOUNJARO),ALOPECIA,2019-01-13,65-74,Female,Europe,Other
FAERS-13976,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2023-07-21,65-74,Female,USA,Other
FAERS-13977,LIRAGLUTIDE (SAXENDA),FATIGUE,2022-09-14,45-64,Female,Europe,Other
FAERS-13978,EXENATIDE (BYETTA),HEADACHE,2020-06-06,65-74,Male,Europe,Other
FAERS-13979,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2021-11-15,18-44,Male,USA,Other
FAERS-13980,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-10-10,Unknown,Male,USA,Hospitalization
FAERS-13981,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-11-21,45-64,Female,USA,Other
FAERS-13982,SEMAGLUTIDE (OZEMPIC),VOMITING,2020-02-01,18-44,Female,USA,Other
FAERS-13983,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2021-11-24,75-84,Female,USA,Not specified
FAERS-13984,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-03-06,45-64,Female,USA,Not specified
FAERS-13985,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2022-02-14,75-84,Female,USA,Other
FAERS-13986,TIRZEPATIDE (MOUNJARO),NAUSEA,2021-09-14,18-44,Male,USA,Other
FAERS-13987,EXENATIDE (BYDUREON),NAUSEA,2021-05-25,45-64,Unknown,Europe,Other
FAERS-13988,EXENATIDE (BYETTA),ASPIRATION,2021-06-21,45-64,Male,USA,Not specified
FAERS-13989,TIRZEPATIDE (ZEPBOUND),FATIGUE,2022-10-07,45-64,Male,Europe,Other
FAERS-13990,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2022-11-18,45-64,Female,Europe,Hospitalization
FAERS-13991,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-10-27,65-74,Female,Europe,Other
FAERS-13992,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2022-09-02,65-74,Female,Other,Other
FAERS-13993,SEMAGLUTIDE (WEGOVY),ALOPECIA,2022-11-11,75-84,Male,USA,Other
FAERS-13994,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-05-24,Unknown,Female,USA,Other
FAERS-13995,TIRZEPATIDE (MOUNJARO),VOMITING,2023-05-08,45-64,Female,USA,Not specified
FAERS-13996,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2020-01-13,45-64,Female,USA,Life-threatening
FAERS-13997,LIRAGLUTIDE (SAXENDA),NAUSEA,2022-11-13,18-44,Female,USA,Other
FAERS-13998,EXENATIDE (BYETTA),THYROID NEOPLASM,2023-06-09,18-44,Female,USA,Other
FAERS-13999,EXENATIDE (BYETTA),PANCREATITIS,2021-01-27,Unknown,Male,USA,Disability
FAERS-14000,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-07-20,0-17,Female,USA,Other
FAERS-14001,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-05-15,65-74,Female,USA,Other
FAERS-14002,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2019-02-06,75-84,Male,Europe,Life-threatening
FAERS-14003,SEMAGLUTIDE (WEGOVY),ALOPECIA,2023-07-23,18-44,Female,Europe,Other
FAERS-14004,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-11-19,65-74,Female,Europe,Not specified
FAERS-14005,TIRZEPATIDE (MOUNJARO),NAUSEA,2022-04-07,65-74,Male,USA,Other
FAERS-14006,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2019-04-17,45-64,Female,USA,Other
FAERS-14007,EXENATIDE (BYDUREON),NAUSEA,2023-04-26,65-74,Male,USA,Other
FAERS-14008,TIRZEPATIDE (ZEPBOUND),THYROID NEOPLASM,2023-08-04,65-74,Male,Canada,Not specified
FAERS-14009,TIRZEPATIDE (ZEPBOUND),ASPIRATION,2023-10-10,45-64,Female,Japan,Other
FAERS-14010,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-01-12,18-44,Female,USA,Other
FAERS-14011,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-10-14,45-64,Female,USA,Other
FAERS-14012,SEMAGLUTIDE (OZEMPIC),VOMITING,2018-01-21,45-64,Female,USA,Other
FAERS-14013,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-09-23,45-64,Male,USA,Not specified
FAERS-14014,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-10-14,Unknown,Male,Japan,Hospitalization
FAERS-14015,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2020-10-12,18-44,Female,USA,Life-threatening
FAERS-14016,TIRZEPATIDE (MOUNJARO),DIARRHEA,2021-11-02,45-64,Female,Europe,Not specified
FAERS-14017,LIRAGLUTIDE (VICTOZA),FATIGUE,2021-09-12,45-64,Female,USA,Other
FAERS-14018,EXENATIDE (BYDUREON),HYPOGLYCEMIA,2022-03-14,45-64,Female,USA,Other
FAERS-14019,EXENATIDE (BYDUREON),DIARRHEA,2021-06-03,18-44,Male,USA,Other
FAERS-14020,SEMAGLUTIDE (OZEMPIC),FATIGUE,2018-11-03,18-44,Male,USA,Other
FAERS-14021,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2022-04-28,45-64,Male,Europe,Other
FAERS-14022,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2021-12-17,75-84,Male,USA,Other
FAERS-14023,SEMAGLUTIDE (WEGOVY),HEADACHE,2020-05-27,75-84,Male,Europe,Other
FAERS-14024,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-02-28,45-64,Female,Europe,Hospitalization
FAERS-14025,TIRZEPATIDE (MOUNJARO),HEADACHE,2023-01-10,45-64,Male,Europe,Other
FAERS-14026,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2020-07-01,18-44,Male,USA,Other
FAERS-14027,DULAGLUTIDE (TRULICITY),ALOPECIA,2023-05-09,65-74,Female,Canada,Other
FAERS-14028,DULAGLUTIDE (TRULICITY),SUICIDAL IDEATION,2022-02-09,65-74,Female,Europe,Hospitalization
FAERS-14029,EXENATIDE (BYETTA),SUICIDAL IDEATION,2022-06-01,45-64,Female,USA,Not specified
FAERS-14030,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-09-02,45-64,Female,USA,Other
FAERS-14031,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-04-22,75-84,Male,USA,Other
FAERS-14032,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-10-09,65-74,Female,USA,Hospitalization
FAERS-14033,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-11-15,45-64,Male,USA,Not specified
FAERS-14034,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2021-07-25,65-74,Female,USA,Other
FAERS-14035,TIRZEPATIDE (MOUNJARO),VOMITING,2021-05-16,45-64,Male,USA,Hospitalization
FAERS-14036,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-09-11,45-64,Female,USA,Other
FAERS-14037,TIRZEPATIDE (ZEPBOUND),DIARRHEA,2023-07-03,65-74,Female,USA,Hospitalization
FAERS-14038,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2023-05-20,65-74,Female,USA,Other
FAERS-14039,LIRAGLUTIDE (SAXENDA),ALOPECIA,2023-11-14,45-64,Female,Japan,Other
FAERS-14040,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-11-10,45-64,Female,Europe,Hospitalization
FAERS-14041,SEMAGLUTIDE (OZEMPIC),VOMITING,2020-12-05,45-64,Female,Other,Other
FAERS-14042,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-01-01,85+,Male,USA,Other
FAERS-14043,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2023-08-06,45-64,Female,USA,Hospitalization
FAERS-14044,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2021-12-08,18-44,Female,USA,Other
FAERS-14045,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-01-11,18-44,Male,USA,Other
FAERS-14046,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2019-12-23,18-44,Female,USA,Hospitalization
FAERS-14047,EXENATIDE (BYETTA),VOMITING,2021-12-08,18-44,Female,USA,Other
FAERS-14048,LIRAGLUTIDE (SAXENDA),ASPIRATION,2023-09-26,45-64,Male,Canada,Other
FAERS-14049,LIRAGLUTIDE (VICTOZA),ABDOMINAL PAIN,2022-08-19,65-74,Female,Europe,Other
FAERS-14050,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-07-17,65-74,Male,USA,Hospitalization
FAERS-14051,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-09-03,45-64,Female,Canada,Other
FAERS-14052,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2020-05-06,85+,Female,USA,Not specified
FAERS-14053,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2021-04-22,45-64,Female,Europe,Other
FAERS-14054,SEMAGLUTIDE (WEGOVY),FATIGUE,2021-03-14,45-64,Male,Australia,Disability
FAERS-14055,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-08-27,45-64,Female,USA,Other
FAERS-14056,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2020-02-03,45-64,Male,USA,Not specified
FAERS-14057,EXENATIDE (BYETTA),DECREASED APPETITE,2023-05-11,65-74,Female,USA,Other
FAERS-14058,EXENATIDE (BYETTA),INJECTION SITE REACTION,2023-08-13,18-44,Female,USA,Other
FAERS-14059,DULAGLUTIDE (TRULICITY),ASPIRATION,2023-05-11,45-64,Female,USA,Other
FAERS-14060,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-06-07,45-64,Female,USA,Hospitalization
FAERS-14061,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-02-12,18-44,Female,USA,Other
FAERS-14062,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-05-23,45-64,Male,Europe,Not specified
FAERS-14063,SEMAGLUTIDE (WEGOVY),VOMITING,2023-01-26,65-74,Male,USA,Other
FAERS-14064,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2022-05-12,45-64,Male,Europe,Other
FAERS-14065,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2022-08-04,75-84,Male,USA,Not specified
FAERS-14066,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2021-10-15,45-64,Male,USA,Life-threatening
FAERS-14067,DULAGLUTIDE (TRULICITY),SUICIDAL IDEATION,2023-11-10,45-64,Male,Europe,Disability
FAERS-14068,LIRAGLUTIDE (SAXENDA),DIZZINESS,2021-09-23,45-64,Female,USA,Other
FAERS-14069,TIRZEPATIDE (ZEPBOUND),INJECTION SITE REACTION,2022-01-23,45-64,Male,Australia,Not specified
FAERS-14070,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-05-07,18-44,Female,USA,Other
FAERS-14071,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-01-07,18-44,Male,Japan,Disability
FAERS-14072,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-08-01,18-44,Female,USA,Other
FAERS-14073,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-09-07,18-44,Male,Australia,Other
FAERS-14074,SEMAGLUTIDE (WEGOVY),HEADACHE,2021-08-01,45-64,Female,Canada,Disability
FAERS-14075,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2018-11-15,65-74,Unknown,USA,Other
FAERS-14076,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2019-03-26,18-44,Unknown,Canada,Other
FAERS-14077,EXENATIDE (BYETTA),DIARRHEA,2022-09-06,45-64,Female,Canada,Other
FAERS-14078,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2022-04-28,18-44,Male,Europe,Hospitalization
FAERS-14079,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2022-11-25,45-64,Female,Europe,Hospitalization
FAERS-14080,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-04-04,45-64,Female,Canada,Death
FAERS-14081,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-05-19,75-84,Male,USA,Not specified
FAERS-14082,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-07-12,18-44,Female,USA,Hospitalization
FAERS-14083,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2020-09-22,18-44,Male,USA,Hospitalization
FAERS-14084,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2020-07-09,18-44,Female,Europe,Other
FAERS-14085,TIRZEPATIDE (MOUNJARO),FATIGUE,2021-06-24,18-44,Female,USA,Not specified
FAERS-14086,TIRZEPATIDE (MOUNJARO),HEADACHE,2020-10-08,45-64,Female,Australia,Other
FAERS-14087,LIRAGLUTIDE (VICTOZA),ASPIRATION,2022-06-19,18-44,Female,USA,Other
FAERS-14088,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2022-06-26,45-64,Female,USA,Other
FAERS-14089,TIRZEPATIDE (ZEPBOUND),CONSTIPATION,2022-10-12,65-74,Male,USA,Disability
FAERS-14090,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-03-14,45-64,Female,Europe,Other
FAERS-14091,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-07-04,18-44,Female,USA,Other
FAERS-14092,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-09-01,18-44,Male,USA,Other
FAERS-14093,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2020-02-09,18-44,Unknown,USA,Not specified
FAERS-14094,SEMAGLUTIDE (WEGOVY),DIZZINESS,2021-07-25,18-44,Female,USA,Not specified
FAERS-14095,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-11-20,65-74,Female,USA,Other
FAERS-14096,TIRZEPATIDE (MOUNJARO),VOMITING,2023-07-15,Unknown,Female,USA,Other
FAERS-14097,EXENATIDE (BYETTA),GALLBLADDER DISEASE,2018-11-13,45-64,Female,USA,Hospitalization
FAERS-14098,LIRAGLUTIDE (VICTOZA),INJECTION SITE REACTION,2020-06-17,45-64,Female,USA,Other
FAERS-14099,EXENATIDE (BYETTA),HEADACHE,2022-08-04,Unknown,Female,Japan,Other
FAERS-14100,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2020-08-15,45-64,Female,USA,Hospitalization
FAERS-14101,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-11-16,45-64,Female,USA,Disability
FAERS-14102,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-07-17,65-74,Female,USA,Other
FAERS-14103,SEMAGLUTIDE (WEGOVY),FATIGUE,2021-02-02,45-64,Female,Europe,Not specified
FAERS-14104,SEMAGLUTIDE (WEGOVY),FATIGUE,2022-08-28,45-64,Female,Australia,Not specified
FAERS-14105,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-07-09,45-64,Female,Australia,Other
FAERS-14106,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-11-14,18-44,Male,USA,Not specified
FAERS-14107,LIRAGLUTIDE (SAXENDA),DIZZINESS,2022-11-24,65-74,Female,Europe,Other
FAERS-14108,EXENATIDE (BYETTA),ABDOMINAL PAIN,2019-06-27,45-64,Male,USA,Other
FAERS-14109,EXENATIDE (BYDUREON),ABDOMINAL PAIN,2022-12-21,65-74,Female,Canada,Hospitalization
FAERS-14110,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-09-24,45-64,Female,USA,Other
FAERS-14111,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-05-11,45-64,Female,Canada,Not specified
FAERS-14112,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-08-17,65-74,Male,USA,Hospitalization
FAERS-14113,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2021-04-06,18-44,Female,USA,Other
FAERS-14114,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-12-09,45-64,Female,Other,Not specified
FAERS-14115,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-02-12,18-44,Male,Other,Hospitalization
FAERS-14116,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2023-06-04,18-44,Female,Europe,Hospitalization
FAERS-14117,EXENATIDE (BYDUREON),SUICIDAL IDEATION,2022-10-14,45-64,Female,Canada,Disability
FAERS-14118,LIRAGLUTIDE (SAXENDA),ASPIRATION,2023-07-28,45-64,Female,USA,Other
FAERS-14119,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2020-10-20,65-74,Female,Japan,Other
FAERS-14120,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-05-27,45-64,Female,Europe,Not specified
FAERS-14121,SEMAGLUTIDE (OZEMPIC),NAUSEA,2018-09-04,18-44,Male,USA,Other
FAERS-14122,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-08-16,18-44,Male,USA,Other
FAERS-14123,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2018-02-09,45-64,Unknown,Canada,Other
FAERS-14124,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-09-19,45-64,Female,USA,Disability
FAERS-14125,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-11-06,75-84,Female,Europe,Other
FAERS-14126,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2022-07-25,45-64,Female,Canada,Other
FAERS-14127,DULAGLUTIDE (TRULICITY),VOMITING,2019-03-20,65-74,Female,Europe,Death
FAERS-14128,EXENATIDE (BYDUREON),GALLBLADDER DISEASE,2020-08-09,18-44,Male,USA,Other
FAERS-14129,EXENATIDE (BYDUREON),DIZZINESS,2023-04-08,85+,Female,USA,Other
FAERS-14130,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-01-16,45-64,Male,Europe,Other
FAERS-14131,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-01-27,45-64,Female,Europe,Other
FAERS-14132,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-11-10,18-44,Female,USA,Other
FAERS-14133,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2021-06-15,45-64,Male,USA,Disability
FAERS-14134,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-05-20,45-64,Male,Europe,Hospitalization
FAERS-14135,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2022-09-08,18-44,Male,USA,Other
FAERS-14136,TIRZEPATIDE (MOUNJARO),ALOPECIA,2019-08-24,65-74,Male,Europe,Other
FAERS-14137,EXENATIDE (BYDUREON),DIZZINESS,2023-09-18,65-74,Female,Other,Other
FAERS-14138,LIRAGLUTIDE (SAXENDA),THYROID NEOPLASM,2023-01-15,45-64,Male,Other,Other
FAERS-14139,LIRAGLUTIDE (SAXENDA),HYPOGLYCEMIA,2022-01-04,65-74,Female,USA,Other
FAERS-14140,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-10-22,65-74,Female,Canada,Other
FAERS-14141,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2020-04-12,18-44,Female,Europe,Not specified
FAERS-14142,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-11-19,45-64,Male,USA,Hospitalization
FAERS-14143,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2022-04-06,65-74,Female,Europe,Hospitalization
FAERS-14144,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-06-01,Unknown,Female,USA,Hospitalization
FAERS-14145,TIRZEPATIDE (MOUNJARO),DIARRHEA,2018-12-28,18-44,Female,USA,Other
FAERS-14146,TIRZEPATIDE (MOUNJARO),FATIGUE,2019-12-02,65-74,Male,USA,Other
FAERS-14147,TIRZEPATIDE (ZEPBOUND),ASPIRATION,2020-09-12,45-64,Female,Europe,Other
FAERS-14148,DULAGLUTIDE (TRULICITY),DIZZINESS,2023-05-27,65-74,Female,USA,Other
FAERS-14149,EXENATIDE (BYDUREON),DECREASED APPETITE,2019-03-16,18-44,Female,USA,Hospitalization
FAERS-14150,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-03-19,65-74,Female,USA,Other
FAERS-14151,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-11-14,45-64,Male,USA,Other
FAERS-14152,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-04-02,45-64,Male,Japan,Not specified
FAERS-14153,SEMAGLUTIDE (WEGOVY),DIARRHEA,2021-05-09,45-64,Female,Europe,Other
FAERS-14154,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2023-05-17,18-44,Female,USA,Other
FAERS-14155,TIRZEPATIDE (MOUNJARO),HEADACHE,2018-10-05,18-44,Female,USA,Other
FAERS-14156,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2018-07-20,65-74,Male,Japan,Not specified
FAERS-14157,LIRAGLUTIDE (SAXENDA),ALOPECIA,2021-06-17,45-64,Female,Australia,Other
FAERS-14158,TIRZEPATIDE (ZEPBOUND),FATIGUE,2023-05-15,65-74,Female,USA,Other
FAERS-14159,DULAGLUTIDE (TRULICITY),DIZZINESS,2020-05-23,75-84,Male,USA,Hospitalization
FAERS-14160,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-04-16,45-64,Female,Europe,Other
FAERS-14161,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-06-20,18-44,Male,USA,Not specified
FAERS-14162,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-12-28,45-64,Female,USA,Not specified
FAERS-14163,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2021-08-04,18-44,Female,USA,Life-threatening
FAERS-14164,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-07-15,18-44,Female,Australia,Other
FAERS-14165,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-03-16,18-44,Male,Europe,Hospitalization
FAERS-14166,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-02-23,45-64,Female,Australia,Other
FAERS-14167,LIRAGLUTIDE (SAXENDA),VOMITING,2021-06-11,65-74,Female,USA,Other
FAERS-14168,LIRAGLUTIDE (SAXENDA),GALLBLADDER DISEASE,2023-03-04,45-64,Male,Europe,Other
FAERS-14169,EXENATIDE (BYETTA),THYROID NEOPLASM,2023-08-23,45-64,Male,Europe,Not specified
FAERS-14170,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-01-10,45-64,Male,Europe,Not specified
FAERS-14171,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2019-04-03,18-44,Female,Europe,Other
FAERS-14172,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2020-11-23,45-64,Female,USA,Other
FAERS-14173,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-10-22,18-44,Female,Canada,Not specified
FAERS-14174,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-09-17,45-64,Female,USA,Other
FAERS-14175,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-09-07,18-44,Male,USA,Other
FAERS-14176,TIRZEPATIDE (MOUNJARO),VOMITING,2021-01-02,45-64,Male,USA,Other
FAERS-14177,LIRAGLUTIDE (VICTOZA),DECREASED APPETITE,2021-08-19,65-74,Female,Australia,Hospitalization
FAERS-14178,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2022-11-03,65-74,Female,USA,Other
FAERS-14179,EXENATIDE (BYETTA),CONSTIPATION,2019-07-25,45-64,Female,USA,Other
FAERS-14180,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2020-01-18,65-74,Male,Europe,Disability
FAERS-14181,SEMAGLUTIDE (OZEMPIC),FATIGUE,2021-05-16,18-44,Male,Europe,Other
FAERS-14182,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-09-07,45-64,Male,USA,Other
FAERS-14183,SEMAGLUTIDE (WEGOVY),ALOPECIA,2020-10-26,65-74,Female,USA,Other
FAERS-14184,SEMAGLUTIDE (WEGOVY),FATIGUE,2023-05-20,45-64,Female,USA,Other
FAERS-14185,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-07-27,45-64,Female,USA,Other
FAERS-14186,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-06-26,45-64,Female,USA,Other
FAERS-14187,LIRAGLUTIDE (SAXENDA),DECREASED APPETITE,2022-10-25,18-44,Male,Australia,Hospitalization
FAERS-14188,EXENATIDE (BYETTA),ASPIRATION,2021-07-22,65-74,Male,Other,Not specified
FAERS-14189,EXENATIDE (BYETTA),VOMITING,2023-10-26,65-74,Female,USA,Other
FAERS-14190,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2020-07-18,65-74,Female,Canada,Other
FAERS-14191,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-05-02,18-44,Female,USA,Not specified
FAERS-14192,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-09-11,18-44,Female,USA,Other
FAERS-14193,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-06-22,75-84,Female,USA,Other
FAERS-14194,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2021-08-17,45-64,Female,Europe,Other
FAERS-14195,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2023-07-21,18-44,Female,USA,Other
FAERS-14196,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2020-07-08,45-64,Male,USA,Life-threatening
FAERS-14197,TIRZEPATIDE (ZEPBOUND),GALLBLADDER DISEASE,2023-05-06,18-44,Female,USA,Hospitalization
FAERS-14198,LIRAGLUTIDE (SAXENDA),DIARRHEA,2022-02-28,Unknown,Female,USA,Other
FAERS-14199,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2022-11-22,18-44,Female,USA,Hospitalization
FAERS-14200,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-09-11,45-64,Male,USA,Hospitalization
FAERS-14201,SEMAGLUTIDE (OZEMPIC),VOMITING,2020-10-17,45-64,Male,USA,Not specified
FAERS-14202,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-11-19,45-64,Female,USA,Other
FAERS-14203,SEMAGLUTIDE (WEGOVY),NAUSEA,2018-01-24,45-64,Male,USA,Not specified
FAERS-14204,SEMAGLUTIDE (WEGOVY),DIZZINESS,2021-03-20,18-44,Female,USA,Hospitalization
FAERS-14205,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2023-10-27,45-64,Female,Europe,Other
FAERS-14206,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2018-03-12,45-64,Male,USA,Other
FAERS-14207,DULAGLUTIDE (TRULICITY),VOMITING,2023-04-02,18-44,Male,USA,Other
FAERS-14208,TIRZEPATIDE (ZEPBOUND),DIZZINESS,2019-01-14,45-64,Female,Europe,Hospitalization
FAERS-14209,EXENATIDE (BYETTA),INJECTION SITE REACTION,2022-08-10,65-74,Unknown,USA,Other
FAERS-14210,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2020-03-02,65-74,Male,Other,Other
FAERS-14211,SEMAGLUTIDE (OZEMPIC),VOMITING,2020-07-14,18-44,Male,Europe,Other
FAERS-14212,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2021-06-11,18-44,Male,USA,Other
FAERS-14213,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2020-08-05,18-44,Female,USA,Not specified
FAERS-14214,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2020-12-11,45-64,Female,Europe,Hospitalization
FAERS-14215,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-07-18,85+,Female,Europe,Other
FAERS-14216,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2019-03-03,0-17,Female,USA,Other
FAERS-14217,TIRZEPATIDE (ZEPBOUND),SUICIDAL IDEATION,2020-04-12,45-64,Female,USA,Other
FAERS-14218,LIRAGLUTIDE (VICTOZA),HEADACHE,2022-06-09,18-44,Female,USA,Other
FAERS-14219,EXENATIDE (BYDUREON),HEADACHE,2021-01-15,45-64,Male,Canada,Other
FAERS-14220,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2020-03-13,65-74,Female,USA,Other
FAERS-14221,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-02-19,45-64,Male,Japan,Hospitalization
FAERS-14222,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2019-12-10,45-64,Female,Europe,Other
FAERS-14223,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-06-24,45-64,Male,USA,Other
FAERS-14224,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-06-23,18-44,Male,USA,Other
FAERS-14225,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-02-13,65-74,Male,Europe,Other
FAERS-14226,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2020-08-01,45-64,Female,USA,Not specified
FAERS-14227,EXENATIDE (BYDUREON),ABDOMINAL PAIN,2023-10-06,18-44,Female,USA,Other
FAERS-14228,EXENATIDE (BYDUREON),SUICIDAL IDEATION,2023-12-16,18-44,Male,Japan,Hospitalization
FAERS-14229,EXENATIDE (BYDUREON),SUICIDAL IDEATION,2021-08-12,45-64,Female,USA,Hospitalization
FAERS-14230,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-04-01,45-64,Female,Other,Other
FAERS-14231,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-02-25,18-44,Male,USA,Other
FAERS-14232,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-07-10,18-44,Female,USA,Other
FAERS-14233,SEMAGLUTIDE (WEGOVY),NAUSEA,2018-06-23,45-64,Female,Europe,Other
FAERS-14234,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-06-19,75-84,Female,Europe,Disability
FAERS-14235,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2023-06-01,45-64,Female,Canada,Other
FAERS-14236,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2021-03-21,65-74,Female,Canada,Not specified
FAERS-14237,LIRAGLUTIDE (VICTOZA),HYPOGLYCEMIA,2023-11-22,45-64,Female,USA,Other
FAERS-14238,EXENATIDE (BYDUREON),ALOPECIA,2023-12-04,18-44,Female,USA,Hospitalization
FAERS-14239,EXENATIDE (BYETTA),ASPIRATION,2022-10-09,65-74,Female,USA,Not specified
FAERS-14240,SEMAGLUTIDE (OZEMPIC),NAUSEA,2023-03-16,45-64,Female,USA,Other
FAERS-14241,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-12-17,45-64,Male,Europe,Other
FAERS-14242,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-08-05,65-74,Female,USA,Other
FAERS-14243,SEMAGLUTIDE (WEGOVY),FATIGUE,2021-11-25,65-74,Male,USA,Other
FAERS-14244,SEMAGLUTIDE (WEGOVY),ASPIRATION,2020-06-20,45-64,Male,USA,Other
FAERS-14245,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2020-01-12,45-64,Male,USA,Not specified
FAERS-14246,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-12-27,18-44,Male,USA,Other
FAERS-14247,EXENATIDE (BYDUREON),DECREASED APPETITE,2022-06-02,65-74,Female,Europe,Hospitalization
FAERS-14248,LIRAGLUTIDE (SAXENDA),VOMITING,2022-11-16,45-64,Male,Europe,Death
FAERS-14249,EXENATIDE (BYETTA),DIARRHEA,2021-08-10,18-44,Male,Europe,Other
FAERS-14250,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-06-21,45-64,Unknown,Japan,Other
FAERS-14251,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-02-06,18-44,Female,USA,Other
FAERS-14252,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2021-05-14,65-74,Female,USA,Other
FAERS-14253,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-10-19,45-64,Female,USA,Death
FAERS-14254,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2023-08-18,45-64,Male,USA,Disability
FAERS-14255,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-08-12,45-64,Male,Europe,Disability
FAERS-14256,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2020-11-09,45-64,Female,USA,Other
FAERS-14257,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2021-11-19,45-64,Male,USA,Disability
FAERS-14258,EXENATIDE (BYDUREON),GALLBLADDER DISEASE,2019-10-08,45-64,Female,USA,Hospitalization
FAERS-14259,EXENATIDE (BYDUREON),HYPOGLYCEMIA,2020-11-09,45-64,Female,USA,Other
FAERS-14260,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2019-06-16,45-64,Female,USA,Other
FAERS-14261,SEMAGLUTIDE (OZEMPIC),FATIGUE,2021-02-05,45-64,Female,USA,Other
FAERS-14262,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-02-03,45-64,Male,USA,Other
FAERS-14263,SEMAGLUTIDE (WEGOVY),FATIGUE,2022-01-20,18-44,Female,Canada,Other
FAERS-14264,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-11-12,65-74,Female,Europe,Not specified
FAERS-14265,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2021-07-27,45-64,Male,USA,Other
FAERS-14266,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2021-05-08,65-74,Female,USA,Other
FAERS-14267,EXENATIDE (BYETTA),DIZZINESS,2023-01-10,45-64,Female,USA,Hospitalization
FAERS-14268,DULAGLUTIDE (TRULICITY),ALOPECIA,2021-10-05,45-64,Male,USA,Hospitalization
FAERS-14269,TIRZEPATIDE (ZEPBOUND),VOMITING,2022-07-20,45-64,Male,USA,Not specified
FAERS-14270,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-10-08,18-44,Female,Europe,Other
FAERS-14271,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-02-04,45-64,Female,Europe,Hospitalization
FAERS-14272,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-11-03,18-44,Male,USA,Not specified
FAERS-14273,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2021-05-27,45-64,Female,Europe,Not specified
FAERS-14274,SEMAGLUTIDE (WEGOVY),ASPIRATION,2020-02-27,45-64,Unknown,USA,Disability
FAERS-14275,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2020-04-19,65-74,Female,Europe,Other
FAERS-14276,TIRZEPATIDE (MOUNJARO),FATIGUE,2021-05-13,65-74,Female,USA,Other
FAERS-14277,TIRZEPATIDE (ZEPBOUND),ASPIRATION,2021-11-02,65-74,Female,Europe,Other
FAERS-14278,TIRZEPATIDE (ZEPBOUND),HYPOGLYCEMIA,2023-02-02,65-74,Male,USA,Other
FAERS-14279,LIRAGLUTIDE (SAXENDA),VOMITING,2023-02-24,18-44,Male,USA,Life-threatening
FAERS-14280,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2021-07-17,18-44,Female,USA,Hospitalization
FAERS-14281,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-06-09,45-64,Female,USA,Hospitalization
FAERS-14282,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2018-09-11,18-44,Female,Europe,Not specified
FAERS-14283,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-06-18,75-84,Male,USA,Hospitalization
FAERS-14284,SEMAGLUTIDE (WEGOVY),DIZZINESS,2020-01-23,18-44,Female,USA,Other
FAERS-14285,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2022-02-21,45-64,Male,USA,Other
FAERS-14286,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2022-05-04,18-44,Female,USA,Other
FAERS-14287,TIRZEPATIDE (ZEPBOUND),CONSTIPATION,2023-10-07,45-64,Female,Europe,Other
FAERS-14288,LIRAGLUTIDE (SAXENDA),SUICIDAL IDEATION,2023-12-01,45-64,Male,Japan,Hospitalization
FAERS-14289,LIRAGLUTIDE (SAXENDA),ASPIRATION,2021-05-14,18-44,Female,USA,Other
FAERS-14290,SEMAGLUTIDE (OZEMPIC),FATIGUE,2021-02-23,85+,Female,USA,Other
FAERS-14291,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-11-11,75-84,Female,USA,Not specified
FAERS-14292,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-02-11,75-84,Male,USA,Disability
FAERS-14293,SEMAGLUTIDE (WEGOVY),DIARRHEA,2019-01-17,18-44,Female,Canada,Other
FAERS-14294,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-04-10,18-44,Female,Canada,Death
FAERS-14295,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2023-12-09,65-74,Male,USA,Other
FAERS-14296,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-01-05,45-64,Male,USA,Other
FAERS-14297,LIRAGLUTIDE (SAXENDA),DIARRHEA,2021-07-01,45-64,Female,USA,Other
FAERS-14298,LIRAGLUTIDE (VICTOZA),DIZZINESS,2022-10-25,65-74,Female,USA,Other
FAERS-14299,EXENATIDE (BYDUREON),INJECTION SITE REACTION,2021-09-23,65-74,Female,Japan,Not specified
FAERS-14300,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-03-26,45-64,Male,USA,Other
FAERS-14301,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-06-28,18-44,Female,Europe,Hospitalization
FAERS-14302,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-03-10,65-74,Female,Europe,Other
FAERS-14303,SEMAGLUTIDE (WEGOVY),ALOPECIA,2021-02-14,18-44,Male,USA,Other
FAERS-14304,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2022-07-25,45-64,Female,USA,Other
FAERS-14305,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2020-09-22,65-74,Female,USA,Hospitalization
FAERS-14306,TIRZEPATIDE (MOUNJARO),HEADACHE,2021-04-22,65-74,Female,USA,Other
FAERS-14307,DULAGLUTIDE (TRULICITY),HEADACHE,2023-01-09,45-64,Male,Canada,Death
FAERS-14308,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2022-10-12,75-84,Female,USA,Other
FAERS-14309,TIRZEPATIDE (ZEPBOUND),ALOPECIA,2022-11-07,65-74,Female,USA,Other
FAERS-14310,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-11-01,45-64,Male,USA,Other
FAERS-14311,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-05-22,65-74,Female,Europe,Other
FAERS-14312,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-07-23,75-84,Male,USA,Not specified
FAERS-14313,SEMAGLUTIDE (WEGOVY),DIARRHEA,2021-10-12,18-44,Female,USA,Hospitalization
FAERS-14314,SEMAGLUTIDE (WEGOVY),ALOPECIA,2023-03-12,18-44,Male,USA,Other
FAERS-14315,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2018-06-20,18-44,Female,USA,Hospitalization
FAERS-14316,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2019-12-23,45-64,Male,Europe,Not specified
FAERS-14317,TIRZEPATIDE (ZEPBOUND),NAUSEA,2020-07-08,45-64,Male,USA,Other
FAERS-14318,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2021-08-08,0-17,Female,Europe,Other
FAERS-14319,LIRAGLUTIDE (VICTOZA),DIARRHEA,2023-08-28,45-64,Female,Europe,Not specified
FAERS-14320,SEMAGLUTIDE (OZEMPIC),NAUSEA,2020-11-27,45-64,Female,Europe,Other
FAERS-14321,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-10-21,18-44,Male,Europe,Other
FAERS-14322,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-12-11,45-64,Female,Europe,Not specified
FAERS-14323,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2021-10-14,18-44,Female,USA,Other
FAERS-14324,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-04-08,65-74,Male,USA,Not specified
FAERS-14325,TIRZEPATIDE (MOUNJARO),VOMITING,2023-01-27,18-44,Female,USA,Other
FAERS-14326,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-01-08,65-74,Female,USA,Not specified
FAERS-14327,EXENATIDE (BYETTA),VOMITING,2022-06-23,65-74,Male,USA,Hospitalization
FAERS-14328,TIRZEPATIDE (ZEPBOUND),ASPIRATION,2023-01-18,18-44,Female,USA,Hospitalization
FAERS-14329,TIRZEPATIDE (ZEPBOUND),DIARRHEA,2022-09-15,45-64,Female,USA,Other
FAERS-14330,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-01-07,18-44,Male,USA,Other
FAERS-14331,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2021-12-07,45-64,Female,Europe,Other
FAERS-14332,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-05-27,18-44,Female,Canada,Other
FAERS-14333,SEMAGLUTIDE (WEGOVY),VOMITING,2021-06-24,45-64,Male,USA,Other
FAERS-14334,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2020-11-05,18-44,Female,Other,Other
FAERS-14335,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-11-03,45-64,Female,Other,Other
FAERS-14336,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-09-19,18-44,Female,Europe,Other
FAERS-14337,EXENATIDE (BYDUREON),HEADACHE,2023-06-28,65-74,Female,USA,Hospitalization
FAERS-14338,EXENATIDE (BYETTA),FATIGUE,2022-09-19,45-64,Male,USA,Disability
FAERS-14339,DULAGLUTIDE (TRULICITY),DIZZINESS,2020-05-12,65-74,Male,USA,Hospitalization
FAERS-14340,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-02-21,45-64,Female,Japan,Other
FAERS-14341,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-01-16,65-74,Male,USA,Not specified
FAERS-14342,SEMAGLUTIDE (OZEMPIC),HEADACHE,2020-11-26,45-64,Male,Europe,Hospitalization
FAERS-14343,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-02-25,65-74,Female,USA,Not specified
FAERS-14344,SEMAGLUTIDE (WEGOVY),DIZZINESS,2021-05-27,18-44,Female,USA,Other
FAERS-14345,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2022-05-01,18-44,Male,USA,Not specified
FAERS-14346,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2020-01-24,45-64,Female,USA,Other
FAERS-14347,EXENATIDE (BYDUREON),VOMITING,2020-11-12,45-64,Female,Europe,Other
FAERS-14348,EXENATIDE (BYDUREON),PANCREATITIS,2021-01-15,45-64,Male,USA,Other
FAERS-14349,EXENATIDE (BYETTA),INJECTION SITE REACTION,2022-09-18,45-64,Female,Europe,Not specified
FAERS-14350,SEMAGLUTIDE (OZEMPIC),HEADACHE,2020-02-25,65-74,Female,Canada,Not specified
FAERS-14351,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-01-25,45-64,Male,Europe,Other
FAERS-14352,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2020-07-04,65-74,Male,USA,Other
FAERS-14353,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2021-01-23,45-64,Female,Canada,Not specified
FAERS-14354,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-03-14,45-64,Male,USA,Hospitalization
FAERS-14355,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-09-14,65-74,Female,USA,Other
FAERS-14356,TIRZEPATIDE (MOUNJARO),VOMITING,2023-04-08,18-44,Male,USA,Life-threatening
FAERS-14357,DULAGLUTIDE (TRULICITY),ALOPECIA,2023-08-08,45-64,Female,USA,Hospitalization
FAERS-14358,DULAGLUTIDE (TRULICITY),DECREASED APPETITE,2022-05-20,65-74,Female,USA,Not specified
FAERS-14359,EXENATIDE (BYDUREON),VOMITING,2023-09-04,18-44,Female,USA,Not specified
FAERS-14360,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-05-13,45-64,Female,Australia,Not specified
FAERS-14361,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2019-11-07,45-64,Male,USA,Hospitalization
FAERS-14362,SEMAGLUTIDE (OZEMPIC),FATIGUE,2019-05-12,65-74,Male,USA,Other
FAERS-14363,SEMAGLUTIDE (WEGOVY),ALOPECIA,2021-02-27,18-44,Female,USA,Other
FAERS-14364,SEMAGLUTIDE (WEGOVY),NAUSEA,2020-03-12,45-64,Female,USA,Not specified
FAERS-14365,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-12-11,45-64,Male,Europe,Disability
FAERS-14366,TIRZEPATIDE (MOUNJARO),DIARRHEA,2019-06-09,18-44,Female,USA,Hospitalization
FAERS-14367,TIRZEPATIDE (ZEPBOUND),VOMITING,2018-01-16,65-74,Female,USA,Hospitalization
FAERS-14368,EXENATIDE (BYDUREON),GALLBLADDER DISEASE,2023-03-03,45-64,Male,USA,Not specified
FAERS-14369,LIRAGLUTIDE (SAXENDA),ABDOMINAL PAIN,2022-04-24,45-64,Female,Japan,Other
FAERS-14370,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2021-02-27,45-64,Female,USA,Other
FAERS-14371,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-05-24,45-64,Female,USA,Hospitalization
FAERS-14372,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2021-08-25,18-44,Male,Europe,Other
FAERS-14373,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-10-12,45-64,Male,USA,Hospitalization
FAERS-14374,SEMAGLUTIDE (WEGOVY),VOMITING,2021-01-06,65-74,Female,Canada,Other
FAERS-14375,TIRZEPATIDE (MOUNJARO),DIARRHEA,2021-01-23,45-64,Female,USA,Disability
FAERS-14376,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2022-01-11,75-84,Male,USA,Hospitalization
FAERS-14377,DULAGLUTIDE (TRULICITY),PANCREATITIS,2022-11-27,65-74,Female,USA,Other
FAERS-14378,LIRAGLUTIDE (VICTOZA),GALLBLADDER DISEASE,2021-05-23,65-74,Female,Japan,Other
FAERS-14379,DULAGLUTIDE (TRULICITY),FATIGUE,2021-10-08,18-44,Female,USA,Hospitalization
FAERS-14380,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-09-05,65-74,Male,USA,Other
FAERS-14381,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-04-16,18-44,Female,USA,Other
FAERS-14382,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-05-21,65-74,Unknown,USA,Not specified
FAERS-14383,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-08-06,18-44,Male,Canada,Not specified
FAERS-14384,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2018-07-02,Unknown,Female,USA,Other
FAERS-14385,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-05-15,65-74,Female,USA,Hospitalization
FAERS-14386,TIRZEPATIDE (MOUNJARO),HEADACHE,2023-02-23,45-64,Male,Europe,Other
FAERS-14387,LIRAGLUTIDE (VICTOZA),DIARRHEA,2019-04-24,45-64,Male,USA,Other
FAERS-14388,EXENATIDE (BYDUREON),ALOPECIA,2023-05-09,45-64,Female,USA,Not specified
FAERS-14389,DULAGLUTIDE (TRULICITY),HEADACHE,2019-08-19,45-64,Female,USA,Not specified
FAERS-14390,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-12-12,65-74,Male,Europe,Other
FAERS-14391,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-04-24,45-64,Female,USA,Hospitalization
FAERS-14392,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2020-12-04,45-64,Female,Europe,Other
FAERS-14393,SEMAGLUTIDE (WEGOVY),DIARRHEA,2020-10-07,18-44,Female,Japan,Other
FAERS-14394,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-05-23,18-44,Female,USA,Hospitalization
FAERS-14395,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2021-06-04,Unknown,Male,Japan,Hospitalization
FAERS-14396,TIRZEPATIDE (MOUNJARO),HEADACHE,2018-01-05,18-44,Male,USA,Other
FAERS-14397,LIRAGLUTIDE (VICTOZA),HEADACHE,2021-11-11,45-64,Male,Europe,Other
FAERS-14398,LIRAGLUTIDE (VICTOZA),ALOPECIA,2021-07-16,75-84,Unknown,Australia,Other
FAERS-14399,LIRAGLUTIDE (SAXENDA),CONSTIPATION,2023-04-27,45-64,Male,USA,Other
FAERS-14400,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-04-20,18-44,Female,Europe,Other
FAERS-14401,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2018-03-13,18-44,Female,USA,Hospitalization
FAERS-14402,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-12-17,18-44,Male,Canada,Other
FAERS-14403,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-04-28,45-64,Female,Europe,Other
FAERS-14404,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2021-01-18,45-64,Male,Other,Other
FAERS-14405,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2022-06-02,45-64,Male,Europe,Other
FAERS-14406,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2020-03-20,18-44,Female,Europe,Other
FAERS-14407,LIRAGLUTIDE (VICTOZA),ASPIRATION,2021-03-22,45-64,Male,USA,Other
FAERS-14408,EXENATIDE (BYDUREON),ASPIRATION,2018-03-14,45-64,Female,Canada,Other
FAERS-14409,TIRZEPATIDE (ZEPBOUND),NAUSEA,2022-08-03,18-44,Male,USA,Not specified
FAERS-14410,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2021-03-08,18-44,Female,Europe,Other
FAERS-14411,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2020-02-27,45-64,Female,USA,Other
FAERS-14412,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-02-15,65-74,Female,Europe,Other
FAERS-14413,SEMAGLUTIDE (WEGOVY),ALOPECIA,2023-09-18,18-44,Male,USA,Hospitalization
FAERS-14414,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-01-06,0-17,Female,Australia,Not specified
FAERS-14415,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2021-11-18,18-44,Male,USA,Other
FAERS-14416,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2022-06-01,45-64,Female,USA,Other
FAERS-14417,EXENATIDE (BYETTA),INJECTION SITE REACTION,2023-03-08,45-64,Male,USA,Other
FAERS-14418,EXENATIDE (BYETTA),ABDOMINAL PAIN,2023-02-18,45-64,Female,USA,Not specified
FAERS-14419,LIRAGLUTIDE (SAXENDA),ALOPECIA,2020-09-09,18-44,Male,Other,Other
FAERS-14420,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2021-02-16,18-44,Female,USA,Not specified
FAERS-14421,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-05-04,18-44,Male,Canada,Other
FAERS-14422,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2021-01-15,75-84,Female,USA,Other
FAERS-14423,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-12-27,45-64,Female,USA,Not specified
FAERS-14424,SEMAGLUTIDE (WEGOVY),HEADACHE,2019-07-21,45-64,Female,Other,Not specified
FAERS-14425,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2019-08-20,45-64,Unknown,USA,Disability
FAERS-14426,TIRZEPATIDE (MOUNJARO),HEADACHE,2022-02-06,45-64,Female,USA,Other
FAERS-14427,LIRAGLUTIDE (VICTOZA),SUICIDAL IDEATION,2022-09-05,18-44,Female,USA,Not specified
FAERS-14428,LIRAGLUTIDE (SAXENDA),THYROID NEOPLASM,2021-05-02,Unknown,Female,USA,Other
FAERS-14429,EXENATIDE (BYETTA),CONSTIPATION,2021-10-06,45-64,Female,Europe,Not specified
FAERS-14430,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-04-22,65-74,Male,USA,Not specified
FAERS-14431,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-03-12,45-64,Male,USA,Other
FAERS-14432,SEMAGLUTIDE (OZEMPIC),FATIGUE,2018-09-25,18-44,Male,Canada,Other
FAERS-14433,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2021-03-23,65-74,Male,USA,Other
FAERS-14434,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-01-28,45-64,Male,USA,Other
FAERS-14435,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-04-01,45-64,Female,USA,Disability
FAERS-14436,TIRZEPATIDE (MOUNJARO),ASPIRATION,2022-06-21,18-44,Female,USA,Death
FAERS-14437,EXENATIDE (BYETTA),FATIGUE,2023-10-28,45-64,Female,USA,Other
FAERS-14438,EXENATIDE (BYDUREON),ALOPECIA,2018-01-01,65-74,Male,USA,Other
FAERS-14439,DULAGLUTIDE (TRULICITY),VOMITING,2018-01-26,45-64,Male,Canada,Other
FAERS-14440,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-05-07,65-74,Female,Other,Other
FAERS-14441,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-09-23,45-64,Female,Europe,Other
FAERS-14442,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-05-27,18-44,Female,USA,Hospitalization
FAERS-14443,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2019-03-10,Unknown,Female,USA,Other
FAERS-14444,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2021-04-21,45-64,Male,USA,Hospitalization
FAERS-14445,TIRZEPATIDE (MOUNJARO),VOMITING,2021-12-09,65-74,Female,USA,Other
FAERS-14446,TIRZEPATIDE (MOUNJARO),DIARRHEA,2022-10-27,45-64,Male,Europe,Not specified
FAERS-14447,LIRAGLUTIDE (VICTOZA),DIARRHEA,2023-04-28,45-64,Male,USA,Not specified
FAERS-14448,EXENATIDE (BYDUREON),DECREASED APPETITE,2023-06-14,45-64,Male,USA,Other
FAERS-14449,DULAGLUTIDE (TRULICITY),VOMITING,2023-11-23,65-74,Female,USA,Other
FAERS-14450,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-02-13,45-64,Female,Europe,Other
FAERS-14451,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-11-15,45-64,Female,USA,Other
FAERS-14452,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-05-16,45-64,Female,USA,Not specified
FAERS-14453,SEMAGLUTIDE (WEGOVY),NAUSEA,2023-11-05,45-64,Male,Europe,Other
FAERS-14454,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2021-05-19,65-74,Female,USA,Other
FAERS-14455,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-08-12,45-64,Female,USA,Other
FAERS-14456,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2022-12-02,18-44,Female,Europe,Other
FAERS-14457,EXENATIDE (BYETTA),DIARRHEA,2022-07-26,65-74,Female,Europe,Other
FAERS-14458,TIRZEPATIDE (ZEPBOUND),VOMITING,2023-04-19,65-74,Male,USA,Hospitalization
FAERS-14459,LIRAGLUTIDE (VICTOZA),ALOPECIA,2022-04-19,18-44,Male,USA,Not specified
FAERS-14460,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2019-09-09,65-74,Female,USA,Other
FAERS-14461,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-06-05,18-44,Female,USA,Other
FAERS-14462,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2020-10-15,45-64,Male,USA,Not specified
FAERS-14463,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-10-18,45-64,Female,USA,Disability
FAERS-14464,SEMAGLUTIDE (WEGOVY),FATIGUE,2021-07-14,65-74,Male,USA,Not specified
FAERS-14465,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-12-26,65-74,Female,USA,Other
FAERS-14466,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2022-09-05,65-74,Female,USA,Other
FAERS-14467,EXENATIDE (BYDUREON),GALLBLADDER DISEASE,2022-02-25,18-44,Male,USA,Not specified
FAERS-14468,EXENATIDE (BYDUREON),HYPOGLYCEMIA,2022-07-23,45-64,Female,USA,Not specified
FAERS-14469,EXENATIDE (BYETTA),CONSTIPATION,2020-09-28,65-74,Female,USA,Other
FAERS-14470,SEMAGLUTIDE (OZEMPIC),VOMITING,2022-10-02,85+,Female,USA,Hospitalization
FAERS-14471,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-02-20,18-44,Unknown,Europe,Other
FAERS-14472,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-03-27,Unknown,Male,Europe,Hospitalization
FAERS-14473,SEMAGLUTIDE (WEGOVY),HEADACHE,2019-06-21,45-64,Male,Japan,Hospitalization
FAERS-14474,SEMAGLUTIDE (WEGOVY),NAUSEA,2020-05-27,45-64,Female,Europe,Not specified
FAERS-14475,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-07-07,45-64,Male,USA,Other
FAERS-14476,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2020-04-24,18-44,Female,USA,Hospitalization
FAERS-14477,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2020-11-16,45-64,Male,USA,Other
FAERS-14478,EXENATIDE (BYETTA),INJECTION SITE REACTION,2020-03-10,65-74,Male,USA,Other
FAERS-14479,LIRAGLUTIDE (VICTOZA),INJECTION SITE REACTION,2023-12-20,45-64,Female,USA,Disability
FAERS-14480,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-10-20,75-84,Female,Canada,Other
FAERS-14481,SEMAGLUTIDE (OZEMPIC),NAUSEA,2020-01-20,45-64,Male,Japan,Hospitalization
FAERS-14482,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-04-05,45-64,Male,Europe,Other
FAERS-14483,SEMAGLUTIDE (WEGOVY),FATIGUE,2021-08-13,45-64,Male,USA,Hospitalization
FAERS-14484,SEMAGLUTIDE (WEGOVY),DIARRHEA,2021-02-10,45-64,Female,USA,Other
FAERS-14485,TIRZEPATIDE (MOUNJARO),VOMITING,2023-04-19,65-74,Female,USA,Disability
FAERS-14486,TIRZEPATIDE (MOUNJARO),ALOPECIA,2022-01-27,65-74,Male,USA,Hospitalization
FAERS-14487,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2023-04-21,75-84,Male,Canada,Other
FAERS-14488,TIRZEPATIDE (ZEPBOUND),HYPOGLYCEMIA,2022-06-17,45-64,Female,USA,Death
FAERS-14489,LIRAGLUTIDE (SAXENDA),ALOPECIA,2022-03-20,45-64,Male,Canada,Not specified
FAERS-14490,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2019-08-12,18-44,Female,Europe,Other
FAERS-14491,SEMAGLUTIDE (OZEMPIC),HEADACHE,2019-05-26,65-74,Male,Europe,Death
FAERS-14492,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2020-12-13,18-44,Female,USA,Not specified
FAERS-14493,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2021-05-07,45-64,Male,USA,Other
FAERS-14494,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2020-10-26,45-64,Male,USA,Other
FAERS-14495,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-01-21,18-44,Male,Europe,Hospitalization
FAERS-14496,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-04-11,18-44,Female,USA,Life-threatening
FAERS-14497,EXENATIDE (BYETTA),NAUSEA,2023-06-22,45-64,Female,Japan,Other
FAERS-14498,TIRZEPATIDE (ZEPBOUND),DIZZINESS,2018-01-19,18-44,Female,USA,Hospitalization
FAERS-14499,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2023-07-21,18-44,Unknown,USA,Not specified
FAERS-14500,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2021-08-06,65-74,Male,USA,Other
FAERS-14501,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-11-07,45-64,Male,USA,Disability
FAERS-14502,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-07-28,65-74,Female,Europe,Not specified
FAERS-14503,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-04-11,65-74,Male,USA,Hospitalization
FAERS-14504,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-09-12,18-44,Unknown,Europe,Hospitalization
FAERS-14505,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2021-10-12,Unknown,Female,Europe,Not specified
FAERS-14506,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2022-04-23,65-74,Male,Europe,Disability
FAERS-14507,EXENATIDE (BYDUREON),PANCREATITIS,2022-11-05,18-44,Female,Europe,Hospitalization
FAERS-14508,EXENATIDE (BYETTA),DIARRHEA,2021-06-16,Unknown,Male,USA,Not specified
FAERS-14509,EXENATIDE (BYDUREON),GALLBLADDER DISEASE,2022-07-02,65-74,Female,USA,Other
FAERS-14510,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-08-02,75-84,Male,USA,Other
FAERS-14511,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2019-10-25,45-64,Male,USA,Disability
FAERS-14512,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-03-20,18-44,Female,Europe,Other
FAERS-14513,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-07-05,65-74,Female,Australia,Other
FAERS-14514,SEMAGLUTIDE (WEGOVY),NAUSEA,2023-04-20,65-74,Female,Europe,Hospitalization
FAERS-14515,TIRZEPATIDE (MOUNJARO),HEADACHE,2021-08-13,45-64,Male,Other,Other
FAERS-14516,TIRZEPATIDE (MOUNJARO),DIZZINESS,2021-07-14,18-44,Unknown,USA,Not specified
FAERS-14517,DULAGLUTIDE (TRULICITY),DIZZINESS,2023-11-19,45-64,Male,Japan,Other
FAERS-14518,LIRAGLUTIDE (VICTOZA),FATIGUE,2023-01-17,45-64,Female,Europe,Other
FAERS-14519,EXENATIDE (BYETTA),CONSTIPATION,2023-07-13,65-74,Female,USA,Other
FAERS-14520,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2021-03-16,18-44,Female,USA,Other
FAERS-14521,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-10-23,65-74,Female,Japan,Life-threatening
FAERS-14522,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2023-11-08,65-74,Male,USA,Other
FAERS-14523,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2018-02-10,65-74,Female,USA,Other
FAERS-14524,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2022-03-17,18-44,Male,USA,Not specified
FAERS-14525,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2022-10-06,65-74,Female,USA,Other
FAERS-14526,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2020-11-22,65-74,Male,USA,Not specified
FAERS-14527,LIRAGLUTIDE (SAXENDA),VOMITING,2023-04-22,75-84,Female,USA,Other
FAERS-14528,TIRZEPATIDE (ZEPBOUND),SUICIDAL IDEATION,2023-09-08,Unknown,Male,Europe,Other
FAERS-14529,TIRZEPATIDE (ZEPBOUND),GALLBLADDER DISEASE,2019-03-21,65-74,Male,USA,Not specified
FAERS-14530,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2020-10-18,45-64,Female,Other,Not specified
FAERS-14531,SEMAGLUTIDE (OZEMPIC),VOMITING,2018-07-07,45-64,Male,Australia,Hospitalization
FAERS-14532,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-06-05,18-44,Male,USA,Disability
FAERS-14533,SEMAGLUTIDE (WEGOVY),ASPIRATION,2022-11-03,18-44,Female,USA,Other
FAERS-14534,SEMAGLUTIDE (WEGOVY),NAUSEA,2020-02-18,45-64,Male,USA,Other
FAERS-14535,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2021-01-28,18-44,Female,USA,Not specified
FAERS-14536,TIRZEPATIDE (MOUNJARO),VOMITING,2023-12-23,65-74,Female,USA,Hospitalization
FAERS-14537,EXENATIDE (BYDUREON),NAUSEA,2023-08-13,18-44,Female,Other,Not specified
FAERS-14538,LIRAGLUTIDE (VICTOZA),ALOPECIA,2020-04-26,18-44,Male,USA,Not specified
FAERS-14539,DULAGLUTIDE (TRULICITY),VOMITING,2021-10-04,75-84,Male,Europe,Hospitalization
FAERS-14540,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2018-08-05,18-44,Female,USA,Other
FAERS-14541,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2020-12-24,18-44,Male,USA,Other
FAERS-14542,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-11-04,45-64,Female,USA,Life-threatening
FAERS-14543,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2021-10-28,18-44,Female,USA,Other
FAERS-14544,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2023-06-06,45-64,Female,USA,Other
FAERS-14545,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2020-04-04,45-64,Female,USA,Hospitalization
FAERS-14546,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-04-06,45-64,Male,USA,Not specified
FAERS-14547,DULAGLUTIDE (TRULICITY),DECREASED APPETITE,2022-02-26,18-44,Female,USA,Other
FAERS-14548,DULAGLUTIDE (TRULICITY),ALOPECIA,2022-03-11,65-74,Female,USA,Hospitalization
FAERS-14549,LIRAGLUTIDE (VICTOZA),FATIGUE,2020-01-06,65-74,Female,USA,Life-threatening
FAERS-14550,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-04-21,45-64,Female,Europe,Not specified
FAERS-14551,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2022-05-25,45-64,Female,USA,Hospitalization
FAERS-14552,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-09-11,18-44,Male,USA,Life-threatening
FAERS-14553,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2022-05-14,75-84,Female,USA,Other
FAERS-14554,SEMAGLUTIDE (WEGOVY),FATIGUE,2023-11-15,65-74,Female,Europe,Other
FAERS-14555,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2021-12-01,65-74,Male,USA,Hospitalization
FAERS-14556,TIRZEPATIDE (MOUNJARO),ASPIRATION,2021-12-05,45-64,Female,USA,Other
FAERS-14557,EXENATIDE (BYETTA),NAUSEA,2018-02-03,65-74,Female,USA,Other
FAERS-14558,TIRZEPATIDE (ZEPBOUND),SUICIDAL IDEATION,2021-01-03,18-44,Female,USA,Not specified
FAERS-14559,EXENATIDE (BYETTA),NAUSEA,2019-11-16,18-44,Male,USA,Other
FAERS-14560,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2019-01-22,65-74,Female,USA,Other
FAERS-14561,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-09-13,75-84,Female,USA,Not specified
FAERS-14562,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-01-15,18-44,Female,Europe,Other
FAERS-14563,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-09-22,45-64,Male,Europe,Other
FAERS-14564,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-06-23,75-84,Male,Europe,Other
FAERS-14565,TIRZEPATIDE (MOUNJARO),ALOPECIA,2022-06-05,45-64,Female,Japan,Other
FAERS-14566,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-08-14,18-44,Female,USA,Other
FAERS-14567,TIRZEPATIDE (ZEPBOUND),ASPIRATION,2018-03-22,45-64,Female,Europe,Disability
FAERS-14568,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2022-03-15,Unknown,Female,USA,Other
FAERS-14569,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2021-10-21,18-44,Male,USA,Other
FAERS-14570,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-09-16,45-64,Female,Europe,Life-threatening
FAERS-14571,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2020-12-11,18-44,Female,Australia,Other
FAERS-14572,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2018-10-08,45-64,Male,Japan,Other
FAERS-14573,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2021-07-10,45-64,Female,Europe,Other
FAERS-14574,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-07-26,45-64,Male,USA,Other
FAERS-14575,TIRZEPATIDE (MOUNJARO),DIARRHEA,2021-08-13,18-44,Male,Europe,Life-threatening
FAERS-14576,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2020-04-28,45-64,Male,Other,Other
FAERS-14577,TIRZEPATIDE (ZEPBOUND),ASPIRATION,2021-04-09,45-64,Male,USA,Other
FAERS-14578,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2020-12-11,65-74,Male,USA,Life-threatening
FAERS-14579,DULAGLUTIDE (TRULICITY),CONSTIPATION,2020-04-07,18-44,Female,USA,Other
FAERS-14580,SEMAGLUTIDE (OZEMPIC),NAUSEA,2019-11-10,45-64,Female,Europe,Disability
FAERS-14581,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2021-10-09,75-84,Male,USA,Other
FAERS-14582,SEMAGLUTIDE (OZEMPIC),HEADACHE,2019-09-18,45-64,Male,Europe,Other
FAERS-14583,SEMAGLUTIDE (WEGOVY),CONSTIPATION,2019-06-03,45-64,Male,USA,Life-threatening
FAERS-14584,SEMAGLUTIDE (WEGOVY),VOMITING,2022-03-09,Unknown,Female,Europe,Other
FAERS-14585,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2020-08-24,45-64,Female,Other,Disability
FAERS-14586,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2021-11-19,65-74,Female,Canada,Not specified
FAERS-14587,LIRAGLUTIDE (SAXENDA),ABDOMINAL PAIN,2021-11-03,0-17,Female,Europe,Other
FAERS-14588,LIRAGLUTIDE (VICTOZA),SUICIDAL IDEATION,2023-01-11,45-64,Female,Japan,Not specified
FAERS-14589,EXENATIDE (BYETTA),DIARRHEA,2023-02-05,45-64,Male,USA,Other
FAERS-14590,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-07-06,65-74,Male,USA,Other
FAERS-14591,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-01-14,Unknown,Female,Japan,Other
FAERS-14592,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-11-14,45-64,Female,USA,Other
FAERS-14593,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2023-02-17,45-64,Male,Europe,Not specified
FAERS-14594,SEMAGLUTIDE (WEGOVY),DIZZINESS,2021-05-15,45-64,Male,USA,Hospitalization
FAERS-14595,TIRZEPATIDE (MOUNJARO),HEADACHE,2020-04-03,18-44,Female,USA,Other
FAERS-14596,TIRZEPATIDE (MOUNJARO),NAUSEA,2022-09-26,18-44,Male,Japan,Other
FAERS-14597,DULAGLUTIDE (TRULICITY),ALOPECIA,2020-03-02,85+,Female,USA,Other
FAERS-14598,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2018-08-20,45-64,Female,USA,Other
FAERS-14599,DULAGLUTIDE (TRULICITY),DIZZINESS,2023-03-02,65-74,Female,USA,Not specified
FAERS-14600,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2021-01-21,45-64,Male,USA,Other
FAERS-14601,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2021-12-12,18-44,Female,USA,Other
FAERS-14602,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-10-09,45-64,Female,Europe,Other
FAERS-14603,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-12-25,45-64,Female,Canada,Other
FAERS-14604,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-11-27,18-44,Male,USA,Other
FAERS-14605,TIRZEPATIDE (MOUNJARO),HEADACHE,2022-12-21,65-74,Female,USA,Hospitalization
FAERS-14606,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2019-01-25,18-44,Male,Europe,Other
FAERS-14607,LIRAGLUTIDE (VICTOZA),HEADACHE,2023-03-17,Unknown,Male,Europe,Other
FAERS-14608,EXENATIDE (BYETTA),DIZZINESS,2018-10-14,45-64,Female,USA,Disability
FAERS-14609,LIRAGLUTIDE (SAXENDA),DECREASED APPETITE,2021-02-26,65-74,Female,Japan,Life-threatening
FAERS-14610,SEMAGLUTIDE (OZEMPIC),NAUSEA,2020-05-27,45-64,Male,USA,Other
FAERS-14611,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2021-10-10,45-64,Female,USA,Hospitalization
FAERS-14612,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2021-06-06,65-74,Female,USA,Not specified
FAERS-14613,SEMAGLUTIDE (WEGOVY),DIZZINESS,2022-01-27,45-64,Female,Europe,Other
FAERS-14614,SEMAGLUTIDE (WEGOVY),ASPIRATION,2021-04-16,75-84,Female,Europe,Not specified
FAERS-14615,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2023-03-11,65-74,Female,USA,Hospitalization
FAERS-14616,TIRZEPATIDE (MOUNJARO),DIARRHEA,2021-08-26,45-64,Female,USA,Other
FAERS-14617,EXENATIDE (BYDUREON),NAUSEA,2023-08-19,45-64,Female,Europe,Other
FAERS-14618,LIRAGLUTIDE (VICTOZA),DIZZINESS,2021-03-07,45-64,Female,Other,Other
FAERS-14619,DULAGLUTIDE (TRULICITY),FATIGUE,2022-03-02,45-64,Female,Australia,Not specified
FAERS-14620,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-02-11,45-64,Male,USA,Other
FAERS-14621,SEMAGLUTIDE (OZEMPIC),VOMITING,2021-06-08,18-44,Male,USA,Not specified
FAERS-14622,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-08-13,18-44,Unknown,Europe,Other
FAERS-14623,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-12-06,45-64,Female,USA,Hospitalization
FAERS-14624,SEMAGLUTIDE (WEGOVY),VOMITING,2020-07-03,45-64,Male,Europe,Hospitalization
FAERS-14625,TIRZEPATIDE (MOUNJARO),DIZZINESS,2020-07-12,45-64,Male,USA,Not specified
FAERS-14626,TIRZEPATIDE (MOUNJARO),ASPIRATION,2021-12-20,18-44,Male,USA,Hospitalization
FAERS-14627,TIRZEPATIDE (ZEPBOUND),ALOPECIA,2023-12-26,65-74,Male,USA,Other
FAERS-14628,TIRZEPATIDE (ZEPBOUND),FATIGUE,2021-07-21,45-64,Male,USA,Not specified
FAERS-14629,DULAGLUTIDE (TRULICITY),NAUSEA,2020-04-16,18-44,Male,USA,Not specified
FAERS-14630,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-07-16,65-74,Female,USA,Other
FAERS-14631,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-07-11,45-64,Female,Europe,Other
FAERS-14632,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-04-09,45-64,Male,USA,Not specified
FAERS-14633,SEMAGLUTIDE (WEGOVY),FATIGUE,2020-12-24,45-64,Female,Europe,Hospitalization
FAERS-14634,SEMAGLUTIDE (WEGOVY),ASPIRATION,2021-04-27,18-44,Female,USA,Hospitalization
FAERS-14635,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-02-07,65-74,Male,USA,Other
FAERS-14636,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2021-01-15,18-44,Unknown,USA,Hospitalization
FAERS-14637,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2021-05-23,45-64,Female,USA,Hospitalization
FAERS-14638,EXENATIDE (BYDUREON),THYROID NEOPLASM,2022-03-04,65-74,Male,Europe,Not specified
FAERS-14639,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2022-08-23,45-64,Male,Other,Not specified
FAERS-14640,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2019-10-11,45-64,Male,USA,Not specified
FAERS-14641,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-06-17,45-64,Female,USA,Other
FAERS-14642,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-09-25,65-74,Male,USA,Other
FAERS-14643,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-05-27,45-64,Female,Europe,Other
FAERS-14644,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2019-12-23,45-64,Female,USA,Other
FAERS-14645,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2021-05-25,65-74,Female,USA,Other
FAERS-14646,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-05-28,45-64,Male,USA,Life-threatening
FAERS-14647,EXENATIDE (BYDUREON),FATIGUE,2023-02-17,45-64,Female,USA,Other
FAERS-14648,DULAGLUTIDE (TRULICITY),DIZZINESS,2021-08-02,45-64,Male,Canada,Other
FAERS-14649,EXENATIDE (BYETTA),DECREASED APPETITE,2023-01-24,18-44,Female,Europe,Hospitalization
FAERS-14650,SEMAGLUTIDE (OZEMPIC),FATIGUE,2019-08-23,18-44,Female,USA,Hospitalization
FAERS-14651,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2022-02-14,18-44,Female,USA,Hospitalization
FAERS-14652,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2023-12-03,18-44,Female,USA,Other
FAERS-14653,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2021-03-23,45-64,Female,USA,Other
FAERS-14654,SEMAGLUTIDE (WEGOVY),ASPIRATION,2023-08-22,65-74,Female,Europe,Not specified
FAERS-14655,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-07-17,18-44,Female,USA,Not specified
FAERS-14656,TIRZEPATIDE (MOUNJARO),VOMITING,2021-07-22,45-64,Female,Europe,Other
FAERS-14657,DULAGLUTIDE (TRULICITY),HYPOGLYCEMIA,2022-07-24,Unknown,Female,Other,Disability
FAERS-14658,LIRAGLUTIDE (SAXENDA),GALLBLADDER DISEASE,2019-07-04,18-44,Female,USA,Not specified
FAERS-14659,TIRZEPATIDE (ZEPBOUND),CONSTIPATION,2020-06-03,45-64,Female,USA,Other
FAERS-14660,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-11-23,45-64,Male,USA,Other
FAERS-14661,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-07-19,65-74,Female,USA,Other
FAERS-14662,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2022-07-24,45-64,Female,USA,Disability
FAERS-14663,SEMAGLUTIDE (WEGOVY),HEADACHE,2022-05-23,75-84,Male,USA,Disability
FAERS-14664,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-12-03,65-74,Male,Europe,Other
FAERS-14665,TIRZEPATIDE (MOUNJARO),DIARRHEA,2021-12-25,0-17,Male,USA,Hospitalization
FAERS-14666,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-09-28,18-44,Male,USA,Other
FAERS-14667,DULAGLUTIDE (TRULICITY),THYROID NEOPLASM,2021-07-01,45-64,Female,USA,Other
FAERS-14668,LIRAGLUTIDE (VICTOZA),DIARRHEA,2020-12-12,18-44,Male,USA,Other
FAERS-14669,LIRAGLUTIDE (SAXENDA),GALLBLADDER DISEASE,2021-02-01,65-74,Male,USA,Other
FAERS-14670,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-08-07,65-74,Female,USA,Hospitalization
FAERS-14671,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-12-13,45-64,Female,Europe,Disability
FAERS-14672,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-02-04,18-44,Female,Europe,Other
FAERS-14673,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2022-11-27,18-44,Female,Europe,Other
FAERS-14674,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-03-22,45-64,Female,USA,Hospitalization
FAERS-14675,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-02-21,75-84,Female,Canada,Not specified
FAERS-14676,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-04-21,18-44,Female,USA,Other
FAERS-14677,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2022-09-03,45-64,Female,USA,Other
FAERS-14678,LIRAGLUTIDE (VICTOZA),HYPOGLYCEMIA,2018-04-22,65-74,Female,USA,Other
FAERS-14679,TIRZEPATIDE (ZEPBOUND),INJECTION SITE REACTION,2018-04-16,45-64,Female,Other,Other
FAERS-14680,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2020-12-09,45-64,Female,USA,Other
FAERS-14681,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-02-19,45-64,Female,USA,Other
FAERS-14682,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-09-15,65-74,Female,USA,Other
FAERS-14683,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2021-05-28,18-44,Female,Europe,Not specified
FAERS-14684,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2023-10-17,45-64,Male,USA,Disability
FAERS-14685,TIRZEPATIDE (MOUNJARO),FATIGUE,2021-05-19,18-44,Male,Europe,Other
FAERS-14686,TIRZEPATIDE (MOUNJARO),FATIGUE,2019-06-15,45-64,Male,USA,Other
FAERS-14687,LIRAGLUTIDE (SAXENDA),DIARRHEA,2023-07-04,65-74,Male,USA,Not specified
FAERS-14688,EXENATIDE (BYDUREON),PANCREATITIS,2018-03-19,45-64,Female,Europe,Other
FAERS-14689,LIRAGLUTIDE (SAXENDA),HEADACHE,2021-06-15,45-64,Female,Europe,Other
FAERS-14690,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2020-09-18,45-64,Female,Europe,Not specified
FAERS-14691,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-12-19,45-64,Female,Other,Not specified
FAERS-14692,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2022-03-07,45-64,Female,Europe,Other
FAERS-14693,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2023-04-13,65-74,Female,Other,Not specified
FAERS-14694,SEMAGLUTIDE (WEGOVY),ASPIRATION,2022-07-13,45-64,Male,USA,Hospitalization
FAERS-14695,TIRZEPATIDE (MOUNJARO),ALOPECIA,2022-01-15,45-64,Female,Europe,Hospitalization
FAERS-14696,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2022-04-18,18-44,Female,USA,Not specified
FAERS-14697,TIRZEPATIDE (ZEPBOUND),THYROID NEOPLASM,2021-08-14,18-44,Female,USA,Not specified
FAERS-14698,DULAGLUTIDE (TRULICITY),DIARRHEA,2023-09-08,18-44,Female,USA,Not specified
FAERS-14699,DULAGLUTIDE (TRULICITY),GALLBLADDER DISEASE,2022-01-12,45-64,Female,USA,Other
FAERS-14700,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2020-07-16,45-64,Male,Canada,Other
FAERS-14701,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2019-05-24,45-64,Female,USA,Other
FAERS-14702,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-11-18,65-74,Male,Other,Other
FAERS-14703,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-07-18,65-74,Male,USA,Hospitalization
FAERS-14704,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-03-14,45-64,Unknown,USA,Not specified
FAERS-14705,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2023-11-02,45-64,Unknown,Europe,Other
FAERS-14706,TIRZEPATIDE (MOUNJARO),FATIGUE,2021-06-20,45-64,Female,Europe,Other
FAERS-14707,EXENATIDE (BYDUREON),NAUSEA,2023-01-15,18-44,Female,Europe,Disability
FAERS-14708,EXENATIDE (BYETTA),ASPIRATION,2020-05-24,18-44,Female,Europe,Other
FAERS-14709,LIRAGLUTIDE (VICTOZA),SUICIDAL IDEATION,2023-09-20,65-74,Male,USA,Other
FAERS-14710,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-09-08,45-64,Male,USA,Hospitalization
FAERS-14711,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-05-21,18-44,Male,Australia,Other
FAERS-14712,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-01-07,45-64,Male,Other,Other
FAERS-14713,SEMAGLUTIDE (WEGOVY),DIZZINESS,2022-05-03,65-74,Male,USA,Not specified
FAERS-14714,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2018-11-08,45-64,Female,Europe,Other
FAERS-14715,TIRZEPATIDE (MOUNJARO),DIARRHEA,2023-07-28,45-64,Female,Europe,Other
FAERS-14716,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-06-27,45-64,Male,Europe,Hospitalization
FAERS-14717,LIRAGLUTIDE (VICTOZA),ALOPECIA,2022-08-18,65-74,Male,USA,Disability
FAERS-14718,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2019-04-14,45-64,Female,USA,Disability
FAERS-14719,EXENATIDE (BYDUREON),INJECTION SITE REACTION,2023-12-01,45-64,Female,Canada,Death
FAERS-14720,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2019-05-18,18-44,Male,USA,Hospitalization
FAERS-14721,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-09-14,18-44,Female,USA,Hospitalization
FAERS-14722,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2022-12-26,45-64,Female,USA,Not specified
FAERS-14723,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2020-03-17,45-64,Male,USA,Not specified
FAERS-14724,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2022-03-08,45-64,Female,USA,Other
FAERS-14725,TIRZEPATIDE (MOUNJARO),NAUSEA,2022-10-28,45-64,Female,USA,Other
FAERS-14726,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-08-03,45-64,Female,USA,Death
FAERS-14727,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2021-12-24,65-74,Female,USA,Other
FAERS-14728,LIRAGLUTIDE (VICTOZA),HYPOGLYCEMIA,2023-05-22,65-74,Female,Europe,Not specified
FAERS-14729,EXENATIDE (BYETTA),HEADACHE,2022-10-19,Unknown,Male,Europe,Not specified
FAERS-14730,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2023-02-11,65-74,Female,USA,Other
FAERS-14731,SEMAGLUTIDE (OZEMPIC),FATIGUE,2019-08-14,18-44,Male,Canada,Other
FAERS-14732,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-09-01,Unknown,Female,USA,Not specified
FAERS-14733,SEMAGLUTIDE (WEGOVY),HEADACHE,2022-05-14,45-64,Male,USA,Other
FAERS-14734,SEMAGLUTIDE (WEGOVY),VOMITING,2019-11-10,65-74,Male,Other,Other
FAERS-14735,TIRZEPATIDE (MOUNJARO),ASPIRATION,2023-10-05,45-64,Female,Canada,Other
FAERS-14736,TIRZEPATIDE (MOUNJARO),DIZZINESS,2022-06-03,65-74,Male,Europe,Other
FAERS-14737,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2021-09-18,65-74,Female,USA,Hospitalization
FAERS-14738,EXENATIDE (BYDUREON),CONSTIPATION,2023-03-15,18-44,Male,Europe,Hospitalization
FAERS-14739,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2023-09-21,65-74,Female,USA,Other
FAERS-14740,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-04-21,75-84,Male,USA,Other
FAERS-14741,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2022-08-25,45-64,Female,USA,Not specified
FAERS-14742,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-10-05,45-64,Female,Canada,Life-threatening
FAERS-14743,SEMAGLUTIDE (WEGOVY),HEADACHE,2020-12-08,45-64,Female,Europe,Hospitalization
FAERS-14744,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2021-06-08,0-17,Female,Other,Other
FAERS-14745,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2021-05-03,65-74,Female,USA,Not specified
FAERS-14746,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-02-09,45-64,Female,Canada,Other
FAERS-14747,TIRZEPATIDE (ZEPBOUND),ASPIRATION,2023-09-05,45-64,Male,USA,Other
FAERS-14748,LIRAGLUTIDE (VICTOZA),PANCREATITIS,2021-09-13,45-64,Female,USA,Other
FAERS-14749,TIRZEPATIDE (ZEPBOUND),HYPOGLYCEMIA,2020-04-05,65-74,Female,USA,Other
FAERS-14750,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2021-09-11,18-44,Female,Canada,Other
FAERS-14751,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2022-09-06,18-44,Female,USA,Disability
FAERS-14752,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-11-21,65-74,Female,USA,Other
FAERS-14753,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2021-04-01,65-74,Male,USA,Not specified
FAERS-14754,SEMAGLUTIDE (WEGOVY),ABDOMINAL PAIN,2023-03-17,18-44,Female,Europe,Other
FAERS-14755,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2018-05-26,18-44,Female,USA,Not specified
FAERS-14756,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-05-28,45-64,Female,USA,Other
FAERS-14757,LIRAGLUTIDE (VICTOZA),SUICIDAL IDEATION,2023-12-04,45-64,Male,USA,Other
FAERS-14758,LIRAGLUTIDE (VICTOZA),ALOPECIA,2022-06-27,45-64,Unknown,Other,Other
FAERS-14759,TIRZEPATIDE (ZEPBOUND),ABDOMINAL PAIN,2023-07-05,0-17,Female,USA,Life-threatening
FAERS-14760,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-09-14,18-44,Female,USA,Hospitalization
FAERS-14761,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2022-01-06,Unknown,Female,USA,Not specified
FAERS-14762,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2021-10-22,45-64,Female,USA,Other
FAERS-14763,SEMAGLUTIDE (WEGOVY),FATIGUE,2021-03-10,45-64,Male,Europe,Other
FAERS-14764,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2021-08-28,45-64,Female,USA,Not specified
FAERS-14765,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2023-11-09,18-44,Male,USA,Life-threatening
FAERS-14766,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2021-01-15,45-64,Male,USA,Hospitalization
FAERS-14767,TIRZEPATIDE (ZEPBOUND),DIZZINESS,2022-01-06,18-44,Female,USA,Other
FAERS-14768,EXENATIDE (BYDUREON),NAUSEA,2021-08-04,45-64,Female,USA,Other
FAERS-14769,LIRAGLUTIDE (SAXENDA),CONSTIPATION,2023-05-15,18-44,Male,USA,Other
FAERS-14770,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-09-23,18-44,Female,USA,Life-threatening
FAERS-14771,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2020-11-18,45-64,Male,Europe,Hospitalization
FAERS-14772,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2022-03-04,18-44,Female,Canada,Not specified
FAERS-14773,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2021-07-06,45-64,Male,Europe,Other
FAERS-14774,SEMAGLUTIDE (WEGOVY),NAUSEA,2023-03-09,45-64,Male,Europe,Other
FAERS-14775,TIRZEPATIDE (MOUNJARO),DIZZINESS,2020-12-25,18-44,Female,USA,Life-threatening
FAERS-14776,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-04-18,65-74,Female,USA,Disability
FAERS-14777,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2022-04-16,65-74,Female,Other,Other
FAERS-14778,LIRAGLUTIDE (SAXENDA),ABDOMINAL PAIN,2023-06-24,45-64,Female,USA,Other
FAERS-14779,LIRAGLUTIDE (VICTOZA),CONSTIPATION,2019-09-14,18-44,Female,USA,Other
FAERS-14780,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2018-01-25,45-64,Male,USA,Not specified
FAERS-14781,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2022-06-04,45-64,Female,USA,Other
FAERS-14782,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2019-05-10,45-64,Male,USA,Other
FAERS-14783,SEMAGLUTIDE (WEGOVY),HEADACHE,2019-05-28,18-44,Male,USA,Other
FAERS-14784,SEMAGLUTIDE (WEGOVY),NAUSEA,2023-12-09,65-74,Female,USA,Not specified
FAERS-14785,TIRZEPATIDE (MOUNJARO),HEADACHE,2022-05-20,45-64,Female,Europe,Other
FAERS-14786,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2023-05-28,0-17,Male,USA,Not specified
FAERS-14787,DULAGLUTIDE (TRULICITY),ABDOMINAL PAIN,2020-09-20,18-44,Female,USA,Disability
FAERS-14788,EXENATIDE (BYDUREON),DIARRHEA,2023-11-10,65-74,Male,USA,Hospitalization
FAERS-14789,LIRAGLUTIDE (VICTOZA),HEADACHE,2021-12-11,65-74,Male,USA,Other
FAERS-14790,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-09-02,18-44,Female,USA,Disability
FAERS-14791,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-03-09,45-64,Female,USA,Not specified
FAERS-14792,SEMAGLUTIDE (OZEMPIC),HEADACHE,2021-10-27,18-44,Male,USA,Not specified
FAERS-14793,SEMAGLUTIDE (WEGOVY),FATIGUE,2022-06-08,65-74,Male,USA,Other
FAERS-14794,SEMAGLUTIDE (WEGOVY),DIARRHEA,2022-06-07,45-64,Female,USA,Death
FAERS-14795,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-02-03,65-74,Female,USA,Other
FAERS-14796,TIRZEPATIDE (MOUNJARO),ALOPECIA,2021-12-16,45-64,Female,USA,Disability
FAERS-14797,EXENATIDE (BYDUREON),HYPOGLYCEMIA,2022-10-14,45-64,Male,USA,Other
FAERS-14798,TIRZEPATIDE (ZEPBOUND),DIZZINESS,2021-08-15,45-64,Female,Other,Disability
FAERS-14799,DULAGLUTIDE (TRULICITY),VOMITING,2021-06-16,75-84,Female,Europe,Disability
FAERS-14800,SEMAGLUTIDE (OZEMPIC),ASPIRATION,2023-09-28,45-64,Female,USA,Other
FAERS-14801,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2021-10-21,18-44,Female,Other,Other
FAERS-14802,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2019-11-17,45-64,Female,USA,Other
FAERS-14803,SEMAGLUTIDE (WEGOVY),FATIGUE,2021-10-19,45-64,Female,Europe,Hospitalization
FAERS-14804,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-02-02,45-64,Male,USA,Other
FAERS-14805,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2021-02-05,45-64,Female,Europe,Other
FAERS-14806,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-10-27,45-64,Female,USA,Hospitalization
FAERS-14807,DULAGLUTIDE (TRULICITY),INJECTION SITE REACTION,2023-03-09,45-64,Female,USA,Other
FAERS-14808,EXENATIDE (BYDUREON),HEADACHE,2021-12-23,45-64,Female,USA,Other
FAERS-14809,EXENATIDE (BYETTA),ALOPECIA,2019-05-07,65-74,Male,Europe,Other
FAERS-14810,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-01-16,18-44,Male,USA,Not specified
FAERS-14811,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2023-02-09,45-64,Male,USA,Other
FAERS-14812,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-07-02,18-44,Female,USA,Hospitalization
FAERS-14813,SEMAGLUTIDE (WEGOVY),ALOPECIA,2023-01-15,Unknown,Male,USA,Other
FAERS-14814,SEMAGLUTIDE (WEGOVY),DIZZINESS,2020-09-17,18-44,Female,Europe,Other
FAERS-14815,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-05-19,65-74,Male,Japan,Other
FAERS-14816,TIRZEPATIDE (MOUNJARO),HEADACHE,2019-11-20,65-74,Male,Canada,Other
FAERS-14817,LIRAGLUTIDE (VICTOZA),ALOPECIA,2021-12-12,45-64,Female,USA,Other
FAERS-14818,DULAGLUTIDE (TRULICITY),SUICIDAL IDEATION,2020-11-16,45-64,Female,Other,Not specified
FAERS-14819,TIRZEPATIDE (ZEPBOUND),SUICIDAL IDEATION,2020-11-23,45-64,Unknown,Europe,Other
FAERS-14820,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2021-12-13,45-64,Female,USA,Hospitalization
FAERS-14821,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2021-03-12,45-64,Female,Europe,Other
FAERS-14822,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2021-07-28,18-44,Male,Japan,Other
FAERS-14823,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-08-19,45-64,Unknown,USA,Not specified
FAERS-14824,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2023-01-14,45-64,Female,USA,Not specified
FAERS-14825,TIRZEPATIDE (MOUNJARO),INJECTION SITE REACTION,2023-01-23,18-44,Female,USA,Other
FAERS-14826,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-03-28,45-64,Female,Europe,Life-threatening
FAERS-14827,DULAGLUTIDE (TRULICITY),NAUSEA,2021-04-19,65-74,Male,Other,Hospitalization
FAERS-14828,EXENATIDE (BYETTA),PANCREATITIS,2021-05-13,45-64,Female,USA,Not specified
FAERS-14829,EXENATIDE (BYETTA),DIARRHEA,2018-12-04,45-64,Female,USA,Other
FAERS-14830,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-04-09,45-64,Female,USA,Hospitalization
FAERS-14831,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2020-11-02,Unknown,Male,Canada,Not specified
FAERS-14832,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-01-11,45-64,Female,Other,Disability
FAERS-14833,SEMAGLUTIDE (WEGOVY),DIZZINESS,2022-07-19,45-64,Female,Europe,Other
FAERS-14834,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2021-02-15,45-64,Female,USA,Other
FAERS-14835,TIRZEPATIDE (MOUNJARO),NAUSEA,2022-06-15,45-64,Male,Other,Disability
FAERS-14836,TIRZEPATIDE (MOUNJARO),VOMITING,2023-11-18,45-64,Female,Canada,Other
FAERS-14837,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2018-01-24,45-64,Female,USA,Other
FAERS-14838,LIRAGLUTIDE (SAXENDA),THYROID NEOPLASM,2023-01-18,0-17,Female,USA,Other
FAERS-14839,DULAGLUTIDE (TRULICITY),ASPIRATION,2021-11-19,45-64,Male,Europe,Other
FAERS-14840,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-06-18,45-64,Female,Europe,Other
FAERS-14841,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2021-03-11,45-64,Male,USA,Other
FAERS-14842,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-08-23,18-44,Female,Other,Not specified
FAERS-14843,SEMAGLUTIDE (WEGOVY),VOMITING,2022-04-03,45-64,Female,USA,Not specified
FAERS-14844,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-06-17,65-74,Male,Canada,Other
FAERS-14845,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2019-05-14,45-64,Female,Europe,Other
FAERS-14846,TIRZEPATIDE (MOUNJARO),GALLBLADDER DISEASE,2022-07-25,45-64,Male,USA,Other
FAERS-14847,LIRAGLUTIDE (VICTOZA),ALOPECIA,2023-08-02,18-44,Female,USA,Other
FAERS-14848,EXENATIDE (BYETTA),VOMITING,2019-10-24,Unknown,Male,USA,Other
FAERS-14849,EXENATIDE (BYETTA),HEADACHE,2023-11-09,45-64,Female,USA,Other
FAERS-14850,SEMAGLUTIDE (OZEMPIC),ALOPECIA,2023-12-27,75-84,Female,Europe,Other
FAERS-14851,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-10-08,18-44,Female,USA,Hospitalization
FAERS-14852,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-01-11,65-74,Male,USA,Not specified
FAERS-14853,SEMAGLUTIDE (WEGOVY),ASPIRATION,2020-05-23,45-64,Female,USA,Not specified
FAERS-14854,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2023-01-11,18-44,Female,USA,Other
FAERS-14855,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2023-07-26,18-44,Female,USA,Not specified
FAERS-14856,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-02-14,45-64,Female,Europe,Other
FAERS-14857,EXENATIDE (BYETTA),PANCREATITIS,2020-05-14,18-44,Male,USA,Not specified
FAERS-14858,DULAGLUTIDE (TRULICITY),ALOPECIA,2023-06-19,18-44,Male,Europe,Other
FAERS-14859,LIRAGLUTIDE (VICTOZA),GALLBLADDER DISEASE,2022-09-26,18-44,Female,Europe,Not specified
FAERS-14860,SEMAGLUTIDE (OZEMPIC),HEADACHE,2020-01-28,45-64,Male,USA,Other
FAERS-14861,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-07-22,18-44,Female,USA,Other
FAERS-14862,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2022-09-21,65-74,Female,USA,Hospitalization
FAERS-14863,SEMAGLUTIDE (WEGOVY),NAUSEA,2021-09-19,Unknown,Female,Europe,Other
FAERS-14864,SEMAGLUTIDE (WEGOVY),GALLBLADDER DISEASE,2022-03-24,45-64,Female,USA,Other
FAERS-14865,TIRZEPATIDE (MOUNJARO),HEADACHE,2019-04-01,45-64,Female,USA,Other
FAERS-14866,TIRZEPATIDE (MOUNJARO),DIARRHEA,2023-07-09,45-64,Female,Other,Hospitalization
FAERS-14867,LIRAGLUTIDE (VICTOZA),HYPOGLYCEMIA,2023-06-16,65-74,Female,USA,Other
FAERS-14868,EXENATIDE (BYETTA),GALLBLADDER DISEASE,2022-10-08,45-64,Male,USA,Other
FAERS-14869,TIRZEPATIDE (ZEPBOUND),FATIGUE,2023-11-21,45-64,Female,Japan,Other
FAERS-14870,SEMAGLUTIDE (OZEMPIC),HEADACHE,2020-07-20,45-64,Female,USA,Other
FAERS-14871,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-03-15,18-44,Female,Japan,Other
FAERS-14872,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2020-06-08,18-44,Female,USA,Not specified
FAERS-14873,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-06-21,18-44,Female,Europe,Not specified
FAERS-14874,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2023-03-17,65-74,Female,USA,Hospitalization
FAERS-14875,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2019-05-12,45-64,Female,USA,Not specified
FAERS-14876,TIRZEPATIDE (MOUNJARO),NAUSEA,2021-04-25,65-74,Female,USA,Other
FAERS-14877,LIRAGLUTIDE (VICTOZA),ABDOMINAL PAIN,2020-02-01,Unknown,Female,USA,Other
FAERS-14878,LIRAGLUTIDE (VICTOZA),THYROID NEOPLASM,2023-12-14,65-74,Male,USA,Not specified
FAERS-14879,EXENATIDE (BYETTA),DIZZINESS,2023-08-16,65-74,Female,USA,Other
FAERS-14880,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2023-05-01,18-44,Female,USA,Other
FAERS-14881,SEMAGLUTIDE (OZEMPIC),FATIGUE,2021-02-21,18-44,Female,USA,Other
FAERS-14882,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2020-12-10,45-64,Female,USA,Hospitalization
FAERS-14883,SEMAGLUTIDE (WEGOVY),PANCREATITIS,2021-06-25,45-64,Female,USA,Other
FAERS-14884,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-01-06,18-44,Female,USA,Not specified
FAERS-14885,TIRZEPATIDE (MOUNJARO),DECREASED APPETITE,2019-05-17,45-64,Female,USA,Other
FAERS-14886,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2022-07-23,18-44,Female,USA,Other
FAERS-14887,DULAGLUTIDE (TRULICITY),HEADACHE,2018-12-26,45-64,Male,Europe,Other
FAERS-14888,DULAGLUTIDE (TRULICITY),PANCREATITIS,2022-06-22,45-64,Female,USA,Other
FAERS-14889,EXENATIDE (BYETTA),PANCREATITIS,2023-12-27,65-74,Male,USA,Other
FAERS-14890,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2019-06-10,45-64,Male,USA,Other
FAERS-14891,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2023-07-24,65-74,Female,USA,Not specified
FAERS-14892,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-09-26,45-64,Female,USA,Other
FAERS-14893,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2022-10-23,65-74,Male,USA,Other
FAERS-14894,SEMAGLUTIDE (WEGOVY),DIZZINESS,2019-12-18,Unknown,Female,Europe,Other
FAERS-14895,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2019-10-09,18-44,Female,Other,Other
FAERS-14896,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-10-13,45-64,Male,Europe,Not specified
FAERS-14897,LIRAGLUTIDE (SAXENDA),ABDOMINAL PAIN,2022-10-03,75-84,Female,Canada,Other
FAERS-14898,EXENATIDE (BYETTA),DIZZINESS,2018-12-21,18-44,Female,USA,Hospitalization
FAERS-14899,TIRZEPATIDE (ZEPBOUND),VOMITING,2021-01-13,18-44,Female,USA,Death
FAERS-14900,SEMAGLUTIDE (OZEMPIC),VOMITING,2023-01-19,45-64,Female,USA,Other
FAERS-14901,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2018-09-01,45-64,Female,Other,Hospitalization
FAERS-14902,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2020-03-22,75-84,Female,USA,Life-threatening
FAERS-14903,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-07-14,65-74,Male,Other,Other
FAERS-14904,SEMAGLUTIDE (WEGOVY),DECREASED APPETITE,2018-06-04,45-64,Female,USA,Other
FAERS-14905,TIRZEPATIDE (MOUNJARO),HEADACHE,2020-05-07,18-44,Male,USA,Other
FAERS-14906,TIRZEPATIDE (MOUNJARO),CONSTIPATION,2021-08-16,18-44,Female,USA,Other
FAERS-14907,LIRAGLUTIDE (SAXENDA),ASPIRATION,2023-09-28,65-74,Male,Europe,Other
FAERS-14908,TIRZEPATIDE (ZEPBOUND),CONSTIPATION,2021-02-09,18-44,Male,USA,Hospitalization
FAERS-14909,DULAGLUTIDE (TRULICITY),VOMITING,2018-07-03,65-74,Female,Canada,Not specified
FAERS-14910,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2021-12-14,45-64,Female,USA,Other
FAERS-14911,SEMAGLUTIDE (OZEMPIC),FATIGUE,2023-12-03,45-64,Female,Europe,Other
FAERS-14912,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-11-26,18-44,Female,USA,Other
FAERS-14913,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2021-10-12,18-44,Male,Europe,Other
FAERS-14914,SEMAGLUTIDE (WEGOVY),ASPIRATION,2021-04-11,45-64,Female,Europe,Other
FAERS-14915,TIRZEPATIDE (MOUNJARO),FATIGUE,2022-09-23,45-64,Male,USA,Disability
FAERS-14916,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-12-22,65-74,Female,USA,Not specified
FAERS-14917,TIRZEPATIDE (ZEPBOUND),CONSTIPATION,2023-04-22,45-64,Male,Europe,Other
FAERS-14918,LIRAGLUTIDE (VICTOZA),VOMITING,2021-07-23,45-64,Male,Other,Other
FAERS-14919,LIRAGLUTIDE (VICTOZA),HEADACHE,2022-06-13,65-74,Female,USA,Not specified
FAERS-14920,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-12-04,Unknown,Male,USA,Other
FAERS-14921,SEMAGLUTIDE (OZEMPIC),NAUSEA,2022-12-26,45-64,Female,USA,Other
FAERS-14922,SEMAGLUTIDE (OZEMPIC),DECREASED APPETITE,2019-12-21,65-74,Female,USA,Other
FAERS-14923,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-11-22,65-74,Female,Europe,Other
FAERS-14924,SEMAGLUTIDE (WEGOVY),DIZZINESS,2023-10-11,45-64,Male,Japan,Other
FAERS-14925,TIRZEPATIDE (MOUNJARO),HEADACHE,2021-09-19,45-64,Female,USA,Other
FAERS-14926,TIRZEPATIDE (MOUNJARO),ALOPECIA,2023-07-20,45-64,Unknown,Europe,Other
FAERS-14927,TIRZEPATIDE (ZEPBOUND),PANCREATITIS,2022-01-22,45-64,Male,Europe,Hospitalization
FAERS-14928,LIRAGLUTIDE (VICTOZA),CONSTIPATION,2021-10-07,45-64,Male,Other,Other
FAERS-14929,LIRAGLUTIDE (SAXENDA),HYPOGLYCEMIA,2023-05-03,18-44,Male,Europe,Other
FAERS-14930,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-03-23,45-64,Female,Other,Other
FAERS-14931,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2019-07-22,65-74,Female,USA,Not specified
FAERS-14932,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2021-03-23,45-64,Male,USA,Other
FAERS-14933,SEMAGLUTIDE (WEGOVY),HEADACHE,2020-11-05,45-64,Female,Canada,Other
FAERS-14934,SEMAGLUTIDE (WEGOVY),HEADACHE,2023-06-05,65-74,Male,Japan,Other
FAERS-14935,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2020-10-21,45-64,Male,Europe,Other
FAERS-14936,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-05-14,18-44,Female,USA,Other
FAERS-14937,LIRAGLUTIDE (SAXENDA),PANCREATITIS,2019-01-04,45-64,Male,USA,Not specified
FAERS-14938,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2022-07-24,18-44,Female,Australia,Other
FAERS-14939,LIRAGLUTIDE (SAXENDA),INJECTION SITE REACTION,2018-09-01,65-74,Male,USA,Hospitalization
FAERS-14940,SEMAGLUTIDE (OZEMPIC),HEADACHE,2022-08-26,45-64,Female,Europe,Not specified
FAERS-14941,SEMAGLUTIDE (OZEMPIC),ABDOMINAL PAIN,2023-12-18,45-64,Female,USA,Not specified
FAERS-14942,SEMAGLUTIDE (OZEMPIC),GALLBLADDER DISEASE,2023-04-08,65-74,Female,USA,Disability
FAERS-14943,SEMAGLUTIDE (WEGOVY),ALOPECIA,2020-08-19,45-64,Female,USA,Not specified
FAERS-14944,SEMAGLUTIDE (WEGOVY),DIARRHEA,2023-09-04,65-74,Female,USA,Other
FAERS-14945,TIRZEPATIDE (MOUNJARO),VOMITING,2022-11-16,0-17,Male,USA,Other
FAERS-14946,TIRZEPATIDE (MOUNJARO),THYROID NEOPLASM,2021-06-21,18-44,Female,USA,Hospitalization
FAERS-14947,DULAGLUTIDE (TRULICITY),DIARRHEA,2022-07-06,45-64,Female,Canada,Other
FAERS-14948,LIRAGLUTIDE (SAXENDA),GALLBLADDER DISEASE,2021-01-19,45-64,Female,Other,Other
FAERS-14949,EXENATIDE (BYDUREON),ASPIRATION,2023-08-24,45-64,Female,USA,Disability
FAERS-14950,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-08-26,18-44,Female,USA,Other
FAERS-14951,SEMAGLUTIDE (OZEMPIC),INJECTION SITE REACTION,2021-02-08,45-64,Male,Europe,Hospitalization
FAERS-14952,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-10-13,45-64,Female,USA,Hospitalization
FAERS-14953,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2021-08-16,65-74,Male,USA,Other
FAERS-14954,SEMAGLUTIDE (WEGOVY),HYPOGLYCEMIA,2022-08-12,18-44,Male,USA,Other
FAERS-14955,TIRZEPATIDE (MOUNJARO),ALOPECIA,2022-10-27,65-74,Female,USA,Other
FAERS-14956,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-03-24,45-64,Female,USA,Death
FAERS-14957,EXENATIDE (BYETTA),NAUSEA,2018-05-12,65-74,Female,USA,Other
FAERS-14958,DULAGLUTIDE (TRULICITY),CONSTIPATION,2023-02-19,45-64,Female,USA,Disability
FAERS-14959,LIRAGLUTIDE (SAXENDA),ASPIRATION,2023-02-05,45-64,Male,Europe,Death
FAERS-14960,SEMAGLUTIDE (OZEMPIC),CONSTIPATION,2023-06-08,75-84,Female,Europe,Disability
FAERS-14961,SEMAGLUTIDE (OZEMPIC),SUICIDAL IDEATION,2022-10-22,18-44,Female,USA,Other
FAERS-14962,SEMAGLUTIDE (OZEMPIC),HEADACHE,2023-10-13,Unknown,Male,USA,Not specified
FAERS-14963,SEMAGLUTIDE (WEGOVY),FATIGUE,2022-11-28,45-64,Female,USA,Other
FAERS-14964,SEMAGLUTIDE (WEGOVY),ALOPECIA,2023-04-02,65-74,Unknown,USA,Other
FAERS-14965,TIRZEPATIDE (MOUNJARO),HYPOGLYCEMIA,2020-07-28,18-44,Female,USA,Other
FAERS-14966,TIRZEPATIDE (MOUNJARO),NAUSEA,2023-06-01,45-64,Female,USA,Other
FAERS-14967,TIRZEPATIDE (ZEPBOUND),DECREASED APPETITE,2021-03-20,45-64,Unknown,Europe,Other
FAERS-14968,EXENATIDE (BYETTA),ASPIRATION,2022-01-15,65-74,Unknown,Europe,Other
FAERS-14969,EXENATIDE (BYDUREON),CONSTIPATION,2022-06-10,75-84,Female,USA,Other
FAERS-14970,SEMAGLUTIDE (OZEMPIC),NAUSEA,2021-02-03,45-64,Female,Europe,Other
FAERS-14971,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2023-08-06,45-64,Female,Other,Other
FAERS-14972,SEMAGLUTIDE (OZEMPIC),DIZZINESS,2023-09-15,45-64,Female,USA,Other
FAERS-14973,SEMAGLUTIDE (WEGOVY),THYROID NEOPLASM,2023-04-23,45-64,Male,USA,Other
FAERS-14974,SEMAGLUTIDE (WEGOVY),NAUSEA,2022-07-17,18-44,Female,USA,Disability
FAERS-14975,TIRZEPATIDE (MOUNJARO),DIZZINESS,2023-06-03,45-64,Female,Europe,Other
FAERS-14976,TIRZEPATIDE (MOUNJARO),SUICIDAL IDEATION,2023-09-04,45-64,Female,USA,Other
FAERS-14977,EXENATIDE (BYETTA),ABDOMINAL PAIN,2022-09-11,45-64,Male,Australia,Disability
FAERS-14978,EXENATIDE (BYETTA),SUICIDAL IDEATION,2023-10-06,45-64,Male,USA,Other
FAERS-14979,LIRAGLUTIDE (VICTOZA),FATIGUE,2022-10-02,45-64,Male,Canada,Not specified
FAERS-14980,SEMAGLUTIDE (OZEMPIC),FATIGUE,2022-09-07,45-64,Male,USA,Not specified
FAERS-14981,SEMAGLUTIDE (OZEMPIC),HYPOGLYCEMIA,2021-04-18,75-84,Female,USA,Other
FAERS-14982,SEMAGLUTIDE (OZEMPIC),PANCREATITIS,2021-06-19,45-64,Female,USA,Other
FAERS-14983,SEMAGLUTIDE (WEGOVY),ALOPECIA,2019-01-11,65-74,Female,USA,Not specified
FAERS-14984,SEMAGLUTIDE (WEGOVY),INJECTION SITE REACTION,2020-01-10,45-64,Female,Japan,Hospitalization
FAERS-14985,TIRZEPATIDE (MOUNJARO),PANCREATITIS,2023-09-03,65-74,Female,Europe,Hospitalization
FAERS-14986,TIRZEPATIDE (MOUNJARO),HEADACHE,2020-08-17,45-64,Male,USA,Other
FAERS-14987,LIRAGLUTIDE (SAXENDA),ALOPECIA,2021-02-01,45-64,Male,USA,Other
FAERS-14988,TIRZEPATIDE (ZEPBOUND),GALLBLADDER DISEASE,2021-04-04,65-74,Female,Australia,Other
FAERS-14989,TIRZEPATIDE (ZEPBOUND),FATIGUE,2019-11-12,18-44,Female,Europe,Other
FAERS-14990,SEMAGLUTIDE (OZEMPIC),THYROID NEOPLASM,2021-11-21,18-44,Female,USA,Other
FAERS-14991,SEMAGLUTIDE (OZEMPIC),NAUSEA,2018-11-18,65-74,Male,USA,Other
FAERS-14992,SEMAGLUTIDE (OZEMPIC),DIARRHEA,2022-01-21,45-64,Female,Canada,Other
FAERS-14993,SEMAGLUTIDE (WEGOVY),DIZZINESS,2021-12-28,45-64,Male,USA,Not specified
FAERS-14994,SEMAGLUTIDE (WEGOVY),SUICIDAL IDEATION,2022-04-18,75-84,Female,USA,Disability
FAERS-14995,TIRZEPATIDE (MOUNJARO),ABDOMINAL PAIN,2023-12-04,18-44,Male,USA,Other
FAERS-14996,TIRZEPATIDE (MOUNJARO),FATIGUE,2023-11-22,18-44,Male,Europe,Death
FAERS-14997,LIRAGLUTIDE (SAXENDA),DIZZINESS,2021-12-08,65-74,Female,Europe,Other
FAERS-14998,TIRZEPATIDE (ZEPBOUND),ALOPECIA,2023-12-18,65-74,Male,USA,Hospitalization
FAERS-14999,EXENATIDE (BYDUREON),THYROID NEOPLASM,2023-07-16,65-74,Female,Europe,Other
